FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,O,N,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature1694,α-Lactose,C12 H22 O11,342.11629,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak2,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,4264435167.507026,4099950415.14039,0.9614287130872731,-0.056748204652615125,0.802215065340359,0.9041598940030394,Downregulated
Feature1693,Phenacetin,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak6,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,3610087.0006556,2758734.4345120634,0.7641739476115316,-0.3880270210342945,0.11134924058631408,0.5462476753068062,Downregulated
Feature1692,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21535,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,4308209579.537097,3709897916.9601536,0.8611228976838147,-0.21570894411059466,0.48628660238136445,0.7299573555543155,Downregulated
Feature1691,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak5",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,2337698.76892055,2164055.774376617,0.9257205432742243,-0.11135135678084399,0.45935172568723875,0.7106318021134086,Downregulated
Feature1690,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak13",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,2984707797.84593,2729557249.701063,0.9145140611992204,-0.1289227424459801,0.7042102010889548,0.8514861389326834,Downregulated
Feature1689,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak4",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,3226858.1322234636,4948737.189393337,1.5336085401385198,0.6169302760135797,0.5713518450355821,0.7749159531547447,Upregulated
Feature1688,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine-peak2,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,2181414587.50264,1921677337.1586733,0.8809317349246651,-0.18289786859238225,0.40329254945749055,0.6875574805825382,Downregulated
Feature1687,NA,C30 H32 O10,552.19968,NA,NA,Feature1687,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Lignin,2465608333.7825403,1756072791.3478734,0.7122269856436794,-0.48959099572562864,0.2048479553171478,0.578980340903384,Downregulated
Feature1686,Phenacetin,C10 H13 N O2,179.09467,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak5,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,7956695.957244647,5119351.568868847,0.6434016828565164,-0.6362083854345167,0.16247534961090157,0.5621477224970193,Downregulated
Feature1685,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,NA,Choline O-Sulfate,5,13,4,1,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,1809189147.0819066,1584750967.2857401,0.8759454310467376,-0.19108709813217314,0.17113883227173665,0.5646729954371317,Downregulated
Feature1684,NA,C30 H32 O10,552.19968,NA,NA,Feature1684,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Lignin,2092961381.58248,1676009041.0887866,0.8007835480564686,-0.3205157603003203,0.26812143946057587,0.6292487790932914,Downregulated
Feature1683,NA,C9 H16 O7,236.0896,NA,NA,Feature1683,9,16,7,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,1735609416.3424234,1690886530.7082434,0.974232171585916,-0.037662469519409346,0.8262468391165568,0.9172097938816823,Downregulated
Feature1682,Citric acid,C6 H8 O7,192.02697,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,Citric acid,6,8,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,1625148795.4360867,1501503393.1911967,0.9239174882988413,-0.11416407932546462,0.5197768419160324,0.7430834801967906,Downregulated
Feature1681,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak2,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,221982435.38587135,508067848.8004457,2.288775001126882,1.1945756451945495,0.05327489198998889,0.5434560019812327,Upregulated
Feature1680,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,NA,L-alpha-Glycerylphosphorylcholine-peak2,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,1253396481.4328,1501650050.6833768,1.1980646770021164,0.26070579349526246,0.3937095342353733,0.6830003585350376,Upregulated
Feature1679,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak12",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1512103819.3244133,1137322261.9558046,0.7521456181917087,-0.4109160948124578,0.3860725668210267,0.6807033163836934,Downregulated
Feature1678,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,L-Glutamic acid,5,9,4,1,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,1009700446.9954487,1108682674.3968515,1.0980312801642733,0.13491915370110888,0.4490478524349141,0.7027877448360436,Upregulated
Feature1677,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak5,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,318649491.41439134,343079220.202933,1.0766664609446113,0.10657138853778012,0.5588383912617381,0.7717510790914595,Upregulated
Feature1676,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,954825681.839454,918098359.9320837,0.9615350502129186,-0.05658864673798825,0.7758531157364839,0.8975915430179037,Downregulated
Feature1675,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08991,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak2,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,821297050.7775843,1086705139.5426657,1.323157240749616,0.4039845181320758,0.4656892786942922,0.7150766004537328,Upregulated
Feature1674,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak3,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,1169694783.1039567,1047866375.46894,0.8958459852990648,-0.15867737080120675,0.2567218559289829,0.628842322173499,Downregulated
Feature1673,Choline,C5 H13 N O,103.09967,NA,NA,Choline,5,13,1,1,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,324930652.237669,305212778.409394,0.9393166705188145,-0.0903164812380065,0.48903316741994385,0.7305091897794865,Downregulated
Feature1672,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak3,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,1191194959.91741,995509210.8835766,0.8357231556391064,-0.2589029852760057,0.2578293960723875,0.628842322173499,Downregulated
Feature1671,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak2,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,579914559.2449133,255099724.396552,0.4398919122304991,-1.1847790185136484,0.40924002447589547,0.6875574805825382,Downregulated
Feature1670,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak11",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1284359472.5261,954760694.539091,0.7433749779267416,-0.42783796712426353,0.12308205243302078,0.5515041946002173,Downregulated
Feature1669,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak4,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,824087092.9013267,971235227.1035494,1.1785589599324566,0.23702393429825994,0.40887198731464885,0.6875574805825382,Upregulated
Feature1668,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,DL-Carbidopa,10,14,4,2,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Lignin,990215042.709026,966920932.2615204,0.9764757053338862,-0.03434394450835979,0.6337189092029744,0.8097293288325026,Downregulated
Feature1667,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.1057,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak3",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,219093265.217099,236308845.49732932,1.078576492358957,0.10912849567654186,0.4466298321561769,0.7027877448360436,Upregulated
Feature1666,Maltotriose,C18 H32 O16,504.16909,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak2,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,411321757.535178,407226749.94808435,0.9900442718818651,-0.014435055153359423,0.9657667172200277,0.981458812850857,Downregulated
Feature1665,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak3,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,386636751.96488434,372551231.538203,0.9635691114331505,-0.053539948193987996,0.7041492800008187,0.8514861389326834,Downregulated
Feature1664,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,Other,L-Iditol,6,14,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,79789773.0517169,57312708.25053874,0.7182964189331718,-0.4773487719039821,0.5624528694127434,0.7719911688016345,Downregulated
Feature1663,NA,C32 H36 O10,580.23111,NA,NA,Feature1663,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,383638450.48901033,476404821.466198,1.2418067606595264,0.31244069116855316,0.4405613201694898,0.7009176491269988,Upregulated
Feature1662,Maltotriose,C18 H32 O16,504.16908,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak1,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,279341583.563232,233069437.63666567,0.8343528187378084,-0.26127051672469964,0.06190171248186159,0.5434560019812327,Downregulated
Feature1661,Isoleucine,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,Isoleucine-peak2,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,183534236.43487763,417609259.513888,2.2753752521920663,1.1861044924905444,0.03861769539127388,0.5434560019812327,Upregulated
Feature1660,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine-peak2,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,402860829.981521,307737160.022491,0.7638795760724781,-0.38858287638653505,0.10256158432106163,0.5434560019812327,Downregulated
Feature1659,Dambonitol,C8 H16 O6,208.09467,NA,NA,Dambonitol,8,16,6,0,0,0,2,0.75,-0.5,74.55,1,-5,-2.5,-0.4,-5,Carbohydrate,89243943.9586035,302049809.84486663,3.3845412522890603,1.758960301186188,0.21573866164270883,0.5866152372756802,Upregulated
Feature1658,NA,C6 H11 N O7,209.05352,NA,NA,Feature1658,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,886021424.782761,816216372.4432096,0.9212151643436088,-0.11838993501229611,0.4384797356894975,0.7009176491269988,Downregulated
Feature1657,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak2",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,335927.4559296743,1426782.8919280397,4.2472946665804345,2.0865442026969228,0.15981043171173342,0.5576084046392101,Upregulated
Feature1656,D-Gluconic acid,C6 H12 O7,196.05831,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Gluconic acid,6,12,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,20913829.393011667,27989650.6434316,1.3383321685116314,0.4204362313677169,0.4088306268422857,0.6875574805825382,Upregulated
Feature1655,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Other,Other,Proline,5,9,2,1,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,182100018.71534568,221813519.97596034,1.2180862008734543,0.28461623272878755,0.01911524436184677,0.5434560019812327,Upregulated
Feature1654,N-Acetylneuraminic acid,C11 H19 N O9,309.10605,Metabolic pathways;Other,Other,N-Acetylneuraminic acid,11,19,9,1,0,0,1.7272727272727273,0.8181818181818182,0.18181818181818168,55.11818181818182,3,-6,-7,-0.4545454545454546,-7,Carbohydrate,125335875.91209133,144860434.270801,1.155777890541124,0.20886417724819512,0.3514207018546591,0.6670930191369346,Upregulated
Feature1653,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16789,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak3",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,684056494.344384,600400625.140754,0.8777061983984119,-0.18818999914466256,0.5674294906148415,0.7736998250806465,Downregulated
Feature1652,L-Pyroglutamic acid,C5 H7 N O3,129.04257,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid-peak2,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Lignin,619458343.03382,608982539.558076,0.9830887684481924,-0.024606403633876072,0.841630820924397,0.9263003867197537,Downregulated
Feature1651,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak10",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,243337705.12569633,312727333.2683967,1.285157732160156,0.3619454375826326,0.5271030961090597,0.7465824789370795,Upregulated
Feature1650,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14748,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)-peak2",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,48701528.1471337,180268916.07848182,3.701504304626044,1.888111706353739,0.35234074451437725,0.6670930191369346,Upregulated
Feature1649,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538-peak3,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,117052135.41474803,266679303.95112067,2.278295077712186,1.1879546125344893,0.15063252162358262,0.5574792106914738,Upregulated
Feature1648,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13223,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak8,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,64904585.010210164,76463617.3622254,1.178092693300433,0.236453056064638,0.3118740094391163,0.6547061206079187,Upregulated
Feature1647,NA,C16 H29 N O12,427.16894,NA,NA,Feature1647,16,29,12,1,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,106889210.38604704,247985777.160648,2.3200262801550195,1.2141411476091328,0.17514367528317384,0.5646729954371317,Upregulated
Feature1646,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13226,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak7,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,103076080.81969963,225751139.08083314,2.1901408870571664,1.1310236782835328,0.30260585098635295,0.6471814605405902,Upregulated
Feature1645,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,NP-019445,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,1578848.8442405257,1588575.2246586427,1.006160425333684,0.008860351248030213,0.9871503712976197,0.9930698319787353,Upregulated
Feature1644,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,DL-Tryptophan,11,12,2,2,0,0,1.0909090909090908,0.18181818181818185,-0.18181818181818168,65.48181818181817,7,5,0.42857142857142855,0.5,3,Lignin,125034453.1721596,247444526.31887534,1.9790107449677863,0.9847794454676164,0.07434121589521282,0.5434560019812327,Upregulated
Feature1643,Beauvericin,C45 H57 N3 O9,783.40966,NA,NA,Beauvericin,45,57,9,3,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Lignin,736886.3635698897,607120.4408985274,0.823899682384264,-0.2794594086164494,0.3839991137580032,0.6807033163836934,Downregulated
Feature1642,NA,C11 H15 N O7,273.08486,NA,NA,Feature1642,11,15,7,1,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818168,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Lignin,548226061.29801,457440303.74265665,0.8344008722598776,-0.2611874288749114,0.12028974261089942,0.5462476753068062,Downregulated
Feature1641,1-Linoleoyl glycerol,C21 H38 O4,354.27701,NA,NA,1-Linoleoyl glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,77064666.01631586,93044844.45045221,1.2073606395796626,0.2718566746177345,0.6980546430962364,0.8495004061817706,Upregulated
Feature1640,α-Lactose,C12 H22 O11,342.11628,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak1,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,462011666.37091833,264977404.99006534,0.5735296839394801,-0.8020599377412433,0.1518506092237437,0.5574792106914738,Downregulated
Feature1639,g-Butyrobetaine,C7 H15 N O2,145.1103,NA,NA,g-Butyrobetaine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,217441041.69717667,513929687.059756,2.363535802847605,1.240946718810999,0.1627702581736032,0.5621477224970193,Upregulated
Feature1638,NA,C12 H21 N O9,323.12168,NA,NA,Feature1638,12,21,9,1,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,80136579.10893986,221349177.74996567,2.762149073634121,1.4657911841828384,0.08169094346130734,0.5434560019812327,Upregulated
Feature1637,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,NA,DL-Stachydrine,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,20184325.37502583,21961109.473533034,1.0880279159939439,0.12171557290199587,0.3520599923686615,0.6670930191369346,Upregulated
Feature1636,trans-3-Indoleacrylic acid,C11 H9 N O2,187.06331,Microbial metabolism in diverse environments;Other,NA,trans-3-Indoleacrylic acid,11,9,2,1,0,0,0.8181818181818182,0.18181818181818185,-0.18181818181818168,65.48181818181817,8,6,0.625,0.6666666666666666,5,Lignin,114210819.11995593,224887755.12915233,1.969058245637413,0.97750578744536,0.0742782202611519,0.5434560019812327,Upregulated
Feature1635,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak3",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,5149864.59363185,5570596.78441567,1.0816977190631543,0.1132973936777301,0.6605012172766012,0.8289195086767364,Upregulated
Feature1634,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06332,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Υ-Aminobutyric acid (GABA),4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,119449955.52814914,86274339.4304125,0.7222634704964909,-0.4694028890192294,0.1141996872736555,0.5462476753068062,Downregulated
Feature1633,Isoleucine,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,Isoleucine-peak1,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,55412697.3602394,169794708.860909,3.0641841482119,1.6155030014825056,0.04385635162844717,0.5434560019812327,Upregulated
Feature1632,Crotonic acid,C4 H6 O2,86.03675,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak7,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,112641611.3721064,81154760.37447284,0.7204687449505832,-0.4729922494739486,0.0983950495414859,0.5434560019812327,Downregulated
Feature1631,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15209,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,12,6,2,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,350684474.81934935,297208403.10496134,0.84750944066761,-0.2386986559263045,0.4029375580933265,0.6875574805825382,Downregulated
Feature1630,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03787,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,2,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Lignin,858737.556512895,1347022.369727683,1.5686077306291142,0.6494846156380748,0.22292215324003967,0.5937580622462691,Upregulated
Feature1629,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak9",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,177960431.95002332,289924547.48632896,1.6291517406956426,0.7041209840683356,0.0518489232203206,0.5434560019812327,Upregulated
Feature1628,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Lysine degradation;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,6,2,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,19323962.706341233,34405496.558539264,1.7804576153134972,0.8322480920307411,0.19257898362221196,0.5685889950290117,Upregulated
Feature1627,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",C20 H34 O4,338.24575,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",20,34,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,3499649.100935153,3033360.733821287,0.8667613941668415,-0.20629319812905408,0.48649460119292925,0.7299573555543155,Downregulated
Feature1626,L-Tyrosine,C9 H11 N O3,181.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,L-Tyrosine,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,104038488.31742549,201728005.06852666,1.9389747806893025,0.9552940391274852,0.032043444823657834,0.5434560019812327,Upregulated
Feature1625,NA,C9 H17 N O6,235.10555,NA,NA,Feature1625,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,41387680.481832266,42664179.79214873,1.030842494564942,0.043823915956330374,0.8934344399192777,0.9522105713555311,Upregulated
Feature1624,NA,C74 H117 N10 O14 P3,1462.79612,Other,NA,Feature1624,74,117,14,10,0,3,1.5810810810810811,0.1891891891891892,-1,88.8,23,9,-0.0851063829787234,0.05555555555555555,-4,Lipid,196552.81949924,173304.43730439266,0.8817194164190698,-0.18160846511563078,0.5372460688325841,0.7558927247528218,Downregulated
Feature1623,Homovanillic acid,C9 H10 O4,182.05795,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Other,Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Homovanillic acid,9,10,4,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,457191405.4150083,352232916.22416866,0.7704276853245628,-0.37626854751752314,0.023385656190040183,0.5434560019812327,Downregulated
Feature1622,L-Glutamine,C5 H10 N2 O3,146.06916,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Glutamine,5,10,3,2,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,103360301.26903023,110069648.00295143,1.064912221148213,0.09073451652312871,0.778670341999768,0.8982992411548629,Upregulated
Feature1621,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak3,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,12233152.4411385,10963163.485152567,0.8961846537843241,-0.1581320728142753,0.5701655188819122,0.7745472245276338,Downregulated
Feature1620,Acetylagmatine,C7 H16 N4 O,172.13243,NA,NA,Acetylagmatine,7,16,1,4,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,492715741.28228235,349317926.72866935,0.708964413882083,-0.49621488096885114,0.1591673410716113,0.5574792106914738,Downregulated
Feature1619,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,211401615.93310368,325019453.27129936,1.5374501837968406,0.6205396652462876,0.04220035555941916,0.5434560019812327,Upregulated
Feature1618,NA,C29 H30 O10,538.18407,NA,NA,Feature1618,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,486872271.6731477,307606638.44524133,0.6318015141592355,-0.6624567002726578,0.10932172348460628,0.5462476753068062,Downregulated
Feature1617,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,NA,Tris(hydroxymethyl)aminomethane,4,11,3,1,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,99489594.1194727,69449053.06612247,0.6980534364500889,-0.5185906149700139,0.11967721116140134,0.5462476753068062,Downregulated
Feature1616,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak3,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,47779993.782468304,62381901.147766866,1.3056071424324123,0.38472085482679164,0.7736283822064581,0.8975915430179037,Upregulated
Feature1615,L-Pyroglutamic acid,C5 H7 N O3,129.0426,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid-peak1,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Lignin,99640051.65523897,120547839.560671,1.2098331700767713,0.27480812080833456,0.24101145328031306,0.6130231259111867,Upregulated
Feature1614,2-Hydroxy-N-(2-hydroxyethyl)propionamide,C5 H11 N O3,133.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Hydroxy-N-(2-hydroxyethyl)propionamide,5,11,3,1,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-2,-3,-0.6,-3,Amino Sugar,45544447.197535634,37092872.99921314,0.8144323903709648,-0.29613315565164555,0.40484068928957845,0.6875574805825382,Downregulated
Feature1613,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Valine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,78348909.9125062,173868084.36870068,2.219151288293132,1.15000802509696,0.06216028948258098,0.5434560019812327,Upregulated
Feature1612,Diethylpyrocarbonate,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Diethylpyrocarbonate,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,327602361.38773066,283865906.66257936,0.8664953007668115,-0.20673616959747504,0.26943081097189175,0.6292487790932914,Downregulated
Feature1611,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak7",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,69131383.0655701,58488026.06333833,0.8460416017984668,-0.24119948918671488,0.2494242424203862,0.6202424088784857,Downregulated
Feature1610,Ectoine,C6 H10 N2 O2,142.07426,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine-peak2,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,6517507.781692537,7983495.964261036,1.224930791289028,0.2927002391178564,0.4277507822078806,0.6960709174449085,Upregulated
Feature1609,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10046,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak3,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,6594968.87583739,4302451.704696577,0.6523839286732459,-0.6162068528574876,0.6396248158213867,0.8131666872860749,Downregulated
Feature1608,NA,C9 H19 N O7,253.11617,NA,NA,Feature1608,9,19,7,1,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,326292379.44386333,321794169.503247,0.98621417408435,-0.020027107172795735,0.8229189967113436,0.9159164128968568,Downregulated
Feature1607,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak8,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,69883308.90119956,60954000.1281794,0.872225443909012,-0.1972270186320936,0.5287914165214713,0.7470997994890513,Downregulated
Feature1606,hercynine,C9 H15 N3 O2,197.1165,NA,NA,hercynine,9,15,2,3,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,14585954.891723366,16132258.747835167,1.1060132070605286,0.14536861310152333,0.1571109943433292,0.5574792106914738,Upregulated
Feature1605,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak2,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,172604507.957066,149626311.884937,0.8668737199039747,-0.20610624785002743,0.33829308681880643,0.6636048496469049,Downregulated
Feature1604,NA,C6 H14 O4,150.08923,NA,NA,Feature1604,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,72674008.8474091,60075946.0199484,0.8266496781000153,-0.27465202878566475,0.17846134697695207,0.5646729954371317,Downregulated
Feature1603,NA,C75 H119 N10 O14 P3,1476.81198,NA,NA,Feature1603,75,119,14,10,0,3,1.586666666666667,0.18666666666666668,-1.0133333333333336,89.18,23,9,-0.08333333333333333,0.05454545454545454,-4,Lipid,213620.94137175634,183805.61148645368,0.8604288058378313,-0.2168722700988078,0.524871166759264,0.7459159030957997,Downregulated
Feature1602,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,7,1,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Lignin,15328520.554401867,37540387.5143113,2.4490548439477995,1.2922250818665983,0.36480346602160246,0.6716464598336302,Upregulated
Feature1601,NA,C23 H33 N3 O5,431.24199,NA,NA,Feature1601,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,994667.40107017,971611.4322163037,0.9768204237626967,-0.033834729786123945,0.917675897926208,0.9625653071746106,Downregulated
Feature1600,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.09171,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,1.3,0.5,1.2000000000000002,26.09999999999999,7,2,-Inf,-0.2,-3,Lignin,126377148.085503,153977713.33611667,1.2183983866445536,0.2849859365788123,0.03143955063668058,0.5434560019812327,Upregulated
Feature1599,L-glycero-Î±-D-manno-Heptopyranose,C7 H14 O7,210.07395,Metabolic pathways;Other,NA,L-glycero-Î±-D-manno-Heptopyranose,7,14,7,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,2565389.8214984564,3387155.9366145935,1.3203279705211193,0.4008963406993878,0.16386328368046407,0.5634157173330954,Upregulated
Feature1598,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",C9 H12 N2 O6,244.06954,Metabolic pathways;ABC transporters;Other,Other,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,66232518.2260106,77848368.49808809,1.1753798675212648,0.23312709246772714,0.3908286553643543,0.6823569007873849,Upregulated
Feature1597,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10013,NA,NA,N-(Carboxymethyl)norleucine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,186769376.55427834,240901611.22445866,1.2898346381450203,0.36718611834614756,0.11716982036511173,0.5462476753068062,Upregulated
Feature1596,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak4,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,785387.901278829,907142.3289597786,1.1550245776420796,0.2079235509184656,0.5688293007261018,0.7739733617911779,Upregulated
Feature1595,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",C12 H12 O5,236.06846,NA,NA,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",12,12,5,0,0,0,1,0.4166666666666667,-0.16666666666666696,65.05000000000001,7,2,0.2857142857142857,0.47368421052631576,2,Lignin,596165.765228705,537166.8047256051,0.9010359803527692,-0.15034337770528336,0.43251667814326306,0.7004620007406192,Downregulated
Feature1594,2-Acetamido-2-deoxy-D-gluconolactone,C8 H13 N O6,219.07432,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,2-Acetamido-2-deoxy-D-gluconolactone,8,13,6,1,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,97512979.32240187,100545760.4446298,1.0311013071624118,0.04418608649903619,0.850548808052684,0.9315623676375357,Upregulated
Feature1593,NA,C6 H15 N O7,213.0849,NA,NA,Feature1593,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,17148773.533771,26721178.469607167,1.558197641189049,0.6398782358894948,0.09786160293211256,0.5434560019812327,Upregulated
Feature1592,NA,C6 H15 N O7,213.08492,NA,NA,Feature1592,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,11572040.570396133,12565789.839495264,1.0858750246383826,0.11885807026046284,0.8757031980314673,0.9418674396605116,Upregulated
Feature1591,NA,C10 H20 O7,252.12091,NA,NA,Feature1591,10,20,7,0,0,0,2,0.7,-0.5999999999999996,77.39999999999999,1,-6,-2,-0.38461538461538464,-6,Amino Sugar,17780759.66678011,30132744.857155766,1.694682646965469,0.7610151338245882,0.39762801849139545,0.6848441763516896,Upregulated
Feature1590,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,5568629.592659957,15895775.916545713,2.8545220421013506,1.5132492026054791,0.23195499433946007,0.6032124274284134,Upregulated
Feature1589,NA,C12 H18 O9,306.09515,NA,NA,Feature1589,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,21213310.05762992,83825348.89420277,3.951544981262969,1.9824168307613723,0.21929403440405612,0.5896572925086843,Upregulated
Feature1588,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,222531852.26003033,213603912.971108,0.9598801735650411,-0.059073776338272446,0.7361836328761205,0.87331587821579,Downregulated
Feature1587,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak2,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,1821168.1015763034,1691586.0371287933,0.9288467306585532,-0.10648753828098899,0.748539203236295,0.8799621167815986,Downregulated
Feature1586,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,NA,Acetyl-L-carnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,120463351.81306534,225430114.58832967,1.8713584770424738,0.9040859474154179,0.008762456693794097,0.5434560019812327,Upregulated
Feature1585,3-Deoxy-D-glycero-hexitol,C6 H14 O5,166.08414,NA,NA,3-Deoxy-D-glycero-hexitol,6,14,5,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,16414931.131065432,8318802.502333967,0.5067826624377695,-0.9805609256629876,0.0401788373813843,0.5434560019812327,Downregulated
Feature1584,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",C21 H22 O6,370.14172,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,100720794.83421406,134286736.32544532,1.333257313412594,0.41495524176187326,0.4087990595343944,0.6875574805825382,Upregulated
Feature1583,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak6",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,162431182.548831,203469176.80357632,1.2526484977255414,0.32498164073237745,0.27914327273296136,0.6311415121079224,Upregulated
Feature1582,Leucylproline,C11 H20 N2 O3,228.14739,NA,NA,Leucylproline-peak2,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,76113694.56717573,109800106.366029,1.4425801689224613,0.5286514964049172,0.32295625946242434,0.6622100705596555,Upregulated
Feature1581,Cytarabine,C9 H13 N3 O5,243.08555,Metabolic pathways;ABC transporters;Other,Other,Cytarabine,9,13,5,3,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Lignin,28422408.6018883,39087407.09083087,1.3752320444873916,0.4596750667730215,0.3058529246790872,0.650771219588917,Upregulated
Feature1580,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin-peak2,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,38231264.053544,48233856.4027266,1.2616338380853345,0.3352932600597267,0.07943350320875402,0.5434560019812327,Upregulated
Feature1579,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,Other,(+)-Piperitol,20,20,6,0,0,0,1,0.3,-0.4000000000000003,71.7,11,5,0.35714285714285715,0.4705882352941176,5,Lignin,250153419.41851166,193364162.14248532,0.7729822865982224,-0.37149274067217475,0.4048844496988536,0.6875574805825382,Downregulated
Feature1578,5-Aminolevulinic acid,C5 H9 N O3,131.05823,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,5-Aminolevulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,158606823.18712634,155637185.424643,0.9812767338579141,-0.02726804074340573,0.9203035819655345,0.9629365459231719,Downregulated
Feature1577,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12595,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak2",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,339623.10821499367,198770.63382368768,0.5852682842118585,-0.7728299939913763,0.10893906907164061,0.5462476753068062,Downregulated
Feature1576,.alpha.-Glucoheptitol,C7 H16 O7,212.08964,NA,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,5157151.610958953,8089762.832356493,1.5686494101057136,0.6495229489792725,0.4060500014380658,0.6875574805825382,Upregulated
Feature1575,NA,C9 H17 N O6,235.10557,NA,NA,Feature1575,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,28216025.155476566,42443188.00976756,1.504222787437145,0.5890182575258884,0.2473787241288974,0.6199105897549588,Upregulated
Feature1574,diphthinate,C13 H22 N4 O4,298.16416,NA,NA,diphthinate,13,22,4,4,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,145910.373230328,123190.75610101788,0.8442905968484784,-0.244188448473573,0.463899430613846,0.7137562538236649,Downregulated
Feature1573,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin-peak2,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,182809154.56945464,229193849.66798866,1.253732889951696,0.32623001210343755,0.5627289651602895,0.7719911688016345,Upregulated
Feature1572,NA,C62 H107 N2 O15 P3,1212.68834,NA,NA,Feature1572,62,107,15,2,0,3,1.7258064516129032,0.24193548387096775,-1.387096774193548,99.83225806451613,12,-3,-0.1904761904761905,-0.0101010101010101,-8,Lipid,101157.95727149973,94809.3027205011,0.9372401863161456,-0.09350928051126328,0.7653169180947869,0.8928697384736425,Downregulated
Feature1571,Inosine,C10 H12 N4 O5,268.08079,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Inosine,10,12,5,4,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Lignin,5112759.716652507,1399400.95943509,0.27370755462596313,-1.8692928396839488,0.23293076185251335,0.6042644878685415,Downregulated
Feature1570,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak7,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,128793966.07530634,163335684.82098168,1.2681936102928817,0.3427750130537501,0.18181157333864165,0.5646729954371317,Upregulated
Feature1569,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Adenine,5,5,0,5,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,925137.237889273,36687650.81019978,39.65644156093393,5.309483322814267,0.3909000378545788,0.6823569007873849,Upregulated
Feature1568,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak2,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,630748.6051568337,349376.31720396667,0.5539073956685094,-0.8522832936617155,0.42520510685637314,0.6952678098597452,Downregulated
Feature1567,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C11 H21 N O7,279.13182,NA,NA,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)-peak2",11,21,7,1,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,11976904.05879869,54284212.566720165,4.532407732434069,2.1802776508983435,0.32150372510750036,0.6622100705596555,Upregulated
Feature1566,2'-Deoxyadenosine,C10 H13 N5 O3,251.10191,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak2,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,102332539.10244617,141298324.04954532,1.3807760980902672,0.4654793960887338,0.04686534708063488,0.5434560019812327,Upregulated
Feature1565,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,545379.8385350846,442690.128098184,0.8117097421262768,-0.3009641660689814,0.42188236932181516,0.6945274379311516,Downregulated
Feature1564,NA,C22 H33 N O6,407.23081,NA,NA,Feature1564,22,33,6,1,0,0,1.5,0.2727272727272727,-0.8181818181818183,83.61818181818182,7,1,0,0.16666666666666666,0,Lipid,1088018.2710433467,860245.9534999847,0.7906539590323777,-0.33888167809056774,0.256023770745689,0.628842322173499,Downregulated
Feature1563,NA,C8 H19 N O6,225.12125,NA,NA,Feature1563,8,19,6,1,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,11294798.545857932,49157600.6474695,4.352233503579995,2.121755961326264,0.18435717373979962,0.5646729954371317,Upregulated
Feature1562,NA,C15 H27 N O12,413.15342,NA,NA,Feature1562,15,27,12,1,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,19218225.744980235,59640389.8454437,3.103324450282392,1.6338145374543578,0.11250615009706172,0.5462476753068062,Upregulated
Feature1561,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,NA,N-Caffeoylputrescine,13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,285449.3425009123,247164.37274712833,0.8658782345814595,-0.20776393681394734,0.49534407508225053,0.7334162931788414,Downregulated
Feature1560,NA,C21 H31 N O12,489.18471,NA,NA,Feature1560,21,31,12,1,0,0,1.4761904761904765,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Lignin,5039990.72145541,13290128.768326849,2.6369351657236835,1.3988621001221557,0.058636616780854384,0.5434560019812327,Upregulated
Feature1559,Succinyl proline,C9 H13 N O5,215.07946,Other,NA,Succinyl proline-peak2,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,107609180.7049847,43774098.37643107,0.40678776745303624,-1.2976517984357647,0.40095934134855293,0.685393667249696,Downregulated
Feature1558,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13231,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak6,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,92995039.1907103,75608937.20548527,0.8130426941423149,-0.298596982426974,0.1820023129554938,0.5646729954371317,Downregulated
Feature1557,2-Deoxyhexopyranose,C6 H12 O5,164.0685,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Other,Other,2-Deoxyhexopyranose,6,12,5,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,30039348.849692468,19634022.7611258,0.6536101318097248,-0.6134977475751973,0.004522541069574555,0.5434560019812327,Downregulated
Feature1556,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10572,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,89312402.96484476,72007933.6238488,0.8062478584546945,-0.31070467152723424,0.15769714691268447,0.5574792106914738,Downregulated
Feature1555,Glutarylcarnitine,C12 H21 N O6,275.13695,NA,NA,Glutarylcarnitine,12,21,6,1,0,0,1.75,0.5,-0.5,74.55,3,-3,-0.8,-0.125,-4,Protein,17032169.689397965,59901786.65041137,3.516979207158704,1.814336805586564,0.3862906013261477,0.6807033163836934,Upregulated
Feature1554,NA,C10 H15 N O8,277.07983,NA,NA,Feature1554,10,15,8,1,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,132962860.17501901,136695670.49241441,1.028074082585783,0.03994422827519592,0.9078842178201599,0.9558723314246157,Upregulated
Feature1553,NA,C6 H11 N3 O2,157.08515,NA,NA,Feature1553,6,11,2,3,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,203355794.021132,197894949.151621,0.9731463522060084,-0.03927130558070416,0.827363137278378,0.9174960842656863,Downregulated
Feature1552,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Pinolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,8084541.927429623,9044858.20312952,1.1187842532477554,0.16193185331247037,0.6473601590644873,0.8202154894953189,Upregulated
Feature1551,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak8",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,251833989.02058,170166601.87654632,0.6757094327828808,-0.5655250998621709,0.11210899183590212,0.5462476753068062,Downregulated
Feature1550,NA,C22 H14 N3 O4 P,415.07208,NA,NA,Feature1550,22,14,4,3,0,1,0.6363636363636364,0.18181818181818185,-0.09090909090909084,62.89090909090909,18,14,0.7142857142857143,0.75,10,Condensed HC,683582.7346307503,617487.5379594206,0.9033106113965382,-0.14670593833516332,0.6109222830458394,0.7991290476183568,Downregulated
Feature1549,4-Acetamidobutanoic acid,C6 H11 N O3,145.07391,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak2,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,95217043.95281152,87846664.8579256,0.9225939097779742,-0.11623232596321545,0.5162474655634941,0.7423796321430891,Downregulated
Feature1548,Valylproline,C10 H18 N2 O3,214.13174,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Valylproline,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,75044090.84650481,141195332.84523368,1.881498346539165,0.9118820215658818,0.11583490432762297,0.5462476753068062,Upregulated
Feature1547,D-Glucose 6-phosphate,C6 H13 O9 P,260.02974,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,D-Glucose 6-phosphate,6,13,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,163593921.269809,187839317.867044,1.1482047524079333,0.19937993203445678,0.41878960963561424,0.6943057388507786,Upregulated
Feature1546,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,233791110.23392868,174738312.45410234,0.7474121333324488,-0.42002411056866634,0.16782444878378855,0.5646729954371317,Downregulated
Feature1545,Leucylproline,C11 H20 N2 O3,228.14739,NA,NA,Leucylproline-peak1,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,79677282.33891153,68016909.61094427,0.8536549894062746,-0.2282749824685736,0.7993462989461081,0.9022552886981726,Downregulated
Feature1544,1-linoleoyl-sn-glycerol,C21 H38 O4,354.27689,NA,NA,1-linoleoyl-sn-glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,37394667.50258666,70849255.58293504,1.8946352599079601,0.9219201389665487,0.3628499903508376,0.6716464598336302,Upregulated
Feature1543,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak7",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,29714214.7452173,24865845.26563353,0.8368333297327284,-0.25698778192279775,0.5495163197544479,0.7642698240263012,Downregulated
Feature1542,Pyrone,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak3,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,74737947.0967613,65128676.21994923,0.8714271497935153,-0.1985480329743144,0.33098156967435577,0.6632819814140921,Downregulated
Feature1541,NA,C10 H17 N O9,295.09039,NA,NA,Feature1541,10,17,9,1,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,135752362.21373168,134605288.49225718,0.991550248535134,-0.012242209497731103,0.9714480750603057,0.985409005480334,Downregulated
Feature1540,(5S)-5-(Carboxymethyl)-L-proline,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,(5S)-5-(Carboxymethyl)-L-proline,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,202433118.39303398,148745841.1984321,0.7347900500630269,-0.4445960041238891,0.18339905433743328,0.5646729954371317,Downregulated
Feature1539,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak3,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,1006927.095604799,1895981.9714683534,1.8829386752469444,0.9129860141009342,0.18891079626042367,0.5646729954371317,Upregulated
Feature1538,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,NA,L-Alanyl-L-proline-peak2,8,14,3,2,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,86888794.66022363,153076545.13472,1.7617524300264704,0.8170112040157645,0.09917146320554573,0.5434560019812327,Upregulated
Feature1537,triacetic acid,C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,triacetic acid,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,63562189.742625564,131912462.95557757,2.075329114520979,1.0533401433205098,0.2031110854058391,0.5780722477745703,Upregulated
Feature1536,N-Acetyl-α-D-glucosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-α-D-glucosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,22753551.782058734,26158779.615589365,1.1496569795409113,0.2012034718347857,0.46740133768017456,0.7150766004537328,Upregulated
Feature1535,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12119,NA,NA,Cyclo(phenylalanyl-prolyl)-peak2,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,174673731.79247,160456219.10688433,0.9186053189584481,-0.12248295773307799,0.28664892076748105,0.6353376492471592,Downregulated
Feature1534,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13225,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak5,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,79298891.76415624,101058689.5821727,1.274402294079122,0.34982076900473186,0.06001644905533128,0.5434560019812327,Upregulated
Feature1533,NA,C12 H25 N O12,375.13771,NA,NA,Feature1533,12,25,12,1,0,0,2.0833333333333335,1,0.16666666666666652,55.55,1,-11,12,-1.2,-12,Carbohydrate,5429103.192107887,7470803.07693536,1.376065772298347,0.4605494286889111,0.34252044978177476,0.6638783088447672,Upregulated
Feature1532,NA,C7 H15 N O5,193.09509,NA,NA,Feature1532,7,15,5,1,0,0,2.142857142857143,0.7142857142857143,-0.2857142857142856,68.44285714285714,1,-4,-5,-0.7142857142857143,-5,Carbohydrate,64126965.064168066,71155118.4454782,1.1095974739218903,0.15003640837931734,0.7817976850970243,0.8990938754612078,Upregulated
Feature1531,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09546,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,50091253.17985444,53664221.075326264,1.0713291776239449,0.09940183205698344,0.6398767379883931,0.8131666872860749,Upregulated
Feature1530,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",C7 H13 N O3,159.08956,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,41517856.984181464,30761796.504504766,0.740929294983245,-0.4325922185424351,0.011624771499731705,0.5434560019812327,Downregulated
Feature1529,Proacacipetalin,C11 H17 N O6,259.1056,NA,NA,Proacacipetalin-peak2,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,114860014.00576037,111791029.82227,0.9732806563706631,-0.03907221262548752,0.9658157266956191,0.981458812850857,Downregulated
Feature1528,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine",C11 H13 N O6,255.07427,NA,NA,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine-peak2",11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,168039897.52743033,133780505.242474,0.7961234635996852,-0.3289359122205163,0.12887741243521436,0.5545833428603265,Downregulated
Feature1527,NA,C6 H14 O4,150.08924,NA,NA,Feature1527,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,10518112.17100306,5916229.080416144,0.5624801280144498,-0.8301259669513418,0.047178230455007054,0.5434560019812327,Downregulated
Feature1526,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,Other,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,1036202.787694905,1267711.2868568446,1.2234200698079032,0.29091984832483814,0.6141069907070749,0.7991290476183568,Upregulated
Feature1525,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Lactamide,3,7,2,1,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,39295636.88760743,73063155.46288154,1.8593197934889123,0.8947749277625708,0.08337864289931264,0.5434560019812327,Upregulated
Feature1524,cis-acetylacrylic acid,C5 H6 O3,114.03168,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid-peak2,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,33230832.958886832,42068713.30865546,1.2659542227154779,0.3402252374239065,0.2688293614972311,0.6292487790932914,Upregulated
Feature1523,Buphedrine,C11 H17 N O,179.13104,NA,NA,Buphedrine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,247987.549770469,280527.42083924636,1.1312157448988687,0.17787410564311396,0.5663275420065426,0.7736764969024864,Upregulated
Feature1522,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05587,Metabolic pathways;Other,NA,Glycerylphosphorylethanolamine,5,14,6,1,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,43661367.86052933,26135728.02443167,0.5986007609271179,-0.7403339821303967,0.08966322369869677,0.5434560019812327,Downregulated
Feature1521,NA,C8 H9 N,119.07346,NA,NA,Feature1521,8,9,0,1,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,27741838.982360333,62016552.554832034,2.2354881590317532,1.1605899042113927,0.05626488189506512,0.5434560019812327,Upregulated
Feature1520,Linolenelaidic acid,C18 H30 O2,278.22466,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Linolenelaidic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,10096626.98284912,6643498.518436457,0.6579918748827304,-0.6038583257274008,0.5000521276733791,0.7334162931788414,Downregulated
Feature1519,Glutaric acid,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Glutaric acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,29774568.321959168,44564511.75561767,1.4967307426167018,0.5818147082162533,0.38293170550978584,0.680678183770805,Upregulated
Feature1518,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,"DL-2,6-Diaminopimelic acid",7,14,4,2,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,184282144.91823798,134084607.37423441,0.7276049854625084,-0.4587726666898868,0.09452422326730882,0.5434560019812327,Downregulated
Feature1517,NA,C17 H31 N O12,441.1847,NA,NA,Feature1517,17,31,12,1,0,0,1.8235294117647056,0.7058823529411765,-0.23529411764705888,67.00588235294117,3,-9,-2.5,-0.4,-10,Carbohydrate,5548490.898481146,21333330.366438467,3.8448887736804775,1.9429418639918943,0.03696186816229701,0.5434560019812327,Upregulated
Feature1516,fructosylglycine,C8 H15 N O7,237.08487,NA,NA,fructosylglycine-peak2,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,143490891.41041434,135816866.53189334,0.9465190800399194,-0.07929650665354637,0.7335382259231458,0.8727566292714084,Downregulated
Feature1515,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,Methionine,5,11,2,1,1,0,2.2,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Protein,7284171.588215946,10693145.830632335,1.4679975205322313,0.553849531451647,0.5512121463947713,0.7653853941659798,Upregulated
Feature1514,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Aspartic acid,4,7,4,1,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,45889173.82037417,52594011.08292963,1.1461093478998006,0.19674469518291982,0.2765356691366627,0.6292487790932914,Upregulated
Feature1513,3-Butynoic acid,C4 H4 O2,84.0211,Metabolic pathways;Other,NA,3-Butynoic acid-peak6,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,12374220.29265207,11100087.274977934,0.8970332685582841,-0.15676660306053547,0.44133267021332473,0.7009176491269988,Downregulated
Feature1512,UQ1000000,C6 H6 O3,126.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,UQ1000000,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,41938918.6343925,29020859.431728635,0.6919792015793593,-0.5311994186283181,0.6362490672503704,0.81058614175596,Downregulated
Feature1511,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,Hordenine,10,15,1,1,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,63212246.31012973,112115876.92196201,1.7736417144852434,0.8267146066289105,0.21019215472434816,0.5824800074072752,Upregulated
Feature1510,Pyrogallol,C6 H6 O3,126.03165,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak3,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,25035591.507792436,14879034.469032466,0.5943152756906623,-0.7506996318591522,0.017687485591127053,0.5434560019812327,Downregulated
Feature1509,Methylhippuric acid,C10 H11 N O3,193.07397,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak5,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,1039708.7705427603,870468.1348835827,0.8372230373984162,-0.2563160849144063,0.43986053899547384,0.7009176491269988,Downregulated
Feature1508,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.1028,NA,NA,L-alpha-Glycerylphosphorylcholine-peak1,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,75304096.11804387,88041201.04322164,1.1691422589444744,0.22545048486258434,0.6194627020287748,0.8010456620127822,Upregulated
Feature1507,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak2,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,72656725.79675807,67940899.57825871,0.9350944297752848,-0.09681603310679467,0.8366897128831232,0.9228214443978652,Downregulated
Feature1506,Thymidine,C10 H14 N2 O5,242.09029,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Thymidine,10,14,5,2,0,0,1.4,0.5,0.20000000000000015,54.599999999999994,5,0,-0.6666666666666666,0.09090909090909093,-2,Lignin,28870763.695301034,36520014.5980965,1.2649479931852459,0.33907807146812247,0.14450410265607744,0.5574792106914738,Upregulated
Feature1505,(Z)-dehydrobutyrine,C4 H7 N O2,101.04767,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak2,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,44402707.9294881,49733582.990749136,1.1200574314009522,0.16357270895526438,0.29060573369872256,0.6362566437415571,Upregulated
Feature1504,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,971934.838209832,1799581.7679868934,1.8515456975505389,0.8887301567555405,0.018670284238461034,0.5434560019812327,Upregulated
Feature1503,Î²-Glycerophosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,Î²-Glycerophosphate,3,9,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,10478587.927980384,11160007.688182933,1.0650297315712733,0.09089370556070558,0.44519791821083154,0.7027877448360436,Upregulated
Feature1502,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Lignin,135842761.16512766,77703285.682226,0.5720090273177787,-0.8058901794154756,0.08765542344166304,0.5434560019812327,Downregulated
Feature1501,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,142410563.96863198,116936811.93727356,0.8211245618199406,-0.2843270043228645,0.3664371679276989,0.6716464598336302,Downregulated
Feature1500,pseudouridine,C9 H12 N2 O6,244.06948,Metabolic pathways;ABC transporters;Other,Other,pseudouridine-peak2,9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,3610334.4758327133,4766141.331519937,1.320138442414159,0.40068923239522536,0.15690467425627308,0.5574792106914738,Upregulated
Feature1499,NA,C18 H31 N O11,437.18971,NA,NA,Feature1499,18,31,11,1,0,0,1.7222222222222223,0.6111111111111112,-0.33333333333333304,69.79999999999998,4,-7,-1.3333333333333333,-0.21739130434782608,-8,Amino Sugar,10403385.785266306,36562479.22341856,3.5144788416094133,1.8133107694201251,0.05483527459637925,0.5434560019812327,Upregulated
Feature1498,3-Hydroxy-5-methyl-L-tyrosine,C10 H13 N O4,211.08446,NA,NA,3-Hydroxy-5-methyl-L-tyrosine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,45314881.00191167,48649136.75687353,1.0735797089442032,0.1024293094355575,0.20372439900910183,0.5780722477745703,Upregulated
Feature1497,Mephedrone,C11 H15 N O,177.11538,NA,NA,Mephedrone,11,15,1,1,0,0,1.3636363636363635,0.09090909090909093,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,321752.32418745535,285476.4830790167,0.8872553875094804,-0.17257866537616384,0.50511149361526,0.7344711332053652,Downregulated
Feature1496,2908,C5 H11 N,85.08916,Other,NA,2908-peak2,5,11,0,1,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,30093598.467038833,68245156.0446184,2.267763229424574,1.1812700205418407,0.04306220798814331,0.5434560019812327,Upregulated
Feature1495,NP-011220,C11 H18 N2 O2,210.13681,NA,NA,NP-011220-peak2,11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,129320288.845322,128428466.18357301,0.993103768405469,-0.009983623516013241,0.9418267721285744,0.9702257149779767,Downregulated
Feature1494,Anhydroecgonine,C9 H13 N O2,167.09466,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak3,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,6799944.94758041,7128409.71247256,1.048304032962653,0.06805719324488273,0.6867192116343313,0.8423623059439227,Upregulated
Feature1493,NA,C17 H31 N O13,457.17959,NA,NA,Feature1493,17,31,13,1,0,0,1.8235294117647056,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,11119051.766168546,15809807.375102967,1.4218665141218947,0.507786030039018,0.09616534232239374,0.5434560019812327,Upregulated
Feature1492,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak5,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,54253017.6576144,56988000.0806644,1.0504116183971592,0.0709547787989448,0.8259563806775603,0.9172097938816823,Upregulated
Feature1491,NA,C75 H89 N10 O16 P3 S,1510.53954,NA,NA,Feature1491,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Lignin,140423918.66664732,122861799.27329934,0.8749349857196427,-0.19275227710198417,0.16554689981716014,0.5646729954371317,Downregulated
Feature1490,Linoleamide,C18 H33 N O,279.25629,NA,NA,Linoleamide,18,33,1,1,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909093,1,Lipid,17503098.055903368,21243134.34899753,1.2136785317175744,0.279386344070966,0.6133893910408624,0.7991290476183568,Upregulated
Feature1489,Acrylic acid,C3 H4 O2,72.02113,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid,3,4,2,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,100668971.9522212,122634833.01314351,1.2181989210275,0.28474973172355134,0.33945086406450714,0.6636048496469049,Upregulated
Feature1488,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak3",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,88918950.53252077,88066452.03555837,0.9904126342938493,-0.013898376340010054,0.953401031475066,0.976095117429702,Downregulated
Feature1487,NP-011220,C11 H18 N2 O2,210.13681,NA,NA,NP-011220-peak1,11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,123233175.12916033,122678280.56987101,0.9954971982284175,-0.006510839320947417,0.9627587970831997,0.9812353923389985,Downregulated
Feature1486,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak3,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,35600789.829170235,30185969.1418392,0.8479016697855875,-0.23803112813908547,0.7923491648522741,0.9015670682202759,Downregulated
Feature1485,Isoferulic acid,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Isoferulic acid,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,919023.0304387526,613412.1960099303,0.6674611796366844,-0.5832441645655179,0.26443869942299164,0.6292487790932914,Downregulated
Feature1484,NA,C11 H19 N5 O2,253.15388,NA,NA,Feature1484,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,143002624.91280234,130479311.32164867,0.9124259879929483,-0.132220556375624,0.30796471639053274,0.6523468563546992,Downregulated
Feature1483,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak3,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,2383219.7702588416,2276717.477757367,0.9553115940751417,-0.06595672099915306,0.9292117912632685,0.9678298766261686,Downregulated
Feature1482,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak3,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,23671650.176023033,33490293.541730065,1.4147849132905959,0.5005827399014767,0.10108728288648655,0.5434560019812327,Upregulated
Feature1481,Methylhippuric acid,C10 H11 N O3,193.07394,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak4,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,1474647.1239099132,1395890.79755232,0.9465931034749676,-0.0791836837118971,0.7743384488011961,0.8975915430179037,Downregulated
Feature1480,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,8,1,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,36260633.83357556,45683214.4022737,1.2598570287531292,0.33326002292198514,0.5608313144387419,0.7719911688016345,Upregulated
Feature1479,Methylglutaric acid,C6 H10 O4,146.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Methylglutaric acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,10816429.938672956,10237074.911703754,0.9464375001498617,-0.07942085699958916,0.8943663168315833,0.9522105713555311,Downregulated
Feature1478,NA,C2 H5 N2 O5 P S,199.96575,NA,NA,Feature1478,2,5,5,2,1,1,2.5,2.5,4,-53.7,2,-3,1,1,-7,Other,91329264.6769915,109914374.33511713,1.2034956672853598,0.2672309479634886,0.1193383912590152,0.5462476753068062,Upregulated
Feature1477,NA,C11 H20 N4 O3,256.15356,NA,NA,Feature1477,11,20,3,4,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,1403187.4436475134,1078945.711617688,0.7689248621075344,-0.3790854672607867,0.2072945502819216,0.5820034726922493,Downregulated
Feature1476,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,14171026.454905467,15536516.012802934,1.0963578441013204,0.13271876148208242,0.3978079513164478,0.6848441763516896,Upregulated
Feature1475,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10595,NA,NA,α-Aspartylphenylalanine-peak3,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,50678910.85732193,12951827.776103834,0.25556641918701756,-1.9682298128087172,0.4419344494331855,0.7009709338387793,Downregulated
Feature1474,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak4,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,70431714.6803347,68225375.40791787,0.9686740656190093,-0.045916778076191246,0.7700958195249438,0.8953619205732702,Downregulated
Feature1473,NA,C43 H79 N O9,753.57577,NA,NA,Feature1473,43,79,9,1,0,0,1.837209302325581,0.20930232558139536,-1.348837209302325,98.74186046511628,5,-4,-0.15151515151515152,-0.01333333333333333,-5,Lipid,26133285.528227575,32541020.84398178,1.2451944019374435,0.31637099596145574,0.7755100696992376,0.8975915430179037,Upregulated
Feature1472,NA,C77 H123 N10 O14 P3,1504.84348,NA,NA,Feature1472,77,123,14,10,0,3,1.5974025974025974,0.18181818181818185,-1.0389610389610393,89.91038961038961,23,9,-0.08,0.05263157894736842,-4,Lipid,170752.01333096132,146355.60648850567,0.8571237529412369,-0.22242457682122108,0.4704222772016693,0.7153459044700429,Downregulated
Feature1471,NA,C8 H16 N2 O2,172.12119,NA,NA,Feature1471,8,16,2,2,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,9990763.965454899,15288253.028733334,1.530238636564289,0.6137566548406261,0.06517508450844003,0.5434560019812327,Upregulated
Feature1470,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak6,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,23294329.726495434,39912653.74205194,1.713406404506007,0.776867386229429,0.1318944982237442,0.5545833428603265,Upregulated
Feature1469,arg-leu,C12 H25 N5 O3,287.19576,NA,NA,arg-leu-peak2,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,50544280.50628237,89350549.90373896,1.767767767366541,0.8219287595286021,0.05224364633789446,0.5434560019812327,Upregulated
Feature1468,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11167,NA,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak2",11,14,2,4,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Lignin,121312971.24135067,117431466.49130933,0.968004206719831,-0.0469147777587205,0.7474471157949907,0.8798995233889605,Downregulated
Feature1467,NA,C16 H29 N O13,443.16396,NA,NA,Feature1467,16,29,13,1,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,7432785.724522534,19510111.36850767,2.624872032048382,1.3922470901199444,0.04819167454956764,0.5434560019812327,Upregulated
Feature1466,DL-Mevalonic acid,C6 H12 O4,148.07354,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,DL-Mevalonic acid,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,12385210.836392567,12427046.7278504,1.0033778909386752,0.004865054312570481,0.9541204616246715,0.976095117429702,Upregulated
Feature1465,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,140531523.028927,100017730.94866994,0.7117102895702788,-0.4906380009672704,0.2651572479013594,0.6292487790932914,Downregulated
Feature1464,NA,C12 H18 N6,246.15928,NA,NA,Feature1464,12,18,0,6,0,0,1.5,0,0,60.3,7,7,0.16666666666666666,0.16666666666666666,1,Lipid,82278329.88970096,32623911.106941495,0.39650672480440236,-1.3345827604595222,0.39876241741932017,0.6850948631930308,Downregulated
Feature1463,NA,C11 H23 N O7,281.14745,NA,NA,Feature1463,11,23,7,1,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,114406216.1810269,69666959.05126244,0.6089438264528146,-0.7156189456322196,0.3852358490289524,0.6807033163836934,Downregulated
Feature1462,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,NA,4-Guanidinobutyric acid,5,11,2,3,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,111266268.58031513,110077701.67889467,0.9893178146747815,-0.015494039019175128,0.8948578711376626,0.9522105713555311,Downregulated
Feature1461,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak2,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,475764.21833698265,579227.3766925574,1.2174672965470723,0.28388301933592175,0.6260050837779473,0.8047939832327067,Upregulated
Feature1460,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak4,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,21808601.939636968,20584918.715714067,0.9438898821983235,-0.08330953580131896,0.6356292439844788,0.81058614175596,Downregulated
Feature1459,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,L-Threonine,4,9,3,1,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,45069443.2675445,71503024.34132864,1.5865078234241146,0.665854635524283,0.05207506402609701,0.5434560019812327,Upregulated
Feature1458,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.15227,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,67343774.37234947,76488825.9446869,1.1357965403271528,0.18370442238653942,0.5767254732231966,0.7755170614464124,Upregulated
Feature1457,NA,C18 H31 N O14,485.17458,NA,NA,Feature1457,18,31,14,1,0,0,1.7222222222222223,0.7777777777777778,0,60.3,4,-10,-3.6666666666666665,-0.4,-11,Carbohydrate,12707401.21704156,28026489.4951782,2.2055248761322352,1.1411220326904874,0.06064375282521118,0.5434560019812327,Upregulated
Feature1456,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,4-Phenylbutyric acid,10,12,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Lignin,1893611.3779727332,1264157.5167663076,0.6675907905241318,-0.5829640421593009,0.3861470375854893,0.6807033163836934,Downregulated
Feature1455,Cantharidin,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,Cantharidin,10,12,4,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,1237616.7812699943,1216386.5648943896,0.9828458884067335,-0.024962877163557846,0.9572378303402833,0.9780127807593575,Downregulated
Feature1454,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04228,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak5",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,77813002.32362154,64997260.23426806,0.835300763283066,-0.2596323385347439,0.1744693167971138,0.5646729954371317,Downregulated
Feature1453,NA,C6 H14 O4,150.08923,NA,NA,Feature1453,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,17751209.009597134,11069346.586362498,0.6235826855724527,-0.6813472242370805,0.020063527822633535,0.5434560019812327,Downregulated
Feature1452,NA,C9 H15 N O7,249.08484,NA,NA,Feature1452,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,37912979.221631035,43453346.1269458,1.1461337784331584,0.1967754474263604,0.5205324298740628,0.7430834801967906,Upregulated
Feature1451,Val-Leu,C11 H22 N2 O3,230.16304,NA,NA,Val-Leu-peak2,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,76888279.39917737,57713717.2838715,0.7506178800573989,-0.4138494386047757,0.2755272408643504,0.6292487790932914,Downregulated
Feature1450,Furan,C4 H4 O,68.02623,Other,NA,Furan-peak3,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,43772321.019382134,42682475.785537966,0.9751019546493412,-0.036375022920450924,0.9036620503876531,0.953701139936653,Downregulated
Feature1449,NA,C23 H35 N O6,421.24649,NA,NA,Feature1449,23,35,6,1,0,0,1.5217391304347827,0.2608695652173913,-0.8695652173913047,85.08260869565218,7,1,0,0.15789473684210523,0,Lipid,2282637.5278271167,2447788.2731827567,1.0723508412274505,0.10077698983507599,0.7860151967286145,0.9001754630810936,Upregulated
Feature1448,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Phloroglucinol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,71406768.10476036,93042182.5137783,1.3029882878507646,0.3818241160353176,0.1423787509935006,0.5574792106914738,Upregulated
Feature1447,NA,C11 H19 N3 O2,225.14773,NA,NA,Feature1447,11,19,2,3,0,0,1.7272727272727273,0.18181818181818185,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,114598060.068601,105388111.26037703,0.9196325941057756,-0.12087049516289024,0.33963719282400623,0.6636048496469049,Downregulated
Feature1446,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak4,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,36373792.80068607,43885440.636670366,1.2065126360933858,0.2708430253205933,0.6733263244959116,0.8319582740306887,Upregulated
Feature1445,N-Acetyltyramine,C10 H13 N O2,179.09456,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,82204694.2377494,58057017.55929683,0.7062494191802047,-0.5017503189446461,0.3382980693000182,0.6636048496469049,Downregulated
Feature1444,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak3,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,35023512.54081157,29307890.2726212,0.8368061381184948,-0.25703466084477056,0.3344607390300355,0.6636048496469049,Downregulated
Feature1443,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13229,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak4,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,82541734.09188,99678345.07912253,1.2076114728601073,0.27215636829057216,0.24678917539440004,0.6195339940083167,Upregulated
Feature1442,3-Butynoic acid,C4 H4 O2,84.02112,Metabolic pathways;Other,NA,3-Butynoic acid-peak5,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,27367229.275184866,15762580.279523533,0.5759655141200646,-0.7959456618610943,0.2557697491156498,0.628842322173499,Downregulated
Feature1441,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20371,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak1,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,2373482.016859142,1752374.2488925594,0.7383136827855548,-0.4376941994014921,0.7515168936563877,0.8812502727638638,Downregulated
Feature1440,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",C19 H32 O2,292.24009,Other,NA,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",19,32,2,0,0,0,1.6842105263157894,0.10526315789473684,-1.473684210526316,102.3,4,2,0.1176470588235294,0.16666666666666666,2,Lipid,26534485.247962248,29152456.26085683,1.0986629658887253,0.13574888217954825,0.9410099361621416,0.9702257149779767,Upregulated
Feature1439,NA,C18 H30 O15,486.1586,Metabolic pathways;ABC transporters;Other,NA,Feature1439,18,30,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,20110598.254793067,20189699.464073367,1.0039333096051206,0.005663435526136614,0.9800269387485823,0.9914522005306148,Upregulated
Feature1438,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14735,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one-peak2",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,2340662.1229186677,2378592.4363593305,1.0162049503297665,0.02319139719434649,0.9824558035557737,0.9914522005306148,Upregulated
Feature1437,L-Lysine,C6 H14 N2 O2,146.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,L-Lysine,6,14,2,2,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,18719213.229464002,29127213.607582733,1.5560062942034636,0.6378478961838461,0.04570778425669994,0.5434560019812327,Upregulated
Feature1436,Veronal,C8 H12 N2 O3,184.08481,NA,NA,Veronal-peak2,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,84508869.29001656,80569807.49360937,0.9533887764739916,-0.06886345313891207,0.6718896634962328,0.8312524847517372,Downregulated
Feature1435,NA,C22 H46 O6,406.32947,NA,NA,Feature1435,22,46,6,0,0,0,2.090909090909091,0.2727272727272727,-1.545454545454546,104.34545454545454,0,-6,-0.375,-0.15789473684210523,-6,Lipid,2136054.0559871066,13853777.071262691,6.485686554809881,2.697259301815848,0.4501326464858957,0.7027877448360436,Upregulated
Feature1434,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11624,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak1,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,29657785.364054933,25738199.046918098,0.8678395480639174,-0.2044997625980745,0.6056943360856302,0.7953846552938431,Downregulated
Feature1433,NA,C75 H89 N10 O16 P3 S,1510.53964,NA,NA,Feature1433,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Lignin,14790816.968180401,25450270.47552799,1.7206805094187396,0.7829792471362026,0.5752218365962996,0.7751995156675667,Upregulated
Feature1432,Misoprostol,C22 H38 O5,382.2719,NA,NA,Misoprostol,22,38,5,0,0,0,1.7272727272727273,0.2272727272727273,-1.2727272727272725,96.57272727272726,4,-1,-0.0588235294117647,0.07692307692307693,-1,Lipid,1030494.6806125153,1130310.5196587252,1.096862061419745,0.13338210749294624,0.8678933211331651,0.939303571324255,Upregulated
Feature1431,NA,C15 H18 O11,374.08496,NA,NA,Feature1431,15,18,11,0,0,0,1.2,0.7333333333333333,0.2666666666666666,52.7,7,-4,-1,0.15789473684210523,-4,Tannin,130558.67815364033,61376128.48406105,470.1037828510652,8.876835479492748,0.31553305094725687,0.6582672269761738,Upregulated
Feature1430,"Norspermidine-2,3-dihydroxybenzoate",C13 H21 N3 O3,267.15832,NA,Other,"Norspermidine-2,3-dihydroxybenzoate",13,21,3,3,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,3364851.200439417,2129649.80231548,0.6329105435739234,-0.6599264932787479,0.008775265411287755,0.5434560019812327,Downregulated
Feature1429,Mevalonolactone,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,14746345.520600967,17871532.602383066,1.2119295982463008,0.2773058941813616,0.07713310780157435,0.5434560019812327,Upregulated
Feature1428,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak3,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,35241798.78556697,59622464.8020536,1.6918110555262451,0.7585684547011547,0.04653435621225473,0.5434560019812327,Upregulated
Feature1427,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10574,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,51924794.68972483,9645470.687090013,0.1857584752087371,-2.428500059829115,0.1372664807284792,0.5562904745312051,Downregulated
Feature1426,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04716,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Inosine-5'-monophosphate (IMP),10,13,8,4,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Tannin,354253.99623447633,168197.46778375033,0.4747934238472853,-1.0746281418970374,0.18247270211963806,0.5646729954371317,Downregulated
Feature1425,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.111,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak3,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,22591675.918817267,25000706.2472481,1.1066335378166556,0.1461775521073497,0.3750288236942829,0.676066007850296,Upregulated
Feature1424,NA,C10 H21 N O9,299.12162,NA,NA,Feature1424,10,21,9,1,0,0,2.1,0.9,0,60.3,1,-8,-Inf,-1,-9,Carbohydrate,26337187.821981166,37656068.8173588,1.4297680174468297,0.515781086004504,0.17711071595470823,0.5646729954371317,Upregulated
Feature1423,NA,C5 H14 N O4 P,183.06609,NA,NA,Feature1423,5,14,4,1,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,36118426.25086673,38209318.18925783,1.0578898959735523,0.08118948113914272,0.6089544812513175,0.7990463913553306,Upregulated
Feature1422,6-Aminocaproic acid,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak4,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,9934853.989395307,30198621.239684533,3.039664324399658,1.603912013056099,0.13620741767633565,0.5560403073935072,Upregulated
Feature1421,NA,C16 H27 N O14,457.14329,NA,NA,Feature1421,16,27,14,1,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,9237183.460863419,24425260.515170667,2.6442324782935063,1.4028490227370243,0.11514538075516646,0.5462476753068062,Upregulated
Feature1420,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE-peak2,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,85273317.46667966,81822651.209896,0.9595340446543316,-0.059594100157552114,0.7119561100389118,0.8576248643440788,Downregulated
Feature1419,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",C10 H15 N3 O3,225.11134,Other,NA,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",10,15,3,3,0,0,1.5,0.3,0,60.3,5,2,-0.25,0.09090909090909093,-1,Lipid,82054640.50662114,74259028.44556807,0.904994866677601,-0.14401848593988617,0.5270264180750941,0.7465824789370795,Downregulated
Feature1418,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak4",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,47304120.72693407,42784869.51290283,0.9044638998763155,-0.14486517358730547,0.5683914436025062,0.7739733617911779,Downregulated
Feature1417,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak3,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,54602942.9003883,74291357.56441157,1.3605742404752923,0.4442156801769526,0.2973263638796021,0.6425392932568532,Upregulated
Feature1416,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak2,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,31448890.609342903,38288220.639463834,1.2174744449678325,0.283891490167897,0.35023039162798686,0.6670930191369346,Upregulated
Feature1415,"9S,13R-12-Oxophytodienoic acid",C18 H28 O3,292.20376,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,"9S,13R-12-Oxophytodienoic acid",18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,8395365.018234182,4187093.6311480664,0.4987387233376957,-1.0036438730385029,0.16597751247783238,0.5646729954371317,Downregulated
Feature1414,NA,C14 H25 N O12,399.13775,NA,NA,Feature1414,14,25,12,1,0,0,1.7857142857142858,0.8571428571428571,0.1428571428571428,56.22857142857143,3,-9,-10,-0.5714285714285714,-10,Carbohydrate,7315035.839900037,9448947.819797818,1.2917158612208441,0.36928875525631044,0.30811501716592093,0.6523468563546992,Upregulated
Feature1413,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.0954,Metabolic pathways;ABC transporters;Other,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,16408816.489399433,19313723.2143154,1.1770332873667408,0.2351551214297511,0.31823068550330214,0.6606406632874925,Upregulated
Feature1412,NA,C23 H41 N,331.32396,NA,NA,Feature1412,23,41,0,1,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,106726663.3998677,52109179.6977757,0.4882489345941672,-1.034311198870305,0.15701277312463746,0.5574792106914738,Downregulated
Feature1411,NA,C21 H31 N O13,505.17965,NA,NA,Feature1411,21,31,13,1,0,0,1.4761904761904765,0.6190476190476191,-0.0952380952380949,63.014285714285705,7,-6,-1,-0.03703703703703703,-7,Lignin,863663.1465215567,2032460.0940874866,2.353301865748601,1.2346863916569006,0.0017573685551837556,0.5434560019812327,Upregulated
Feature1410,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak3,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,62930424.32866176,52061747.51121433,0.8272905842699478,-0.2735339325395618,0.4313753435798083,0.6999519463833287,Downregulated
Feature1409,Caffeic acid,C9 H8 O4,180.04227,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak2,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,429027.96696806396,329262.216417044,0.767460962379531,-0.38183472657236744,0.5834302651388685,0.7788265320293485,Downregulated
Feature1408,Isoamylamine,C5 H13 N,87.10481,NA,NA,Isoamylamine,5,13,0,1,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,1395865.3956329466,1428531.1934575133,1.0234018250805297,0.03337271128869602,0.7519014994664007,0.8812502727638638,Upregulated
Feature1407,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,NA,4-guanidinobutanal,5,11,1,3,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,56293807.88681517,64575614.6018515,1.1471175432240754,0.1980132294861937,0.2583056999920669,0.628842322173499,Upregulated
Feature1406,NA,C9 H15 N O7,249.08488,NA,NA,Feature1406,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,21552155.2274204,23796959.9167631,1.1041568541825775,0.1429451328744622,0.5706925013432899,0.7746419048682156,Upregulated
Feature1405,2'-Deoxyguanosine,C10 H13 N5 O4,267.09677,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,2'-Deoxyguanosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,45376327.6574439,56417017.7129402,1.2433138736753875,0.31419054967486615,0.16966754260575795,0.5646729954371317,Upregulated
Feature1404,NP-007065,C8 H10 O3,154.063,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak3,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,84752376.386509,79016486.12171903,0.9323217765761314,-0.10110012997423715,0.2875960003471525,0.6353376492471592,Downregulated
Feature1403,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione-peak2",9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,79212931.6764584,77095566.45220199,0.973269955050967,-0.039088075291236896,0.7801384676324444,0.8982992411548629,Downregulated
Feature1402,NP-016455,C11 H18 N2 O4,242.12665,NA,NA,NP-016455-peak3,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,629994.4700657347,701694.9856493929,1.1138113411950694,0.15550488781991198,0.5746488238779773,0.7751995156675667,Upregulated
Feature1401,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak3,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,1557666.8633774472,165510.61366146532,0.10625546293165222,-3.234391078184812,0.2201202077036212,0.5908673051309424,Downregulated
Feature1400,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,64146887.55225107,58590147.47014027,0.91337475138471,-0.13072118535012975,0.18733589080640356,0.5646729954371317,Downregulated
Feature1399,Isoprenaline,C11 H17 N O3,211.12084,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Isoprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,1982186.82354146,2125278.917213197,1.0721890045742926,0.10055924527990223,0.6722644062041794,0.8312524847517372,Upregulated
Feature1398,2908,C5 H11 N,85.08916,Other,NA,2908-peak1,5,11,0,1,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,10823715.88182662,34703892.987024434,3.206282700499689,1.6809016346715544,0.04108600359226507,0.5434560019812327,Upregulated
Feature1397,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak4,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,40133954.87587987,68610994.09185213,1.7095497890512328,0.7736164405374946,0.05132348728080431,0.5434560019812327,Upregulated
Feature1396,NA,C20 H29 N5 O7,451.2068,NA,NA,Feature1396,20,29,7,5,0,0,1.45,0.35,0,60.3,9,2,-0.375,0.04347826086956521,-3,Lignin,1969828.3504612267,3678981.684602807,1.8676661262091132,0.9012365743658414,0.09238634719233017,0.5434560019812327,Upregulated
Feature1395,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000-peak3,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,13137641.363693118,8999843.039364176,0.6850425270578578,-0.5457345423309311,0.2950858578820195,0.6419851575257671,Downregulated
Feature1394,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21537,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,97061904.36262034,71642357.14485466,0.7381099476185938,-0.4380923611632548,0.27726108249511927,0.6292487790932914,Downregulated
Feature1393,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak6,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,18916477.8713444,12266390.9924204,0.6484500484628867,-0.6249326501104083,0.008779220619721658,0.5434560019812327,Downregulated
Feature1392,Methionine sulfoxide,C5 H11 N O3 S,165.04597,Metabolic pathways;Other,Other,Methionine sulfoxide,5,11,3,1,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,2736624.380076263,5040451.949978917,1.8418501226092459,0.8811556693740318,0.0676228755028216,0.5434560019812327,Upregulated
Feature1391,3-Buten-1-amine,C4 H9 N,71.07352,NA,NA,3-Buten-1-amine-peak2,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,19384615.214249384,45717912.94767427,2.3584637839015556,1.2378474473009273,0.05646205106829061,0.5434560019812327,Upregulated
Feature1390,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak4,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,47836282.9947407,38190319.194765165,0.7983546547494911,-0.32489831462533886,0.07897021106006936,0.5434560019812327,Downregulated
Feature1389,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.2507,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.0588235294117647,0.13513513513513514,1,Lipid,1941916.0946569734,3475539.28786373,1.7897474033128404,0.8397559865381474,0.13089065327364321,0.5545833428603265,Upregulated
Feature1388,lys-leu,C12 H25 N3 O3,259.18959,NA,NA,lys-leu-peak4,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,32106689.6434948,61395228.741796635,1.9122254403526164,0.9352526187715503,0.04294897046947883,0.5434560019812327,Upregulated
Feature1387,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Phloroglucinol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,19394294.866307065,43556859.27575273,2.2458593919504817,1.1672676067742476,0.08248954152921421,0.5434560019812327,Upregulated
Feature1386,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12596,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak1",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,216169.834013575,280221.875152413,1.296304252770142,0.37440436980188613,0.12421760140115773,0.5515041946002173,Upregulated
Feature1385,Ne-Acetyllysine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,65920867.123869404,53344842.8341183,0.8092254419815205,-0.3053864160643715,0.18362957774448865,0.5646729954371317,Downregulated
Feature1384,Uracil,C4 H4 N2 O2,112.02723,Metabolic pathways;Other,Other,Uracil-peak2,4,4,2,2,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Lignin,22396270.07659127,27488411.435420766,1.227365598888354,0.2955650527002529,0.15585943703820795,0.5574792106914738,Upregulated
Feature1383,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,9,2,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Tannin,14813115.2830608,8506948.3130248,0.5742848921693553,-0.8001614859390473,0.13625765337657006,0.5560403073935072,Downregulated
Feature1382,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak7,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,602912.6008054317,552344.0706320127,0.916126267545471,-0.12638163957019516,0.4414870906838889,0.7009176491269988,Downregulated
Feature1381,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",C22 H31 N O4,373.22538,NA,NA,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",22,31,4,1,0,0,1.4090909090909092,0.18181818181818185,-0.9090909090909092,86.2090909090909,8,4,0.17647058823529413,0.2631578947368421,3,Lignin,1545697.4321256967,1301616.7572516433,0.8420902630740706,-0.24795321182148694,0.3911141025190068,0.6823569007873849,Downregulated
Feature1380,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak2,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,792679.4449067273,714982.1392623304,0.9019814300173516,-0.14883036328881125,0.3516816939936694,0.6670930191369346,Downregulated
Feature1379,NA,C5 H13 O6 P,200.04503,NA,NA,Feature1379,5,13,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,4121094.1950536566,3676115.96414073,0.892024251363385,-0.16484516182015913,0.839748862718332,0.9250107505926699,Downregulated
Feature1378,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak3,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,56299837.51555407,32183119.016542498,0.5716378667638464,-0.806826607454764,0.1352031896498164,0.5560403073935072,Downregulated
Feature1377,"16?,17-isopropylidenedioxy-6?-methylprogesterone",C25 H36 O4,400.26153,NA,NA,"16?,17-isopropylidenedioxy-6?-methylprogesterone",25,36,4,0,0,0,1.44,0.16,-1.12,92.22,8,4,0.1904761904761905,0.2608695652173913,4,Lignin,2459311.6387120667,2407143.5291761635,0.9787875156955612,-0.03093239473586124,0.9389547804874409,0.9692805595037932,Downregulated
Feature1376,Acetonedicarboxylic Acid,C5 H6 O5,146.02149,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Acetonedicarboxylic Acid,5,6,5,0,0,0,1.2,1,0.7999999999999998,37.5,3,-2,-Inf,0.2,-2,Tannin,88329265.4684845,80530811.33385791,0.9117115477722494,-0.13335064596142332,0.37663519313636323,0.6770680790879628,Downregulated
Feature1375,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak6",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,35652411.0725043,61612275.009206735,1.7281376814574847,0.7892181622022864,0.09346841293425515,0.5434560019812327,Upregulated
Feature1374,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak6",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,46588996.01728234,49173842.4023861,1.0554819078768065,0.0779018495139532,0.8683290393705924,0.939303571324255,Upregulated
Feature1373,NP-021733,C7 H13 N O2,143.09463,ABC transporters,NA,NP-021733-peak2,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,297278.77590261266,289674.1809214437,0.9744193141334105,-0.03738536545229592,0.9511721927180466,0.9759453025223326,Downregulated
Feature1372,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine-peak6,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,69382693.04927574,56588967.450583436,0.8156063848717119,-0.2940550255324849,0.4407818645566125,0.7009176491269988,Downregulated
Feature1371,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol-peak2,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,39861047.436089866,27088226.387203302,0.6795663468360805,-0.55731368505923,0.1436319355119198,0.5574792106914738,Downregulated
Feature1370,NA,C16 H28 N2 O13,456.15926,NA,NA,Feature1370,16,28,13,2,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,4089968.6789791267,13092209.44985454,3.20105371885694,1.678546887842013,0.09436822518507887,0.5434560019812327,Upregulated
Feature1369,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",C19 H34 O4,326.24576,NA,NA,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",19,34,4,0,0,0,1.7894736842105263,0.21052631578947367,-1.3684210526315788,99.29999999999998,3,-1,-0.06666666666666667,0.0588235294117647,-1,Lipid,8640623.511227988,9127226.446890583,1.0563157201595792,0.07904110347648138,0.8398267617541477,0.9250107505926699,Upregulated
Feature1368,Glucosamine,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,41867128.96641847,50016463.902331434,1.1946475704710855,0.2565850756753201,0.6662372188441432,0.8298572417073372,Upregulated
Feature1367,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde-peak2,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Lignin,611108.8686461584,501097.143384805,0.8199801526280059,-0.2863391047318639,0.4563179773292456,0.7078778879081887,Downregulated
Feature1366,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak3",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,47304120.72693407,43211108.469865166,0.9134745093203177,-0.13056362415202846,0.5962774491048212,0.7885106188767821,Downregulated
Feature1365,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,NA,L-Alanyl-L-proline-peak1,8,14,3,2,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,35049049.42442877,53580099.4246213,1.528717620149681,0.6123219412748501,0.21830516293926597,0.5888239456480585,Upregulated
Feature1364,"5,6,7,4'-Tetramethoxyisoflavone",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,NA,"5,6,7,4'-Tetramethoxyisoflavone",19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,89560661.08880466,67114603.8240816,0.7493759314430867,-0.4162384531495094,0.17416636168798336,0.5646729954371317,Downregulated
Feature1363,Zalcitabine,C9 H13 N3 O3,211.0957,Other,NA,Zalcitabine-peak2,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Lignin,69168269.68442394,55409810.3827988,0.8010871261577414,-0.31996893634814705,0.06521032834423061,0.5434560019812327,Downregulated
Feature1362,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak3,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,3371938.481855177,3203098.6118973633,0.9499279506828603,-0.07411000158526103,0.6607343068346037,0.8289195086767364,Downregulated
Feature1361,ile-his,C12 H20 N4 O3,268.15355,NA,NA,ile-his-peak4,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,25204892.86766623,55993501.154388934,2.221532995532763,1.1515555692740824,0.04282670418885634,0.5434560019812327,Upregulated
Feature1360,glu-thr,C9 H16 N2 O6,248.10093,NA,NA,glu-thr,9,16,6,2,0,0,1.7777777777777777,0.6666666666666666,0.22222222222222232,53.96666666666666,3,-3,-5,-0.5,-5,Amino Sugar,1871760.793824437,7195367.738697274,3.844170559847813,1.9426723476589463,0.14571068517440294,0.5574792106914738,Upregulated
Feature1359,NA,C17 H30 N2 O8,390.20035,NA,NA,Feature1359,17,30,8,2,0,0,1.7647058823529411,0.4705882352941176,-0.47058823529411775,73.71176470588236,4,-4,-0.8571428571428571,-0.18181818181818185,-6,Protein,32670626.585923165,32614184.252956565,0.9982723829058449,-0.0024945800748755005,0.9929816333562116,0.9965111889250132,Downregulated
Feature1358,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin-peak2,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Lignin,853608.8098689624,1882389.7732709567,2.2052136195266336,1.1409184167370443,0.13604026548790066,0.5560403073935072,Upregulated
Feature1357,Leu-Glu,C11 H20 N2 O5,260.13724,NA,NA,Leu-Glu-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,59096940.55956403,48655560.594657764,0.8233177578053746,-0.28047875156241125,0.21863651818927318,0.5888239456480585,Downregulated
Feature1356,mycosporine,C11 H19 N O6,261.12123,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak3,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,1104770.169381171,1521553.5301403333,1.3772579784559358,0.46179882046007176,0.48861951839550516,0.7305091897794865,Upregulated
Feature1355,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16304,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate-peak2,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,38684719.86719537,58238764.172256865,1.5054720409554605,0.5902159151370119,0.16396927310815587,0.5634157173330954,Upregulated
Feature1354,"4-(Î²-D-Glucopyranosyloxy)-2,5-dimethyl-3(2H)-furanone",C12 H18 O8,290.10021,NA,NA,"4-(Î²-D-Glucopyranosyloxy)-2,5-dimethyl-3(2H)-furanone",12,18,8,0,0,0,1.5,0.6666666666666666,-0.16666666666666696,65.05000000000001,4,-4,-1,0,-4,Amino Sugar,3148115.266269827,11079199.688690856,3.5193119538531064,1.815293401080967,0.022180894712025116,0.5434560019812327,Upregulated
Feature1353,NA,C12 H18 O9,306.09516,NA,NA,Feature1353,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,22578127.019839767,18900597.609346967,0.8371198192276403,-0.25649396048237283,0.20785838310437474,0.5820034726922493,Downregulated
Feature1352,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Other,Other,Asparagine,4,8,3,2,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,38004468.73605997,50343883.92220856,1.3246832700608315,0.4056474545168853,0.09311781483385792,0.5434560019812327,Upregulated
Feature1351,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",C21 H32 N4 O6,436.23229,NA,NA,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",21,32,6,4,0,0,1.5238095238095235,0.2857142857142857,-0.3809523809523814,71.15714285714287,8,2,-0.18181818181818185,0.07142857142857142,-2,Lipid,460047.6687150173,483995.061466943,1.0520541552113813,0.07320897026137495,0.8566380512086721,0.9356715651701699,Upregulated
Feature1350,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak5",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,16342494.940269733,44216834.6849484,2.7056355132161114,1.435967501290355,0.0350938343771178,0.5434560019812327,Upregulated
Feature1349,Veronal,C8 H12 N2 O3,184.0848,NA,NA,Veronal-peak1,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,8738577.316388879,8135229.519485343,0.9309558323902474,-0.10321537168233384,0.5789019227620562,0.7758384945877558,Downregulated
Feature1348,NA,C10 H15 N O5,229.09503,NA,NA,Feature1348,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,68141143.47730628,61198103.13931407,0.8981079567544311,-0.1550392208418582,0.05471270254009392,0.5434560019812327,Downregulated
Feature1347,Imidazoleacetic acid riboside,C10 H14 N2 O6,258.08518,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Imidazoleacetic acid riboside,10,14,6,2,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Lignin,7896563.896818613,14831284.8992078,1.8781947557193914,0.9093466681794242,0.004091609647873505,0.5434560019812327,Upregulated
Feature1346,2-Methylhippuric Acid,C10 H11 N O3,193.07391,Phenylalanine metabolism;Other,NA,2-Methylhippuric Acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,21230596.560034066,20953935.259274468,0.9869687457920798,-0.01892369511419995,0.7393291877190704,0.8757924356982758,Downregulated
Feature1345,NA,C14 H27 N O11,385.1585,NA,NA,Feature1345,14,27,11,1,0,0,1.9285714285714288,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,14350781.025378225,35205954.8521301,2.453243122438503,1.2946902156140685,0.12755998435109653,0.5545833428603265,Upregulated
Feature1344,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09574,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak2,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,9144193.889410213,7814732.158275437,0.8546113799408376,-0.22665956692181016,0.17727825202539071,0.5646729954371317,Downregulated
Feature1343,AC-LYS-OH,C8 H16 N2 O3,188.1161,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,44520952.9233204,41370756.2334393,0.9292423795306725,-0.1058731429097051,0.6004925477996981,0.7913634360065066,Downregulated
Feature1342,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid-peak2,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,10404383.8865876,12523008.6424297,1.2036280839822955,0.26738967425422633,0.09404567036593196,0.5434560019812327,Upregulated
Feature1341,L-(+)-Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-(+)-Valine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,35215281.9076873,60082057.807351634,1.706135931691521,0.7707325939978605,0.050776727670118274,0.5434560019812327,Upregulated
Feature1340,NA,C37 H71 N O5,609.53331,NA,NA,Feature1340,37,71,5,1,0,0,1.9189189189189189,0.13513513513513514,-1.5675675675675675,104.97567567567567,3,-2,-0.0967741935483871,-0.01492537313432835,-3,Lipid,1914814.72959398,1978503.8764081735,1.0332612580370626,0.047205082876021535,0.8741069972194405,0.9409146589428623,Upregulated
Feature1339,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",C31 H42 O3,462.31357,NA,NA,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",31,42,3,0,0,0,1.3548387096774193,0.0967741935483871,-1.161290322580645,93.39677419354838,11,8,0.2857142857142857,0.3220338983050847,8,Unsaturated HC,720764.3639605823,650051.090042905,0.9018912734127008,-0.14897457356073798,0.7636309937075914,0.8927473453006625,Downregulated
Feature1338,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak6,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,640306.288229423,809332.4901714217,1.2639771075954767,0.33797033451378283,0.42048538443997724,0.6943057388507786,Upregulated
Feature1337,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Tyrosine metabolism;Other,Other,Pyridoxine-peak2,8,11,3,1,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Lignin,66857119.48952117,60457534.652781,0.9042796805246268,-0.1451590486826101,0.11662940168382009,0.5462476753068062,Downregulated
Feature1336,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15318,NA,NA,4-Hydroxyprolyllysine-peak4,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,40037001.69338637,38887407.12007643,0.9712866966883827,-0.042030893124834816,0.8672184275120757,0.939303571324255,Downregulated
Feature1335,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak4",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,9781920.854344727,8724104.523297323,0.8918600603298108,-0.1651107368790485,0.2107992530708886,0.582534966887578,Downregulated
Feature1334,ALA-GLU,C8 H14 N2 O5,218.09029,NA,NA,ALA-GLU,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,40120392.3898158,44639309.24807503,1.1126339148020477,0.15397898694990106,0.609535144532601,0.7991290476183568,Upregulated
Feature1333,MFCD01318772,C8 H13 N3 O2,183.10077,NA,NA,MFCD01318772,8,13,2,3,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,17211832.3599113,16476686.812635632,0.9572883623368351,-0.06297452414815582,0.503733061710716,0.7335255813534236,Downregulated
Feature1332,NP-008177,C28 H41 N O5,471.29851,NA,NA,NP-008177,28,41,5,1,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Lignin,1658814.8698818665,1528614.5357335967,0.9215100271210239,-0.11792823071442185,0.7868049265904818,0.9001754630810936,Downregulated
Feature1331,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak2,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,25795167.869299967,41851013.81719047,1.6224361876318438,0.6981617364077648,0.15177675850737107,0.5574792106914738,Upregulated
Feature1330,Valylvaline,C10 H20 N2 O3,216.14739,NA,NA,Valylvaline,10,20,3,2,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,35653132.569426164,39790537.375378735,1.1160460388128852,0.1583965420390094,0.6862742340170804,0.8423623059439227,Upregulated
Feature1329,NA,C6 H15 N O6,197.08997,NA,NA,Feature1329,6,15,6,1,0,0,2.5,1,0,60.3,0,-6,7,-2,-7,Carbohydrate,24246257.297860768,22496180.97759957,0.9278207643034619,-0.10808196132903683,0.30562930345599276,0.650771219588917,Downregulated
Feature1328,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak3",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,2000288.0026699933,3865154.32115571,1.9322989069556409,0.9503182816619388,0.03755670305151746,0.5434560019812327,Upregulated
Feature1327,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak3,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,9356898.45276677,9924223.686044924,1.0606317612766654,0.08492385663697716,0.3931208670427783,0.6830003585350376,Upregulated
Feature1326,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",C10 H16 N2 O3 S,244.08813,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;ABC transporters;Other,Other,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",10,16,3,2,1,0,1.6,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,56556247.78367557,52889417.39008707,0.9351648926991424,-0.09670732464092321,0.5103395255886642,0.7389018430317925,Downregulated
Feature1325,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,L-Cystathionine,7,14,4,2,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,7409475.207153689,2409058.6408319017,0.32513215490700437,-1.6209018522061398,0.4651044988680288,0.7149609991673691,Downregulated
Feature1324,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak1,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,41519803.91638157,25838937.01479887,0.6223280116360126,-0.6842529099848295,0.07809768964097481,0.5434560019812327,Downregulated
Feature1323,Pyrogallol,C6 H6 O3,126.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,47200047.61086723,37356529.89799747,0.7914511062780493,-0.33742786759375065,0.0722394574191979,0.5434560019812327,Downregulated
Feature1322,NA,C14 H25 N O9,351.15307,Biosynthesis of secondary metabolites;Other,NA,Feature1322,14,25,9,1,0,0,1.7857142857142858,0.6428571428571429,-0.2857142857142856,68.44285714285714,3,-6,-1.75,-0.29411764705882354,-7,Amino Sugar,12000444.675449254,22803870.843690734,1.9002521540175377,0.9261908697212681,0.20782799199176474,0.5820034726922493,Upregulated
Feature1321,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11612,NA,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,3,2,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Lignin,56356001.57520547,52759254.54592677,0.936178101200474,-0.0951450765358345,0.52662174879607615,0.7465824789370795,Downregulated
Feature1320,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak2",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,4705321.1621362,1711962.85070036,0.3638354942647814,-1.4586418017552767,0.013241787491884292,0.5434560019812327,Downregulated
Feature1319,afegostat,C6 H13 N O3,147.08955,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak4,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,1563682.4271529894,759758.798289093,0.4858779411318145,-1.0413341593289287,0.40889058092502945,0.6875574805825382,Downregulated
Feature1318,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",C14 H19 N3 O2,261.14775,NA,NA,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",14,19,2,3,0,0,1.3571428571428572,0.14285714285714285,-0.4285714285714288,72.51428571428572,7,5,0.2222222222222222,0.3,2,Lignin,33816473.173058204,37487327.89565803,1.108552263975429,0.14867678933080208,0.6721586665246002,0.8312524847517372,Upregulated
Feature1317,Nojirimycin,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Nojirimycin-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,53946669.433540665,48785565.719869465,0.904329520842257,-0.1450795352321142,0.3410859877153252,0.6636491383576648,Downregulated
Feature1316,NA,C11 H21 N O8 S,327.09883,NA,NA,Feature1316,11,21,8,1,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,15983008.024867734,14766101.731005449,0.9238624987255892,-0.11424994797347678,0.8116021559764082,0.9088169879054063,Downregulated
Feature1315,Maraniol,C12 H12 O3,204.07864,NA,NA,Maraniol,12,12,3,0,0,0,1,0.25,-0.5,74.55,7,4,0.4444444444444444,0.5238095238095238,4,Lignin,762944.4486147229,638930.0366705847,0.8374528942843598,-0.2559200520040698,0.5606142269351024,0.7719911688016345,Downregulated
Feature1314,NA,C30 H46 O11,582.30426,NA,NA,Feature1314,30,46,11,0,0,0,1.5333333333333334,0.36666666666666664,-0.7999999999999998,83.1,8,-3,-0.15789473684210523,0.1020408163265306,-3,Protein,1477785.53844688,1086701.7485108227,0.7353582236654733,-0.4434808767669113,0.23216912791223468,0.6032124274284134,Downregulated
Feature1313,2-Pyrrolidone,C4 H7 N O,85.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Pyrrolidone-peak2,4,7,1,1,0,0,1.75,0.25,-0.5,74.55,2,1,0,0.2,0,Lipid,49776508.11345667,53499481.0174033,1.0747937741124947,0.10405986948284218,0.45490029517833275,0.7069734862679776,Upregulated
Feature1312,4-O-(beta-L-Araf)-cis-L-Hyp,C10 H17 N O7,263.10053,NA,Other,4-O-(beta-L-Araf)-cis-L-Hyp,10,17,7,1,0,0,1.7,0.7,0,60.3,3,-4,-2.5,-0.2727272727272727,-5,Amino Sugar,17500792.900086932,19879172.605521012,1.13590125424673,0.1838374244548196,0.7975593452647474,0.9022552886981726,Upregulated
Feature1311,NA,C15 H21 N3 O5,323.14822,NA,NA,Feature1311,15,21,5,3,0,0,1.4,0.3333333333333333,-0.13333333333333375,64.10000000000001,7,2,-0.14285714285714285,0.15789473684210523,-1,Lignin,42696039.865504965,45876204.95595543,1.0744838420721963,0.10364378789590958,0.4698230556700145,0.7150766004537328,Upregulated
Feature1310,Guanosine monophosphate,C10 H14 N5 O8 P,363.05806,Metabolic pathways;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Guanosine monophosphate,10,14,8,5,0,1,1.4,0.8,1.2000000000000002,26.09999999999999,7,-1,1.75,-Inf,-7,Tannin,17191071.9549592,8462843.966310807,0.49228134164545134,-1.0224450350336511,0.09829304050573567,0.5434560019812327,Downregulated
Feature1309,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26144,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak2,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,5561516.547654377,4824627.7360079065,0.8675021812247847,-0.20506070971724324,0.7145743508253632,0.8585028016299046,Downregulated
Feature1308,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak2,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,9421579.07948492,12453629.30835037,1.3218197505201235,0.4025254576622394,0.42503237987021414,0.6952678098597452,Upregulated
Feature1307,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak3",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,41127105.61247593,41350981.11580093,1.0054435025268855,0.007832016586783608,0.9816740519837149,0.9914522005306148,Upregulated
Feature1306,NA,C18 H34 N2 O12,470.2114,NA,NA,Feature1306,18,34,12,2,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,11237515.5071151,14282869.651052566,1.270998882449531,0.34596276182577645,0.1860718902770907,0.5646729954371317,Upregulated
Feature1305,RV0540000,C5 H12 O4,136.07356,NA,NA,RV0540000,5,12,4,0,0,0,2.4,0.8,-0.7999999999999998,83.1,0,-4,-4,-0.6666666666666666,-4,Carbohydrate,5959130.46413711,6638562.988063127,1.1140153799308368,0.1557691504488431,0.7990942373293675,0.9022552886981726,Upregulated
Feature1304,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene-peak2,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,43324625.06704456,50100190.1295023,1.1563906220070592,0.2096288141362048,0.15104233151971536,0.5574792106914738,Upregulated
Feature1303,"N-Acetyl-1,6-anhydro-Î²-muramic acid",C11 H17 N O7,275.10045,Metabolic pathways;Other,NA,"N-Acetyl-1,6-anhydro-Î²-muramic acid",11,17,7,1,0,0,1.5454545454545454,0.6363636363636364,0,60.3,4,-3,-1.3333333333333333,-0.07692307692307693,-4,Amino Sugar,2083940.3968538768,2045273.1755481968,0.9814451404828776,-0.027020466793718733,0.9095001909170399,0.9569523747909724,Downregulated
Feature1302,(+)-castanospermine,C8 H15 N O4,189.10013,NA,NA,(+)-castanospermine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,629383.6671311536,499081.5268001677,0.7929686657981974,-0.33466423600816153,0.46078840523028275,0.7109067016940792,Downregulated
Feature1301,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Other,Other,Agmatine,5,14,0,4,0,0,2.8,0,-0.4000000000000003,71.7,1,1,-3,-3,-3,Other,1118781.5610117423,2265073.1034504,2.02458923384654,1.017629231253833,0.14345760154387202,0.5574792106914738,Upregulated
Feature1300,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak5,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,27828156.275225267,24822797.374300532,0.892002945822166,-0.16487962026194758,0.271530230591261,0.6292487790932914,Downregulated
Feature1299,Val-Leu,C11 H22 N2 O3,230.16304,NA,NA,Val-Leu-peak1,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,36215459.232841,29401440.005384266,0.8118477751822176,-0.30071885341003163,0.6584355003474883,0.828145395741197,Downregulated
Feature1298,N-(3-Hydroxy-4-methoxybenzoyl)glycine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,N-(3-Hydroxy-4-methoxybenzoyl)glycine,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,37085581.7959017,31384163.1668152,0.8462632011420524,-0.24082166094285826,0.39625308064443465,0.6848441763516896,Downregulated
Feature1297,α-Linolenic acid,C18 H30 O2,278.22444,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Linolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,2939592.42046757,16298250.465044817,5.544391239943538,2.471029064836422,0.2882105276692726,0.6353376492471592,Upregulated
Feature1296,Propionylcarnitine,C10 H19 N O4,217.13141,NA,NA,Propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,18432850.9317903,21862315.402890965,1.1860517661533314,0.24616697880708652,0.3006273937351299,0.6452426827392128,Upregulated
Feature1295,Glu-Gly,C7 H12 N2 O5,204.07472,NA,NA,Glu-Gly,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,4455166.292866903,10954796.715150047,2.4588973777902745,1.2980115252379791,0.05622354588253852,0.5434560019812327,Upregulated
Feature1294,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak3,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,20770120.118308745,43274188.9081276,2.083482842739154,1.0589972196483066,0.08109693266916124,0.5434560019812327,Upregulated
Feature1293,NA,C15 H22 N4 O6,354.15406,NA,NA,Feature1293,15,22,6,4,0,0,1.4666666666666666,0.4,0.1333333333333333,56.5,7,1,-0.6,0,-3,Lignin,913346.785007025,6743647.404139686,7.383446807761871,2.8842944655520046,0.13677523272976239,0.5560403073935072,Upregulated
Feature1292,arg-leu,C12 H25 N5 O3,287.19577,NA,NA,arg-leu-peak1,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,20510591.5347722,28948148.795743167,1.4113756176493757,0.4971019919067501,0.19325927270101328,0.569358622531333,Upregulated
Feature1291,Tridemorph,C19 H39 N O,297.30319,NA,NA,Tridemorph,19,39,1,1,0,0,2.0526315789473686,0.05263157894736842,-1.7894736842105263,111.3,1,0,-0.0588235294117647,-0.02857142857142857,-1,Lipid,293918.6197649203,2940548.9438019055,10.00463647438802,3.32259684172864,0.18395294712267327,0.5646729954371317,Upregulated
Feature1290,NA,C15 H22 N4 O6,354.15401,NA,NA,Feature1290,15,22,6,4,0,0,1.4666666666666666,0.4,0.1333333333333333,56.5,7,1,-0.6,0,-3,Lignin,194630.424802021,221721.698273479,1.1391934148991114,0.1880127119507845,0.4907078847003098,0.7317422153893703,Upregulated
Feature1289,ornithinoalanine,C8 H17 N3 O4,219.12181,NA,NA,ornithinoalanine,8,17,4,3,0,0,2.125,0.5,0,60.3,2,-2,-5,-1,-5,Protein,254928.86706833934,872017.6504045164,3.4206312546423105,1.7742625894106752,0.01737604934336301,0.5434560019812327,Upregulated
Feature1288,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-D-galactosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,11644255.95913993,15758019.608864967,1.3532869480162895,0.4364677776643716,0.06055916400183398,0.5434560019812327,Upregulated
Feature1287,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Superpathway of indole-3-acetate conjugate biosynthesis,Indole-3-acetic acid,10,9,2,1,0,0,0.9,0.2,-0.20000000000000015,66,7,5,0.5714285714285714,0.625,4,Lignin,1629472.32799373,1393843.0319964134,0.8553953375278041,-0.22533675129697284,0.11877099200068611,0.5462476753068062,Downregulated
Feature1286,NA,C11 H18 N3 O6 P S,351.06552,NA,NA,Feature1286,11,18,6,3,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,1232180.9683143566,1234123.6622081434,1.001576630335757,0.0022728055500568288,0.9903757154476847,0.9950750070986819,Upregulated
Feature1285,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin-peak2,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,509337.33730904065,277329.4920453157,0.5444907956493398,-0.8770204337932785,0.03719613675792629,0.5434560019812327,Downregulated
Feature1284,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine,C12 H18 N2 O4,254.12666,NA,NA,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine-peak2,12,18,4,2,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,5,1,-0.16666666666666666,0.125,-1,Protein,24957570.8782368,18405984.394877836,0.7374910196459865,-0.4393026129710557,0.09021729430040559,0.5434560019812327,Downregulated
Feature1283,Pyrone,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak1,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,29721809.0306393,22824240.04784103,0.7679290323247897,-0.38095510352928086,0.03918073037631612,0.5434560019812327,Downregulated
Feature1282,NA,C22 H33 N6 O10 P S,604.17155,NA,NA,Feature1282,22,33,10,6,1,1,1.5,0.4545454545454546,0.09090909090909084,57.70909090909091,10,0,-2,-0.3333333333333333,-8,Protein,43900520.364301436,44117007.511362836,1.0049313116397007,0.007096894694377317,0.9844289556228158,0.9926325302530059,Upregulated
Feature1281,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14749,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)-peak1",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,51110520.39538284,41250119.90549583,0.8070768911447482,-0.3092219676187407,0.19553971991492883,0.5701278580652142,Downregulated
Feature1280,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,C19 H32 O3,308.23512,NA,NA,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,19,32,3,0,0,0,1.6842105263157894,0.15789473684210523,-1.3684210526315788,99.29999999999998,4,1,0.0625,0.14285714285714285,1,Lipid,4059860.9010285735,4591568.042689518,1.1309668371953914,0.1775566264849441,0.8367495505284067,0.9228214443978652,Upregulated
Feature1279,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",C6 H6 O4,142.02662,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",6,6,4,0,0,0,1,0.6666666666666666,0.3333333333333335,50.8,4,0,0,0.5,0,Tannin,48272942.84180883,44938001.50055236,0.9309148946608636,-0.10327881395930678,0.3502765428134707,0.6670930191369346,Downregulated
Feature1278,N-Methyltyramine,C9 H13 N O,151.09973,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,N-Methyltyramine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,16969160.32199777,34464956.5150636,2.031034880988505,1.0222150166882336,0.17441744366934847,0.5646729954371317,Upregulated
Feature1277,NP-013538,C12 H16 O8,288.08462,NA,NA,NP-013538-peak2,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,24252527.280066468,17445224.2341876,0.7193157246142385,-0.47530295237713743,0.06715051273872792,0.5434560019812327,Downregulated
Feature1276,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11608,NA,Other,N1-Acetyl-5-methoxykynuramine-peak2,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,27341001.978248864,20240780.255878866,0.7403086496969431,-0.43380120988959175,0.09505017236457158,0.5434560019812327,Downregulated
Feature1275,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak5,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,4019144.149418333,1596319.9794099834,0.3971790809346834,-1.3321384554716058,0.0019123385107855018,0.5434560019812327,Downregulated
Feature1274,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak5,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1112492.34138236,663776.6678783994,0.5966572920885047,-0.7450255804333106,0.03141903407391194,0.5434560019812327,Downregulated
Feature1273,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,5881316.95653889,4620701.7686615735,0.7856576686492376,-0.34802726500468306,0.1550531389239307,0.5574792106914738,Downregulated
Feature1272,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Eleostearic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,32307280.195246264,26334463.077495,0.8151247309691482,-0.2949072564246413,0.3892959466045034,0.6823569007873849,Downregulated
Feature1271,imazamethabenz-methyl,C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,imazamethabenz-methyl,16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,129370.015315701,126234.97262669753,0.9757668523007202,-0.035391620471175465,0.9418103032478468,0.9702257149779767,Downregulated
Feature1270,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine-peak2,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,16309935.282564979,30681134.262178365,1.8811315759772471,0.9116007618707243,0.08384631649886035,0.5434560019812327,Upregulated
Feature1269,Isobutyraldehyde,C4 H8 O,72.05754,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Isobutyraldehyde,4,8,1,0,0,0,2,0.25,-1.5,103.05,1,0,0,0.14285714285714285,0,Lipid,2009997.224152644,1491821.99438006,0.7422010221974155,-0.43011810689675434,0.4694664582251836,0.7150766004537328,Downregulated
Feature1268,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,C12 H16 O5,240.09978,NA,NA,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Lignin,2153949.4612722234,37295854.7171288,17.315102042877143,4.113958984664434,0.2024452894579903,0.5780722477745703,Upregulated
Feature1267,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak2,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,42084743.32837397,25308707.275320064,0.6013748753994818,-0.7336634994957969,0.13457491886261516,0.5560403073935072,Downregulated
Feature1266,"3,4,5-Trimethoxyphenyl acetate",C11 H14 O5,226.08413,NA,NA,"3,4,5-Trimethoxyphenyl acetate",11,14,5,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Lignin,42482449.72177587,10991622.601665188,0.25873325746634257,-1.950462585518966,0.21400352588670837,0.5856574682586171,Downregulated
Feature1265,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13723,NA,NA,L-gamma-Glutamyl-L-leucine-peak3,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,28676342.394327536,39653491.814777836,1.3827946140935214,0.4675868895086539,0.3522523460947163,0.6670930191369346,Upregulated
Feature1264,NA,C18 H33 N O15,503.18514,NA,NA,Feature1264,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,9091283.528115354,9156453.991613798,1.0071684557298097,0.010305004020613413,0.9679743039133599,0.9824736194303366,Upregulated
Feature1263,pentobarbital,C11 H18 N2 O3,226.13174,NA,NA,pentobarbital,11,18,3,2,0,0,1.6363636363636365,0.2727272727272727,-0.5454545454545459,75.84545454545456,4,1,-0.16666666666666666,0.06666666666666667,-1,Lipid,24087375.828691434,18665016.7318282,0.7748879273762797,-0.3679404274815526,0.02667208922423073,0.5434560019812327,Downregulated
Feature1262,NA,C11 H23 N O7,281.14745,NA,NA,Feature1262,11,23,7,1,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,21658323.034277793,16504862.655992141,0.7620563526488423,-0.39203040861105976,0.7180757538584032,0.8614874837366395,Downregulated
Feature1261,NA,C5 H16 N5 O7 P,289.07872,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,Feature1261,5,16,7,5,0,1,3.2,1.4,1.6,14.699999999999996,1,-6,1.5,1.8888888888888888,-12,Other,25814600.4406921,30081780.780151468,1.1653010415273723,0.22070270596477423,0.3810883119601896,0.6781130256938668,Upregulated
Feature1260,5-Hydroxy-2-furoic acid,C5 H4 O4,128.01093,NA,NA,5-Hydroxy-2-furoic acid,5,4,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,53094653.5770703,48026062.11084706,0.9045366882587179,-0.14474907474347784,0.35373805771739597,0.6680404345298425,Downregulated
Feature1259,Pipecolic acid,C6 H11 N O2,129.07898,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid-peak2,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,1453957.2994146133,2114879.41278518,1.4545677604401894,0.5405905053581193,0.5191561904808407,0.7430834801967906,Upregulated
Feature1258,mebutamate,C10 H20 N2 O4,232.1423,Other,NA,mebutamate-peak4,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,33995454.72172527,32040958.238528732,0.942507123402368,-0.0854245726774828,0.7343863135164947,0.8730178351557488,Downregulated
Feature1257,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak3,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,50958592.50240523,46263429.28529247,0.9078631691624695,-0.1394532203295447,0.5120144701986356,0.7400618707478572,Downregulated
Feature1256,NA,C7 H11 N O6,205.0586,NA,NA,Feature1256,7,11,6,1,0,0,1.5714285714285714,0.8571428571428571,0.5714285714285716,44.014285714285705,3,-3,-Inf,-0.3333333333333333,-4,Carbohydrate,48803066.2921622,45706352.23800913,0.936546731805448,-0.09457711103101325,0.350237872459704,0.6670930191369346,Downregulated
Feature1255,DL-2-(acetylamino)-3-phenylpropanoic acid,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,DL-2-(acetylamino)-3-phenylpropanoic acid,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,2730793.4487714935,3400130.0932225566,1.245107019995298,0.31626975079206554,0.08583726013686506,0.5434560019812327,Upregulated
Feature1254,NA,C16 H21 N8 O2 P,388.15237,NA,NA,Feature1254,16,21,2,8,0,1,1.3125,0.125,0.125,56.7375,11,9,0,0.16666666666666666,0,Unsaturated HC,37574911.82542027,23491333.599673435,0.6251866593544745,-0.6776411014002129,0.3605375961591578,0.6692796802688192,Downregulated
Feature1253,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11068,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak3,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,49014510.7300193,43129154.0086968,0.8799262374822,-0.18454550440886738,0.07959081626659002,0.5434560019812327,Downregulated
Feature1252,NA,C14 H31 N O,229.24056,NA,NA,Feature1252,14,31,1,1,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.2285714285714,0,-1,-0.16666666666666666,-0.12,-2,Lipid,51726723.22834403,20222771.09687395,0.3909540337129404,-1.3549291017607132,0.143478597377892,0.5574792106914738,Downregulated
Feature1251,11-Aminoundecanoic acid,C11 H23 N O2,201.1728,NA,NA,11-Aminoundecanoic acid,11,23,2,1,0,0,2.090909090909091,0.18181818181818185,-1.454545454545454,101.75454545454544,1,-1,-0.25,-0.1111111111111111,-2,Lipid,6336771.611673516,8502923.4293291,1.3418383919131829,0.42421092695913604,0.6370860546793019,0.810836796864566,Upregulated
Feature1250,2-Pyrrolidone,C4 H7 N O,85.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Pyrrolidone-peak1,4,7,1,1,0,0,1.75,0.25,-0.5,74.55,2,1,0,0.2,0,Lipid,19179987.700378865,18672787.80680733,0.9735557758693706,-0.038664460302276014,0.8191819884403653,0.9141596102885237,Downregulated
Feature1249,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid-peak3,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,21332638.387400832,18908687.0574017,0.8863735799585517,-0.1740132151144675,0.1773349352424875,0.5646729954371317,Downregulated
Feature1248,NA,C12 H19 N O7,289.11624,NA,NA,Feature1248,12,19,7,1,0,0,1.5833333333333333,0.5833333333333334,-0.16666666666666696,65.05000000000001,4,-3,-1,-0.06666666666666667,-4,Amino Sugar,45425843.385639496,40919870.846847765,0.9008059685201969,-0.15071170849279544,0.5946452581935948,0.7882074079655318,Downregulated
Feature1247,"1D-myo-Inositol 1,2-cyclic phosphate",C6 H11 O8 P,242.01913,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis",Other,"1D-myo-Inositol 1,2-cyclic phosphate",6,11,8,0,0,1,1.8333333333333333,1.3333333333333333,0,60.3,2,-6,2.3333333333333335,-3,-7,Carbohydrate,27778345.865033735,40733701.032744266,1.4663832479679149,0.5522622096676989,0.014122244026633859,0.5434560019812327,Upregulated
Feature1246,APM,C7 H13 N O4,175.08447,NA,NA,APM-peak4,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,31401188.749651533,36155708.42546537,1.1514120918707766,0.20340426830542566,0.6116658976878913,0.7991290476183568,Upregulated
Feature1245,NA,C16 H23 N5 O9,429.1496,NA,NA,Feature1245,16,23,9,5,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Lignin,30152105.618552968,29000089.9335587,0.9617931928347512,-0.05620137942265362,0.9313724634731438,0.9690304198820222,Downregulated
Feature1244,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak3,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,215757.71452575398,321578.53042737435,1.4904613312864372,0.5757589463556079,0.10858948053994623,0.5462476753068062,Upregulated
Feature1243,Etilevodopa,C11 H15 N O4,225.1001,NA,NA,Etilevodopa-peak2,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Lignin,37019978.720674396,32536634.223319963,0.8788939201942156,-0.1862390478863174,0.24886494938352713,0.6202424088784857,Downregulated
Feature1242,NA,C11 H20 N2 O8,308.12197,NA,NA,Feature1242,11,20,8,2,0,0,1.818181818181818,0.7272727272727273,0.18181818181818168,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,3155051.0013554767,7264642.44360257,2.302543585026526,1.2032284654616674,0.17724654384437807,0.5646729954371317,Upregulated
Feature1241,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide-peak2,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,660462.6199810617,682078.2946222844,1.0327280817828002,0.04646044132323586,0.8997448690954561,0.953701139936653,Upregulated
Feature1240,cis-4-Decenedioic acid,C10 H16 O4,200.10487,NA,NA,cis-4-Decenedioic acid,10,16,4,0,0,0,1.6,0.4,-0.7999999999999998,83.1,3,-1,-0.16666666666666666,0.125,-1,Protein,30372270.24001157,27558389.927565735,0.9073536390197494,-0.1402631474149251,0.596735899291638,0.7885106188767821,Downregulated
Feature1239,EDDA,C6 H12 N2 O4,176.07974,Other,NA,EDDA,6,12,4,2,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,30633963.125178333,43346083.169183366,1.4149681839094734,0.5007696138825506,0.07029684228877171,0.5434560019812327,Upregulated
Feature1238,Leucylasparagine,C10 H19 N3 O4,245.13753,NA,NA,Leucylasparagine-peak4,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,24763046.9981734,32583919.484355167,1.3158283585521062,0.3959713109457824,0.20488273444354693,0.578980340903384,Upregulated
Feature1237,Neolinustatin,C17 H29 N O11,423.17418,NA,NA,Neolinustatin,17,29,11,1,0,0,1.7058823529411764,0.6470588235294118,-0.23529411764705888,67.00588235294117,4,-7,-1.6,-0.23809523809523808,-8,Amino Sugar,1399381.7244334642,5361916.550880427,3.8316325397569297,1.9379592107374721,0.1079501274078873,0.5462476753068062,Upregulated
Feature1236,NA,C12 H19 N3 O4 S,301.10964,NA,NA,Feature1236,12,19,4,3,1,0,1.5833333333333333,0.3333333333333333,0,60.3,5,1,-0.75,-0.16666666666666666,-3,Protein,349083.02414393297,328015.590764063,0.939649218315516,-0.0898058119757064,0.6507239332420365,0.8233015940783776,Downregulated
Feature1235,ARG-PHE,C15 H23 N5 O3,321.18018,NA,NA,ARG-PHE-peak2,15,23,3,5,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.0588235294117647,-1,Lipid,17754797.7976727,31277034.736949902,1.761610303500595,0.8168948122334372,0.03646196643109577,0.5434560019812327,Upregulated
Feature1234,Gly-Phe,C11 H14 N2 O3,222.10044,NA,NA,Gly-Phe-peak2,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,21602102.8545864,34814313.98628477,1.6116168976990706,0.6885088372427636,0.08122588376396797,0.5434560019812327,Upregulated
Feature1233,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",C9 H16 N2 O4,216.11101,Metabolic pathways;Other,Other,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,27515495.4735636,36619434.431467734,1.3308658921534244,0.4123652019989098,0.3756380770852383,0.6762283768144459,Upregulated
Feature1232,N-Acetyl-6-oxo-L-norleucine,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetyl-6-oxo-L-norleucine,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,1106833.7852921314,1053588.1836395983,0.9518937690915537,-0.07112751647629979,0.7256327189377805,0.8674818813553988,Downregulated
Feature1231,Hymexazol N-glucoside,C10 H15 N O7,261.08485,NA,NA,Hymexazol N-glucoside,10,15,7,1,0,0,1.5,0.7,0.20000000000000015,54.599999999999994,4,-3,-2,-0.09090909090909093,-4,Amino Sugar,458439.212852273,379347.75436412834,0.8274766724337104,-0.2732094537089922,0.5540483888417443,0.768050712518752,Downregulated
Feature1230,"(2Z,4E)-2,4-Pentadecadienal",C15 H26 O,222.19833,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2Z,4E)-2,4-Pentadecadienal",15,26,1,0,0,0,1.7333333333333334,0.06666666666666667,-1.5999999999999996,105.89999999999998,3,2,0.14285714285714285,0.1724137931034483,2,Lipid,733518.1747389063,558391.0683879796,0.7612504878788278,-0.39355684725737117,0.27577991255607637,0.6292487790932914,Downregulated
Feature1229,pro-his,C11 H16 N4 O3,252.12227,NA,NA,pro-his,11,16,3,4,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818168,55.11818181818182,6,3,-0.25,0.09090909090909093,-1,Lignin,16534284.20455678,23793424.983697202,1.4390356842384404,0.5251023675024841,0.3012450402658925,0.6452426827392128,Upregulated
Feature1228,N-[(2S)-2-Hydroxypropanoyl]-L-tryptophan,C14 H16 N2 O4,276.11103,NA,NA,N-[(2S)-2-Hydroxypropanoyl]-L-tryptophan,14,16,4,2,0,0,1.1428571428571428,0.2857142857142857,-0.14285714285714324,64.37142857142858,8,4,0.25,0.4,2,Lignin,7953015.526402573,13116431.275018632,1.6492399934935942,0.7218013516134683,0.045496831545250804,0.5434560019812327,Upregulated
Feature1227,NA,C21 H35 N O16,557.19585,NA,NA,Feature1227,21,35,16,1,0,0,1.6666666666666667,0.7619047619047619,0,60.3,5,-11,-3,-0.3333333333333333,-12,Carbohydrate,5367431.672408007,9025919.34328799,1.681608615473751,0.7498419658669483,0.22131973755440273,0.5917165652855003,Upregulated
Feature1226,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,C11 H23 N3 O2,229.17901,NA,NA,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,11,23,2,3,0,0,2.090909090909091,0.18181818181818185,-0.9090909090909092,86.2090909090909,2,0,-0.5,-0.2857142857142857,-3,Lipid,1275398.65063168,1199435.5790087397,0.9404397428323158,-0.08859258654768908,0.8028285997539487,0.9042497659462694,Downregulated
Feature1225,NA,C12 H19 N O8,305.11113,NA,NA,Feature1225,12,19,8,1,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,937069.1513973504,862280.9459925836,0.920189235454776,-0.11999751526303544,0.660798723337207,0.8289195086767364,Downregulated
Feature1224,NA,C18 H33 N O15,503.18519,NA,NA,Feature1224,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,18627570.5189434,21417226.332736067,1.149759508947005,0.20133212940209047,0.472445007033829,0.7177774366953421,Upregulated
Feature1223,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C11 H21 N O7,279.13182,NA,NA,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)-peak1",11,21,7,1,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,32541249.163534466,34602428.36586683,1.0633405064438064,0.08860365547212536,0.36882509915685535,0.6732647822971045,Upregulated
Feature1222,2762577,C15 H23 N3 O4,309.16894,NA,NA,2762577-peak2,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,8832823.0452224109,31563702.20505223,3.5734557392865165,1.8373199192073333,0.03344411993671476,0.5434560019812327,Upregulated
Feature1221,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10012,NA,NA,N-(Carboxymethyl)norleucine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,9500409.92551376,8786862.929604597,0.9248930307740826,-0.11264157563208231,0.5005676260276604,0.7334162931788414,Downregulated
Feature1220,2'-Deoxycytidine,C9 H13 N3 O4,227.0906,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxycytidine,9,13,4,3,0,0,1.4444444444444444,0.4444444444444444,0.44444444444444464,47.633333333333326,5,1,-1,0,-2,Lignin,5439837.938036436,10977385.80451408,2.0179619190046085,1.012898949577283,0.20273307070389507,0.5780722477745703,Upregulated
Feature1219,NA,C7 H17 N O6,211.10558,NA,NA,Feature1219,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,40848741.8283583,28238400.38891683,0.6912918030026808,-0.5326332759072404,0.13651634093848994,0.5560403073935072,Downregulated
Feature1218,NA,C20 H42 O5,362.30324,NA,NA,Feature1218,20,42,5,0,0,0,2.1,0.25,-1.5999999999999996,105.89999999999998,0,-5,-0.3333333333333333,-0.14285714285714285,-5,Lipid,868885.8407190354,4896475.9020560505,5.635350091565578,2.4945052394439013,0.4399297273943424,0.7009176491269988,Upregulated
Feature1217,leu-phe,C15 H22 N2 O3,278.16307,NA,NA,leu-phe-peak2,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,20822376.396337368,17613726.671219032,0.8459037689049396,-0.24143454504117226,0.4463535891923206,0.7027877448360436,Downregulated
Feature1216,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate-peak2,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,3508260.3910164735,5169721.137926614,1.4735853561966514,0.5593306297833064,0.2050697783601124,0.578980340903384,Upregulated
Feature1215,Tiglic acid,C5 H8 O2,100.05241,NA,NA,Tiglic acid-peak2,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,6258123.88854298,5783781.777780863,0.9242037838799396,-0.11371709868128217,0.6822360187755261,0.8393333924224875,Downregulated
Feature1214,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538-peak1,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,7787749.249521471,13512986.83948032,1.7351594673275652,0.795068257702987,0.4491370885962732,0.7027877448360436,Upregulated
Feature1213,"(2E,4E,7E)-2,4,7-Decatrienoic acid",C10 H14 O2,166.0994,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2E,4E,7E)-2,4,7-Decatrienoic acid",10,14,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Lignin,1447971.7915533881,1448632.52111966,1.0004563138385196,6.581715569443943e-4,0.9989120966934113,0.9989120966934113,Upregulated
Feature1212,NA,C32 H36 O10,580.23105,NA,NA,Feature1212,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,36416225.98042907,35885955.5602183,0.98543862231918955,-0.021162078548381813,0.9484796601093277,0.9747079432618944,Downregulated
Feature1211,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08922,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak2",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,36630982.04861837,29092938.025219534,0.7942167094129776,-0.3323953810488421,0.09755214404817598,0.5434560019812327,Downregulated
Feature1210,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,C14 H18 N2 O8,342.10633,Biosynthesis of secondary metabolites;Other,NA,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,14,18,8,2,0,0,1.2857142857142858,0.5714285714285714,0.2857142857142856,52.15714285714286,7,-1,-0.75,0.125,-3,Lignin,973217.7670786887,316724.6627999573,0.3254406911935762,-1.6195334464799822,0.42061548578397273,0.6943057388507786,Downregulated
Feature1209,10-Deoxymethymycin,C25 H43 N O6,453.30918,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,10-Deoxymethymycin,25,43,6,1,0,0,1.72,0.24,-1.12,92.22,5,-1,-0.1111111111111111,0.04761904761904761,-2,Lipid,2133626.4916980797,1435350.4120064767,0.6727280606945083,-0.5719046580641786,0.2774325710931974,0.6292487790932914,Downregulated
Feature1208,NA,C12 H22 N4 O7,334.14893,NA,NA,Feature1208,12,22,7,4,0,0,1.8333333333333333,0.5833333333333334,0.3333333333333335,50.8,4,-3,-7,-0.7777777777777778,-7,Amino Sugar,8373420.517074403,7540782.794019153,0.9005618168396772,-0.15110278512215464,0.6978165429450165,0.8495004061817706,Downregulated
Feature1207,NA,C46 H84 N10 O13 P2 S,1078.54184,NA,NA,Feature1207,46,84,13,10,1,2,1.826086956521739,0.2826086956521739,-0.7826086956521738,82.60434782608695,11,-2,-0.75,-0.32075471698113206,-15,Lipid,432071.476058832,435970.80601883034,1.0090247335824303,0.012961538744938625,0.9642832723643824,0.981458812850857,Upregulated
Feature1206,Diethyl tartrate,C8 H14 O6,206.07905,NA,NA,Diethyl tartrate,8,14,6,0,0,0,1.75,0.75,-0.25,67.425,2,-4,-2,-0.2,-4,Carbohydrate,195626.425039691,237290.44240465466,1.2129774510601539,0.2785527313767537,0.18651062090563877,0.5646729954371317,Upregulated
Feature1205,NA,C9 H19 N O3,189.13649,NA,NA,Feature1205,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,1623994.0651297267,1436767.7303518334,0.8847124267274109,-0.1767195074372913,0.43758342409973994,0.7009176491269988,Downregulated
Feature1204,NA,C16 H5 O13 P3,497.89406,NA,NA,Feature1204,16,5,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,26415655.4257068,30028776.6788641,1.136779542090829,0.18495249664821886,0.43496478351571954,0.7009176491269988,Upregulated
Feature1203,5-guanidino-2-oxopentanoic acid,C6 H11 N3 O3,173.08005,Metabolic pathways;Other,NA,5-guanidino-2-oxopentanoic acid,6,11,3,3,0,0,1.8333333333333333,0.5,0.6666666666666665,41.3,3,0,-Inf,-1,-3,Protein,12711168.333207559,27595166.8000777,2.1709386640711954,1.1183189658008919,0.1357909073031668,0.5560403073935072,Upregulated
Feature1202,"(E,E)-alpha-Farnesene",C15 H24,204.18778,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,"(E,E)-alpha-Farnesene",15,24,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,532299.729630849,300910.36972359166,0.565302503407758,-0.8229050089926336,0.23446584413841093,0.6058888718354483,Downregulated
Feature1201,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Nicotinamide,6,6,1,2,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Lignin,24841849.5068594,6591392.512550106,0.26533420994801826,-1.914117398436694,0.05015379531282579,0.5434560019812327,Downregulated
Feature1200,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam-peak2,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,9353341.204029826,7841532.559562463,0.8383669951208441,-0.254346172993804,0.16824172093230283,0.5646729954371317,Downregulated
Feature1199,NA,C11 H17 N O5,243.11065,NA,NA,Feature1199,11,17,5,1,0,0,1.5454545454545454,0.4545454545454546,-0.3636363636363633,70.66363636363636,4,-1,-0.4,0.06666666666666667,-2,Protein,12360298.649827776,5600597.856566133,0.453111855565413,-1.1420608557648935,0.0567965095913632,0.5434560019812327,Downregulated
Feature1198,8722455,C11 H17 N O8,291.09546,NA,NA,8722455,11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,19581332.376859665,21042544.871719465,1.0746227308100134,0.10383025988951972,0.7938489669341408,0.9022120322538062,Upregulated
Feature1197,Fluoranthene,C16 H10,202.07833,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak4,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,16398828.092547633,15755652.7771738,0.9607791903333556,-0.05772319106279297,0.6904435829042184,0.8457675805262119,Downregulated
Feature1196,Nicotinic acid,C6 H5 N O2,123.03199,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Aminobenzoate degradation;Other,Other,Nicotinic acid,6,5,2,1,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Lignin,15142733.251348166,29345593.47172753,1.9379324052422886,0.9545182506691772,0.004147812453084554,0.5434560019812327,Upregulated
Feature1195,"2-oxa-4-azatetracyclo[6.3.1.1~6,10~.0~1,5~]tridecan-3-one",C11 H15 N O2,193.11027,NA,NA,"2-oxa-4-azatetracyclo[6.3.1.1~6,10~.0~1,5~]tridecan-3-one",11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Lignin,16844605.20846103,16366744.363275267,0.9716312232152681,-0.041519243392326814,0.6179449740742433,0.8003048823255108,Downregulated
Feature1194,2-methylbutyrylcarnitine,C12 H23 N O4,245.1627,NA,NA,2-methylbutyrylcarnitine,12,23,4,1,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,7112239.3898064,13672661.653397234,1.9224130269002957,0.9429183297876464,0.02938767106662203,0.5434560019812327,Upregulated
Feature1193,dihydropyranone,C5 H6 O2,98.03675,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak1,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,30260799.023958035,28619743.572290633,0.9457695928528475,-0.08043933599034887,0.8052501463575414,0.9063745833419768,Downregulated
Feature1192,"2,5-Furandicarboxylic acid",C6 H4 O5,156.00587,Microbial metabolism in diverse environments;Other,NA,"2,5-Furandicarboxylic acid",6,4,5,0,0,0,0.6666666666666666,0.8333333333333334,1,31.799999999999997,5,0,0,0.7142857142857143,0,Condensed HC,42568205.873623036,36852393.18602097,0.8657257788930256,-0.2080179753406725,0.22706487680805873,0.596353335368762,Downregulated
Feature1191,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak5",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,7840013.03843341,11661402.699274426,1.487421340003869,0.5728133757234701,0.2782156290440667,0.6300765716586216,Upregulated
Feature1190,MFCD00025555,C9 H18 N2 O3,202.13171,NA,NA,MFCD00025555-peak1,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,20849202.699899666,23471432.179955766,1.125771211388756,0.1709136606929263,0.6230577016300685,0.8031390289317553,Upregulated
Feature1189,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04732,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak2,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,554200.764918868,655801.3347380987,1.1833280938074933,0.24285013596263033,0.7032321051759232,0.8514861389326834,Upregulated
Feature1188,UNII:74D1OHC38H,C19 H32 O4,324.23008,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak2,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,2287950.0826353934,1279918.740009775,0.5594172485334515,-0.83800335771602,0.2871947744126051,0.6353376492471592,Downregulated
Feature1187,Meglutol,C6 H10 O5,162.05283,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak1,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,36187708.7250491,33322067.1948198,0.9208117443410916,-0.11902186068459589,0.6142066233760924,0.7991290476183568,Downregulated
Feature1186,NA,C7 H17 N O6,211.10569,NA,NA,Feature1186,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,20425314.5356051,31666282.723650567,1.5503449246008125,0.6325892255969232,0.08688315736071685,0.5434560019812327,Upregulated
Feature1185,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",C11 H19 N O7,277.11616,NA,NA,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",11,19,7,1,0,0,1.7272727272727273,0.6363636363636364,-0.18181818181818168,65.48181818181817,3,-4,-1.6666666666666667,-0.2307692307692308,-5,Amino Sugar,35377544.189667135,36371816.86357297,1.0281046267252274,0.039987090190172776,0.8742619086045249,0.9409146589428623,Upregulated
Feature1184,NP-019722,C8 H13 N O4,187.08445,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722-peak2,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,23753528.12068023,22379125.380108435,0.9421390063156463,-0.08598815933055191,0.6705333978261947,0.8312524847517372,Downregulated
Feature1183,Tolycaine,C15 H22 N2 O3,278.16307,NA,NA,Tolycaine-peak2,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,29584451.25724373,23237925.9833253,0.785477674784842,-0.34835782374079094,0.3089039290458711,0.6523468563546992,Downregulated
Feature1182,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Other,Thymine,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Lignin,5383833.036538834,7946084.581530207,1.4759158628438072,0.5616104803970972,0.03606139804926168,0.5434560019812327,Upregulated
Feature1181,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol-peak2,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,2483086.94685852,2717490.0201195,1.0943998652796008,0.13013995774099538,0.5699715643411942,0.7745472245276338,Upregulated
Feature1180,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin-peak1,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,584081.9449473947,603832.926209701,1.0338154285253334,0.04797863814814773,0.8283024362861112,0.9174960842656863,Upregulated
Feature1179,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Other,NA,pyroglutamine,5,8,2,2,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,19655702.2509909,23361037.0233292,1.1885119506300774,0.24915640982478784,0.2676073088082025,0.6292487790932914,Upregulated
Feature1178,pyr-gln-OH,C10 H15 N3 O5,257.10118,NA,NA,pyr-gln-OH,10,15,5,3,0,0,1.5,0.5,0.3999999999999999,48.9,5,0,-1.5,-0.1111111111111111,-3,Protein,3364678.09625509,1840988.260511204,0.5471513790755307,-0.8699880596254307,0.18890308696071545,0.5646729954371317,Downregulated
Feature1177,NA,C9 H17 N5 O2,227.1382,NA,NA,Feature1177,9,17,2,5,0,0,1.8888888888888888,0.2222222222222222,0.22222222222222232,53.96666666666666,4,2,-1.5,-0.6666666666666666,-3,Lipid,40341859.97530803,35143543.78977477,0.8711433684833821,-0.1990179248818743,0.24170519559335207,0.6138659690181985,Downregulated
Feature1176,NA,C5 H10 N6 O,170.09157,NA,NA,Feature1176,5,10,1,6,0,0,2,0.2,2,3.299999999999997,4,3,1.5,1.6666666666666667,-3,Lipid,17257141.116603334,17914871.55709245,1.0381135227466098,0.053964218019722524,0.9389321812445537,0.9692805595037932,Upregulated
Feature1175,NA,C15 H27 N O5,301.18898,NA,NA,Feature1175,15,27,5,1,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.04347826086956521,-3,Protein,2398045.5186026767,2449876.37447422,1.0216137915104067,0.030849906278340743,0.9020956447061683,0.953701139936653,Upregulated
Feature1174,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak4",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,6971483.675767303,8763354.033809554,1.2570285525118197,0.3300174199249869,0.4696386495700827,0.7150766004537328,Upregulated
Feature1173,Bis(4-ethylbenzylidene)sorbitol,C24 H30 O6,414.20433,NA,NA,Bis(4-ethylbenzylidene)sorbitol,24,30,6,0,0,0,1.25,0.25,-0.75,81.675,10,4,0.2222222222222222,0.3333333333333333,4,Lignin,32175095.383958258,12802801.480006233,0.39791028829053315,-1.3294848933328602,0.27617467269890095,0.6292487790932914,Downregulated
Feature1172,NA,C31 H40 O6,508.28264,NA,NA,Feature1172,31,40,6,0,0,0,1.2903225806451613,0.1935483870967742,-0.903225806451613,86.04193548387097,12,6,0.24,0.32142857142857145,6,Lignin,173241.252401292,146466.26583143533,0.8454468193993673,-0.24221408632164237,0.43860755460421214,0.7009176491269988,Downregulated
Feature1171,2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid,C14 H20 N2 O3,264.14741,Metabolic pathways;Other,NA,2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid,14,20,3,2,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,27689907.617268566,17853920.641025033,0.6447807947864223,-0.633119321987709,0.12843565338512203,0.5545833428603265,Downregulated
Feature1170,Troxipide,C15 H22 N2 O4,294.15799,NA,NA,Troxipide-peak4,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,21598277.746302266,25323406.550596133,1.1724734188554282,0.22955521577250615,0.4919439339509171,0.7329402146990797,Upregulated
Feature1169,N6-Acetyl-L-lysine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,N6-Acetyl-L-lysine,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,12858921.66363965,6958073.4288847,0.5411086256602371,-0.886009855788282,0.36473984486281336,0.6716464598336302,Downregulated
Feature1168,Apocynin,C9 H10 O3,166.06303,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak2,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,3972980.346914993,20269003.922906555,5.101712606921243,2.3509816303697013,0.17274289942910337,0.5646729954371317,Upregulated
Feature1167,NA,C6 H9 O7 P,224.00856,NA,NA,Feature1167,6,9,7,0,0,1,1.5,1.1666666666666667,0,60.3,3,-4,2.5,-1,-5,Carbohydrate,19330289.093688633,32603669.043398432,1.6866622576298447,0.7541711129115486,0.02400639124646919,0.5434560019812327,Upregulated
Feature1166,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.2981,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak2,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,148540.07960053734,7059453.4687599065,47.52558021878406,5.570632335094227,0.18858511420637544,0.5646729954371317,Upregulated
Feature1165,Glycylproline,C7 H12 N2 O3,172.08476,NA,NA,Glycylproline,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,16318950.510720767,28788377.7918369,1.76410718158158,0.8189382171531998,0.07425937090703133,0.5434560019812327,Upregulated
Feature1164,Phosphoric acid,H3 O4 P,97.97687,ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of purine nucleotide salvage;Other,Phosphoric acid,0,3,4,0,0,1,Inf,Inf,NA,NA,0,-4,1,1,-5,Other,19987509.001344234,22990520.3694243,1.1502444035361334,0.20194043708857484,0.27444167958626103,0.6292487790932914,Upregulated
Feature1163,arg-val,C11 H23 N5 O3,273.18012,NA,NA,arg-val,11,23,3,5,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818168,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,16397260.203170836,26411811.237878602,1.6107453873770443,0.6877284633809229,0.2529127506014062,0.6262438905425377,Upregulated
Feature1162,NA,C52 H85 N10 O8 P3,1070.57651,NA,NA,Feature1162,52,85,8,10,0,3,1.6346153846153846,0.15384615384615383,-1.0384615384615383,89.89615384615384,17,9,-0.12903225806451613,0,-4,Lipid,160306.88351548434,140847.20606251,0.8786098449035428,-0.18670542983644559,0.5632710062802954,0.7719911688016345,Downregulated
Feature1161,Glycylglutamic acid,C7 H12 N2 O5,204.07457,NA,NA,Glycylglutamic acid,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,14453783.23441355,24476374.999490835,1.6934234174215457,0.7599427445501777,0.10443372026467367,0.5434560019812327,Upregulated
Feature1160,NA,C12 H22 N4 O6,318.15394,NA,NA,Feature1160,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,5019617.39603143,4270490.535418769,0.8507601672579808,-0.2331756072453956,0.6706074535401252,0.8312524847517372,Downregulated
Feature1159,NA,C12 H22 N4 O6,318.1539,NA,NA,Feature1159,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,4467961.686825033,2424218.2394042932,0.5425781171205523,-0.8820972318571282,0.3699501401195138,0.6743129559814706,Downregulated
Feature1158,AC-LYS-OH,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,26101569.274183866,28062012.796531934,1.075108262716107,0.10448194560008994,0.4967680580593982,0.7334162931788414,Upregulated
Feature1157,Cytidine 5'-monophosphate (hydrate),C9 H14 N3 O8 P,323.05194,Metabolic pathways;Other,Other,Cytidine 5'-monophosphate (hydrate)-peak2,9,14,8,3,0,1,1.5555555555555556,0.8888888888888888,0.6666666666666665,41.3,5,-3,2.3333333333333335,-3,-7,Carbohydrate,10457750.719428763,7034416.391519956,0.6726509916182244,-0.5720699455704634,0.3390467951779514,0.6636048496469049,Downregulated
Feature1156,Trachelogenin,C21 H24 O7,388.1523,NA,NA,Trachelogenin,21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,30041924.767751236,24775082.10490177,0.8246835812429966,-0.2780874098751818,0.441209239714865,0.7009176491269988,Downregulated
Feature1155,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",C12 H14 N2 O5,266.0903,NA,NA,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",12,14,5,2,0,0,1.1666666666666667,0.4166666666666667,0.16666666666666652,55.55,7,2,0,0.3333333333333333,0,Lignin,25290208.6178643,15336544.52663214,0.6064222228597526,-0.7216054716189508,0.33164121941425706,0.6632819814140921,Downregulated
Feature1154,Leu-arg,C12 H25 N5 O3,287.19576,NA,NA,Leu-arg-peak2,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,15672532.2396385,27684124.9261274,1.7664104627655217,0.8208206225951306,0.015786699121726998,0.5434560019812327,Upregulated
Feature1153,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13724,NA,NA,L-gamma-Glutamyl-L-leucine-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,14154304.27520007,10209381.449537914,0.72129164747616,-0.4713453773196871,0.3418312254814502,0.6636491383576648,Downregulated
Feature1152,Pipecolic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid-peak1,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,2555511.895622417,2585870.6304015866,1.0118797078703388,0.01703779282470652,0.8484350313746412,0.930860714474509,Upregulated
Feature1151,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin-peak1,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,379451.9206672153,363041.83639843663,0.956753192235992,-0.06378128538987889,0.7800200892138278,0.8982992411548629,Downregulated
Feature1150,NA,C11 H14 N O P S,239.05347,NA,NA,Feature1150,11,14,1,1,1,1,1.2727272727272727,0.09090909090909093,-1.0909090909090908,91.39090909090908,6,5,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,186229.55556932933,179713.88302296534,0.9650126827267311,-0.051380191691387495,0.7949709027407373,0.9022552886981726,Downregulated
Feature1149,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",C13 H21 N O2,223.15721,NA,NA,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",13,21,2,1,0,0,1.6153846153846154,0.15384615384615383,-1.0769230769230766,90.99230769230768,4,2,0.1,0.18181818181818185,1,Lipid,41509381.25187653,29062348.69529043,0.700139289452227,-0.5142861268134756,0.23084857405525186,0.6025539051611659,Downregulated
Feature1148,NA,C16 H21 N5 O9,427.13398,NA,NA,Feature1148,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,21106477.329973098,19210136.718450066,0.9101536186320368,-0.1358180263515212,0.5411673992572209,0.7595174601008552,Downregulated
Feature1147,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12155,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak5",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,24205794.910262767,24223913.580296468,1.0007485261318982,0.0010794909752469327,0.9977211989362575,0.9983105203768579,Upregulated
Feature1146,NA,C4 H11 O6 P,186.02935,NA,NA,Feature1146,4,11,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,734237.0390450847,1743175.9629230131,2.3741324262122605,1.2474004089947004,0.11056948911428428,0.5462476753068062,Upregulated
Feature1145,NA,C13 H19 N O6,285.1213,NA,NA,Feature1145,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Lignin,581402.7527873497,391461.6878955447,0.6733055287729662,-0.5706667834811159,0.1945831517763166,0.5699904136593773,Downregulated
Feature1144,Kanosamine,C6 H13 N O5,179.07944,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,28726448.281587232,26409056.835853934,0.9193289952514362,-0.1213468515676017,0.25343634285788547,0.6262438905425377,Downregulated
Feature1143,asn-leu,C10 H19 N3 O4,245.13755,NA,NA,asn-leu-peak3,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,23256459.104510702,28730459.431218933,1.2353754843808755,0.30494960628067164,0.1592191794028114,0.5574792106914738,Upregulated
Feature1142,NA,C15 H29 N O12,415.16907,NA,NA,Feature1142,15,29,12,1,0,0,1.9333333333333331,0.8,-0.13333333333333375,64.10000000000001,2,-10,-5.5,-0.625,-11,Carbohydrate,4765205.762004817,3890496.7488246234,0.8164383540046367,-0.2925841371216189,0.5901681503092413,0.7841136051951803,Downregulated
Feature1141,mebutamate,C10 H20 N2 O4,232.14229,Other,NA,mebutamate-peak3,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,15079555.003090417,26680086.0431757,1.7692886850910297,0.8231694638393457,0.06374617766310811,0.5434560019812327,Upregulated
Feature1140,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12155,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak4",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,19523531.63500921,28251554.246507633,1.447051423618845,0.5331161915874418,0.2261711851310717,0.5958985050006134,Upregulated
Feature1139,Ser-Glu,C8 H14 N2 O6,234.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,Ser-Glu,8,14,6,2,0,0,1.75,0.75,0.5,46.05,3,-3,-Inf,-0.6666666666666666,-5,Carbohydrate,15874107.071237465,28013554.769424498,1.7647326330677637,0.8194496236291393,0.028042779679117783,0.5434560019812327,Upregulated
Feature1138,Apocynin,C9 H10 O3,166.06304,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak1,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,2665635.6511629634,17933259.203649644,6.727573288504647,2.7500862023110724,0.18218720082434076,0.5646729954371317,Upregulated
Feature1137,Adenosine 5'-monophosphate,C10 H14 N5 O7 P,347.06316,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of chorismate metabolism;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,Adenosine 5'-monophosphate,10,14,7,5,0,1,1.4,0.7,1,31.799999999999997,7,0,2,-5,-6,Tannin,32931621.1023398,13456942.375497568,0.4086328557491343,-1.291122887584015,0.09297509773638593,0.5434560019812327,Downregulated
Feature1136,Ethyl lactate,C5 H10 O3,118.06297000000001,Metabolic pathways;Other,NA,Ethyl lactate,5,10,3,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,2709500.5888027768,2145764.502831,0.7919409619981408,-0.3365352113087623,0.13193452607598086,0.5545833428603265,Downregulated
Feature1135,Furan,C4 H4 O,68.02622,Other,NA,Furan-peak2,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,18900397.624582484,6844263.46906191,0.3621227238182563,-1.4654493836593658,0.39375126779478103,0.6830003585350376,Downregulated
Feature1134,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,10823953.988141917,20196831.170126468,1.8659383800275686,0.8999013440157653,0.0916791932863489,0.5434560019812327,Upregulated
Feature1133,Acetylcholine,C7 H15 N O2,145.11029,NA,NA,Acetylcholine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,2999657.8258281667,3036682.36071078,1.01234291943695,0.01769806905389394,0.9379448002436921,0.9692805595037932,Upregulated
Feature1132,3-Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,3-Methylhippuric acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,10888010.271796381,4007240.39327752,0.36804156987779707,-1.4420593686336098,0.30129100475012827,0.6452426827392128,Downregulated
Feature1131,glycidyl oleate,C21 H38 O3,338.28215,NA,NA,glycidyl oleate,21,38,3,0,0,0,1.8095238095238095,0.14285714285714285,-1.5238095238095235,103.72857142857144,3,0,0,0.07692307692307693,0,Lipid,1569558.0598642034,1431439.19133359,0.9120014276231596,-0.13289201213852894,0.8109711836948682,0.9088169879054063,Downregulated
Feature1130,Lys-phe,C15 H23 N3 O3,293.17394,NA,NA,Lys-phe-peak2,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,14639214.617631,21802034.87878853,1.4892899276530083,0.5746246380506337,0.12972570002249534,0.5545833428603265,Upregulated
Feature1129,2805789,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,2805789,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,29072231.107877433,28301827.561621767,0.9735003638559093,-0.03874657671938055,0.5629400011512924,0.7719911688016345,Downregulated
Feature1128,Muramic acid,C9 H17 N O7,251.10052,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak1,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,15389871.859152267,20535616.775746834,1.3343591787955287,0.41614705911548105,0.44636078502154136,0.7027877448360436,Upregulated
Feature1127,val-arg,C11 H23 N5 O3,273.18012,NA,NA,val-arg,11,23,3,5,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818168,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,19693279.12878227,28877212.5231246,1.4663486123506857,0.5522281331577438,0.32322894434821814,0.6622100705596555,Upregulated
Feature1126,NP-001346,C11 H15 N5 O3 S,297.08963,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,NP-001346,11,15,3,5,1,0,1.3636363636363635,0.2727272727272727,0.7272727272727271,39.57272727272728,7,4,-1,-0.14285714285714285,-2,Lignin,20215214.594067767,22812451.139395066,1.128479296286544,0.17437995028098752,0.4664197025668279,0.7150766004537328,Upregulated
Feature1125,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",C8 H15 N O5,205.09502,NA,NA,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,25343866.557171065,25967257.953660365,1.0245973279208618,0.03505703446089381,0.9252624410559556,0.9660448321014614,Upregulated
Feature1124,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose-peak2",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,4166381.32611328,1970806.1523551333,0.47302587019648834,-1.080009006917716,0.11841365266070977,0.5462476753068062,Downregulated
Feature1123,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10594,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,5,2,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Lignin,490248.346427311,1925722.70565293,3.928055483892298,1.9738153079038627,0.13684361143141896,0.5560403073935072,Upregulated
Feature1122,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine-peak1,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,356687.2877992387,475050.95349343866,1.3318415590992996,0.4134224641676898,0.17348416911788,0.5646729954371317,Upregulated
Feature1121,L-Theanine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,L-Theanine,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,10684674.543869717,25598795.153660033,2.3958422924867864,1.2605329451319176,0.02615134337681315,0.5434560019812327,Upregulated
Feature1120,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08948,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak2",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,295366.359006408,378415.812765548,1.2811743830221987,0.35746685694337726,0.7357536761248777,0.87331587821579,Upregulated
Feature1119,Fluoranthene,C16 H10,202.07831,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak3,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,24778453.217921566,24719912.765782632,0.9976374452584235,-0.003412478682500981,0.9917823756299552,0.9958976551968844,Downregulated
Feature1118,Icacine,C22 H31 N O6,405.21526,NA,NA,Icacine-peak2,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,578092.8645458753,485154.16373252537,0.8392322297796244,-0.2528580108111062,0.39953412721616605,0.685393667249696,Downregulated
Feature1117,NA,C5 H13 N O5,167.07939,NA,NA,Feature1117,5,13,5,1,0,0,2.6,1,0,60.3,0,-5,6,-2.3333333333333335,-6,Other,24659386.708977565,28090011.524369933,1.1391204435000568,0.1879202966979951,0.5190951396422298,0.7430834801967906,Upregulated
Feature1116,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak3,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,11721332.469346367,13760613.843341133,1.1739803370758313,0.23140824504017138,0.5588575972136474,0.7717510790914595,Upregulated
Feature1115,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak3,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,17871953.463939466,25399241.9624009,1.4211788327252175,0.5070881062010134,0.13964952282293727,0.5574792106914738,Upregulated
Feature1114,NA,C42 H55 N10 O17 P3,1064.29584,NA,NA,Feature1114,42,55,17,10,0,3,1.3095238095238095,0.4047619047619048,-0.14285714285714324,64.37142857142858,22,5,-0.6666666666666666,0.02439024390243902,-8,Lignin,29550317.8779399,30474228.405960202,1.0312656713825075,0.04441604309570454,0.8621192804641931,0.9385797307881382,Upregulated
Feature1113,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature1113,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,104792.44776460294,98279.46594371853,0.9378487480747216,-0.09257282459613732,0.767454502352235,0.8941320009755906,Downregulated
Feature1112,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,NA,Cytidine 5'-diphosphocholine,14,26,11,4,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,3504313.0160261565,1633316.3237196368,0.4660874517344901,-1.1013274225256617,0.005333361155949592,0.5434560019812327,Downregulated
Feature1111,Pro-tyr,C14 H18 N2 O4,278.1267,Metabolic pathways;Biosynthesis of cofactors;Other,NA,Pro-tyr,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,10011842.160846973,12670376.466139866,1.2655389750039756,0.33975193904014034,0.4497929150358167,0.7027877448360436,Upregulated
Feature1110,NA,C18 H28 O,260.21405,NA,NA,Feature1110,18,28,1,0,0,0,1.5555555555555556,0.05555555555555555,-1.4444444444444446,101.46666666666668,5,4,0.2352941176470588,0.2571428571428571,4,Lipid,2212954.03941317,1710080.7320043433,0.7727592627535191,-0.3719090526968093,0.5449652097766436,0.7610643572643316,Downregulated
Feature1109,Pogostone,C12 H16 O4,224.10484,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,Pogostone,12,16,4,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,5,1,0.125,0.3,1,Lignin,119902.08605654801,108445.75381685367,0.9044526028155063,-0.144883193450115,0.22653992752089433,0.5958985050006134,Downregulated
Feature1108,NA,C13 H18 O9,318.09513,NA,NA,Feature1108,13,18,9,0,0,0,1.3846153846153846,0.6923076923076923,0,60.3,5,-4,-1,0.0588235294117647,-4,Tannin,1188201.7443499274,1260377.6120046186,1.0607437819359364,0.08507622159684933,0.9261747304640319,0.9660448321014614,Upregulated
Feature1107,D-lysopine,C9 H18 N2 O4,218.12664,Lysine degradation,NA,D-lysopine-peak5,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,16524219.195246983,24565202.9833419,1.486618078172663,0.5720340572776467,0.14426713886672432,0.5574792106914738,Upregulated
Feature1106,Acetylarginine,C8 H16 N4 O3,216.12223,NA,NA,Acetylarginine,8,16,3,4,0,0,2,0.375,0.25,53.175,3,0,-4,-1,-4,Protein,3353929.5857902034,3826688.9890396297,1.140956866015433,0.19024425143211263,0.4008941891338429,0.685393667249696,Upregulated
Feature1105,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11096,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak2,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,17259304.5444362,22654692.213713866,1.3126074782090191,0.39243555758316684,0.2926590305839474,0.6380494180298673,Upregulated
Feature1104,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",C11 H17 N O8,291.09544,NA,NA,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,33189433.517544765,28939887.780725468,0.8719608837381065,-0.197664677892987,0.23211689071252992,0.6032124274284134,Downregulated
Feature1103,NA,C6 H15 N O4 S,197.07221,NA,NA,Feature1103,6,15,4,1,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,415611.60077071865,621713.625441745,1.4959005578497486,0.5810142731764661,0.518144734623785,0.7430834801967906,Upregulated
Feature1102,NA,C10 H25 N10 O4 P,380.1797,NA,NA,Feature1102,10,25,4,10,0,1,2.5,0.4,0.7999999999999998,37.5,4,0,2.2,3,-11,Other,953152.938562652,928631.490923669,0.9742733336415442,-0.037601515836315165,0.7989819823872326,0.9022552886981726,Downregulated
Feature1101,4149853,C21 H41 N O4,371.30356,NA,NA,4149853,21,41,4,1,0,0,1.9523809523809523,0.1904761904761905,-1.4285714285714288,101.01428571428572,2,-2,-0.1875,-0.05555555555555555,-3,Lipid,2286678.209363343,4277638.763113179,1.8706780628762625,0.9035612971915677,0.37206130253843195,0.6751790275958873,Upregulated
Feature1100,Terpendole I,C27 H35 N O5,453.2516,Biosynthesis of secondary metabolites;Other,NA,Terpendole I,27,35,5,1,0,0,1.2962962962962965,0.18518518518518515,-0.8148148148148149,83.52222222222223,11,6,0.23809523809523808,0.3191489361702128,5,Lignin,677706.705104067,1090133.5372966747,1.608562419534091,0.6857719202026781,0.33185863658555614,0.6632819814140921,Upregulated
Feature1099,mycosporine,C11 H19 N O6,261.12118,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak2,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,11710088.258761033,16640534.517448347,1.4210426215189749,0.5069498261724698,0.3794563479670907,0.6779003876754276,Upregulated
Feature1098,N-Benzylformamide,C8 H9 N O,135.06844,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,N-Benzylformamide,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,15828146.190928767,20208229.74240447,1.276727514305242,0.35245065056316766,0.3200998279952128,0.6620868237165941,Upregulated
Feature1097,Arg-Glu,C11 H21 N5 O5,303.15426,NA,NA,Arg-Glu,11,21,5,5,0,0,1.9090909090909092,0.4545454545454546,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,14041436.96176463,24900551.514296833,1.7733620556145349,0.8264871118232106,0.11374828705813789,0.5462476753068062,Upregulated
Feature1096,Mesalazine,C7 H7 N O3,153.04261,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,Mesalazine,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,17497888.954541035,20411329.309298266,1.166502391364253,0.2221892648924614,0.5512220666366561,0.7653853941659798,Upregulated
Feature1095,Fluoranthene,C16 H10,202.07828,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak2,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,24989041.5125542,25348127.402379733,1.014369734415189,0.020583605774788325,0.9367347973765354,0.9692805595037932,Upregulated
Feature1094,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak3,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,935811.912823788,1231178.8944500394,1.3156264390084427,0.39574990617368166,0.5473383899904553,0.7624927900031507,Upregulated
Feature1093,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate-peak1,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,17425409.461225398,13186689.761823833,0.7567506399873436,-0.4021101047405182,0.34134464253723207,0.6636491383576648,Downregulated
Feature1092,1726033,C6 H13 N O6,195.07432,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak2,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,21376068.622189235,22971724.245480265,1.0746468235807718,0.1038626043861185,0.6947614101730317,0.8467092293763423,Upregulated
Feature1091,Hydrocotarnine,C12 H15 N O3,221.10517,NA,NA,Hydrocotarnine,12,15,3,1,0,0,1.25,0.25,-0.5,74.55,6,3,0.25,0.3684210526315789,2,Lignin,23089909.5212477,22577561.877015367,0.9778107556566706,-0.03237282019461772,0.7502961440499875,0.8811551295896695,Downregulated
Feature1090,Norharman,C11 H8 N2,168.06878,NA,NA,Norharman,11,8,0,2,0,0,0.7272727272727273,0,-0.18181818181818168,65.48181818181817,9,9,0.7777777777777778,0.7777777777777778,7,Condensed HC,14656755.109553933,18465262.659531333,1.2598465705069222,0.3332480468626234,0.1740492191859879,0.5646729954371317,Upregulated
Feature1089,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11607,NA,Other,N1-Acetyl-5-methoxykynuramine-peak1,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,17953083.028389167,17408967.034216832,0.969692336780712,-0.044401012131645025,0.8696493928343497,0.9401315069951426,Downregulated
Feature1088,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature1088,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,7878973.978857074,9039293.87510254,1.1472678929209743,0.19820230736213254,0.5118187614063258,0.7400618707478572,Upregulated
Feature1087,4-Acetamidobutanoic acid,C6 H11 N O3,145.07388,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak1,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,25233282.588122133,26062155.060634233,1.0328483806899649,0.04662848607020139,0.7074473159414455,0.85469678804133,Upregulated
Feature1086,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak4,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,8998623.27783337,8516887.31525667,0.9464655928242515,-0.07937803477358002,0.8609547132375778,0.9385182009166388,Downregulated
Feature1085,NP-016455,C11 H18 N2 O4,242.12664,NA,NA,NP-016455-peak2,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,1198719.5535277857,1445838.2008110064,1.2061521784273561,0.2704119414104117,0.5815332684823941,0.7781337731510076,Upregulated
Feature1084,N-Acetylglucosaminitol,C8 H17 N O6,223.10552,NA,NA,N-Acetylglucosaminitol-peak1,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,900035.1076173519,688813.0871141504,0.7653180206910305,-0.3858687241615412,0.13368253998591337,0.5560403073935072,Downregulated
Feature1083,D-Alanyl-D-alanine,C6 H12 N2 O3,160.08481,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,D-Alanyl-D-alanine,6,12,3,2,0,0,2,0.5,0,60.3,2,-1,-3,-0.6,-3,Protein,23486056.9832982,26531743.325843267,1.1296806162358783,0.1759149509577027,0.4948129105493435,0.7334162931788414,Upregulated
Feature1082,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol-peak1,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,14805845.165053066,12919841.426268034,0.8726176237992374,-0.19657848352568374,0.3703152358876294,0.6743129559814706,Downregulated
Feature1081,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08924,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak1",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,32075364.8491652,23850734.102071967,0.7435841872486981,-0.42743200405499465,0.07419756163561488,0.5434560019812327,Downregulated
Feature1080,NA,C23 H26 N4 O5,438.1904,NA,NA,Feature1080,23,26,5,4,0,0,1.1304347826086956,0.21739130434782608,-0.17391304347826075,65.25652173913043,13,8,0.2857142857142857,0.3939393939393939,4,Lignin,14157141.140642533,15154956.6218537,1.0704814249782835,0.09825976225848634,0.5200468924667225,0.7430834801967906,Upregulated
Feature1079,cys-val,C8 H16 N2 O3 S,220.08814,NA,NA,cys-val-peak2,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,574215.9962984247,763210.8173860763,1.32913541647389,0.41048809838595773,0.02541758948831297,0.5434560019812327,Upregulated
Feature1078,"Methyl (3,5-dihydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)acetate",C11 H11 N O5,237.06372,NA,NA,"Methyl (3,5-dihydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)acetate",11,11,5,1,0,0,1,0.4545454545454546,0.18181818181818168,55.11818181818182,7,2,0.2,0.4666666666666667,1,Lignin,23613867.005378768,22842826.031571332,0.9673479581454487,-0.04789316982330233,0.3265483807054851,0.6622174503652659,Downregulated
Feature1077,NA,C29 H30 O10,538.18408,NA,NA,Feature1077,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,30795009.815588832,22691603.570919935,0.7368597609419547,-0.4405380229826577,0.12067778910569103,0.5462476753068062,Downregulated
Feature1076,2'-O-Methyladenosine,C11 H15 N5 O4,281.11245,NA,NA,2'-O-Methyladenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Lignin,5523932.908335891,12977800.012601595,2.3493768349390063,1.2322781370600433,0.03559115367253023,0.5434560019812327,Upregulated
Feature1075,Kanosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,23385855.669417534,26600583.116937168,1.1374646065110048,0.185821654932898,0.06794112417951349,0.5434560019812327,Upregulated
Feature1074,NA,C4 H N4 O7 P3,309.90566,NA,NA,Feature1074,4,1,7,4,0,3,0.25,1.75,2.5,-10.950000000000005,8,1,0.6,0.38461538461538464,-6,Other,28111368.586642932,25286453.145785768,0.8995098572966875,-0.15278900352163716,0.2849943953140504,0.6352375074500018,Downregulated
Feature1073,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid-peak1,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,2292702.5445033233,1145468.5737376981,0.4996149964956947,-1.0011113132071818,0.0031734960077539455,0.5434560019812327,Downregulated
Feature1072,Imidazoleacetic acid,C5 H6 N2 O2,126.04288,Metabolic pathways;Other,Other,Imidazoleacetic acid,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Lignin,10124843.2362331,8687250.008027647,0.8580132852762762,-0.22092810863828255,0.35118572440867896,0.6670930191369346,Downregulated
Feature1071,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10594,NA,NA,α-Aspartylphenylalanine-peak2,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,16822350.604053833,23178114.528948635,1.3778166365979316,0.462383903228903,0.1311522928831798,0.5545833428603265,Upregulated
Feature1070,Indole-3-lactic acid,C11 H11 N O3,205.07389,Metabolic pathways;Other,Other,Indole-3-lactic acid,11,11,3,1,0,0,1,0.2727272727272727,-0.18181818181818168,65.48181818181817,7,4,0.42857142857142855,0.5294117647058824,3,Lignin,24228333.3766261,24794189.7987362,1.0233551525527547,0.033306915275672234,0.35626705640236384,0.6692796802688192,Upregulated
Feature1069,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10622,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak3,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,18188898.637502767,23200398.188923534,1.2755251789180797,0.35109137807932117,0.10326264845259503,0.5434560019812327,Upregulated
Feature1068,Dicyclomine,C19 H35 N O2,309.26682,NA,NA,Dicyclomine,19,35,2,1,0,0,1.8421052631578947,0.10526315789473684,-1.473684210526316,102.3,3,1,0,0.0588235294117647,0,Lipid,5551812.007697555,9622818.36669313,1.7332752538002274,0.7935007807297477,0.7120507064555877,0.8576248643440788,Upregulated
Feature1067,Maltol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Maltol,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,8854794.420303829,18605028.463210132,2.101124834761748,1.071161879831747,0.06878193759228048,0.5434560019812327,Upregulated
Feature1066,Proacaciberin,C16 H25 N O10,391.14794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,Proacaciberin,16,25,10,1,0,0,1.5625,0.625,-0.125,63.8625,5,-5,-1.2,-0.1,-6,Amino Sugar,606162.024077565,682152.1845240337,1.125362786562071,0.17039016233251247,0.7282681327224247,0.8691848843400948,Upregulated
Feature1065,N-Acetylvaline,C7 H13 N O3,159.08955,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,5811676.893536896,4199482.35915068,0.7225939149887839,-0.4687429890963426,0.11585855936227044,0.5462476753068062,Downregulated
Feature1064,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06372,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid-peak2,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,29832280.472190768,24697997.4453638,0.8278950537618781,-0.27248019553616165,0.10423864923196094,0.5434560019812327,Downregulated
Feature1063,N6-Me-Adenosine,C11 H15 N5 O4,281.11242,NA,NA,N6-Me-Adenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Lignin,185241.93357676535,317537.213905615,1.7141756608474705,0.7775149577865644,0.4093084466268467,0.6875574805825382,Upregulated
Feature1062,Prolylglycine,C7 H12 N2 O3,172.08478,NA,NA,Prolylglycine,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,11311688.137893107,10813499.95295195,0.9559581046729645,-0.0649807021049631,0.7914736976525054,0.9015670682202759,Downregulated
Feature1061,NA,C10 H22 N2 O6,266.14776,NA,NA,Feature1061,10,22,6,2,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-5,-3.5,-0.8,-7,Amino Sugar,727180.3981663993,482062.8299072407,0.6629205505577052,-0.5930921177390485,0.3328156341215929,0.6632819814140921,Downregulated
Feature1060,Acetyl-L-methionine,C7 H13 N O3 S,191.06162,NA,NA,Acetyl-L-methionine-peak2,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,1159377.1310445932,1357755.5973779634,1.1711077966102645,0.22787387727157124,0.4460631181791533,0.7027877448360436,Upregulated
Feature1059,NP-007735,C18 H24 O12,432.1269,NA,NA,NP-007735,18,24,12,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,7,-5,-0.8333333333333334,0.08333333333333333,-5,Tannin,123021.14288806901,1777272.0717319357,14.446883113002695,3.852686362529706,0.3218878937039006,0.6622100705596555,Upregulated
Feature1058,NA,C16 H28 N2 O8,376.18453,NA,NA,Feature1058,16,28,8,2,0,0,1.75,0.5,-0.375,70.9875,4,-4,-1,-0.2,-6,Protein,5026413.607366,8024675.583471483,1.596501245283845,0.6749136782222107,0.36698161879616664,0.6716464598336302,Upregulated
Feature1057,HC blue 2,C12 H19 N3 O5,285.1325,NA,NA,HC blue 2-peak2,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,33545937.2375738,20526946.394020967,0.6119055863202817,-0.7086190247394043,0.15212984245604777,0.5574792106914738,Downregulated
Feature1056,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Stavudine,10,12,4,2,0,0,1.2,0.4,0.20000000000000015,54.599999999999994,6,2,0,0.3333333333333333,0,Lignin,24535684.868587535,16118264.421712734,0.6569315064177634,-0.6061851360637054,0.18249612921799477,0.5646729954371317,Downregulated
Feature1055,val-his,C11 H18 N4 O3,254.1379,NA,NA,val-his,11,18,3,4,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909093,-2,Lipid,17734443.116181333,23958447.275637835,1.350955714745707,0.433980382906438,0.2276556042560239,0.5968370259975382,Upregulated
Feature1054,NA,C23 H32 N2 O12,528.19573,NA,NA,Feature1054,23,32,12,2,0,0,1.391304347826087,0.5217391304347826,-0.08695652173913082,62.77826086956522,9,-3,-0.5555555555555556,0.06666666666666667,-5,Lignin,1183904.2470000666,958051.7299034427,0.8092307569054517,-0.3053769405970669,0.09912357714863135,0.5434560019812327,Downregulated
Feature1053,lamifiban,C24 H28 N4 O6,468.20096,NA,NA,lamifiban-peak3,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,9229883.185206817,8813765.590724716,0.9549162664215476,-0.0665538615448475,0.6468446301354771,0.8201757510849538,Downregulated
Feature1052,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak3,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,7311651.74071899,5924090.00516967,0.8102259537579023,-0.30360379564664025,0.0068280467463414886,0.5434560019812327,Downregulated
Feature1051,NA,C6 H19 N4 O P,194.12956,NA,NA,Feature1051,6,19,1,4,0,1,3.1666666666666665,0.16666666666666666,-1.666666666666667,107.8,0,-1,-Inf,-11,-6,Other,1805837.1245278867,1357110.025295721,0.7515129724949697,-0.4121300869631155,0.4268077339132197,0.6954800040321182,Downregulated
Feature1050,ascopyrone M,C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,ascopyrone M,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,24079617.323408134,21635950.591269534,0.898517210663349,-0.15438195676053512,0.6116998783071971,0.7991290476183568,Downregulated
Feature1049,indospicine,C7 H15 N3 O2,173.11643,NA,NA,indospicine,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,1282288.4408543666,875806.5589424507,0.6830027714816769,-0.5500366622069032,0.34374907721163955,0.6654982134817341,Downregulated
Feature1048,Xanthine,C5 H4 N4 O2,152.03344,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Other,Other,Xanthine,5,4,2,4,0,0,0.8,0.4,2.4,-8.099999999999994,6,4,-0,Inf,0,Condensed HC,78816.34809170307,94426.36324830756,1.1980555498263152,0.2606948026183287,0.04126689330602529,0.5434560019812327,Upregulated
Feature1047,ser-gln,C8 H15 N3 O5,233.10121,NA,NA,ser-gln,8,15,5,3,0,0,1.875,0.625,0.5,46.05,3,-2,-Inf,-1,-5,Amino Sugar,20182734.442305084,22713275.698363934,1.1253814869978458,0.17041413575878955,0.7140226431954191,0.8584487988453087,Upregulated
Feature1046,Isovalerylglutamic acid,C10 H17 N O5,231.11068,NA,NA,Isovalerylglutamic acid-peak6,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,306262.1573556757,223690.584234243,0.7303892396162458,-0.4532625837637928,0.3512411063144659,0.6670930191369346,Downregulated
Feature1045,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak2,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,725992.3448538136,614246.1031956726,0.8460779339475786,-0.2411375358669296,0.5776890065107575,0.7755170614464124,Downregulated
Feature1044,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak3",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,6434856.7014068365,10039752.579923427,1.5602138549143543,0.6417437895226975,0.06052175816230106,0.5434560019812327,Upregulated
Feature1043,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak4,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1289196.8616356067,1385988.2724594134,1.0750788445924444,0.10444246868110114,0.6146958389360633,0.7991517660458105,Upregulated
Feature1042,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",C9 H12 O4,184.07358,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",9,12,4,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Lignin,22460774.863225933,18575738.133106235,0.8270301557369465,-0.273988160002332,0.024975886877880594,0.5434560019812327,Downregulated
Feature1041,NA,C26 H40 O3 S2,464.24195,Other,NA,Feature1041,26,40,3,0,2,0,1.5384615384615383,0.1153846153846154,-1.1538461538461542,93.1846153846154,7,4,0.09523809523809525,0.15555555555555556,2,Lipid,22876347.698215384,16066537.836757027,0.7023209320258058,-0.509797660884155,0.5381538551646174,0.7559142874368673,Downregulated
Feature1040,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid-peak2,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,27590786.3357253,27223505.075076435,0.9866882641118024,-0.019333745624384797,0.9523530988226456,0.9760437899599327,Downregulated
Feature1039,4-Oxo-4-(3-pyridyl)butyric acid,C9 H9 N O3,179.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,4-Oxo-4-(3-pyridyl)butyric acid,9,9,3,1,0,0,1,0.3333333333333333,0,60.3,6,3,0.4,0.5384615384615384,2,Lignin,22417077.630899835,21622845.93799757,0.9645702394406891,-0.052041796578641684,0.6201728357241959,0.8013522377702424,Downregulated
Feature1038,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",C21 H22 O7,386.13664,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",21,22,7,0,0,0,1.0476190476190477,0.3333333333333333,-0.3809523809523814,71.15714285714287,11,4,0.2857142857142857,0.42857142857142855,4,Lignin,4948527.255884304,15054669.4221969,3.0422525013468125,1.605139899059471,0.026256212400790048,0.5434560019812327,Upregulated
Feature1037,Pyridoxal,C8 H9 N O3,167.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak4,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,24894012.166858535,22086835.278693065,0.8872348551390735,-0.1726120518082254,0.30922935398631846,0.6523468563546992,Downregulated
Feature1036,nicotianamine,C12 H21 N3 O6,303.14313,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,nicotianamine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,31952433.354281865,16100552.650067616,0.503891283382022,-0.9888155949803678,0.09756069031225215,0.5434560019812327,Downregulated
Feature1035,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam-peak2,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,16437200.095362667,22325481.70621,1.3582289913541028,0.4417267320424372,0.16496648169185227,0.5646729954371317,Upregulated
Feature1034,N-(2-morpholinophenyl)-2-furamide,C15 H16 N2 O3,272.11607,NA,NA,N-(2-morpholinophenyl)-2-furamide,15,16,3,2,0,0,1.0666666666666669,0.2,-0.2666666666666666,67.89999999999999,9,6,0.4,0.4782608695652174,4,Lignin,24166005.7384126,24822383.361979067,1.0271611962138674,0.03866260690380771,0.6255558738181457,0.8047939832327067,Upregulated
Feature1033,17-Methyl-6Z-octadecenoic acid,C19 H36 O2,296.27159,NA,NA,17-Methyl-6Z-octadecenoic acid,19,36,2,0,0,0,1.894736842105263,0.10526315789473684,-1.6842105263157894,108.3,2,0,0,0.05555555555555555,0,Lipid,3880949.395376393,3292668.126499667,0.8484182067466325,-0.23715251397500284,0.7892506266432827,0.9015670682202759,Downregulated
Feature1032,NA,C23 H33 N3 O5,431.24203,NA,NA,Feature1032,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,108817.9734841909,101988.5777638143,0.9372401865086307,-0.09350928021497065,0.7653169186916935,0.8928697384736425,Downregulated
Feature1031,threonylphenylalanine,C13 H18 N2 O4,266.12655,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak5,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,137657.19412613,97201.03861538917,0.7061093990215114,-0.5020363742821846,0.264029730619007,0.6292487790932914,Downregulated
Feature1030,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak2",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,23519793.4328412,18039850.701287232,0.7670071913173266,-0.38268799065431924,0.1016511176991721,0.5434560019812327,Downregulated
Feature1029,NA,C27 H33 N8 O7 P,612.22109,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Feature1029,27,33,7,8,0,1,1.2222222222222223,0.25925925925925924,0,60.3,16,9,0,0.2413793103448276,0,Lignin,1003281.3025245407,11388023.242426,11.350777906226797,3.5047192684386164,0.28054873590157353,0.6311415121079224,Upregulated
Feature1028,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak1,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,445641.32337293465,368466.4217351373,0.8268228335431685,-0.27434986410098544,0.684889874509675,0.8413368001590931,Downregulated
Feature1027,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol-peak1,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,734527.9271824963,734117.5425436113,0.9994412947095705,-8.062666055089728e-4,0.9976563030208051,0.9983105203768579,Downregulated
Feature1026,Phenacetin,C10 H13 N O2,179.09465,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak3,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,26542394.70940084,1194667.1456869594,0.0450097724326219,-4.4736179192338374,0.10259559190017822,0.5434560019812327,Downregulated
Feature1025,(DL)-3-O-Methyldopa,C10 H13 N O4,211.08446,NA,NA,(DL)-3-O-Methyldopa,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,23652518.655940834,22907176.415234335,0.9684878278060551,-0.04619417809207496,0.6822062096878567,0.8393333924224875,Downregulated
Feature1024,NA,C18 H29 N3 O12,479.17524,NA,NA,Feature1024,18,29,12,3,0,0,1.6111111111111112,0.6666666666666666,0.22222222222222232,53.96666666666666,6,-6,-3,-0.3333333333333333,-9,Amino Sugar,1278035.74967454,1356741.4158171583,1.0615833056021016,0.08621758826004618,0.7805764362337415,0.8982992411548629,Upregulated
Feature1023,2181,C11 H15 N O2,193.11028,NA,NA,2181,11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Lignin,673102.442339749,664216.744516963,0.9867988923173437,-0.019171998674916067,0.9583832444277056,0.9780127807593575,Downregulated
Feature1022,NA,C12 H23 N5 O2,269.18519,NA,NA,Feature1022,12,23,2,5,0,0,1.9166666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,4,2,-0.6,-0.3333333333333333,-3,Lipid,25823758.818802234,20868362.945490133,0.8081071036915011,-0.3073815794789785,0.14372089753899853,0.5574792106914738,Downregulated
Feature1021,NA,C10 H23 N O7,269.14745,NA,NA,Feature1021,10,23,7,1,0,0,2.3,0.7,-0.5999999999999996,77.39999999999999,0,-7,-4,-0.8181818181818182,-8,Carbohydrate,3098183.44145277,3751361.186678447,1.2108260397000234,0.27599160682425705,0.04646608557152558,0.5434560019812327,Upregulated
Feature1020,N-Acetyl-L-leucine,C8 H15 N O3,173.10517,Other,NA,N-Acetyl-L-leucine-peak4,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,15911669.470805533,17117044.767188065,1.075754168888069,0.10534843119720509,0.5621970411393644,0.7719911688016345,Upregulated
Feature1019,NA,C20 H30 N4 O6,422.21665,NA,NA,Feature1019,20,30,6,4,0,0,1.5,0.3,-0.2999999999999998,68.85,8,2,-0.2,0.07692307692307693,-2,Lipid,1198005.9754934134,1106032.0354015767,0.9232274780149105,-0.11524193133951639,0.39476886946895334,0.683781661431909,Downregulated
Feature1018,MFCD03548046,C12 H16 N2 O4,252.111,NA,NA,MFCD03548046,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,20993273.8450513,17142642.334409967,0.8165778458823356,-0.2923376677470911,0.35559924056714565,0.6692796802688192,Downregulated
Feature1017,1â€²-Acetoxyeugenol acetate,C14 H16 O5,264.09978,NA,NA,1â€²-Acetoxyeugenol acetate,14,16,5,0,0,0,1.1428571428571428,0.35714285714285715,-0.4285714285714288,72.51428571428572,7,2,0.2222222222222222,0.391304347826087,2,Lignin,240904.648596946,293577.264485759,1.2186450788541603,0.2852780131327841,0.3685983221964703,0.6732647822971045,Upregulated
Feature1016,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak3",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,858264.1194944533,842706.0998018086,0.9818726900737632,-0.0263921185205504,0.83179684964902,0.9197544799643863,Downregulated
Feature1015,Guanine,C5 H5 N5 O,151.04939,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak2,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,11728287.1711275,15597834.702225033,1.3299328772084913,0.4113534335744813,0.015318295134231904,0.5434560019812327,Upregulated
Feature1014,Val-lys,C11 H23 N3 O3,245.17392,NA,NA,Val-lys,11,23,3,3,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,13403134.120925836,21981002.8458985,1.6399897701225226,0.7136868156729103,0.11065490757677944,0.5462476753068062,Upregulated
Feature1013,3-Hydroxy-2-methylpyridine,C6 H7 N O,109.05272,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,3-Hydroxy-2-methylpyridine,6,7,1,1,0,0,1.1666666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,4,3,0.5,0.5555555555555556,2,Lignin,20055377.992601734,18459114.145709,0.9204071921515724,-0.11965583792154963,0.565121465415297,0.7732760601078457,Downregulated
Feature1012,Crotanecine,C8 H13 N O3,171.08958,Other,NA,Crotanecine-peak2,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,398403.0512115603,1467764.7870412758,3.6841203464123624,1.8813201896421865,0.16187875744819905,0.5619315883550188,Upregulated
Feature1011,1-Hydroxy-3-methoxy-10-methyl-9(10H)-acridinone,C15 H13 N O3,255.08951,NA,NA,1-Hydroxy-3-methoxy-10-methyl-9(10H)-acridinone,15,13,3,1,0,0,0.8666666666666667,0.2,-0.2666666666666666,67.89999999999999,10,7,0.5454545454545454,0.6,6,Lignin,19776600.408365432,19617384.2265511,0.991949264356528,-0.011661762514220157,0.8712442836948746,0.9406550774882839,Downregulated
Feature1010,NA,C10 H15 N O5,229.09503,NA,NA,Feature1010,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,25096564.10577,17050608.328610267,0.679400106594278,-0.5576666503190207,0.119551711059235,0.5462476753068062,Downregulated
Feature1009,thiodiglycol,C4 H10 O2 S,122.04011,NA,NA,thiodiglycol,4,10,2,0,1,0,2.5,0.5,-1,88.8,0,-2,-3,-1,-3,Other,6548399.69237003,12963219.38197006,1.9796011225573718,0.9852097654159038,0.12408547516322438,0.5515041946002173,Upregulated
Feature1008,lys-leu,C12 H25 N3 O3,259.18959,NA,NA,lys-leu-peak3,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,8378297.740435207,15000124.870474001,1.7903547158607933,0.8402454512407955,0.07873149885344329,0.5434560019812327,Upregulated
Feature1007,NA,C17 H29 N O12,439.16903,NA,NA,Feature1007,17,29,12,1,0,0,1.7058823529411764,0.7058823529411765,-0.117647058823529,63.65294117647058,4,-8,-2.25,-0.3,-9,Carbohydrate,2035938.7002566368,7943128.890015417,3.9014577840748146,1.9640132893304156,0.04212688758346077,0.5434560019812327,Upregulated
Feature1006,NA,C17 H29 N3 O7,387.20043,NA,NA,Feature1006,17,29,7,3,0,0,1.7058823529411764,0.4117647058823529,-0.35294117647058787,70.35882352941175,5,-2,-0.7142857142857143,-0.14285714285714285,-5,Protein,24759438.2776019,22255891.584468335,0.8988851578511639,-0.15379128702527334,0.14607164094795008,0.5574792106914738,Downregulated
Feature1005,Pyridoxine,C8 H11 N O3,169.07393,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Tyrosine metabolism;Other,Other,Pyridoxine-peak1,8,11,3,1,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Lignin,14350254.500169333,12826655.829157732,0.8938277595708409,-0.16193124373992915,0.06344882253102711,0.5434560019812327,Downregulated
Feature1004,Perillartine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,Perillartine,10,15,1,1,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,594159.0844251093,547253.2032019753,0.921055012954117,-0.11864076642545218,0.5778471996259681,0.7755170614464124,Downregulated
Feature1003,NA,C16 H22 N2 O8,370.13769,NA,NA,Feature1003,16,22,8,2,0,0,1.375,0.5,0,60.3,7,-1,-0.5,0.1,-3,Lignin,23942518.426506568,22443616.583329767,0.9373958154077318,-0.09326974033497436,0.39391461056005417,0.6830003585350376,Downregulated
Feature1002,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10596,NA,NA,α-Aspartylphenylalanine-peak1,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,2946136.5239853375,584293.783943533,0.1983254269402082,-2.334058440170364,0.33046618556698776,0.6632819814140921,Downregulated
Feature1001,2-Mercaptoethanol,C2 H6 O S,78.01397,Metabolic pathways;Other,Other,2-Mercaptoethanol,2,6,1,0,1,0,3,0.5,-1,88.8,0,-1,-Inf,-3,-2,Other,14105858.472359767,13150088.505858667,0.9322430486330259,-0.10122196045353135,0.5230290150593859,0.7445471861433611,Downregulated
Feature1000,N-Acetyl-L-leucine,C8 H15 N O3,173.10514,Other,NA,N-Acetyl-L-leucine-peak3,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,4009500.18329773,4498093.83026654,1.1218589910543293,0.16589135180136605,0.35788614572218136,0.6692796802688192,Upregulated
Feature0999,metharbital,C9 H14 N2 O3,198.10045,NA,NA,metharbital-peak2,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,18489228.0000702,18881442.172048334,1.0212131178206383,0.030283974872194083,0.8984395096216578,0.953701139936653,Upregulated
Feature0998,Furan,C4 H4 O,68.02622,Other,NA,Furan-peak1,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,14218840.4708209,11642007.215445867,0.8187733197609844,-0.2884640028773389,0.15311305255430913,0.5574792106914738,Downregulated
Feature0997,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",C23 H28 O7,416.18357,NA,NA,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",23,28,7,0,0,0,1.2173913043478262,0.30434782608695654,-0.6086956521739131,77.64782608695651,10,3,0.1875,0.3333333333333333,3,Lignin,19215360.992473867,18609901.070361134,0.9684908380149675,-0.04618969398128269,0.8942216581445707,0.9522105713555311,Downregulated
Feature0996,Benserazide,C10 H15 N3 O5,257.1012,NA,NA,Benserazide,10,15,5,3,0,0,1.5,0.5,0.3999999999999999,48.9,5,0,-1.5,-0.1111111111111111,-3,Protein,6392053.939519473,11587719.615466487,1.812831951217483,0.8582451940384925,0.15308126952299975,0.5574792106914738,Upregulated
Feature0995,MFCD00672375,C5 H9 N O5,163.04806,Metabolic pathways;Other,NA,MFCD00672375,5,9,5,1,0,0,1.8,1,0.7999999999999998,37.5,2,-3,4,-1,-4,Carbohydrate,18073002.089560967,24432710.81397867,1.3518900010580475,0.4349777689395271,0.28786364453616725,0.6353376492471592,Upregulated
Feature0994,NA,C11 H18 N2 O4,242.12664,NA,NA,Feature0994,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,4640677.995772246,5043589.627915103,1.086821717108991,0.12011529920805039,0.8224804477060716,0.9159164128968568,Upregulated
Feature0993,Phe-his,C15 H18 N4 O3,302.13799,NA,NA,Phe-his,15,18,3,4,0,0,1.2,0.2,0,60.3,9,6,0.25,0.3684210526315789,2,Lignin,6887204.471859944,18234971.151617467,2.647659326236465,1.4047175028219783,0.057056005131392785,0.5434560019812327,Upregulated
Feature0992,Cytidine 5'-monophosphate (hydrate),C9 H14 N3 O8 P,323.05194,Metabolic pathways;Other,Other,Cytidine 5'-monophosphate (hydrate)-peak1,9,14,8,3,0,1,1.5555555555555556,0.8888888888888888,0.6666666666666665,41.3,5,-3,2.3333333333333335,-3,-7,Carbohydrate,10621447.59953899,6010537.029672157,0.5658868034083261,-0.8214146010068046,0.1533243382287199,0.5574792106914738,Downregulated
Feature0991,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",C10 H14 O4,198.08925,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",10,14,4,0,0,0,1.4,0.4,-0.5999999999999996,77.39999999999999,4,0,0,0.25,0,Lignin,19249145.592635933,17111808.108825132,0.8889645530745804,-0.16980220128009488,0.4834801126485188,0.7286613085645827,Downregulated
Feature0990,lamifiban,C24 H28 N4 O6,468.20102,NA,NA,lamifiban-peak2,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,3917786.1203954103,1569019.436613617,0.40048624105474667,-1.3201754160562724,0.41125054284066626,0.6883976477985067,Downregulated
Feature0989,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10008,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak3",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,24906026.8512695,21583510.738878533,0.8665979069149838,-0.2065653427998743,0.09586462769590029,0.5434560019812327,Downregulated
Feature0988,NA,C14 H27 N O9,353.16869,Biosynthesis of secondary metabolites;Other,NA,Feature0988,14,27,9,1,0,0,1.9285714285714288,0.6428571428571429,-0.4285714285714288,72.51428571428572,2,-7,-2,-0.4117647058823529,-8,Amino Sugar,126906.75671703297,13779536.926908253,108.58001010641865,6.762614713037848,0.33184541587900535,0.6632819814140921,Upregulated
Feature0987,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07865,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak1",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,570582.507394888,720005.3490573106,1.261877712207904,0.3355721064064268,0.4106446561073394,0.6883976477985067,Upregulated
Feature0986,met-pro,C10 H18 N2 O3 S,246.10387,NA,NA,met-pro,10,18,3,2,1,0,1.8,0.3,-0.4000000000000003,71.7,3,0,-0.75,-0.2727272727272727,-3,Lipid,5697694.275433376,4599666.69936128,0.8072856276605717,-0.3088488876761613,0.2858594908538769,0.6353376492471592,Downregulated
Feature0985,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam-peak1,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,7671181.909408467,8882903.2031109,1.1579575752487754,0.21158239745546725,0.1941763363916231,0.5699904136593773,Upregulated
Feature0984,Valylglutamine,C10 H19 N3 O4,245.13752,NA,NA,Valylglutamine,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,12225091.434163226,11356956.514740815,0.9289874497791981,-0.10626898833714725,0.8507243109417164,0.9315623676375357,Downregulated
Feature0983,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak2,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,1482608.7795034023,806093.2872213527,0.5436992538863505,-0.87911924654756,0.20708942735866057,0.5820034726922493,Downregulated
Feature0982,NA,C16 H25 N O9,375.15303,NA,NA,Feature0982,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,16150848.796261033,15947824.337345932,0.9874294867423871,-0.018250367225980356,0.8706738492535586,0.9406387121400053,Downregulated
Feature0981,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone-peak2,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,427839.085172634,348683.5713213,0.8149876516789143,-0.2951498944351248,0.6174929891387612,0.8003048823255108,Downregulated
Feature0980,NA,C18 H35 N5 O8,449.24869,NA,NA,Feature0980,18,35,8,5,0,0,1.9444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,-4,-1.8,-0.5555555555555556,-9,Protein,1156339.9118741348,2554747.0767768933,2.2093391835245866,1.1436149220090301,0.10437150006978367,0.5434560019812327,Upregulated
Feature0979,D-lysopine,C9 H18 N2 O4,218.12662,Lysine degradation,NA,D-lysopine-peak4,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,14072504.14343716,19328697.232217968,1.3735080150061338,0.45786532918032447,0.15015003010344802,0.5574792106914738,Upregulated
Feature0978,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C12 H19 N3 O7,317.12236,NA,NA,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",12,19,7,3,0,0,1.5833333333333333,0.5833333333333334,0.3333333333333335,50.8,5,-2,-2.5,-0.2727272727272727,-5,Amino Sugar,22170788.28417647,20146164.2268077,0.9086805560804635,-0.13815488644825344,0.18538466826474873,0.5646729954371317,Downregulated
Feature0977,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07395,NA,NA,Phenyl D-glucopyranosiduronic acid-peak4,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,15395383.245194333,13962169.737703634,0.9069062793264289,-0.14097462609292621,0.6904938393552249,0.8457675805262119,Downregulated
Feature0976,gamma-Glu-gln,C10 H17 N3 O6,275.11175,NA,NA,gamma-Glu-gln,10,17,6,3,0,0,1.7,0.6,0.3999999999999999,48.9,4,-2,-5,-0.5,-5,Amino Sugar,12334607.9298071,13810819.901367167,1.1196804940992684,0.1630871114442271,0.3895247176266295,0.6823569007873849,Upregulated
Feature0975,Borrelidin,C28 H43 N O6,489.30914,NA,NA,Borrelidin,28,43,6,1,0,0,1.5357142857142858,0.21428571428571427,-1,88.8,8,2,0.04761904761904761,0.16666666666666666,1,Lipid,1158562.931170851,984599.7668652496,0.8498457359327101,-0.23472710799330124,0.5677148067150198,0.7736998250806465,Downregulated
Feature0974,Tolycaine,C15 H22 N2 O3,278.16307,NA,NA,Tolycaine-peak1,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,12851636.6417238,7070615.6152449,0.5501723875611,-0.8620443604101163,0.037121264280016684,0.5434560019812327,Downregulated
Feature0973,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",C11 H12 O6,240.06344000000001,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",11,12,6,0,0,0,1.0909090909090908,0.5454545454545454,0,60.3,6,0,0,0.375,0,Lignin,23365860.204285666,20850572.4401034,0.8923520151969015,-0.1643151578390742,0.16796793479965857,0.5646729954371317,Downregulated
Feature0972,L-Ergothioneine,C9 H15 N3 O2 S,229.08852,NA,NA,L-Ergothioneine,9,15,2,3,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,2413385.4662412233,2806731.0160811865,1.1629849666960113,0.21783244796049508,0.5379499791391746,0.7559142874368673,Upregulated
Feature0971,Propoxur,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Propoxur,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,16313975.143626567,14524141.864170434,0.8902883409041252,-0.16765543226739923,0.06581830737440174,0.5434560019812327,Downregulated
Feature0970,Nojirimycin,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Nojirimycin-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,24244830.511565402,20431834.71952057,0.8427295340247507,-0.2468584085954356,0.41468241274281525,0.6907296039196943,Downregulated
Feature0969,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,10120329.918186696,9970943.988247596,0.9852390256892073,-0.021454320224263423,0.9630356698750067,0.9812353923389985,Downregulated
Feature0968,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0968,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Lignin,238922.69430673867,190664.11165731467,0.7980159114250249,-0.3255105826438449,0.32437249560549586,0.6622100705596555,Downregulated
Feature0967,Methoxyphenamine,C11 H17 N O,179.13104,NA,NA,Methoxyphenamine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,21900459.199005067,19576146.0718885,0.8938692058465075,-0.1618643483571714,0.22560962526349437,0.5958985050006134,Downregulated
Feature0966,Vorinostat,C14 H20 N2 O3,264.14742,Metabolic pathways;Other,NA,Vorinostat,14,20,3,2,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,15426903.016240634,13137055.088100167,0.8515678794551418,-0.2318065615188624,0.34060748683805114,0.6636491383576648,Downregulated
Feature0965,NA,C5 H10 N9 O2 P,259.06957,NA,NA,Feature0965,5,10,2,9,0,1,2,0.4,3.2,-30.90000000000001,6,4,0.8571428571428571,0.8333333333333334,-6,Protein,10088491.092159918,11112878.59420724,1.1015402097984115,0.13952215905873708,0.7264132069365505,0.8678025194291372,Upregulated
Feature0964,NA,C11 H19 N5 O2,253.15395,NA,NA,Feature0964,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,21364138.3154285,18677839.391232368,0.8742613025372443,-0.19386355253854534,0.35743219585884645,0.6692796802688192,Downregulated
Feature0963,pyroglutamylglycine,C7 H10 N2 O4,186.06407,NA,NA,pyroglutamylglycine,7,10,4,2,0,0,1.4285714285714286,0.5714285714285714,0.5714285714285716,44.014285714285705,4,0,-2,0,-2,Lignin,13653850.642516833,14247099.483104333,1.0434491965761057,0.061360360313801744,0.3666005727450242,0.6716464598336302,Upregulated
Feature0962,NA,C16 H30 N2 O9,394.19526,NA,NA,Feature0962,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,279791.31284773466,360478.957519055,1.2883850961992926,0.3655638771002593,0.34474468866970603,0.6666638157608242,Upregulated
Feature0961,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak3,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,4877104.28758682,2771520.82659453,0.568271798831243,-0.8153469731913,0.056097614915604326,0.5434560019812327,Downregulated
Feature0960,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak2",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,8074997.27935922,7784541.71591329,0.9640302586617121,-0.052849664888463745,0.8574772104427197,0.935823535475987,Downregulated
Feature0959,NA,C9 H19 N O9,285.106,NA,NA,Feature0959,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,6111888.332601677,6140222.67868181,1.0046359397518758,0.006672791882633508,0.9632789005075293,0.9812353923389985,Upregulated
Feature0958,NA,C13 H25 N3 O4,287.18454,NA,NA,Feature0958,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,10737758.102335447,11307140.5929094,1.0530261983132319,0.07454132972204246,0.6291316193581076,0.8073855781762381,Upregulated
Feature0957,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde-peak1,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Lignin,2196962.53171931,2045399.15904666,0.9310123088198327,-0.1031278532515815,0.703370352352247,0.8514861389326834,Downregulated
Feature0956,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0956,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Lignin,110817.57822860533,99308.5821515832,0.8961446707192947,-0.15819643974601982,0.46066054273484797,0.7109067016940792,Downregulated
Feature0955,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak3,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,451513.0922787507,270283.9432320507,0.5986181748749502,-0.7402920131714529,0.37889903835986055,0.677777160487438,Downregulated
Feature0954,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,NA,N8-Acetylspermidine,9,21,1,3,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666664,1,0,-0.6,-0.4545454545454546,-3,Lipid,291698.32203520165,619911.6262607067,2.125180638460775,1.0875854742553241,0.27747865288234275,0.6292487790932914,Upregulated
Feature0953,NA,C7 H9 O5 P S,235.99087,NA,NA,Feature0953,7,9,5,0,1,1,1.2857142857142858,0.7142857142857143,-0.2857142857142856,68.44285714285714,4,-1,-Inf,-0.2,-3,Tannin,16367565.598187601,15354863.479084967,0.9381275050936853,-0.09214407570216547,0.8726025024869322,0.9409146589428623,Downregulated
Feature0952,NA,C19 H41 N O2,315.3138,NA,NA,Feature0952,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,134250.23674159366,4411720.109394908,32.861916794133,5.038344728210616,0.18206639059501764,0.5646729954371317,Upregulated
Feature0951,Guanine,C5 H5 N5 O,151.0494,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak1,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,10007196.90732397,14771918.523891266,1.4761294956712743,0.561819289533723,0.007561467628012206,0.5434560019812327,Upregulated
Feature0950,NA,C18 H34 N2 O8,406.23161,NA,NA,Feature0950,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,462763.0653733033,443074.8279701457,0.9574550371964636,-0.0627233562954891,0.9430020648396678,0.9705015175202899,Downregulated
Feature0949,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,C9 H15 N3 O3 S,245.08343,NA,NA,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,9,15,3,3,1,0,1.6666666666666667,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,2739426.02083571,4327162.90908379,1.5795874304222726,0.65954779270097,0.11581365286978695,0.5462476753068062,Upregulated
Feature0948,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak3,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,185526.68372010367,163691.244602771,0.8823056679529998,-0.18064954200354388,0.49705011970960494,0.7334162931788414,Downregulated
Feature0947,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine-peak2,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Lignin,11271942.952799024,10953514.778590847,0.9717503738670797,-0.04134233726646779,0.8579303132197212,0.935823535475987,Downregulated
Feature0946,NA,C5 H11 N3,113.09524,NA,NA,Feature0946,5,11,0,3,0,0,2.2,0,-0.4000000000000003,71.7,2,2,-0.5,-0.5,-1,Lipid,15145537.927720433,13520787.3283611,0.8927241404621489,-0.16371365601425092,0.4454734305977584,0.7027877448360436,Downregulated
Feature0945,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10593,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine-peak2,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,13700142.475972414,16234264.653800434,1.1849704981004696,0.24485114117081255,0.44944265767532743,0.7027877448360436,Upregulated
Feature0944,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak3,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1428408.81282161,1418343.3421118967,0.9929533683779014,-0.01020212818067516,0.9811533713010642,0.9914522005306148,Downregulated
Feature0943,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07396,NA,NA,Phenyl D-glucopyranosiduronic acid-peak3,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,351727.8042552826,237075.66849731235,0.6740316393219905,-0.5691117811929919,0.3727130272805218,0.6751790275958873,Downregulated
Feature0942,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine-peak1,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Lignin,2975635.328444883,6129045.89457595,2.0597436238193514,1.0424647764072883,0.07175045303522726,0.5434560019812327,Upregulated
Feature0941,Glu-Glu,C10 H16 N2 O7,276.09576,Other,NA,Glu-Glu,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,21013003.180312134,18555944.678146634,0.883069617365898,-0.1794009167311258,0.34201044733544356,0.6636491383576648,Downregulated
Feature0940,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",C25 H34 O3,382.25081,NA,NA,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",25,34,3,0,0,0,1.36,0.12,-1.12,92.22,9,6,0.2727272727272727,0.3191489361702128,6,Unsaturated HC,2028479.2753647,1627977.0427635133,0.8025603527405127,-0.31731820754277146,0.27194765566177315,0.6292487790932914,Downregulated
Feature0939,387122,C12 H18 O,178.13575,NA,NA,387122,12,18,1,0,0,0,1.5,0.08333333333333333,-1.333333333333333,98.29999999999998,4,3,0.2727272727272727,0.30434782608695654,3,Lipid,1303725.508108478,1126700.105616112,0.8642157406667567,-0.21053658673793804,0.61895166276245,0.8009962694572882,Downregulated
Feature0938,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak1",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,4911017.02811439,21110183.587092865,4.298536019370763,2.103845395346131,0.06312837357279856,0.5434560019812327,Upregulated
Feature0937,NA,C19 H41 N O2,315.31381,NA,NA,Feature0937,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,179654.646310695,11621792.77754882,64.68963100152764,6.0154625783337,0.18374299623643006,0.5646729954371317,Upregulated
Feature0936,NA,C12 H21 N O8,307.12685,NA,NA,Feature0936,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,2889132.579326093,5134887.043668807,1.7773109757623338,0.8296961315288643,0.08139673760900691,0.5434560019812327,Upregulated
Feature0935,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak2,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,3837909.4300969234,4218314.683008224,1.0991178295996666,0.13634605695764473,0.6618060647697083,0.8289195086767364,Upregulated
Feature0934,NA,C62 H106 N2 O14 P2 S2,1228.65592,NA,NA,Feature0934,62,106,14,2,2,2,1.7096774193548387,0.2258064516129032,-1.258064516129032,96.1548387096774,12,-2,-0.1904761904761905,-0.02040816326530612,-8,Lipid,104162.0157289561,97688.21608694887,0.9378487484453742,-0.09257282402596148,0.7674545037889662,0.8941320009755906,Downregulated
Feature0933,gamma glutamyl ornithine,C10 H19 N3 O5,261.13251,NA,NA,gamma glutamyl ornithine,10,19,5,3,0,0,1.9,0.5,0,60.3,3,-2,-2.5,-0.5555555555555556,-5,Protein,4550741.279121984,1868354.23197356,0.41056041584812725,-1.2843335580705142,0.04925616899003381,0.5434560019812327,Downregulated
Feature0932,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak1,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,4768779.144542307,3251283.81878063,0.681785362717333,-0.5526104683660835,0.06893553447827777,0.5434560019812327,Downregulated
Feature0931,NA,C9 H19 N O9,285.10601,NA,NA,Feature0931,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,19631030.18772054,9146346.113548283,0.4659126915952398,-1.1018684644793588,0.24678231064866119,0.6195339940083167,Downregulated
Feature0930,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak2,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,878260.9703820127,761491.3956543,0.8670445588890031,-0.20582195699237504,0.5778382234107772,0.7755170614464124,Downregulated
Feature0929,NA,C20 H28 N2 O9,440.17967,NA,NA,Feature0929,20,28,9,2,0,0,1.4,0.45,-0.20000000000000015,66,8,-1,-0.3333333333333333,0.1111111111111111,-3,Lignin,6744772.465989657,6493151.547539607,0.9626939352337174,-0.05485089318863839,0.7711923093097032,0.8960217914750598,Downregulated
Feature0928,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin-peak1,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Lignin,12518908.188905757,9834386.479474124,0.7855626330249268,-0.34820178849311056,0.27560203156569807,0.6292487790932914,Downregulated
Feature0927,Anhalamine,C11 H15 N O3,209.10518,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak3,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,498417.9764545573,511261.113544313,1.0257678047270966,0.03670419597410541,0.9382463843009023,0.9692805595037932,Upregulated
Feature0926,NA,C24 H40 N8 O7,552.30201,NA,NA,Feature0926,24,40,7,8,0,0,1.6666666666666667,0.2916666666666667,-0.08333333333333304,62.67499999999999,9,2,-0.6666666666666666,-0.2,-6,Lipid,77284.33188146967,67063.02750838244,0.8677441581721433,-0.20465834731335783,0.575068999426171,0.7751995156675667,Downregulated
Feature0925,NA,C4 H5 N O,83.03712,NA,NA,Feature0925,4,5,1,1,0,0,1.25,0.25,0,60.3,3,2,0.5,0.6,1,Lignin,19499712.5935742,19368266.253138267,0.9932590626756597,-0.00975804310297553,0.9200585107007255,0.9629365459231719,Downregulated
Feature0924,MFCD02728197,C14 H20 N2 O4,280.14234,NA,NA,MFCD02728197-peak2,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,9997749.954316176,16158962.072104868,1.6162598730656197,0.6926591828920202,0.06647454774483205,0.5434560019812327,Upregulated
Feature0923,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine-peak2,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,18085540.421477467,18364835.988838866,1.0154430313306935,0.022109303423204,0.8545873425313223,0.9351879575245866,Upregulated
Feature0922,DiisopropylSulfate,C6 H14 O4 S,182.0613,NA,NA,DiisopropylSulfate,6,14,4,0,1,0,2.3333333333333335,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,15148226.043886,12705587.487568099,0.8387508511398416,-0.2536857695690502,0.20280384040114924,0.5780722477745703,Downregulated
Feature0921,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C24 H32 O8,448.20981,Other,NA,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",24,32,8,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,9,1,0.0625,0.25,1,Lignin,18760156.556175433,13224406.205063159,0.7049198211893373,-0.5044689226961228,0.372329380272888,0.6751790275958873,Downregulated
Feature0920,NA,C17 H25 N3 O4,335.18462,NA,NA,Feature0920,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,14060325.700227268,11149900.12852904,0.7930043987778189,-0.3345992263385065,0.3199161164470088,0.6620868237165941,Downregulated
Feature0919,NA,C7 H9 O7 P,236.00858,NA,NA,Feature0919,7,9,7,0,0,1,1.2857142857142858,1,0,60.3,4,-3,4,-0.2,-4,Tannin,11453805.1560725,7401463.13132397,0.646201243208674,-0.6299445687203848,0.010639299385411194,0.5434560019812327,Downregulated
Feature0918,MFCD00020424,C18 H20 N2 O3,312.14738,NA,NA,MFCD00020424,18,20,3,2,0,0,1.1111111111111112,0.16666666666666666,-0.44444444444444464,72.96666666666667,10,7,0.38461538461538464,0.4482758620689655,5,Lignin,10939240.817713896,6755611.077981587,0.6175575792281889,-0.6953544393329126,0.033791858154344295,0.5434560019812327,Downregulated
Feature0917,NA,C16 H22 N2 O4,306.15784,NA,NA,Feature0917,16,22,4,2,0,0,1.375,0.25,-0.5,74.55,7,3,0.1,0.25,1,Lignin,247449.80605037435,303777.926012337,1.2276345286384895,0.2958811289513859,0.41290462245009185,0.6898031858288517,Upregulated
Feature0916,Panthenol,C9 H19 N O4,205.13142,Other,NA,Panthenol,9,19,4,1,0,0,2.111111111111111,0.4444444444444444,-0.8888888888888893,85.63333333333334,1,-3,-1,-0.3333333333333333,-4,Protein,647473.755193298,378086.9554469887,0.5839417465409296,-0.7761036404539002,0.3649113850706749,0.6716464598336302,Downregulated
Feature0915,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,16017533.38846281,6191284.908369597,0.38653173108595407,-1.3713412424415454,0.300053201238488,0.6452426827392128,Downregulated
Feature0914,Erythritol,C4 H10 O4,122.05787,ABC transporters,NA,Erythritol,4,10,4,0,0,0,2.5,1,-0.5,74.55,0,-4,-Inf,-1,-4,Carbohydrate,7059470.117848117,2941353.073195393,0.41665351989505733,-1.2630799268292334,0.17487802120134688,0.5646729954371317,Downregulated
Feature0913,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.0794,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak2",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,15347398.656890599,16172431.655991066,1.053757188273079,0.07554247263881858,0.692310327025596,0.8459998858209694,Upregulated
Feature0912,NA,C76 H121 N10 O14 P3,1490.82761,NA,NA,Feature0912,76,121,14,10,0,3,1.5921052631578947,0.18421052631578944,-1.026315789473684,89.55,23,9,-0.08163265306122448,0.05357142857142857,-4,Lipid,844872.3002087793,678061.0110752457,0.8025603525026063,-0.31731820797043586,0.27194765505087276,0.6292487790932914,Downregulated
Feature0911,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide-peak2,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,2830738.81953966,3115135.2048959867,1.1004671937210284,0.13811613735900233,0.798373956266736,0.9022552886981726,Upregulated
Feature0910,mebutamate,C10 H20 N2 O4,232.1423,Other,NA,mebutamate-peak2,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,9840879.776649043,12186704.448352834,1.2383755035063113,0.30844883870776446,0.420367688041311,0.6943057388507786,Upregulated
Feature0909,Methylone,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,Methylone-peak2,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,2305732.57525315,1757080.9295978034,0.7620488813213262,-0.3920445531030754,0.2123063342102036,0.5838424190780599,Downregulated
Feature0908,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08007,NA,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Lignin,4080512.9916994534,3112041.21322481,0.7626593076790342,-0.3908893692685571,0.007757343481099104,0.5434560019812327,Downregulated
Feature0907,NA,C12 H18 N4 O4,282.13282,NA,NA,Feature0907,12,18,4,4,0,0,1.5,0.3333333333333333,0.16666666666666652,55.55,6,2,-0.5,0,-2,Protein,14475032.8364242,16620249.696955666,1.1482011740334956,0.199375435875484,0.02653316254425819,0.5434560019812327,Upregulated
Feature0906,pro-asn,C9 H15 N3 O4,229.10627,NA,NA,pro-asn,9,15,4,3,0,0,1.6666666666666667,0.4444444444444444,0.22222222222222232,53.96666666666666,4,0,-1.5,-0.25,-3,Protein,6551607.979660797,8519350.01155138,1.3003448982294665,0.37889432861602185,0.4136482666643546,0.6903646933294746,Upregulated
Feature0905,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine",C11 H13 N O6,255.07429,NA,NA,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine-peak1",11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,1955470.5367508265,647042.101456016,0.33088818741862974,-1.5955843059771795,0.05248726058107404,0.5434560019812327,Downregulated
Feature0904,NA,C15 H27 N O13,429.14831,NA,NA,Feature0904,15,27,13,1,0,0,1.8,0.8666666666666667,0.1333333333333333,56.5,3,-10,-11,-0.6,-11,Carbohydrate,1859491.71652842,2144672.5891915467,1.1533649599663425,0.205849098089701,0.12497445749136127,0.5515041946002173,Upregulated
Feature0903,NA,C6 H2 O4,137.99529,NA,NA,Feature0903,6,2,4,0,0,0,0.3333333333333333,0.6666666666666666,1,31.799999999999997,6,2,1,1,2,Condensed HC,21921649.102180965,18596875.112460833,0.8483337647536128,-0.23729611073719215,0.2812956532814916,0.6319825419878604,Downregulated
Feature0902,NA,C12 H12 N6 O3,288.09707,NA,NA,Feature0902,12,12,3,6,0,0,1,0.25,1,31.799999999999997,10,7,0.3333333333333333,0.5555555555555556,1,Lignin,2081310.69449645,7602082.016047657,3.652545502288353,1.8689022457917732,0.4217454833133213,0.6945274379311516,Upregulated
Feature0901,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone-peak1,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,321360.42629787966,276575.394776343,0.8606392453561662,-0.21651946586098447,0.5007920877914057,0.7334162931788414,Downregulated
Feature0900,Methyldopa,C10 H13 N O4,211.08447,NA,NA,Methyldopa,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,598524.6332420156,851775.8375427357,1.4231257833598923,0.5090631804939106,0.15837912754653663,0.5574792106914738,Upregulated
Feature0899,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,496555.91608960996,331082.38015862467,0.6667574978582604,-0.5847659515459435,0.39829348045403257,0.684983914608255,Downregulated
Feature0898,N-Acetylglucosamine 1-phosphate,C8 H16 N O9 P,301.05635,Metabolic pathways;Other,Other,N-Acetylglucosamine 1-phosphate,8,16,9,1,0,1,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,1509512.90001907,1591976.20385782,1.0546290818963577,0.07673568537785802,0.5670359353921313,0.7736998250806465,Upregulated
Feature0897,NA,C14 H27 N3 O4,301.20023,NA,NA,Feature0897,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,14438998.073472967,7761849.88056575,0.5375615289280814,-0.8954982008381246,0.0362797515402701,0.5434560019812327,Downregulated
Feature0896,NA,C21 H33 N3 O2,359.25734,NA,NA,Feature0896,21,33,2,3,0,0,1.5714285714285714,0.09523809523809525,-0.9523809523809526,87.44285714285715,7,5,0.125,0.17647058823529413,2,Lipid,118752.33337665566,108167.25088934823,0.9108642147372892,-0.1346920917117044,0.596680602206931,0.7885106188767821,Downregulated
Feature0895,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",C18 H18 N2 O2,294.13684,Biosynthesis of secondary metabolites;Other,NA,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",18,18,2,2,0,0,1,0.1111111111111111,-0.44444444444444464,72.96666666666667,11,9,0.5,0.5333333333333333,7,Unsaturated HC,2711127.2741960534,2480624.2924652533,0.9149789152561447,-0.12818959652443226,0.45745035144058355,0.7089632227283429,Downregulated
Feature0894,Troxipide,C15 H22 N2 O4,294.158,NA,NA,Troxipide-peak3,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,12158707.21886303,11974735.360971333,0.9848691267434845,-0.021996068534107426,0.9359392449485648,0.9692805595037932,Downregulated
Feature0893,NA,C10 H17 N3 O3,227.12699,NA,NA,Feature0893,10,17,3,3,0,0,1.7,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,20461839.825195365,17786873.9245907,0.8692705092280661,-0.20212289415094425,0.11687965885173945,0.5462476753068062,Downregulated
Feature0892,NA,C10 H24 N2 O6 S,300.13557,NA,NA,Feature0892,10,24,6,2,1,0,2.4,0.6,-0.4000000000000003,71.7,0,-6,-9,-1.5,-9,Other,20435800.227418866,13348198.900911536,0.6531772062932069,-0.6144536483562858,0.06567703095718563,0.5434560019812327,Downregulated
Feature0891,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26122,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak1,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,3541774.6721636066,1868232.5095891634,0.5274848578799887,-0.9227984148590025,0.2621665372865103,0.6292487790932914,Downregulated
Feature0890,NA,C15 H28 N2 O9,380.17959,NA,NA,Feature0890,15,28,9,2,0,0,1.8666666666666667,0.6,-0.2666666666666666,67.89999999999999,3,-6,-2,-0.4117647058823529,-8,Amino Sugar,1031511.0679944523,1559960.40273605,1.5123060247613744,0.59675010763597,0.24935674881164846,0.6202424088784857,Upregulated
Feature0889,4-Methyleneglutamic acid,C6 H9 N O4,159.05318,Other,NA,4-Methyleneglutamic acid-peak2,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,17446327.26195657,15968101.854550967,0.9152701089914198,-0.1277305291999334,0.31616110356180477,0.6587661862653104,Downregulated
Feature0888,threonylphenylalanine,C13 H18 N2 O4,266.12654,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak4,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,120047.62608140433,104727.76288249627,0.8723851216473064,-0.19696292957248449,0.48343781685751913,0.7286613085645827,Downregulated
Feature0887,CI-976,C23 H39 N O4,393.28787,NA,NA,CI-976,23,39,4,1,0,0,1.6956521739130437,0.17391304347826086,-1.2173913043478262,94.99565217391304,5,1,0,0.1,0,Lipid,2037168.1277058367,1370460.16378822,0.67272806065917,-0.571904658139963,0.2774325707737688,0.6292487790932914,Downregulated
Feature0886,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak2,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,11052153.064671993,16721533.085194767,1.5129661150500027,0.5973796767835011,0.12663477007510657,0.5543134380031797,Upregulated
Feature0885,NA,C13 H27 N O11,373.15852,NA,NA,Feature0885,13,27,11,1,0,0,2.076923076923077,0.8461538461538461,-0.1538461538461542,64.6846153846154,1,-10,-11,-0.8461538461538461,-11,Carbohydrate,16200698.003989883,8315299.10544787,0.5132679532326317,-0.9622159086729327,0.3358961396322836,0.6636048496469049,Downregulated
Feature0884,leu-phe,C15 H22 N2 O3,278.16308,NA,NA,leu-phe-peak1,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,10691638.771984933,10200984.961017463,0.9541086430778863,-0.06777454154385629,0.7437794128873796,0.8780085138214744,Downregulated
Feature0883,"2,3,4,9-Tetrahydro-1H-β-carboline-3-carboxylic acid",C12 H12 N2 O2,216.0899,NA,NA,"2,3,4,9-Tetrahydro-1H-β-carboline-3-carboxylic acid",12,12,2,2,0,0,1,0.16666666666666666,-0.16666666666666696,65.05000000000001,8,6,0.5,0.5555555555555556,4,Lignin,11366118.142500468,9244155.871037196,0.8133080929777795,-0.29812612510613823,0.0672375647373733,0.5434560019812327,Downregulated
Feature0882,NA,C11 H17 N5 O,235.1433,NA,NA,Feature0882,11,17,1,5,0,0,1.5454545454545454,0.09090909090909093,0,60.3,6,5,0,0.09090909090909093,0,Lipid,17666773.0122793,15950186.8884533,0.9028353325967972,-0.14746521516496022,0.04510558044809368,0.5434560019812327,Downregulated
Feature0881,Methionylleucine,C11 H22 N2 O3 S,262.13517,NA,NA,Methionylleucine-peak2,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,7205376.474385907,3328796.2579246233,0.46198783224693707,-1.1140732401901257,0.06568642063807192,0.5434560019812327,Downregulated
Feature0880,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak2,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,17983536.606265135,17127162.1483069,0.9523800864808821,-0.07039063958321835,0.578204278988677,0.7755170614464124,Downregulated
Feature0879,2-ethyl-1H-perimidine,C13 H12 N2,196.10009,NA,NA,2-ethyl-1H-perimidine,13,12,0,2,0,0,0.9230769230769232,0,-0.4615384615384617,73.45384615384616,9,9,0.6363636363636364,0.6363636363636364,7,Unsaturated HC,12554614.74379136,15269647.982433567,1.2162577899879303,0.28244904532783777,0.1811239023082076,0.5646729954371317,Upregulated
Feature0878,NA,C12 H21 N O8,307.12682,NA,NA,Feature0878,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,18812824.468041867,14731957.051299468,0.783080556368623,-0.3527673680919049,0.2764997145818737,0.6292487790932914,Downregulated
Feature0877,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak3,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,14124933.6625836,15103227.414586067,1.0692600599317452,0.09661278060247848,0.5832791713625065,0.7788265320293485,Upregulated
Feature0876,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan-peak2,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Lignin,11124798.750477564,9678698.622364726,0.8700111201516558,-0.2008942538281577,0.27440518665130814,0.6292487790932914,Downregulated
Feature0875,uridine 5′-diphosphate,C9 H14 N2 O12 P2,404.00229,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,uridine 5′-diphosphate,9,14,12,2,0,2,1.5555555555555556,1.3333333333333333,0.6666666666666665,41.3,5,-7,1.5714285714285714,5,-11,Carbohydrate,19004905.28960772,7756101.616838377,0.4081105113993689,-1.2929682253880235,0.15680547648890103,0.5574792106914738,Downregulated
Feature0874,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene-peak1,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,10999124.12223119,13788760.001384934,1.2536234565728188,0.32610407947058073,0.1312694561475139,0.5545833428603265,Upregulated
Feature0873,DH2090000,C9 H10 O5,198.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak2,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,15202465.062538533,15546548.980786966,1.022633429304588,0.03228909278785885,0.8505647248588611,0.9315623676375357,Upregulated
Feature0872,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",C6 H11 N O5,177.06376,Other,NA,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",6,11,5,1,0,0,1.8333333333333333,0.8333333333333334,0.3333333333333335,50.8,2,-3,-Inf,-0.6,-4,Carbohydrate,12039455.0870774,13678893.7249189,1.1361721627751409,0.184181461218242,0.24632260836313066,0.6195339940083167,Upregulated
Feature0871,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak6,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,16903753.525999032,15534067.8587736,0.9189715074158665,-0.12190796323928704,0.10042415793090895,0.5434560019812327,Downregulated
Feature0870,3-Hydroxyhexadecadienoylcarnitine,C23 H41 N O5,411.2985,NA,NA,3-Hydroxyhexadecadienoylcarnitine,23,41,5,1,0,0,1.7826086956521738,0.21739130434782608,-1.2173913043478262,94.99565217391304,4,-1,-0.1176470588235294,0.02564102564102564,-2,Lipid,198158.05495699533,196991.796700109,0.9941145049231562,-0.00851605982960346,0.982673107845869,0.9914522005306148,Downregulated
Feature0869,NA,C12 H21 N O8,307.12679,NA,NA,Feature0869,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,942383.1128828546,1904229.3339677167,2.020653074037445,1.0148216466412403,0.2365142989462604,0.6065864474864333,Upregulated
Feature0868,NA,C17 H32 N2 O8,392.21597,NA,NA,Feature0868,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,1197243.2094995168,1620219.900586779,1.3532922030638028,0.4364733798881116,0.3957875725970761,0.6848441763516896,Upregulated
Feature0867,Maleic acid,C4 H4 O4,116.01093,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Tyrosine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of purine nucleotide salvage;Other,Maleic acid,4,4,4,0,0,0,1,1,1,31.799999999999997,3,-1,-Inf,0.5,-1,Tannin,754461.5776339266,726515.4702427717,0.9629588726323254,-0.05445391210049189,0.7851753792173072,0.9001754630810936,Downregulated
Feature0866,NA,C12 H21 N3 O4,271.15326,NA,NA,Feature0866,12,21,4,3,0,0,1.75,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,0,-0.6,-0.14285714285714285,-3,Protein,17478840.845409997,11046559.479360534,0.6319961133041266,-0.6620124088490728,0.25906298961001467,0.6292487790932914,Downregulated
Feature0865,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak2",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,5320820.003912402,8025990.7203428205,1.5084123714843398,0.5930308881339227,0.4004291498349095,0.685393667249696,Upregulated
Feature0864,(Ac)2-L-Lys-D-Ala,C13 H23 N3 O5,301.16384,NA,NA,(Ac)2-L-Lys-D-Ala,13,23,5,3,0,0,1.7692307692307692,0.38461538461538464,-0.3076923076923075,69.06923076923076,4,-1,-0.8,-0.2,-4,Protein,1738947.88693615,1076774.8111098865,0.6192105118268119,-0.6914981317517986,0.05181582091915886,0.5434560019812327,Downregulated
Feature0863,Pro-Hyp,C10 H16 N2 O4,228.111,NA,NA,Pro-Hyp-peak2,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,13055699.2606593,11835443.415474966,0.9065346236289827,-0.14156597245360097,0.29768087220273043,0.6425392932568532,Downregulated
Feature0862,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak2,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,4000952.2902643,2535331.75128802,0.633682075504214,-0.6581688872251166,0.15616375618302394,0.5574792106914738,Downregulated
Feature0861,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,6365868.4552319,5016944.403176744,0.7881005456613669,-0.3435483948078761,0.4237505464581631,0.6952327705369785,Downregulated
Feature0860,1-Naphthol,C10 H8 O,144.05749,Other,NA,1-Naphthol,10,8,1,0,0,0,0.8,0.1,-0.5999999999999996,77.39999999999999,7,6,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,138972.194674706,140375.56941018134,1.0100982411536368,0.014495614890516968,0.9476805614463844,0.9747079432618944,Upregulated
Feature0859,thr-pro,C9 H16 N2 O4,216.11107,Metabolic pathways;Other,Other,thr-pro-peak2,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,6675212.371229127,6848500.8269691365,1.0259599913984612,0.036974472332438245,0.6791000709135188,0.8378700073761841,Upregulated
Feature0858,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13227,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak2,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,15630420.921896266,14181682.486413833,0.9073128969001129,-0.14032792896327173,0.3726731997668061,0.6751790275958873,Downregulated
Feature0857,Nonivamide,C17 H27 N O3,293.199,NA,NA,Nonivamide,17,27,3,1,0,0,1.588235294117647,0.17647058823529413,-1.0588235294117645,90.47647058823529,5,2,0.07692307692307693,0.1724137931034483,1,Lipid,493526.08967214334,363104.7845734827,0.7357357436051629,-0.4427404126376299,0.2696643276990556,0.6292487790932914,Downregulated
Feature0856,NA,C18 H34 N2 O8,406.23163,NA,NA,Feature0856,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,1733485.5938670516,3225865.0737347365,1.8609125366530976,0.8960102499687443,0.1202404321263677,0.5462476753068062,Upregulated
Feature0855,NA,C11 H24 N4 O5,292.17471,NA,NA,Feature0855,11,24,5,4,0,0,2.1818181818181817,0.4545454545454546,-0.18181818181818168,65.48181818181817,2,-3,-3.5,-1,-7,Protein,7043675.3418242065,10099103.667983873,1.4337832421118313,0.5198269353597961,0.013903501256335521,0.5434560019812327,Upregulated
Feature0854,butalbital,C11 H16 N2 O3,224.11607,NA,NA,butalbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,1494291.63786165,1752254.4975172773,1.1726322045305528,0.22975058377992733,0.6703782590423808,0.8312524847517372,Upregulated
Feature0853,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10734,NA,NA,N(6)-OH-Me-Adenosine-peak2,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,17567354.141758632,16201726.6542808,0.922263337070683,-0.1167493476583966,0.3123063432821932,0.6547061206079187,Downregulated
Feature0852,Arg-pro,C11 H21 N5 O3,271.16445,NA,NA,Arg-pro,11,21,3,5,0,0,1.9090909090909092,0.2727272727272727,0,60.3,4,1,-1.3333333333333333,-0.5555555555555556,-4,Lipid,9540612.18116787,13776484.793202868,1.4439833138167117,0.5300540710249656,0.16293655947227653,0.5621477224970193,Upregulated
Feature0851,NA,C10 H18 N2 O7,278.11141,NA,NA,Feature0851,10,18,7,2,0,0,1.8,0.7,0.20000000000000015,54.599999999999994,3,-4,-6,-0.5555555555555556,-6,Amino Sugar,778705.7478877354,1219807.8421643127,1.5664554235962442,0.6475037157213108,0.4392204236863298,0.7009176491269988,Upregulated
Feature0850,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide-peak1,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,1097438.6905123966,825991.2404495981,0.7526536539949588,-0.4099419572310049,0.35763643754773794,0.6692796802688192,Downregulated
Feature0849,Paracetamol,C8 H9 N O2,151.06336,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak2,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,2184689.6984966067,2124001.3833277966,0.9722210823758758,-0.04064367593331371,0.8896542527613905,0.9518018467985121,Downregulated
Feature0848,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.0957,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak1,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,4452119.63938096,4061024.553398097,0.9121553063121991,-0.13264861197672,0.308672679326672,0.6523468563546992,Downregulated
Feature0847,1-linoleoyl-sn-glycero-3-phosphoethanolamine,C23 H44 N O7 P,477.28563,NA,NA,1-linoleoyl-sn-glycero-3-phosphoethanolamine,23,44,7,1,0,1,1.9130434782608696,0.30434782608695654,-1.391304347826087,99.95217391304348,3,-4,-0.42857142857142855,-0.14285714285714285,-6,Protein,10074703.227742177,1131443.6578847205,0.11230540814037321,-3.154500691552842,0.38696416391823896,0.6807033163836934,Downregulated
Feature0846,Leucylasparagine,C10 H19 N3 O4,245.13754,NA,NA,Leucylasparagine-peak3,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,9951169.986615254,11928080.513787,1.1986611152086413,0.26142383847421624,0.4479988965266291,0.7027877448360436,Upregulated
Feature0845,NA,C17 H29 N O14,471.15895,NA,NA,Feature0845,17,29,14,1,0,0,1.7058823529411764,0.8235294117647058,0.11764705882352944,56.94705882352941,4,-10,-5.5,-0.4444444444444444,-11,Carbohydrate,1060910.1646441573,3365340.286455887,3.172125594238853,1.6654498929203567,0.08212136832246127,0.5434560019812327,Upregulated
Feature0844,lys-leu,C12 H25 N3 O3,259.1896,NA,NA,lys-leu-peak2,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,3850032.706875943,6208767.5157979,1.6126531872597831,0.6894362098401268,0.35536860751249133,0.6692796802688192,Upregulated
Feature0843,NA,C13 H19 N O6,285.1213,NA,NA,Feature0843,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Lignin,1293588.12442549,789111.0083257123,0.6100172020952753,-0.7130781685599922,0.021473959777230992,0.5434560019812327,Downregulated
Feature0842,(+)-sesamin monocatechol,C19 H18 O6,342.11045,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak2,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,16827363.70117654,12652928.111284867,0.7519257523625164,-0.4113378824349151,0.5022168737438653,0.7334162931788414,Downregulated
Feature0841,(2S)-2-Amino-4-hexynoic acid,C6 H9 N O2,127.06329,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,(2S)-2-Amino-4-hexynoic acid,6,9,2,1,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,1,0,0.25,0,Protein,1081645.6417636867,1145102.3160887526,1.0586667868615418,0.08224857555493541,0.8092160704365918,0.9088169879054063,Upregulated
Feature0840,DL-Lactic Acid,C3 H6 O3,90.03171,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,DL-Lactic Acid,3,6,3,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,15751915.176044099,13640412.9012875,0.8659526634597535,-0.2076399314346678,0.2573063625494683,0.628842322173499,Downregulated
Feature0839,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",C7 H15 N O4,177.10012,NA,NA,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",7,15,4,1,0,0,2.142857142857143,0.5714285714285714,-0.5714285714285712,76.58571428571427,1,-3,-2,-0.5,-4,Amino Sugar,3314773.07294668,2662418.0580181233,0.8031976848573097,-0.3161729840270787,0.21718718764411551,0.587247735354029,Downregulated
Feature0838,thr-pro,C9 H16 N2 O4,216.111,Metabolic pathways;Other,Other,thr-pro-peak1,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,13525506.677065667,13973358.4665839,1.0331116460337584,0.04699617141074206,0.8013866629433847,0.9038275679268266,Upregulated
Feature0837,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C12 H19 N3 O7,317.12237,NA,NA,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",12,19,7,3,0,0,1.5833333333333333,0.5833333333333334,0.3333333333333335,50.8,5,-2,-2.5,-0.2727272727272727,-5,Amino Sugar,15120329.586894533,15447685.622939866,1.021650059554857,0.030901122109178704,0.7904760570758929,0.9015670682202759,Upregulated
Feature0836,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine-peak1,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,6848705.136286964,10322502.73992403,1.5072196180897914,0.5918896484183341,0.018411050864039876,0.5434560019812327,Upregulated
Feature0835,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak3,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,2215863.331704053,3671833.3046262735,1.65706668461477,0.7286316614774256,0.14485259524285873,0.5574792106914738,Upregulated
Feature0834,N-acetyldopamine,C10 H13 N O3,195.08954,Other,NA,N-acetyldopamine,10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,14442170.8892717,11739944.1243488,0.812893311840657,-0.2988620766319264,0.1493083790301423,0.5574792106914738,Downregulated
Feature0833,NA,C16 H30 N2 O9,394.19522,NA,NA,Feature0833,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,3063213.0165034803,4496803.171604143,1.4680021099992067,0.5538540418072865,0.20959980036561715,0.5821476316614936,Upregulated
Feature0832,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",C25 H36 O3,384.26647,NA,NA,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",25,36,3,0,0,0,1.44,0.12,-1.2000000000000002,94.5,8,5,0.2272727272727273,0.2765957446808511,5,Unsaturated HC,381325.4725329127,342074.5038638137,0.8970670162463087,-0.1567123278089538,0.6336448770909815,0.8097293288325026,Downregulated
Feature0831,NA,C6 H11 N O7,209.05351,NA,NA,Feature0831,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,14398913.977267,14400156.9729369,1.0000863256542725,1.2453621806246683e-4,0.9970732137148041,0.9983105203768579,Upregulated
Feature0830,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature0830,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,123866.10067820101,115972.69441708067,0.9362746851809998,-0.09499624369917135,0.7645011580251517,0.8928697384736425,Downregulated
Feature0829,NA,C15 H5 N10 O18 P3 S2,769.84371,NA,NA,Feature0829,15,5,18,10,2,3,0.3333333333333333,1.2,3.3333333333333335,-34.7,20,2,0.7222222222222222,0.4444444444444444,-13,Other,8530391.80244718,11300021.050085908,1.324677847369705,0.40564154872356395,0.1751158203114177,0.5646729954371317,Upregulated
Feature0828,NA,C18 H34 N2 O8,406.23164,NA,NA,Feature0828,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,5600296.832492634,6268036.476871913,1.1192329021749505,0.1625102792547977,0.4943994259568543,0.7334162931788414,Upregulated
Feature0827,N-glycoloyl-beta-D-glucosamine,C8 H15 N O7,237.08484,NA,NA,N-glycoloyl-beta-D-glucosamine,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,18854065.762830734,13268508.667917768,0.7037478724655538,-0.5068694391694997,0.19266238674536762,0.5685889950290117,Downregulated
Feature0826,Pro-Hyp,C10 H16 N2 O4,228.11102,NA,NA,Pro-Hyp-peak1,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,3213898.98674689,2907451.01535501,0.9046491589637462,-0.14456970021559531,0.09746803816773006,0.5434560019812327,Downregulated
Feature0825,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine-peak3,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,8223466.049948406,11908410.801010666,1.4481011691031884,0.5341623973554097,0.2676663402713546,0.6292487790932914,Upregulated
Feature0824,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,1083790.3413044005,6199231.307761747,5.719954378169339,2.516003640246439,0.32111292845755535,0.6622100705596555,Upregulated
Feature0823,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13666,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,15989169.1820903,12769187.7291946,0.7986148363166707,-0.32442822091081036,0.37306231985227306,0.6751790275958873,Downregulated
Feature0822,Leu-arg,C12 H25 N5 O3,287.19576,NA,NA,Leu-arg-peak1,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,7009805.452950453,7634451.761912837,1.089110363069986,0.12315015440958796,0.747008091360438,0.8798995233889605,Upregulated
Feature0821,Gly-Tyr,C11 H14 N2 O4,238.09534,Other,NA,Gly-Tyr-peak3,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,6552623.7705766335,11170112.924208697,1.7046778993120373,0.7694991662497126,0.09101886613557639,0.5434560019812327,Upregulated
Feature0820,4-Methyleneglutamic acid,C6 H9 N O4,159.05324,Other,NA,4-Methyleneglutamic acid-peak1,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,9684784.96899219,11497913.56479588,1.1872141303713803,0.2475801683107395,0.358557390306206,0.6692796802688192,Upregulated
Feature0819,9-Nitrooleate,C18 H33 N O4,327.24099,NA,NA,9-Nitrooleate,18,33,4,1,0,0,1.8333333333333333,0.2222222222222222,-1.2222222222222223,95.13333333333333,3,-1,-0.15384615384615383,0,-2,Lipid,1253434.93012411,1274309.323363242,1.0166537510144742,0.023828413955291804,0.9488350478316009,0.9747079432618944,Upregulated
Feature0818,4-Nitrosodiphenylamine,C12 H10 N2 O,198.07934,NA,NA,4-Nitrosodiphenylamine,12,10,1,2,0,0,0.8333333333333334,0.08333333333333333,-0.16666666666666696,65.05000000000001,9,8,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,10849603.368818467,13245545.2532291,1.220832209525421,0.2878649307759013,0.30617748642996867,0.650771219588917,Upregulated
Feature0817,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",C17 H18 N2 O5,330.12166,NA,NA,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",17,18,5,2,0,0,1.0588235294117647,0.29411764705882354,-0.117647058823529,63.65294117647058,10,5,0.3,0.44,3,Lignin,18885028.100128766,15279498.0699322,0.8090799753603765,-0.3056457786930269,0.22541834141182143,0.5958985050006134,Downregulated
Feature0816,3-(6-Amino-1H-purin-1-yl)-1-propanol,C8 H11 N5 O,193.09636,NA,NA,3-(6-Amino-1H-purin-1-yl)-1-propanol,8,11,1,5,0,0,1.375,0.125,0.75,38.925,6,5,0,0.2,0,Unsaturated HC,92546.2326745795,99633.61219232141,1.0765820424334642,0.10645826627877247,0.7123247840213216,0.8576248643440788,Upregulated
Feature0815,NA,C20 H28 N2 O8,424.18475,NA,NA,Feature0815,20,28,8,2,0,0,1.4,0.4,-0.2999999999999998,68.85,8,0,-0.2,0.14285714285714285,-2,Lignin,7617708.923863816,6716048.827112867,0.8816363153590261,-0.18174444390328648,0.37514878829945586,0.676066007850296,Downregulated
Feature0814,NA,C17 H30 N2 O12,454.18001,NA,NA,Feature0814,17,30,12,2,0,0,1.7647058823529411,0.7058823529411765,0,60.3,4,-8,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,189520.74816189567,180948.40838522435,0.9547683308565851,-0.06677738107961638,0.6129815012952288,0.7991290476183568,Downregulated
Feature0813,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak1,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,10855435.353179717,13976518.971166966,1.2875134452413313,0.36458749814572816,0.008723328083061298,0.5434560019812327,Upregulated
Feature0812,Aspartyl-L-proline,C9 H14 N2 O5,230.09027,Biosynthesis of secondary metabolites;Other,NA,Aspartyl-L-proline,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,6023463.600281213,12856663.78762099,2.1344303943367002,1.093851115791159,0.06928835594597241,0.5434560019812327,Upregulated
Feature0811,Tyrosylalanine,C12 H16 N2 O4,252.11103,NA,NA,Tyrosylalanine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,8710399.573563557,13264114.343416067,1.5227905713617584,0.6067175423284517,0.19418585810706254,0.5699904136593773,Upregulated
Feature0810,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one-peak1",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,265748.10670277034,300678.003101039,1.1314398692493282,0.17815991413114549,0.7850273372873261,0.9001754630810936,Upregulated
Feature0809,MFCD02728197,C14 H20 N2 O4,280.14233,NA,NA,MFCD02728197-peak1,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,10021665.986345263,7649854.648839553,0.7633316316132114,-0.38961811864249696,0.2953263663955855,0.6419851575257671,Downregulated
Feature0808,NA,C11 H23 N O11,345.1272,NA,NA,Feature0808,11,23,11,1,0,0,2.090909090909091,1,0.18181818181818168,55.11818181818182,1,-10,11,-1.2222222222222223,-11,Carbohydrate,10946218.737284044,10735478.001141837,0.9807476224255961,-0.02804616202976295,0.8849183155585192,0.9481667467148207,Downregulated
Feature0807,NA,C11 H19 N3 O5,273.13241,Biosynthesis of secondary metabolites;Other,NA,Feature0807,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,9103107.017243262,10215491.534566633,1.1221983346143545,0.16632767690709102,0.4884900172381099,0.7305091897794865,Upregulated
Feature0806,NA,C10 H15 N O5,229.09493,NA,NA,Feature0806,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,10489837.702288067,9790304.57565083,0.9333132555058833,-0.09956670907983384,0.7522360651809604,0.8812502727638638,Downregulated
Feature0805,Methohexital,C14 H18 N2 O3,262.13173,NA,NA,Methohexital,14,18,3,2,0,0,1.2857142857142858,0.21428571428571427,-0.4285714285714288,72.51428571428572,7,4,0.2222222222222222,0.3333333333333333,2,Lignin,732270.7320115484,470979.72132015537,0.6431770392165936,-0.6367121902356022,0.5613553002315583,0.7719911688016345,Downregulated
Feature0804,NA,C9 H17 N3 O2,199.13214,NA,NA,Feature0804,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,15383061.578160167,14203403.605613668,0.923314486745519,-0.11510597226937186,0.6283838354771268,0.8070373141002675,Downregulated
Feature0803,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak1",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,981221.5049481144,1291360.520620407,1.3160744175584416,0.396241068713784,0.7116798002512115,0.8576248643440788,Upregulated
Feature0802,2-Aminooctanedioic acid,C8 H15 N O4,189.10014,NA,NA,2-Aminooctanedioic acid-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,13672218.156808333,13847043.783253634,1.0127869248749695,0.01833068474085497,0.5895222032915548,0.7841136051951803,Upregulated
Feature0801,Myristicin,C11 H12 O3,192.07871,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,Myristicin,11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1632671.3601070268,1122991.0642201556,0.6878243176548035,-0.5398879724221727,0.15997502045729406,0.5576084046392101,Downregulated
Feature0800,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",C14 H14 O6,278.07905,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",14,14,6,0,0,0,1,0.42857142857142855,-0.14285714285714324,64.37142857142858,8,2,0.25,0.4545454545454546,2,Lignin,586128.973790932,484278.90462333435,0.8262326659798824,-0.27537999509570005,0.23650954375660452,0.6065864474864333,Downregulated
Feature0799,NA,C12 H23 N3 O2,241.17901,NA,NA,Feature0799,12,23,2,3,0,0,1.9166666666666667,0.16666666666666666,-0.833333333333333,84.04999999999998,3,1,-0.2857142857142857,-0.125,-2,Lipid,15415801.8045326,15173407.844768066,0.984276266467485,-0.022864787125347147,0.8771274122799773,0.9428006576156609,Downregulated
Feature0798,b-Ala-Lys,C9 H19 N3 O3,217.14263,Metabolic pathways;Other,Other,b-Ala-Lys,9,19,3,3,0,0,2.111111111111111,0.3333333333333333,-0.44444444444444464,72.96666666666667,2,-1,-1.3333333333333333,-0.5555555555555556,-4,Protein,8173598.200548157,12648701.999941066,1.547507192009119,0.6299461143518367,0.07719038326323455,0.5434560019812327,Upregulated
Feature0797,6-Methoxyquinoline,C10 H9 N O,159.06843,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,6-Methoxyquinoline,10,9,1,1,0,0,0.9,0.1,-0.4000000000000003,71.7,7,6,0.625,0.6470588235294118,5,Unsaturated HC,738244.5542698443,718227.2927816143,0.9728853245547773,-0.03965833247725639,0.9334657608385769,0.9692805595037932,Downregulated
Feature0796,D-PANTOTHENIC ACID,C9 H17 N O5,219.11064,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak2,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,6894043.488767597,9502667.766035713,1.378388137747945,0.462982191058949,0.1287794322396112,0.5545833428603265,Upregulated
Feature0795,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.12123,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak2,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,12150276.110553574,8252617.3770731995,0.6792123324592667,-0.5580654407427292,0.29070994229986136,0.6362566437415571,Downregulated
Feature0794,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak2,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,10998690.431061333,12112105.640968934,1.1012316163352696,0.13911793538331482,0.172207515761637,0.5646729954371317,Upregulated
Feature0793,Aspartame,C14 H18 N2 O5,294.1216,Other,NA,Aspartame-peak2,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,10065076.537869094,12593445.430235468,1.2512021525970096,0.3233148998058244,0.3803364164129913,0.6779003876754276,Upregulated
Feature0792,mebutamate,C10 H20 N2 O4,232.14227,Other,NA,mebutamate-peak1,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,7999501.084547644,7069757.118385733,0.8837747559084823,-0.17824937226243942,0.5746165715215477,0.7751995156675667,Downregulated
Feature0791,Methyl alpha-aspartylphenylalaninate,C14 H18 N2 O5,294.12162,Other,NA,Methyl alpha-aspartylphenylalaninate,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,11375141.914341424,8348134.020165323,0.7338927358471244,-0.4463588775542813,0.1376235308063923,0.5564063512793044,Downregulated
Feature0790,delta-guanidinovaleric acid,C6 H13 N3 O2,159.1008,NA,NA,delta-guanidinovaleric acid-peak2,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,15830318.280318266,13547186.885838034,0.8557747637128159,-0.22469695951464294,0.14985100922033875,0.5574792106914738,Downregulated
Feature0789,Cynometrine,C16 H19 N3 O2,285.14778,NA,NA,Cynometrine,16,19,2,3,0,0,1.1875,0.125,-0.375,70.9875,9,7,0.3636363636363637,0.4166666666666667,4,Unsaturated HC,201272.54058377634,191216.62200949868,0.9500382985919927,-0.07394242136480436,0.78640105586493,0.9001754630810936,Downregulated
Feature0788,2-Amino-3-methoxybenzoic acid,C8 H9 N O3,167.05827,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,2-Amino-3-methoxybenzoic acid,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,4228689.623935146,7433823.024123319,1.7579495506235643,0.8138936688262837,0.04061480567023927,0.5434560019812327,Upregulated
Feature0787,Fluoranthene,C16 H10,202.0783,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak1,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,11808470.92850386,13233493.613169033,1.120678002536754,0.16437181706010373,0.6846813983532288,0.8413368001590931,Upregulated
Feature0786,NA,C7 H11 O3 P S,206.01667,NA,NA,Feature0786,7,11,3,0,1,1,1.5714285714285714,0.42857142857142855,-1.1428571428571432,92.87142857142858,3,0,-1,-0.14285714285714285,-2,Protein,14331404.441056034,11108242.751510616,0.7750979882814671,-0.36754938673080434,0.2566319855337105,0.628842322173499,Downregulated
Feature0785,NA,C15 H27 N3 O6,345.19012,NA,NA,Feature0785,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,12455925.882918067,10161312.736254983,0.8157814065183309,-0.2937454696268605,0.3514291225074522,0.6670930191369346,Downregulated
Feature0784,Pro-Pro,C10 H16 N2 O3,212.11603,NA,NA,Pro-Pro,10,16,3,2,0,0,1.6,0.3,-0.4000000000000003,71.7,4,1,-0.2,0.07692307692307693,-1,Lipid,10163552.885105073,8702172.2323982,0.8562136027403803,-0.2239573389481857,0.2133646372141643,0.5848538761177902,Downregulated
Feature0783,NA,C79 H121 N6 O18 P3,1534.79514,NA,NA,Feature0783,79,121,18,6,0,3,1.5316455696202531,0.2278481012658228,-1.037974683544304,89.88227848101266,24,6,-0.05769230769230769,0.09836065573770492,-3,Lipid,404799.56360270333,328537.8873218933,0.8116063278278179,-0.3011479815298234,0.33561368965258026,0.6636048496469049,Downregulated
Feature0782,NA,C13 H24 N2 O8,336.15338,NA,NA,Feature0782,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,12907694.116858633,13186994.2345608,1.0216382659190364,0.03088446795450019,0.6996425844320889,0.8502112898335427,Upregulated
Feature0781,Pyroquilon,C11 H11 N O,173.08408,NA,NA,Pyroquilon,11,11,1,1,0,0,1,0.09090909090909093,-0.5454545454545459,75.84545454545456,7,6,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,7138573.06046562,12163507.156104563,1.7039129603460537,0.7688516413828272,0.04955465503716055,0.5434560019812327,Upregulated
Feature0780,NA,C11 H19 N O5,245.12631,NA,NA,Feature0780,11,19,5,1,0,0,1.7272727272727273,0.4545454545454546,-0.5454545454545459,75.84545454545456,3,-2,-0.6,-0.06666666666666667,-3,Protein,14423220.4185757,14330845.674299866,0.9935954147828966,-0.009269579023452663,0.9524205341226497,0.9760437899599327,Downregulated
Feature0779,7-Methylguanine,C6 H7 N5 O,165.06508,NA,NA,7-Methylguanine-peak2,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,1229400.82777751,1565063.9242791666,1.273029827959741,0.34826622296704146,0.050027424591814786,0.5434560019812327,Upregulated
Feature0778,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16888,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak5,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,6451085.019463167,3732763.323612883,0.5786256594589896,-0.7892977931314026,0.030115760667219417,0.5434560019812327,Downregulated
Feature0777,Alanyltyrosine,C12 H16 N2 O4,252.11102,NA,NA,Alanyltyrosine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,9191958.52460197,7506958.325790427,0.8166875759609123,-0.2921438143313266,0.15109487023764132,0.5574792106914738,Downregulated
Feature0776,asn-leu,C10 H19 N3 O4,245.13754,NA,NA,asn-leu-peak2,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,6911666.526263706,10874948.90541,1.573419212875242,0.65390310543877594,0.17941630916667461,0.5646729954371317,Upregulated
Feature0775,6-Aminocaproic acid,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak1,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,186161.450040879,194481.54933432332,1.0446929226841397,0.0630789384545482,0.9164356502062614,0.9624562873213929,Upregulated
Feature0774,NA,C16 H31 N3 O4,329.23158,NA,NA,Feature0774,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,9574123.840330873,5231143.850727807,0.5463835582209289,-0.8720140241986416,0.1591222988459428,0.5574792106914738,Downregulated
Feature0773,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak2,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,6690681.889382773,10494767.668871874,1.5685647356102346,0.64944507130240825,0.09293241326687832,0.5434560019812327,Upregulated
Feature0772,Betaine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine-peak1,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,1484101.0368568,1637086.98615841,1.1030832439990887,0.14154166778609847,0.5426763707700374,0.7605745869440796,Upregulated
Feature0771,"3-(2,6-Dioxocyclohexyl)propanenitrile",C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,"3-(2,6-Dioxocyclohexyl)propanenitrile",9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,5864504.22480596,5321790.933507,0.9074579417978138,-0.1400973152123751,0.2916817362114979,0.6367382231214915,Downregulated
Feature0770,NA,C22 H40 N2 O7,444.2837,NA,NA,Feature0770,22,40,7,2,0,0,1.818181818181818,0.3181818181818182,-0.9090909090909092,86.2090909090909,4,-3,-0.38461538461538464,-0.09090909090909093,-5,Protein,572324.8198314363,362226.20144378964,0.6329031852060412,-0.6599432664904954,0.25836732953527464,0.628842322173499,Downregulated
Feature0769,NA,C20 H30 N2 O8,426.2003,NA,NA,Feature0769,20,30,8,2,0,0,1.5,0.4,-0.4000000000000003,71.7,7,-1,-0.3,0.07142857142857142,-3,Protein,507735.89899747266,651429.5955166777,1.2830087389978315,0.3595309971352308,0.5295620779428507,0.7475651333626575,Upregulated
Feature0768,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,C18 H20 N2 O4,328.14237,NA,NA,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,8089168.761716537,9425354.445641853,1.1651820753510618,0.22055541297517664,0.4258022478180516,0.6954800040321182,Upregulated
Feature0767,N-Methylhexanamide,C7 H15 N O,129.11533,NA,NA,N-Methylhexanamide,7,15,1,1,0,0,2.142857142857143,0.14285714285714285,-1.4285714285714288,101.01428571428572,1,0,-0.2,-0.09090909090909093,-1,Lipid,345836.75435349066,474011.223111653,1.3706213036777206,0.45483001621176433,0.44688597607780206,0.7027877448360436,Upregulated
Feature0766,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam-peak1,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,518622.4826229457,1392899.008055754,2.6857667276804773,1.4253340049018934,0.07793908360690263,0.5434560019812327,Upregulated
Feature0765,NA,C11 H19 N3 O5,273.13243,Biosynthesis of secondary metabolites;Other,NA,Feature0765,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,12067945.570722567,10250005.21412023,0.8493579254274439,-0.2355554510956359,0.26562799194871567,0.6292487790932914,Downregulated
Feature0764,"β,β-dimethylacrylshikonin",C21 H22 O6,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"β,β-dimethylacrylshikonin",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,14538763.704013033,11094381.058617806,0.7630897155000533,-0.3900754120108666,0.43239428575882244,0.7004620007406192,Downregulated
Feature0763,Prolylleucine,C11 H20 N2 O3,228.14738,NA,NA,Prolylleucine-peak2,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,1286448.2785795038,2095401.2051179633,1.6288266228874007,0.7038330473180764,0.11123408361635853,0.5462476753068062,Upregulated
Feature0762,Troxipide,C15 H22 N2 O4,294.15799,NA,NA,Troxipide-peak2,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,5156162.384383413,3160854.6350131934,0.6130246488331217,-0.7059830111272996,0.04209347119441598,0.5434560019812327,Downregulated
Feature0761,Troxipide,C15 H22 N2 O4,294.158,NA,NA,Troxipide-peak1,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,5574485.825969657,8387633.849772947,1.5046470852428717,0.5894251427486743,0.13687651014350208,0.5560403073935072,Upregulated
Feature0760,NA,C13 H24 N2 O9,352.14823,NA,NA,Feature0760,13,24,9,2,0,0,1.8461538461538465,0.6923076923076923,0,60.3,3,-6,-4,-0.5384615384615384,-8,Amino Sugar,1198541.601344202,1358150.0548325765,1.133168889014256,0.18036289839149622,0.6209819546066153,0.8017861517557976,Upregulated
Feature0759,MFCD15144952,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,MFCD15144952,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,10554928.569577318,11622638.306405883,1.1011574573707725,0.1390207783717449,0.512617962726713,0.7403024968960373,Upregulated
Feature0758,threonylphenylalanine,C13 H18 N2 O4,266.12671,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak3,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,8037433.170052103,11507865.566185717,1.4317836705709264,0.5178135310303343,0.16855981258206473,0.5646729954371317,Upregulated
Feature0757,NA,C6 H14 O4,150.08923,NA,NA,Feature0757,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,8086024.47724762,6456909.145526663,0.7985270343535384,-0.32458684358453155,0.13253704028016555,0.5557369956301991,Downregulated
Feature0756,NA,C17 H26 N2 O8,386.16898,NA,NA,Feature0756,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,12744632.0422751,9268521.8625265,0.7272490748875271,-0.4594785387711664,0.09202370533892154,0.5434560019812327,Downregulated
Feature0755,Proacacipetalin,C11 H17 N O6,259.10561,NA,NA,Proacacipetalin-peak1,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,13275628.914907267,12731415.398039663,0.9590065735976919,-0.060387390525825424,0.910809627193828,0.9577352628593075,Downregulated
Feature0754,NA,C17 H34 N6 O4,386.26429,NA,NA,Feature0754,17,34,4,6,0,0,2,0.2352941176470588,-0.47058823529411775,73.71176470588236,4,0,-0.8571428571428571,-0.4444444444444444,-6,Lipid,14232467.794672532,8070142.260083264,0.5670233986479887,-0.818519824593049,0.07228370793456343,0.5434560019812327,Downregulated
Feature0753,Ectoine,C6 H10 N2 O2,142.07423,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine-peak1,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,14854646.2412261,13041417.781004068,0.8779352647800001,-0.18781352941373172,0.2166972302142018,0.587247735354029,Downregulated
Feature0752,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak5,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,13256207.052097833,12666017.1320311,0.9554782210516746,-0.06570510576504554,0.36714558548166565,0.6716464598336302,Downregulated
Feature0751,Malonyl-L-carnitine,C10 H17 N O6,247.10558,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Malonyl-L-carnitine,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,2178109.2374019,1447078.99035308,0.6643739283155468,-0.5899326354159145,0.20617531345123358,0.5811330798442425,Downregulated
Feature0750,NA,C12 H19 N O9,321.10608,NA,NA,Feature0750,12,19,9,1,0,0,1.5833333333333333,0.75,0.16666666666666652,55.55,4,-5,-3,-0.2307692307692308,-6,Carbohydrate,987372.674869233,1035934.2070952291,1.04918257661164,0.0692657546096459,0.8561966738819515,0.9356715651701699,Upregulated
Feature0749,NA,C6 H15 N O4,165.10013,NA,NA,Feature0749,6,15,4,1,0,0,2.5,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,2920716.2664025133,1612250.2929271,0.5520051062381801,-0.8572464823940131,0.025808373576445956,0.5434560019812327,Downregulated
Feature0748,NA,C18 H29 N O12,451.16875,NA,NA,Feature0748,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,1585869.3150769128,3858979.6200045967,2.4333528515352105,1.282945535340042,0.11011008260530102,0.5462476753068062,Upregulated
Feature0747,Isovalerylglutamic acid,C10 H17 N O5,231.11065,NA,NA,Isovalerylglutamic acid-peak5,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,7320592.794898449,5084939.01826169,0.6946075489686115,-0.5257300049269332,0.42463200656571315,0.6952678098597452,Downregulated
Feature0746,NA,C11 H19 N3 O5,273.13243,Biosynthesis of secondary metabolites;Other,NA,Feature0746,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,7527505.516370207,9261722.052533636,1.230383960847587,0.29910860171823844,0.0043778474472281285,0.5434560019812327,Upregulated
Feature0745,NA,C11 H20 N4 O5,288.1433,NA,NA,Feature0745,11,20,5,4,0,0,1.818181818181818,0.4545454545454546,0.18181818181818168,55.11818181818182,4,-1,-2.5,-0.5555555555555556,-5,Protein,4154337.435198603,7587094.600411937,1.8263067742471975,0.8689291226669592,0.2351897847423162,0.6064101907967788,Upregulated
Feature0744,Imazapyr,C13 H15 N3 O3,261.1114,NA,NA,Imazapyr,13,15,3,3,0,0,1.1538461538461535,0.2307692307692308,0,60.3,8,5,0.2857142857142857,0.4117647058823529,2,Lignin,7118717.244753897,8363158.0888771005,1.174812512049174,0.2324305359228056,0.45095266271865303,0.7032665602753505,Upregulated
Feature0743,NA,C17 H26 N2 O8,386.16902,NA,NA,Feature0743,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,5996484.514312644,5011923.63167455,0.8358103184810858,-0.2587525253517094,0.1022723443675881,0.5434560019812327,Downregulated
Feature0742,Gly-Phe,C11 H14 N2 O3,222.1005,NA,NA,Gly-Phe-peak1,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,6468287.2711272435,11345484.41558868,1.7540167806448517,0.8106625500844161,0.13874676018832874,0.5574792106914738,Upregulated
Feature0741,NA,C14 H24 N2 O11,396.13811,NA,NA,Feature0741,14,24,11,2,0,0,1.7142857142857142,0.7857142857142857,0.2857142857142856,52.15714285714286,4,-7,-9,-0.5384615384615384,-9,Carbohydrate,1842037.9419142033,2288584.7614002633,1.2424199900149824,0.3131529473808923,0.28722014829948955,0.6353376492471592,Upregulated
Feature0740,NA,C22 H32 N4 O5,432.23734,NA,NA,Feature0740,22,32,5,4,0,0,1.4545454545454546,0.2272727272727273,-0.45454545454545414,73.25454545454544,9,4,0,0.16129032258064516,0,Lignin,8584160.65483523,2637836.3094134,0.30729111621735283,-1.7023220356506992,0.43547042740802155,0.7009176491269988,Downregulated
Feature0739,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak2,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,6027994.473763326,7177421.602493463,1.1906815166690987,0.25178757292773335,0.6940247937702577,0.8464204468299615,Upregulated
Feature0738,Adipic acid,C6 H10 O4,146.05793,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,1351758.7034874966,1350577.947099684,0.9991265035802868,-0.0012607396589403293,0.9975872882737642,0.9983105203768579,Downregulated
Feature0737,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide-peak1,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,484819.7320106007,387290.7820748873,0.7988346111012229,-0.3240312531140531,0.3243540944118293,0.6622100705596555,Downregulated
Feature0736,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea",C14 H20 N4 O2,276.15866,Metabolic pathways;Other,NA,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea-peak2",14,20,2,4,0,0,1.4285714285714286,0.14285714285714285,-0.2857142857142856,68.44285714285714,7,5,0.125,0.2222222222222222,1,Lignin,1565294.2005882266,1045848.2049964587,0.6681480098779107,-0.5817603672420572,0.5239237102693082,0.7451945971420723,Downregulated
Feature0735,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",C14 H24 N2 O9,364.14823,NA,NA,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",14,24,9,2,0,0,1.7142857142857142,0.6428571428571429,0,60.3,4,-5,-2.3333333333333335,-0.3333333333333333,-7,Amino Sugar,4953463.46457179,6772584.215860777,1.367242186058244,0.4512688169585181,0.12052381548282688,0.5462476753068062,Upregulated
Feature0734,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak1",11,14,2,4,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Lignin,12102785.071568167,12471543.470775567,1.0304688877003763,0.043300947149879816,0.7851755564556783,0.9001754630810936,Upregulated
Feature0733,Stearidonic acid,C18 H28 O2,276.20889,Biosynthesis of secondary metabolites;Other,NA,Stearidonic acid,18,28,2,0,0,0,1.5555555555555556,0.1111111111111111,-1.333333333333333,98.29999999999998,5,3,0.1875,0.2352941176470588,3,Lipid,1122440.4700073702,779731.0613096,0.6946747574991483,-0.5255904200299903,0.5198468289020135,0.7430834801967906,Downregulated
Feature0732,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,C26 H50 N O7 P,519.33266,NA,NA,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,26,50,7,1,0,1,1.9230769230769231,0.2692307692307692,-1.4615384615384617,101.95384615384616,3,-4,-0.35294117647058826,-0.12195121951219512,-6,Lipid,7890621.691764896,3966420.843042297,0.5026753274943951,-0.9923012150345271,0.599234102699666,0.7909735546574881,Downregulated
Feature0731,NA,C12 H22 N2 O9,338.1325,NA,NA,Feature0731,12,22,9,2,0,0,1.8333333333333333,0.75,0.16666666666666652,55.55,3,-6,-8,-0.6363636363636364,-8,Carbohydrate,1971245.9702154594,3612936.2143790135,1.8328185670224175,0.8740639787789529,0.08468149564813846,0.5434560019812327,Upregulated
Feature0730,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0730,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,8253688.803033973,9004195.932643034,1.0909299038913585,0.1255584063754093,0.6127088520177257,0.7991290476183568,Upregulated
Feature0729,Pyridoxal,C8 H9 N O3,167.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak3,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,3503849.10535273,3543249.51434546,1.0112448932040308,0.01613241705048382,0.9196338140931841,0.9629365459231719,Upregulated
Feature0728,NA,C12 H17 N3 O7,315.10673,NA,NA,Feature0728,12,17,7,3,0,0,1.4166666666666667,0.5833333333333334,0.5,46.05,6,-1,-2,-0.09090909090909093,-4,Lignin,239687.42636962832,254963.79598573365,1.063734547312245,0.08913817428217218,0.8730714258352592,0.9409146589428623,Upregulated
Feature0727,NS1800000,C8 H9 N O4,183.05316,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,NS1800000,8,9,4,1,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Lignin,2405833.9703598334,1777330.1505886966,0.7387584398946976,-0.4368253875333377,0.07319778475802205,0.5434560019812327,Downregulated
Feature0726,NA,C16 H23 N5 O10,445.14456,NA,NA,Feature0726,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,4414401.356558528,5541452.12726135,1.2553122563330925,0.3280462762312513,0.655482015028366,0.8255661958795926,Upregulated
Feature0725,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak3,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,7756115.0459542265,7549840.522667604,0.9734049170152239,-0.038888032685614374,0.9328499942452302,0.9692805595037932,Downregulated
Feature0724,methoxyresorcinol,C7 H8 O3,140.04734,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak2,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,4563787.642343214,3118723.80666682,0.6833630420773816,-0.5492758694401514,0.027533334360437162,0.5434560019812327,Downregulated
Feature0723,fructosylglycine,C8 H15 N O7,237.08491,NA,NA,fructosylglycine-peak1,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,6139419.323903743,6050862.8597350735,0.9855757589608065,-0.020961322678730847,0.8954376860503902,0.9522105713555311,Downregulated
Feature0722,pseudouridine,C9 H12 N2 O6,244.06949,Metabolic pathways;ABC transporters;Other,Other,pseudouridine-peak1,9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,1479394.8460276932,3088545.71191613,2.0877088494725733,1.061920528617538,0.050405095562791324,0.5434560019812327,Upregulated
Feature0721,NA,C22 H28 N2 O9,464.17958,NA,NA,Feature0721,22,28,9,2,0,0,1.2727272727272727,0.4090909090909091,-0.18181818181818168,65.48181818181817,10,1,-0.09090909090909093,0.2258064516129032,-1,Lignin,3978181.1278988165,4934419.492968603,1.2403707459079043,0.31077140556229693,0.5767232050797843,0.7755170614464124,Upregulated
Feature0720,Xamoterol [USAN:BAN:INN],C16 H25 N3 O5,339.17949,NA,NA,Xamoterol [USAN:BAN:INN],16,25,5,3,0,0,1.5625,0.3125,-0.375,70.9875,6,1,-0.25,0.04761904761904761,-2,Protein,211482.221736543,174240.75865750067,0.8239026298606017,-0.2794542474275569,0.5481279851256096,0.7629653301584081,Downregulated
Feature0719,N2-Dimethylguanosine,C12 H17 N5 O5,311.12308,NA,NA,N2-Dimethylguanosine,12,17,5,5,0,0,1.4166666666666667,0.4166666666666667,0.6666666666666665,41.3,7,2,-1.5,-0.1111111111111111,-3,Lignin,1160102.250145274,3306162.2306719967,2.849888645813748,1.5109055497086767,0.03880656958366012,0.5434560019812327,Upregulated
Feature0718,UNII:74D1OHC38H,C19 H32 O4,324.23009,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak1,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1244995.4711858516,1331154.9498198403,1.0692046522481902,0.09653802006062373,0.9173965321950655,0.9625653071746106,Upregulated
Feature0717,NA,C33 H47 N O8,585.33043,NA,NA,Feature0717,33,47,8,1,0,0,1.4242424242424243,0.24242424242424243,-0.8484848484848486,84.48181818181818,11,3,0.08333333333333333,0.21428571428571427,2,Lignin,187209.694407681,158275.84069775732,0.8454468193996658,-0.24221408632113292,0.4386075543138774,0.7009176491269988,Downregulated
Feature0716,perlolyrine,C16 H12 N2 O2,264.0899,Other,NA,perlolyrine,16,12,2,2,0,0,0.75,0.125,-0.125,63.8625,12,10,0.6666666666666666,0.6923076923076923,8,Condensed HC,881535.0232005017,1654179.0781131634,1.876475732192125,0.9080256324724422,0.14101598444968674,0.5574792106914738,Upregulated
Feature0715,"4-(4-methylphenyl)-2-phenyl-1,3-thiazole",C16 H13 N S,251.07697,NA,NA,"4-(4-methylphenyl)-2-phenyl-1,3-thiazole",16,13,0,1,1,0,0.8125,0,-0.5,74.55,11,11,0.6428571428571429,0.6428571428571429,9,Unsaturated HC,10611759.843550596,10824138.620921396,1.0200135303193725,0.028588289446961134,0.9032237156849652,0.953701139936653,Upregulated
Feature0714,N-acetyl-L-2-aminoadipic acid 6-phosphate,C8 H14 N O8 P,283.04574,NA,NA,N-acetyl-L-2-aminoadipic acid 6-phosphate,8,14,8,1,0,1,1.75,1,0,60.3,3,-5,3.5,-1.5,-7,Carbohydrate,869958.2887759546,985770.2640644027,1.1331235954443257,0.18030523168767992,0.28380953011259397,0.6342656253439766,Upregulated
Feature0713,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak1,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,1468318.9153845867,4678414.573851987,3.1862387147867,1.671854358431833,0.2127614322935495,0.5841456504137323,Upregulated
Feature0712,threonylphenylalanine,C13 H18 N2 O4,266.12668,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak2,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,9483846.279210247,8344654.3357295,0.8798808089099889,-0.18461998936560464,0.5280348171576082,0.747050825595009,Downregulated
Feature0711,NA,C29 H28 O9,520.17351,NA,NA,Feature0711,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,12156445.963472817,6566499.873521667,0.5401660891063401,-0.8885250226334948,0.2832149592021483,0.6337729734325485,Downregulated
Feature0710,asn-phe,C13 H17 N3 O4,279.12195,NA,NA,asn-phe-peak2,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,9229147.694249153,9150188.42442093,0.9914445762009613,-0.0123959698108824,0.9493908538265206,0.9747079432618944,Downregulated
Feature0709,N-Acetylvanilalanine,C12 H15 N O5,253.09509,NA,NA,N-Acetylvanilalanine-peak4,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,11614699.578502636,11659119.533237394,1.0038244600675659,0.005507005611573024,0.9870241536486077,0.9930698319787353,Upregulated
Feature0708,gepefrine,C9 H13 N O,151.09965,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,gepefrine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,233879.76657237532,212401.99216101467,0.9081674540464609,-0.1389697589917789,0.6364106071637703,0.81058614175596,Downregulated
Feature0707,D-lysopine,C9 H18 N2 O4,218.12663,Lysine degradation,NA,D-lysopine-peak2,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,7323614.396236323,9942201.9682605,1.3575539931990268,0.4410095786347247,0.22795369292822146,0.5968370259975382,Upregulated
Feature0706,NA,C22 H28 N2 O9,464.17958,NA,NA,Feature0706,22,28,9,2,0,0,1.2727272727272727,0.4090909090909091,-0.18181818181818168,65.48181818181817,10,1,-0.09090909090909093,0.2258064516129032,-1,Lignin,6356224.679367786,7465484.695661986,1.1745155453511331,0.23206580832888365,0.31343958902775804,0.6547061206079187,Upregulated
Feature0705,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13662,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,14984395.629283834,9469492.82946506,0.6319569413236085,-0.6621018318254192,0.11992101067623778,0.5462476753068062,Downregulated
Feature0704,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine,C12 H18 N2 O4,254.12667,NA,NA,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine-peak1,12,18,4,2,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,5,1,-0.16666666666666666,0.125,-1,Protein,4438559.776210937,5162387.007024927,1.163077049157576,0.21794667269725287,0.06934562522057618,0.5434560019812327,Upregulated
Feature0703,NA,C12 H17 N3 O5,283.11687,NA,NA,Feature0703,12,17,5,3,0,0,1.4166666666666667,0.4166666666666667,0.16666666666666652,55.55,6,1,-0.5,0.07692307692307693,-2,Lignin,317676.632979644,359102.1916946127,1.1304016550616838,0.17683548308768846,0.38056863558402104,0.6779003876754276,Upregulated
Feature0702,Isovalerylglutamic acid,C10 H17 N O5,231.11063,NA,NA,Isovalerylglutamic acid-peak4,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,6850685.199560944,5897414.709032876,0.8608503437598969,-0.21616564365531582,0.6775467736718426,0.8365628532070709,Downregulated
Feature0701,NA,C20 H42 N9 O17 P,711.2437,NA,NA,Feature0701,20,42,17,9,0,1,2.1,0.85,0.7000000000000002,40.349999999999994,5,-12,3.142857142857143,-9,-22,Carbohydrate,421678.48136409,229580.025490814,0.5444433036946641,-0.8771462750311964,0.07206960730781649,0.5434560019812327,Downregulated
Feature0700,NA,C77 H114 N8 O16 P2,1468.7833,NA,NA,Feature0700,77,114,16,8,0,2,1.4805194805194806,0.2077922077922078,-0.883116883116883,85.46883116883116,26,10,0,0.13559322033898305,0,Lignin,283270.50607151835,347299.38951501367,1.2260344161185976,0.29399947761493317,0.5086290422788381,0.7370552588711307,Upregulated
Feature0699,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12154,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak2",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,8033385.360660917,7467563.674682507,0.9295662213903979,-0.10537044989488516,0.8097687534213677,0.9088169879054063,Downregulated
Feature0698,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak1",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,8999295.818582848,9175058.317782916,1.019530694705816,0.027905210796634657,0.9041582235763074,0.953701139936653,Upregulated
Feature0697,MFCD00056023,C12 H14 N2 O3,234.10044,NA,NA,MFCD00056023,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,11048430.029311366,9649266.76537455,0.8733608974103243,-0.19535015545120887,0.13038641877930865,0.5545833428603265,Downregulated
Feature0696,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak3",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,479535.92790135765,609568.5302639357,1.2711634202918916,0.34614951459863247,0.6648693415428053,0.8294471376272293,Upregulated
Feature0695,Linamarin,C10 H17 N O6,247.10559,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin-peak1,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,6859490.77966455,3536877.0629638433,0.5156180213040257,-0.9556254068441316,0.006950171924632874,0.5434560019812327,Downregulated
Feature0694,Otonecine,C9 H15 N O3,185.10524,Other,NA,Otonecine,9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,14107536.256571572,9175156.751178706,0.6503727216653251,-0.6206613466125815,0.2360676800691395,0.6065864474864333,Downregulated
Feature0693,N-(Carboxyacetyl)phenylalanine,C12 H13 N O5,251.07938,NA,NA,N-(Carboxyacetyl)phenylalanine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Lignin,836735.0242577937,943712.233218963,1.1278507602284977,0.17357617968474864,0.6822680527542888,0.8393333924224875,Upregulated
Feature0692,NA,C10 H23 N O6,253.1525,NA,NA,Feature0692,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,1559938.5594132734,4452939.687553776,2.854560944521189,1.513268864021616,0.08875335284456587,0.5434560019812327,Upregulated
Feature0691,Meconin,C10 H10 O4,194.05794,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak1,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,190644.334384255,169097.021256489,0.8869763783048695,-0.1730324112812123,0.7505943636351198,0.8811551295896695,Downregulated
Feature0690,1581740,C12 H13 N O4,235.08444,NA,NA,1581740-peak2,12,13,4,1,0,0,1.0833333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,7,3,0.2857142857142857,0.4444444444444444,2,Lignin,455868.21919722634,629670.830094715,1.3812562569146654,0.4659809997433914,0.20207312627983937,0.5780722477745703,Upregulated
Feature0689,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin-peak2,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,7051912.28490322,4275583.21806114,0.6063012478493722,-0.7218933031854068,0.06539365344593025,0.5434560019812327,Downregulated
Feature0688,NA,C9 H23 N10 O5 P,382.15886,NA,NA,Feature0688,9,23,5,10,0,1,2.5555555555555554,0.5555555555555556,1.3333333333333337,22.29999999999999,4,-1,1.7142857142857142,2.111111111111111,-12,Other,1422583.58338703,1488297.356442632,1.0461932598006958,0.0651493804588519,0.861768910349767,0.9385797307881382,Upregulated
Feature0687,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0687,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,7574582.196985897,3809188.968095727,0.5028909673211405,-0.991682454212816,0.4691403844143565,0.7150766004537328,Downregulated
Feature0686,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",C8 H17 N O7,239.10053,Metabolic pathways;Biosynthesis of cofactors;Other,NA,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",8,17,7,1,0,0,2.125,0.875,0,60.3,1,-6,-Inf,-1,-7,Carbohydrate,529373.1364791883,632532.6276981636,1.194871035400624,0.25685491391454157,0.25235223051174704,0.6258926478578323,Upregulated
Feature0685,ser-asn,C7 H13 N3 O5,219.08553,Biosynthesis of secondary metabolites;Other,NA,ser-asn,7,13,5,3,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,3,-2,5,-1.6666666666666667,-5,Carbohydrate,7518902.290325204,10135279.003066327,1.3479732295640674,0.43079184521512187,0.10086630767890954,0.5434560019812327,Upregulated
Feature0684,dihydroxyphenylalanine,C9 H11 N O4,197.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,dihydroxyphenylalanine,9,11,4,1,0,0,1.2222222222222223,0.4444444444444444,0,60.3,5,1,0,0.3333333333333333,0,Lignin,12579233.755462434,11173885.8947767,0.8882803286745925,-0.17091305235934118,0.2708708751744487,0.6292487790932914,Downregulated
Feature0683,D-Glucono-delta-lactone,C6 H10 O6,178.04778,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Glucono-delta-lactone,6,10,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,150930.49915758966,172888.44698886934,1.1454838349693188,0.1959570995206737,0.21526629681674475,0.5862718758964077,Upregulated
Feature0682,NA,C18 H29 N O12,451.16881,NA,NA,Feature0682,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,2979984.2152752266,3922737.41804543,1.3163618108907105,0.39655607800625253,0.40953099050046105,0.6875574805825382,Upregulated
Feature0681,leu-lys,C12 H25 N3 O3,259.18959,NA,NA,leu-lys,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,3917737.0310654268,6322814.1361981435,1.6138944717478032,0.6905462477213565,0.2956011941381927,0.6419851575257671,Upregulated
Feature0680,lys-leu,C12 H25 N3 O3,259.18958,NA,NA,lys-leu-peak1,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,3730688.64228949,6110872.50907325,1.6380012096970555,0.7119364224388108,0.3452930818455753,0.6669629197792526,Upregulated
Feature0679,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0679,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,10684736.566890093,7128988.84134481,0.6672124105928967,-0.5837819707715934,0.03195329390303713,0.5434560019812327,Downregulated
Feature0678,Zalcitabine,C9 H13 N3 O3,211.09565,Other,NA,Zalcitabine-peak1,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Lignin,3081094.438809513,2980401.9438612065,0.9673192442010273,-0.047935994206921274,0.6654183353219626,0.8294471376272293,Downregulated
Feature0677,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11578,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak2,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,11092081.494960366,9126724.34068087,0.8228143964527805,-0.2813610585484188,0.26021562322377534,0.6292487790932914,Downregulated
Feature0676,2'-O-Methylguanosine,C11 H15 N5 O5,297.10741,NA,NA,2'-O-Methylguanosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,792070.1725139329,2059361.9732315065,2.599974149632912,1.3784972792607288,0.06861098051669687,0.5434560019812327,Upregulated
Feature0675,NA,C16 H23 N5 O10,445.14457,NA,NA,Feature0675,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,10672734.412444122,9285302.240283918,0.870002183269688,-0.20090907347956002,0.30850979556623936,0.6523468563546992,Downregulated
Feature0674,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12117,NA,NA,Cyclo(phenylalanyl-prolyl)-peak1,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,11098287.401499901,10040658.86023595,0.904703446306408,-0.14448312772570412,0.10141603057887388,0.5434560019812327,Downregulated
Feature0673,NA,C14 H20 N2 O10,376.1119,NA,NA,Feature0673,14,20,10,2,0,0,1.4285714285714286,0.7142857142857143,0.4285714285714284,48.08571428571429,6,-4,-3,-0.14285714285714285,-6,Tannin,184096.14734618968,159629.82819339735,0.8671003195586497,-0.2057291785370068,0.24559664052640667,0.6195339940083167,Downregulated
Feature0672,N(6)-[(indol-3-yl)acetyl]-L-lysine,C16 H21 N3 O3,303.15835,NA,NA,N(6)-[(indol-3-yl)acetyl]-L-lysine,16,21,3,3,0,0,1.3125,0.1875,-0.375,70.9875,8,5,0.2,0.30434782608695654,2,Lignin,5567611.170803066,4669467.410205443,0.8386841801547582,-0.25380045168526594,0.40549890918347115,0.6875574805825382,Downregulated
Feature0671,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak5,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,301261.718095299,477315.414576899,1.5843878790663621,0.6639255694467259,0.3920000820678215,0.6827896969169881,Upregulated
Feature0670,Leu-Gly-Pro,C13 H23 N3 O4,285.16888,NA,NA,Leu-Gly-Pro-peak3,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,6387775.1472099135,4367665.481558417,0.6837537923460173,-0.548451165251097,0.05379471145454149,0.5434560019812327,Downregulated
Feature0669,NA,C21 H32 N2 O8,440.21604,NA,NA,Feature0669,21,32,8,2,0,0,1.5238095238095235,0.380952380952381,-0.4761904761904763,73.87142857142857,7,-1,-0.2727272727272727,0.06666666666666667,-3,Protein,608287.2392897853,796062.2610608008,1.3086946587770854,0.38812853070263315,0.6261620247347742,0.8047939832327067,Upregulated
Feature0668,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10731,NA,NA,N(6)-OH-Me-Adenosine-peak1,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,10278192.03119829,9873825.678038834,0.9606578324347271,-0.05790543220489872,0.7193837234449736,0.8624458793459203,Downregulated
Feature0667,2762577,C15 H23 N3 O4,309.16893,NA,NA,2762577-peak1,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,3298909.31748071,5639819.922983093,1.7096013804011063,0.7736599780009948,0.13086640408483058,0.5545833428603265,Upregulated
Feature0666,NA,C19 H35 P S,326.21985,NA,NA,Feature0666,19,35,0,0,1,1,1.8421052631578947,0,-2,117.3,3,3,0.0588235294117647,0.0588235294117647,1,Lipid,4331118.196132024,1428579.009628765,0.3298406889252251,-1.6001587152454246,0.27716328728106476,0.6292487790932914,Downregulated
Feature0665,xylometazoline,C16 H24 N2,244.19396,NA,NA,xylometazoline,16,24,0,2,0,0,1.5,0,-1.125,92.3625,6,6,0.2857142857142857,0.2857142857142857,4,Lipid,134701.74819982168,120048.34668685403,0.8912159514720608,-0.1661530398309559,0.564658472483699,0.7732671401676525,Downregulated
Feature0664,Threonylglutamine,C9 H17 N3 O5,247.11681,NA,NA,Threonylglutamine,9,17,5,3,0,0,1.8888888888888888,0.5555555555555556,0.22222222222222232,53.96666666666666,3,-2,-5,-0.7142857142857143,-5,Amino Sugar,4913731.979690867,9529324.023011154,1.9393251529381674,0.9555547102029195,0.02964926495383514,0.5434560019812327,Upregulated
Feature0663,(S)-(+)-2-Aminobutyric Acid,C4 H9 N O2,103.06328,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,(S)-(+)-2-Aminobutyric Acid,4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,9057297.35066039,9259513.000992063,1.0223262682567147,0.0318556957635731,0.8682212734212307,0.939303571324255,Upregulated
Feature0662,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14231,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak2",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,324791.607967211,249214.706846997,0.7673064843231917,-0.38212514806526304,0.25768883507693213,0.628842322173499,Downregulated
Feature0661,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak2,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1128120.9909354497,996566.8723492747,0.8833865164789736,-0.17888328283686553,0.575114959408046,0.7751995156675667,Downregulated
Feature0660,Prolylleucine,C11 H20 N2 O3,228.14739,NA,NA,Prolylleucine-peak1,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,1156632.035154739,1701156.93929566,1.4707849061677358,0.5565862761679267,0.18826523309978607,0.5646729954371317,Upregulated
Feature0659,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak1",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,7743411.306417016,7293988.30981583,0.9419605934882024,-0.08626138830653647,0.4065967185258031,0.6875574805825382,Downregulated
Feature0658,2'-deamino-2'-hydroxy-6'-dehydroparomamine,C12 H22 N2 O8,322.13771,Biosynthesis of secondary metabolites;Other,Kanamycin biosynthesis,2'-deamino-2'-hydroxy-6'-dehydroparomamine,12,22,8,2,0,0,1.8333333333333333,0.6666666666666666,0,60.3,3,-5,-3.5,-0.5,-7,Amino Sugar,1763945.1561525501,1679278.81801419,0.9520017173759353,-0.07096391878322923,0.7845383554136527,0.9001754630810936,Downregulated
Feature0657,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak3,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,9245813.179638833,8198681.697714933,0.8867453341767821,-0.17340826079284405,0.3607156718331948,0.6692796802688192,Downregulated
Feature0656,NA,C16 H29 N3 O9,407.19049,NA,NA,Feature0656,16,29,9,3,0,0,1.8125,0.5625,-0.125,63.8625,4,-5,-2,-0.4117647058823529,-8,Amino Sugar,858845.636181821,1838832.2465030332,2.141050928171387,1.098319112839934,0.1281362549993697,0.5545833428603265,Upregulated
Feature0655,butoctamide,C16 H29 N O5,315.20464,NA,NA,butoctamide,16,29,5,1,0,0,1.8125,0.3125,-1,88.8,3,-2,-0.3,-0.04,-3,Protein,3864783.40748682,3445131.88819877,0.8914165491201641,-0.1658283501001695,0.6214767593796939,0.8018138845309988,Downregulated
Feature0654,NA,C23 H33 N3 O5,431.24202,NA,NA,Feature0654,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,191773.31153277634,200324.34209005535,1.0445892626504367,0.06293577941386509,0.889996532071336,0.9518018467985121,Upregulated
Feature0653,NA,C18 H31 N O14,485.17464,NA,NA,Feature0653,18,31,14,1,0,0,1.7222222222222223,0.7777777777777778,0,60.3,4,-10,-3.6666666666666665,-0.4,-11,Carbohydrate,10265761.96177864,11607292.562941387,1.130680080656216,0.17719078490643583,0.4976368449319136,0.7334162931788414,Upregulated
Feature0652,NA,C29 H28 O9,520.17353,NA,NA,Feature0652,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,12246380.960039634,9059808.477072576,0.7397947611327008,-0.4348030108550752,0.27272199345609566,0.6292487790932914,Downregulated
Feature0651,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11098,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak1,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,4381460.804445824,5326890.981893904,1.215779672498442,0.2818818026347683,0.645600449546518,0.8192113569526602,Upregulated
Feature0650,1-(5-Amino-5-carboxypentyl)-5-oxoproline,C11 H18 N2 O5,258.12159,NA,NA,1-(5-Amino-5-carboxypentyl)-5-oxoproline,11,18,5,2,0,0,1.6363636363636365,0.4545454545454546,-0.18181818181818168,65.48181818181817,4,-1,-0.75,-0.07692307692307693,-3,Protein,161303.218576234,126181.541607683,0.7822630119934523,-0.35427434374485034,0.21043551625339577,0.5824800074072752,Downregulated
Feature0649,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23298,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak2,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,12490196.708036933,7020871.399610787,0.5621105546795065,-0.8310741904160502,0.03931625354480101,0.5434560019812327,Downregulated
Feature0648,NA,C14 H29 N O2,243.2198,NA,NA,Feature0648,14,29,2,1,0,0,2.0714285714285716,0.14285714285714285,-1.5714285714285712,105.08571428571427,1,-1,-0.18181818181818185,-0.08333333333333333,-2,Lipid,161146.99885037466,6014400.696153991,37.32244931063454,5.221971762008326,0.18909655478060378,0.5646729954371317,Upregulated
Feature0647,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan-peak1,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Lignin,6945029.35224614,5789061.224445516,0.8335546087466478,-0.26265137715468995,0.4936728017326015,0.7334162931788414,Downregulated
Feature0646,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak2",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,334079.940807001,350310.85016442486,1.0485839087441664,0.068442311969084485,0.9342645464892901,0.9692805595037932,Upregulated
Feature0645,NA,C32 H37 N4 O2 P3,602.213,NA,NA,Feature0645,32,37,2,4,0,3,1.15625,0.0625,-1.125,92.3625,18,16,0.391304347826087,0.4166666666666667,9,Unsaturated HC,4398702.81090197,2924193.67307444,0.6647854603468479,-0.5890392659001717,0.3535830774728756,0.6680404345298425,Downregulated
Feature0644,N-Acetylserotonin,C12 H14 N2 O2,218.10552,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-Acetylserotonin,12,14,2,2,0,0,1.1666666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,7,5,0.375,0.4444444444444444,3,Lignin,9463267.532980183,9408169.097750047,0.9941776521652681,-0.00842442117102257,0.9346081667386739,0.9692805595037932,Downregulated
Feature0643,Homo-L-arginine,C7 H16 N4 O2,188.12733,NA,NA,Homo-L-arginine,7,16,2,4,0,0,2.2857142857142856,0.2857142857142857,0,60.3,2,0,-4,-1.5,-4,Lipid,4334463.558203206,2730943.12895994,0.6300533139311975,-0.6664541829576273,0.09402394159841111,0.5434560019812327,Downregulated
Feature0642,NA,C9 H19 N O3,189.13649,NA,NA,Feature0642,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,297429.6677098577,228375.819006275,0.767831335605214,-0.381138656349078,0.2915677245787629,0.6367382231214915,Downregulated
Feature0641,N-Aceyl-L-tyrosine,C11 H13 N O4,223.08448,NA,NA,N-Aceyl-L-tyrosine,11,13,4,1,0,0,1.181818181818182,0.3636363636363637,-0.18181818181818168,65.48181818181817,6,2,0.16666666666666666,0.375,1,Lignin,9755745.968078103,10263925.54168828,1.0520902835388497,0.07325851263871315,0.38022443669884926,0.6779003876754276,Upregulated
Feature0640,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0640,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,6344510.463368027,2932724.2580092,0.46224594867361024,-1.1132674196150676,0.08361927155766252,0.5434560019812327,Downregulated
Feature0639,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak4,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,807123.5150187816,498696.012382473,0.6178682730744977,-0.6946288005097997,0.12855875609718437,0.5545833428603265,Downregulated
Feature0638,apronalide,C9 H16 N2 O2,184.12119,NA,NA,apronalide-peak2,9,16,2,2,0,0,1.7777777777777777,0.2222222222222222,-0.666666666666667,79.30000000000001,3,1,-0.2,0,-1,Lipid,10251437.6484621,11092964.43053492,1.0820886602377242,0.1138187102969341,0.5264995397728772,0.7465824789370795,Upregulated
Feature0637,Leucylasparagine,C10 H19 N3 O4,245.13752,NA,NA,Leucylasparagine-peak2,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,5415024.674189833,4193794.52774525,0.7744737614464708,-0.3687117324022603,0.28462035110465234,0.6352375074500018,Downregulated
Feature0636,Acetophenone,C8 H8 O,120.05748,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Phenylalanine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,Acetophenone-peak2,8,8,1,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,2484867.111322697,5113000.36247655,2.0576554533553693,1.0410014286118767,0.18044884960829685,0.5646729954371317,Upregulated
Feature0635,NA,C16 H23 N5 O10,445.14463,NA,NA,Feature0635,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,9729960.028954873,8756240.267899023,0.8999256155052838,-0.152122336307958,0.30401668709633295,0.6486199848125793,Downregulated
Feature0634,NA,C9 H12 N2 O4,212.0797,NA,NA,Feature0634,9,12,4,2,0,0,1.3333333333333333,0.4444444444444444,0.22222222222222232,53.96666666666666,5,1,-0.3333333333333333,0.2,-1,Lignin,11028582.519428333,10568451.115313323,0.9582782825168669,-0.061483421694917925,0.5001816459279111,0.7334162931788414,Downregulated
Feature0633,HC Blue 1,C11 H17 N3 O4,255.12193,NA,NA,HC Blue 1,11,17,4,3,0,0,1.5454545454545454,0.3636363636363637,0,60.3,5,1,-0.5,0,-2,Protein,654654.3484021307,507530.7144573386,0.7752651696213598,-0.36723824454492643,0.43998852417353757,0.7009176491269988,Downregulated
Feature0632,beta-Pyracin,C8 H7 N O3,165.04262,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,beta-Pyracin,8,7,3,1,0,0,0.875,0.375,0.25,53.175,6,3,0.5,0.6363636363636364,2,Lignin,8625451.87799242,8551381.983168384,0.9914126360135377,-0.012442448144996628,0.9079094340390831,0.9558723314246157,Downregulated
Feature0631,ET8750000,C4 H7 N,69.05786,NA,Superpathway of linamarin and lotaustralin biosynthesis;Other,ET8750000,4,7,0,1,0,0,1.75,0,-1,88.8,2,2,0.3333333333333333,0.3333333333333333,1,Lipid,6501273.0972407535,7936804.543575114,1.2208077440930183,0.2878360189308528,0.19203449334579084,0.5685889950290117,Upregulated
Feature0630,Isovalerylglutamic acid,C10 H17 N O5,231.11073,NA,NA,Isovalerylglutamic acid-peak3,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,5233194.570248026,5514221.602058504,1.0537008567210904,0.07546534725934836,0.48902507548939067,0.7305091897794865,Upregulated
Feature0629,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NA,NP-021733-peak1,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,7557733.823109673,7980676.4582780665,1.0559615679868402,0.07855732836704331,0.6910354785781865,0.845819436930237,Upregulated
Feature0628,propionylcarnitine,C10 H19 N O4,217.13149,NA,NA,propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,5989350.61726484,7268570.504177324,1.213582401274859,0.2792720696547536,0.11697687894811179,0.5462476753068062,Upregulated
Feature0627,Tetrahydrothiophene,C4 H8 S,88.03465,NA,NA,Tetrahydrothiophene,4,8,0,0,1,0,2,0,-1.5,103.05,1,1,0,0,0,Lipid,177072.736123757,172479.30344439967,0.9740590630725503,-0.037918840630650694,0.8093777643929498,0.9088169879054063,Downregulated
Feature0626,4-[(Z)-2-Aminovinyl]phenol,C8 H9 N O,135.06839,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,4-[(Z)-2-Aminovinyl]phenol,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,2771036.064190617,5094321.480878013,1.8384176036936557,0.8784645176310117,0.048872697673579574,0.5434560019812327,Upregulated
Feature0625,glu-asp,C9 H14 N2 O7,262.08011,NA,NA,glu-asp,9,14,7,2,0,0,1.5555555555555556,0.7777777777777778,0.6666666666666665,41.3,4,-3,-Inf,-0.42857142857142855,-5,Carbohydrate,974861.2236387277,797283.585815275,0.8178431621676021,-0.29010389091039074,0.4894497818180149,0.7305091897794865,Downregulated
Feature0624,NA,C13 H15 N O4,249.1001,NA,NA,Feature0624,13,15,4,1,0,0,1.1538461538461535,0.3076923076923077,-0.3076923076923075,69.06923076923076,7,3,0.25,0.4,2,Lignin,1703120.9849571434,1870459.3008653435,1.0982539217038718,0.1352116510925239,0.7286285668969723,0.8691848843400948,Upregulated
Feature0623,NA,C10 H20 N2 O4 S,264.11437,NA,NA,Feature0623,10,20,4,2,1,0,2,0.4,-0.4000000000000003,71.7,2,-2,-1.6666666666666667,-0.6,-5,Protein,1217510.4455952463,1241430.8380585567,1.0196469710381957,0.028069739166179625,0.9318480247861949,0.9690304198820222,Upregulated
Feature0622,Succinic anhydride,C4 H4 O3,100.01602,NA,NA,Succinic anhydride,4,4,3,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,5291958.69228103,3634479.628407357,0.686792894606054,-0.5420529812456788,0.10461193999466999,0.5434560019812327,Downregulated
Feature0621,dapdiamide A,C12 H20 N4 O5,300.14339,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,dapdiamide A,12,20,5,4,0,0,1.6666666666666667,0.4166666666666667,0.16666666666666652,55.55,5,0,-1.3333333333333333,-0.2727272727272727,-4,Protein,1767083.1918766533,1666362.6805921833,0.9430018282401836,-0.08466752696632274,0.7913674440727227,0.9015670682202759,Downregulated
Feature0620,Pyridostigmine,C9 H12 N2 O2,180.08989,Metabolic pathways;Other,NA,Pyridostigmine,9,12,2,2,0,0,1.3333333333333333,0.2222222222222222,-0.22222222222222232,66.63333333333333,5,3,0.2,0.3333333333333333,1,Lignin,7156884.7409821935,8318528.559906193,1.16231137722145,0.21699661107951543,0.6635270683386391,0.8289195086767364,Upregulated
Feature0619,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",C10 H11 N O2,177.07899,NA,NA,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",10,11,2,1,0,0,1.1,0.2,-0.4000000000000003,71.7,6,4,0.42857142857142855,0.5,3,Lignin,5705032.877601869,8339982.23408717,1.4618640090279218,0.5478091097675992,0.12010204868713822,0.5462476753068062,Upregulated
Feature0618,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak6,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,3859697.65427344,3159664.643346457,0.8186300913617133,-0.28871639627100887,0.14293273497937237,0.5574792106914738,Downregulated
Feature0617,NA,C61 H95 N10 O14 P3,1284.62434,NA,NA,Feature0617,61,95,14,10,0,3,1.5573770491803278,0.22950819672131148,-0.8524590163934427,84.5950819672131,21,7,-0.17647058823529413,0.02439024390243902,-6,Lipid,107038.03355784886,95367.8345695072,0.8909714743401514,-0.16654885223869745,0.5735992607417149,0.7751995156675667,Downregulated
Feature0616,5-Hydroxyindole-3-acetic acid,C10 H9 N O3,191.05831,Metabolic pathways;Other,NA,5-Hydroxyindole-3-acetic acid,10,9,3,1,0,0,0.9,0.3,0,60.3,7,4,0.5,0.6,3,Lignin,9454005.141975757,8782796.931930643,0.9290027665560545,-0.10624520194923266,0.3592239408869169,0.6692796802688192,Downregulated
Feature0615,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0615,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,4766093.877286224,4583587.664635527,0.9617073819044004,-0.056330102029112976,0.6816318034696887,0.8393333924224875,Downregulated
Feature0614,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0614,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,5292191.75061009,4336572.303592866,0.8194284160419814,-0.2873101715931681,0.15703605333034487,0.5574792106914738,Downregulated
Feature0613,NA,C16 H23 N5 O10,445.14459,NA,NA,Feature0613,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,5384664.88272897,4548217.27390546,0.8446611577432847,-0.24355538554278275,0.179234235072121,0.5646729954371317,Downregulated
Feature0612,MFCD00142316,C12 H14 N2 O3,234.1004,NA,NA,MFCD00142316,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,119888.55978198966,105218.9977429207,0.8776400178153387,-0.18829878497638752,0.48517952149476473,0.7299237206146816,Downregulated
Feature0611,NP-015145,C14 H13 N O2,227.09462,Other,NA,NP-015145,14,13,2,1,0,0,0.9285714285714286,0.14285714285714285,-0.4285714285714288,72.51428571428572,9,7,0.5454545454545454,0.5833333333333334,6,Lignin,9063454.480124693,8723772.085963741,0.9625217520641998,-0.05510895030617473,0.4423954546377276,0.7010457438319089,Downregulated
Feature0610,NA,C13 H25 N3 O5,303.17945,NA,NA,Feature0610,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,9423792.64534359,3558316.24804585,0.37758855504997313,-1.4051130585321066,0.2366904615044465,0.6065864474864333,Downregulated
Feature0609,2-Hexenoylcarnitine,C13 H23 N O4,257.16273,NA,NA,2-Hexenoylcarnitine,13,23,4,1,0,0,1.7692307692307692,0.3076923076923077,-0.9230769230769234,86.6076923076923,3,-1,-0.25,0,-2,Protein,274526.016966242,303921.2982319833,1.107076486194589,0.1467548991219192,0.36380409254050033,0.6716464598336302,Upregulated
Feature0608,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak3,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,3804367.30005626,7214420.809667284,1.896352334213522,0.923227035754454,0.1435478294850399,0.5574792106914738,Upregulated
Feature0607,Leonurine,C14 H21 N3 O5,311.14823,NA,NA,Leonurine-peak2,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,146687.311791419,151380.64981216966,1.0319955281982693,0.045436719346285084,0.812784056066213,0.9088169879054063,Upregulated
Feature0606,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak4,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,4992222.340367917,7293773.688867169,1.4610274125590392,0.5469832469928636,0.15412057463598333,0.5574792106914738,Upregulated
Feature0605,ile-his,C12 H20 N4 O3,268.15359,NA,NA,ile-his-peak2,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,3522896.6204343596,7836220.276369887,2.2243685014531343,1.1533958128724446,0.03162413724802238,0.5434560019812327,Upregulated
Feature0604,Apaxifylline,C16 H22 N4 O3,318.1693,NA,NA,Apaxifylline,16,22,3,4,0,0,1.375,0.1875,-0.25,67.425,8,5,0.1111111111111111,0.23809523809523808,1,Lignin,59419.9150557312,54306.19392995233,0.9139392723637756,-0.1298297877771883,0.4997199806114949,0.7334162931788414,Downregulated
Feature0603,Levetiracetam,C8 H14 N2 O2,170.10558,NA,NA,Levetiracetam-peak2,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,633741.5511727179,718329.5238156184,1.1334739255874466,0.18075120373122924,0.2670581532152238,0.6292487790932914,Upregulated
Feature0602,Butenylcarnitine,C11 H19 N O4,229.13142,NA,NA,Butenylcarnitine,11,19,4,1,0,0,1.7272727272727273,0.3636363636363637,-0.7272727272727275,81.02727272727273,3,-1,-0.3333333333333333,0,-2,Protein,5948417.080195163,8315275.832748624,1.3978972423493554,0.4832583139310717,0.02471092452450638,0.5434560019812327,Upregulated
Feature0601,NA,C12 H24 N O13 P,421.09864,NA,NA,Feature0601,12,24,13,1,0,1,2,1.0833333333333333,0,60.3,2,-11,4.333333333333333,-1.8571428571428572,-13,Carbohydrate,8439415.87044127,8200988.923934846,0.9717484065050634,-0.04134525808479113,0.7559071034040307,0.884874126082974,Downregulated
Feature0600,NA,C10 H20 N2 O6,264.13219,NA,NA,Feature0600,10,20,6,2,0,0,2,0.6,-0.20000000000000015,66,2,-4,-3,-0.6,-6,Amino Sugar,11605908.795491245,9025308.65178617,0.7776477319287908,-0.36281132076938155,0.1518113889710543,0.5574792106914738,Downregulated
Feature0599,NA,C16 H14 O3 S,286.0665,NA,NA,Feature0599,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,4414882.7625864,5351614.8962607635,1.2121759928967155,0.2775991754169463,0.03315461725251271,0.5434560019812327,Upregulated
Feature0598,NA,C10 H22 N2 O4,234.15795,NA,NA,Feature0598,10,22,4,2,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-3,-1.25,-0.5,-5,Protein,7735052.486197086,6833176.69648913,0.8834040504162939,-0.1788546477231242,0.670263108974202,0.8312524847517372,Downregulated
Feature0597,NP-021030,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,NP-021030,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,8911831.997770587,9076234.886132957,1.0184477095622424,0.026371909521422727,0.8837217975001775,0.9474840031425954,Upregulated
Feature0596,NA,C7 H15 N O6,209.08992,NA,NA,Feature0596,7,15,6,1,0,0,2.142857142857143,0.8571428571428571,0,60.3,1,-5,-Inf,-1,-6,Carbohydrate,5289385.657405237,7182075.12831201,1.357827844951516,0.44130057606355294,0.32365315523226884,0.6622100705596555,Upregulated
Feature0595,NA,C13 H25 N3 O4,287.18456,NA,NA,Feature0595,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,111072.08180595834,111938.50309188254,1.0078005316172773,0.011210122445712503,0.965337284368635,0.981458812850857,Upregulated
Feature0594,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",C10 H13 N O3,195.08955,Other,NA,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,634130.6057931383,942117.7030451933,1.485684012786042,0.5711273045289244,0.07297138240976206,0.5434560019812327,Upregulated
Feature0593,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine-peak1,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,7555601.20929383,8496454.25388385,1.1245239152422066,0.16931434322728992,0.09662304914165878,0.5434560019812327,Upregulated
Feature0592,7098783,C14 H18 N2 O4,278.1267,Metabolic pathways;Biosynthesis of cofactors;Other,NA,7098783,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,2654280.1879062066,2621445.9391391533,0.9876296975290487,-0.017957876639025955,0.8646017905592622,0.939303571324255,Downregulated
Feature0591,NA,C18 H27 N O12,449.1534,NA,NA,Feature0591,18,27,12,1,0,0,1.5,0.6666666666666666,0,60.3,6,-6,-1.4,-0.09090909090909093,-7,Amino Sugar,72374.5352282428,67890.69635112137,0.9380467333851464,-0.09226829544789607,0.7412969667821501,0.8765412536513055,Downregulated
Feature0590,5-Pentylresorcinol,C11 H16 O2,180.11499,NA,NA,5-Pentylresorcinol,11,16,2,0,0,0,1.4545454545454546,0.18181818181818185,-1.0909090909090908,91.39090909090908,4,2,0.2222222222222222,0.3,2,Lignin,1394816.7757677068,1865641.7012378366,1.3375532425834125,0.4195963205098439,0.44557242579262507,0.7027877448360436,Upregulated
Feature0589,NA,C16 H28 N2 O5,328.19992,NA,NA,Feature0589,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,92172.44618681884,85570.39330926327,0.9283728147544846,-0.10722381756593041,0.7040574716079091,0.8514861389326834,Downregulated
Feature0588,NA,C16 H25 N O9,375.15307,NA,NA,Feature0588,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,372208.7649692223,421863.94834497233,1.1334068083535216,0.18066577382826138,0.5898405138742477,0.7841136051951803,Upregulated
Feature0587,asn-phe,C13 H17 N3 O4,279.12194,NA,NA,asn-phe-peak1,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,7669333.83082133,8223713.5839699535,1.072285255196572,0.10068875049070682,0.7869892921033645,0.9001754630810936,Upregulated
Feature0586,4'-Methoxyacetophenone,C9 H10 O2,150.06812,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Other,Other,4'-Methoxyacetophenone,9,10,2,0,0,0,1.1111111111111112,0.2222222222222222,-0.666666666666667,79.30000000000001,5,3,0.42857142857142855,0.5,3,Lignin,876672.0780858814,555173.1244294377,0.6332734192260328,-0.65909956933488,0.50608454964652,0.734624873265814,Downregulated
Feature0585,N6-Dimethyladenosine,C12 H17 N5 O4,295.1281,NA,NA,N6-Dimethyladenosine,12,17,4,5,0,0,1.4166666666666667,0.3333333333333333,0.5,46.05,7,3,-0.6666666666666666,0,-2,Lignin,298152.99845109263,477960.7757252323,1.6030721750518782,0.68083938135356,0.02594505129100264,0.5434560019812327,Upregulated
Feature0584,NA,C20 H38 N4 O6,430.27924,NA,NA,Feature0584,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,320831.3446765647,101518.9616476273,0.31642469893323616,-1.6600658792809302,0.12444184491592875,0.5515041946002173,Downregulated
Feature0583,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0583,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,2555440.0221142867,2514845.3983550235,0.9841144290580233,-0.023102018513523906,0.9350196205712744,0.9692805595037932,Downregulated
Feature0582,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16772,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,3,1,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,1423803.66809343,1105563.0056002743,0.7764855719754524,-0.36496897701380626,0.29693267400441103,0.6425392932568532,Downregulated
Feature0581,NA,C22 H37 N2 O8 P3 S,582.1482,NA,NA,Feature0581,22,37,8,2,1,3,1.681818181818182,0.3636363636363637,-1.2727272727272725,96.57272727272726,7,-1,-0.875,-0.25,-7,Protein,12285840.276339244,7676031.4118342735,0.6247868472307264,-0.6785640121416815,0.17511336469924665,0.5646729954371317,Downregulated
Feature0580,NA,C16 H29 N3 O6,359.20575,NA,NA,Feature0580,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,2668495.4035429866,2842428.755656107,1.0651803079301494,0.09109766269409536,0.7414897381831882,0.8765412536513055,Upregulated
Feature0579,VLK,C17 H34 N4 O4,358.25811,NA,NA,VLK,17,34,4,4,0,0,2,0.2352941176470588,-0.8235294117647056,83.7705882352941,3,-1,-0.5555555555555556,-0.2727272727272727,-5,Lipid,10868426.205805963,6965654.92426175,0.6409074131211991,-0.6418121378540693,0.1516156554991731,0.5574792106914738,Downregulated
Feature0578,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16891,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak3,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,4746898.444032307,3864868.7034661165,0.8141882007871776,-0.29656578078989954,0.5440115177804079,0.760766703579418,Downregulated
Feature0577,NA,C8 H9 N5 O3,223.07054,NA,NA,Feature0577,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,5393116.248364363,4728487.121604056,0.8767634339493652,-0.1897404639702698,0.15476807638022022,0.5574792106914738,Downregulated
Feature0576,NA,C15 H21 N5 O2,303.16956,NA,NA,Feature0576,15,21,2,5,0,0,1.4,0.13333333333333333,-0.13333333333333375,64.10000000000001,8,6,0.125,0.2222222222222222,1,Lignin,11118970.990816267,10115239.061069474,0.9097279837697366,-0.13649286290732346,0.4310857531654743,0.6999519463833287,Downregulated
Feature0575,Methionylleucine,C11 H22 N2 O3 S,262.13515,NA,NA,Methionylleucine-peak1,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,8026068.015361897,6289853.526874427,0.7836780743491888,-0.3516669608532963,0.41675667714704573,0.6935027613822157,Downregulated
Feature0574,NA,C11 H19 N3 O4,257.13761,NA,NA,Feature0574,11,19,4,3,0,0,1.7272727272727273,0.3636363636363637,-0.18181818181818168,65.48181818181817,4,0,-0.75,-0.16666666666666666,-3,Protein,157902.71767476966,143462.78209685668,0.9085516969527102,-0.13835948817110338,0.48097213009484796,0.726821399090698,Downregulated
Feature0573,NA,C19 H23 N3 O5,373.16384,NA,NA,Feature0573,19,23,5,3,0,0,1.2105263157894737,0.2631578947368421,-0.21052631578947345,66.29999999999998,10,5,0.18181818181818185,0.3333333333333333,2,Lignin,158644.09252623434,155924.943440206,0.9828600671936228,-0.024942064624965104,0.9201687045286897,0.9629365459231719,Downregulated
Feature0572,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06369,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid-peak1,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,10449422.37347053,9404835.664258897,0.9000340237118104,-0.1519485546533819,0.21735792802064707,0.587247735354029,Downregulated
Feature0571,NA,C11 H22 N4 O3,258.16921,NA,NA,Feature0571,11,22,3,4,0,0,2,0.2727272727272727,-0.3636363636363633,70.66363636363636,3,0,-1,-0.4545454545454546,-4,Lipid,116985.32169470939,88028.8947833229,0.7524781186912269,-0.41027846452948685,0.651882893669305,0.8240967327431362,Downregulated
Feature0570,glu-leu,C11 H20 N2 O5,260.13722,NA,NA,glu-leu,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,271039.8199034743,557107.165065547,2.055443975958773,1.0394500497379258,0.009961963215745252,0.5434560019812327,Upregulated
Feature0569,NA,C13 H24 N2 O10,368.14308,NA,NA,Feature0569,13,24,10,2,0,0,1.8461538461538465,0.7692307692307693,0.15384615384615374,55.91538461538462,3,-7,-9,-0.6666666666666666,-9,Carbohydrate,239086.72041197366,248421.70462977732,1.0390443442518196,0.05525722678014944,0.81886238793546,0.9141596102885237,Upregulated
Feature0568,6-methyltetrahydropterin,C7 H11 N5 O,181.09637,NA,NA,6-methyltetrahydropterin,7,11,1,5,0,0,1.5714285714285714,0.14285714285714285,0.8571428571428572,35.87142857142857,5,4,-1,-0.3333333333333333,-1,Lipid,244021.34732043368,221225.31942557168,0.9065818292326381,-0.1414908495455234,0.27686964940955794,0.6292487790932914,Downregulated
Feature0567,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak3,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,244359.08586414933,286930.3274148927,1.1742159142566555,0.23169771491005048,0.7315407539435976,0.8714697870467331,Upregulated
Feature0566,NA,C39 H72 N2 O5,648.54423,NA,NA,Feature0566,39,72,5,2,0,0,1.8461538461538465,0.1282051282051282,-1.435897435897436,101.22307692307692,5,0,-0.0625,0.0144927536231884,-2,Lipid,8834117.757482715,2802276.795689251,0.317210713352293,-1.6564865979967405,0.31043960234732987,0.654085430816389,Downregulated
Feature0565,NA,C13 H24 N2 O3,256.17864,NA,NA,Feature0565,13,24,3,2,0,0,1.8461538461538465,0.2307692307692308,-0.9230769230769234,86.6076923076923,3,0,-0.25,-0.05263157894736842,-2,Lipid,335541.1280556947,331390.39890494634,0.9876297454955824,-0.017957806571187073,0.9580196226260858,0.9780127807593575,Downregulated
Feature0564,NP-004713,C15 H24 O2,236.17762,Other,Other,NP-004713,15,24,2,0,0,0,1.6,0.13333333333333333,-1.333333333333333,98.29999999999998,4,2,0.15384615384615383,0.21428571428571427,2,Lipid,319051.6186240627,316295.0406932953,0.9913600879297985,-0.012518917685777653,0.9817873734775662,0.9914522005306148,Downregulated
Feature0563,NA,C16 H31 N3 O4,329.23156,NA,NA,Feature0563,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,2331497.6478939,2293429.82593366,0.9836723738517911,-0.02375020953057461,0.9263807322753614,0.9660448321014614,Downregulated
Feature0562,1774244,C7 H15 N3 O2,173.11643,NA,NA,1774244,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,2132184.606002313,2014146.7334269632,0.9446399377225305,-0.08216356348926221,0.5141850172836024,0.7414202284113551,Downregulated
Feature0561,1-Methyl-4-(1-methyl-2-propenyl)-benzene,C13 H18,174.14087,NA,NA,1-Methyl-4-(1-methyl-2-propenyl)-benzene,13,18,0,0,0,0,1.3846153846153846,0,-1.384615384615385,99.76153846153846,5,5,0.38461538461538464,0.38461538461538464,5,Unsaturated HC,1148900.2381915408,541113.0731676844,0.47098351552214734,-1.0862515286599885,0.05101752385458998,0.5434560019812327,Downregulated
Feature0560,anthramycin,C16 H17 N3 O4,315.12196,NA,NA,anthramycin,16,17,4,3,0,0,1.0625,0.25,0,60.3,10,6,0.3333333333333333,0.4545454545454546,3,Lignin,277485.710846953,1026193.506450515,3.6981850464239265,1.8868174148121282,0.22516188191372719,0.5958985050006134,Upregulated
Feature0559,"(8Z,11Z,14Z)-Heptadecatrienal",C17 H28 O,248.21402,Other,NA,"(8Z,11Z,14Z)-Heptadecatrienal",17,28,1,0,0,0,1.6470588235294117,0.0588235294117647,-1.5294117647058822,103.88823529411764,4,3,0.1875,0.21212121212121213,3,Lipid,755979.743952634,847136.8995770627,1.1205814790060566,0.16424755298421337,0.8633735641824137,0.939303571324255,Upregulated
Feature0558,NA,C30 H51 N4 O17 P3,832.24652,NA,NA,Feature0558,30,51,17,4,0,3,1.7,0.5666666666666667,-0.666666666666667,79.30000000000001,9,-8,-2.5,-0.4482758620689655,-15,Amino Sugar,9491402.858041067,8313426.02163605,0.8758901235124541,-0.1911781933325799,0.5068432147137064,0.7350962377782695,Downregulated
Feature0557,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0557,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,7186647.08250427,8028546.253417597,1.1171476992327773,0.1598199386090176,0.36555142621406583,0.6716464598336302,Upregulated
Feature0556,NA,C12 H23 N3 O5,289.16381,NA,NA,Feature0556,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,3689488.967332823,4153590.13339043,1.125790094554236,0.17093785958915286,0.5811237225608913,0.7781337731510076,Upregulated
Feature0555,NA,C17 H31 N3 O9,421.20619,NA,NA,Feature0555,17,31,9,3,0,0,1.8235294117647056,0.5294117647058824,-0.23529411764705888,67.00588235294117,4,-5,-1.6,-0.3684210526315789,-8,Protein,3394963.2478592,5421600.856651287,1.5969542115279292,0.6753229478470737,0.22044163922240592,0.5908673051309424,Upregulated
Feature0554,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose-peak1",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,2364000.230853803,2402138.9126053434,1.0161331125326354,0.023089406255332432,0.9242659277672125,0.9658892545574694,Upregulated
Feature0553,Hopantenic acid,C10 H19 N O5,233.12632,NA,NA,Hopantenic acid,10,19,5,1,0,0,1.9,0.5,-0.5999999999999996,77.39999999999999,2,-3,-1,-0.2307692307692308,-4,Protein,1836670.6378370733,3631636.37808475,1.9772932083029815,0.983526820889833,0.12528224882558095,0.5515041946002173,Upregulated
Feature0552,4-Acetamidobenzoic acid,C9 H9 N O3,179.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,4-Acetamidobenzoic acid,9,9,3,1,0,0,1,0.3333333333333333,0,60.3,6,3,0.4,0.5384615384615384,2,Lignin,9967498.94332356,8828028.783763226,0.8856814366332514,-0.17514021375099403,0.09164452409532017,0.5434560019812327,Downregulated
Feature0551,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak2,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,757321.3782209597,906577.274972974,1.1970839607124715,0.2595243431381681,0.7689689098471006,0.8946657508797998,Upregulated
Feature0550,NA,C32 H66 N3 O18 P3 S,905.32735,NA,NA,Feature0550,32,66,18,3,1,3,2.0625,0.5625,-1.0625,90.58125,3,-15,-3.142857142857143,-0.8125,-22,Amino Sugar,65503.5532731101,65948.77534368847,1.0067969147982256,0.009772700661867958,0.9790396531201484,0.9913288537869286,Upregulated
Feature0549,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak2,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,3841906.6681607533,2411448.726846057,0.6276697835558032,-0.6719223366011946,0.030714317385716564,0.5434560019812327,Downregulated
Feature0548,1726033,C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak1,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,4699018.800440896,5545101.538079277,1.1800551931307435,0.23885433839546055,0.12092259636366726,0.5462476753068062,Upregulated
Feature0547,4-Hydroxyprolylproline,C10 H16 N2 O4,228.111,NA,NA,4-Hydroxyprolylproline,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,9233234.23415691,8699899.43816893,0.9422374887864329,-0.08583736125732509,0.5589956163194928,0.7717510790914595,Downregulated
Feature0546,NA,C13 H24 N2 O8,336.15337,NA,NA,Feature0546,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,7022309.048474753,4176791.9814597564,0.59478897220665,-0.749550195799428,0.26844444674023554,0.6292487790932914,Downregulated
Feature0545,valienone,C7 H10 O5,174.05284,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,valienone,7,10,5,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,312814.4542612057,592080.4383669507,1.892752813374004,0.9204860126238739,0.20881295822481724,0.5821476316614936,Upregulated
Feature0544,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak1,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,1113595.5128481432,684655.6648670203,0.6148153947890271,-0.7017748047647987,0.004293136610539979,0.5434560019812327,Downregulated
Feature0543,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0543,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,6731685.9852719,5007875.289766677,0.7439258605828155,-0.42676924492389134,0.05957694574628984,0.5434560019812327,Downregulated
Feature0542,NA,C16 H29 N3 O6,359.20576,NA,NA,Feature0542,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,4388901.323569223,2604196.5582614066,0.5933595600056859,-0.7530214905621949,0.07015035231505942,0.5434560019812327,Downregulated
Feature0541,NA,C37 H51 N3 O12,729.34763,NA,NA,Feature0541,37,51,12,3,0,0,1.3783783783783785,0.32432432432432434,-0.4864864864864869,74.16486486486487,14,2,-0.04545454545454545,0.17857142857142858,-1,Lignin,78597.9941599692,70152.06751562186,0.892542720274038,-0.16400687156914862,0.5433587616275293,0.760702266278541,Downregulated
Feature0540,NA,C9 H16 N2 O3,200.1161,NA,NA,Feature0540,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,8722583.49112536,7911657.250028873,0.9070314154147622,-0.1407755749183633,0.48482518651374634,0.7299237206146816,Downregulated
Feature0539,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak4,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,2659707.049934403,1460133.45067482,0.5489828102349962,-0.8651671186568587,0.20024969709352783,0.5778926522596868,Downregulated
Feature0538,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0538,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,5871158.790822342,2929990.598219756,0.4990480929931326,-1.0027492408892347,0.4361670248346975,0.7009176491269988,Downregulated
Feature0537,Anhydroecgonine methyl ester,C10 H15 N O2,181.11031,NA,NA,Anhydroecgonine methyl ester,10,15,2,1,0,0,1.5,0.2,-0.7999999999999998,83.1,4,2,0.14285714285714285,0.25,1,Lipid,1320714.4130628733,1257544.8351647432,0.9521701457382953,-0.07070869942150829,0.4201981830681458,0.6943057388507786,Downregulated
Feature0536,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10587,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one-peak2",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,3632827.2832704536,4350711.39360724,1.1976103057920529,0.2601585413813075,0.49492565386132503,0.7334162931788414,Upregulated
Feature0535,NA,C14 H25 N3 O7,347.16934,NA,NA,Feature0535,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,1854926.70170873,682343.124513801,0.36785449467369086,-1.4427928756818251,0.002221519198592182,0.5434560019812327,Downregulated
Feature0534,NA,C10 H21 N O10,315.11663,NA,NA,Feature0534,10,21,10,1,0,0,2.1,1,0.20000000000000015,54.599999999999994,1,-9,10,-1.25,-10,Carbohydrate,976127.2188941477,1656935.05807078,1.697458103819621,0.763375966718854,0.24397288391718602,0.6174652236779057,Upregulated
Feature0533,NA,C16 H14 O3 S,286.06646,NA,NA,Feature0533,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,6353770.823987104,6249871.670481403,0.9836476391132247,-0.023786486988674017,0.9162317610660519,0.9624562873213929,Downregulated
Feature0532,NA,C19 H34 N4 O5,398.25301,NA,NA,Feature0532,19,34,5,4,0,0,1.7894736842105263,0.2631578947368421,-0.6315789473684212,78.30000000000001,5,0,-0.4,-0.12,-4,Lipid,6095945.538144093,1513695.6855349403,0.24831187812674982,-2.0097748196606333,0.38403734494759983,0.6807033163836934,Downregulated
Feature0531,1-Aminocyclohexanecarboxylic acid,C7 H13 N O2,143.09463,ABC transporters,NA,1-Aminocyclohexanecarboxylic acid,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,260056.59655496868,2168093.7945200643,8.33700749468122,3.0595296321931285,0.19198528516766947,0.5685889950290117,Upregulated
Feature0530,ascopyrone P,C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,ascopyrone P,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,1429814.4471108534,3601570.91632221,2.518907906966323,1.3327983770972738,0.28902929833302926,0.6358644563326644,Upregulated
Feature0529,gln-phe,C14 H19 N3 O4,293.13766,NA,NA,gln-phe-peak2,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,7068831.66535503,7881229.190324023,1.1149267040762372,0.156948869659949,0.5283157550547939,0.747050825595009,Upregulated
Feature0528,lys-gln,C11 H22 N4 O4,274.16413,NA,NA,lys-gln,11,22,4,4,0,0,2,0.3636363636363637,-0.18181818181818168,65.48181818181817,3,-1,-1.6666666666666667,-0.6,-5,Protein,4136748.7936593564,5418191.43705206,1.3097704761180684,0.3893140163593922,0.0733687470129025,0.5434560019812327,Upregulated
Feature0527,2-O-ETHYL ASCORBIC ACID,C8 H12 O6,204.06331,NA,NA,2-O-ETHYL ASCORBIC ACID,8,12,6,0,0,0,1.5,0.75,0,60.3,3,-3,-1.5,0,-3,Carbohydrate,502287.23060299334,643556.2621208787,1.2812514890101676,0.35755368125132186,0.21497228696948092,0.5862718758964077,Upregulated
Feature0526,NA,C9 H16 N2 O3,200.11609,NA,NA,Feature0526,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,8669505.705333194,8508048.55609606,0.9813764296691321,-0.02712147317330409,0.7968709150708474,0.9022552886981726,Downregulated
Feature0525,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10586,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one-peak1",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,1759998.85291964,2104584.5799152665,1.195787472488404,0.25796100188338084,0.5618852757631103,0.7719911688016345,Upregulated
Feature0524,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak1",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,372267.642106912,131005.77896817907,0.35191288242708824,-1.5067097672917034,0.42395245098270296,0.6952327705369785,Downregulated
Feature0523,4-Ethoxy-m-anisaldehyde,C10 H12 O3,180.07871,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,4-Ethoxy-m-anisaldehyde,10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,1251031.0461234907,1649142.430591885,1.3182266225142876,0.3985984121307867,0.5553112131968874,0.7691718684836689,Upregulated
Feature0522,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine-peak2,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Lignin,5211616.178284937,4836020.132198661,0.927930984700819,-0.10791058666004441,0.5167405949808507,0.7424584969444963,Downregulated
Feature0521,Gabexate,C16 H23 N3 O4,321.16895,NA,NA,Gabexate,16,23,4,3,0,0,1.4375,0.25,-0.375,70.9875,7,3,0,0.18181818181818185,0,Lignin,10125863.752180643,7334611.584957284,0.7243442894812551,-0.46525250439699106,0.29775286021642844,0.6425392932568532,Downregulated
Feature0520,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",C13 H12 N2 O2,228.08992,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",13,12,2,2,0,0,0.9230769230769232,0.15384615384615383,-0.1538461538461542,64.6846153846154,9,7,0.5555555555555556,0.6,5,Lignin,8037696.775882663,7390993.4756544065,0.919541217060003,-0.12101385215296402,0.274853385293874,0.6292487790932914,Downregulated
Feature0519,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone-peak2,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,1411304.66404635,1544473.0918471399,1.0943583842619657,0.13008527426149027,0.33325362493990934,0.6633744308439559,Upregulated
Feature0518,NA,C13 H17 N O5,267.11069,NA,NA,Feature0518,13,17,5,1,0,0,1.3076923076923077,0.38461538461538464,-0.3076923076923075,69.06923076923076,6,1,0,0.2631578947368421,0,Lignin,1547732.8911482901,2689628.8543163636,1.7377861966355712,0.7972505953700281,0.10648649856207602,0.5462476753068062,Upregulated
Feature0517,NA,C20 H20 N6 O5,424.14931,NA,NA,Feature0517,20,20,5,6,0,0,1,0.25,0.3999999999999999,48.9,14,9,0.3333333333333333,0.4782608695652174,3,Lignin,2004898.0180784634,3155617.6550426134,1.5739541994594937,0.6543935604298808,0.10581342505311261,0.5462476753068062,Upregulated
Feature0516,gamma-Glu-His,C11 H16 N4 O5,284.11217,NA,NA,gamma-Glu-His,11,16,5,4,0,0,1.4545454545454546,0.4545454545454546,0.5454545454545454,44.75454545454545,6,1,-1.5,-0.1111111111111111,-3,Lignin,3268291.91411532,4562787.884163573,1.3960772183345975,0.48137874056435914,0.05917935023431555,0.5434560019812327,Upregulated
Feature0515,6-methoxymellein,C11 H12 O4,208.07356,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak2,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,346297.86517330015,181801.90549284843,0.5249870812858407,-0.9296461730498715,0.3524487911024537,0.6670930191369346,Downregulated
Feature0514,NA,C8 H18 N2 O3,190.13174,NA,NA,Feature0514,8,18,3,2,0,0,2.25,0.375,-0.75,81.675,1,-2,-1.3333333333333333,-0.5555555555555556,-4,Protein,3226015.1877957666,2356789.624886797,0.7305575106412057,-0.4529302461556416,0.335629995505598,0.6636048496469049,Downregulated
Feature0513,NP-019722,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722-peak1,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,9129816.004394883,7279188.915475394,0.7972985339432207,-0.3268080785804094,0.2028562190793698,0.5780722477745703,Downregulated
Feature0512,glutaral,C5 H8 O2,100.05243,NA,NA,glutaral,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,1115459.4612199797,807335.4765631773,0.7237694462514965,-0.4663978889064508,0.0893801877561497,0.5434560019812327,Downregulated
Feature0511,Pyridoxal,C8 H9 N O3,167.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak2,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,8074156.9923498435,8504567.808158956,1.0533072141422222,0.07492628316094598,0.46906439425245317,0.7150766004537328,Upregulated
Feature0510,D-lysopine,C9 H18 N2 O4,218.12663,Lysine degradation,NA,D-lysopine-peak1,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,3568308.58556466,2646677.4784286935,0.7417176555681423,-0.43105798409366064,0.283061923312147,0.6337729734325485,Downregulated
Feature0509,NA,C14 H25 N3 O6,331.17445,NA,NA,Feature0509,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,5407561.988759734,4699345.67638659,0.8690322341481695,-0.2025184044032258,0.240436659943815,0.6124807548042445,Downregulated
Feature0508,N-valeryl-Glycine,C7 H13 N O3,159.08952,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-valeryl-Glycine,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,660595.7469136347,211608.1690127,0.3203292936737077,-1.6423723582629484,0.3263728485065792,0.6622174503652659,Downregulated
Feature0507,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1813048.3145871365,1766054.0292608466,0.9740799597295942,-0.03788789057715182,0.8286711977134003,0.9174960842656863,Downregulated
Feature0506,gamma-Glutamyl-N~5~-acetylornithine,C12 H21 N3 O6,303.14309,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,gamma-Glutamyl-N~5~-acetylornithine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,5455718.412307177,6336050.120157126,1.1613594473395237,0.21581456362060616,0.5215621357461535,0.7430834801967906,Upregulated
Feature0505,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak3,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,6145245.204363316,3485818.8758516833,0.5672383704683814,-0.8179729688471016,0.1157082019677616,0.5462476753068062,Downregulated
Feature0504,NA,C9 H7 N O3 S,209.01467,NA,NA,Feature0504,9,7,3,1,1,0,0.7777777777777778,0.3333333333333333,0.44444444444444464,47.633333333333326,7,4,0.5,0.6363636363636364,2,Condensed HC,285058.66716851766,166757.21374498575,0.5849926101226179,-0.7735096948183131,0.27071340719956166,0.6292487790932914,Downregulated
Feature0503,Acetylcarnitine,C9 H17 N O4,203.1157,NA,NA,Acetylcarnitine-peak2,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,266213.44451427297,401584.4185888373,1.5085053999491242,0.5931198608637196,0.49544060104842036,0.7334162931788414,Upregulated
Feature0502,NA,C20 H31 N O14,509.17464,NA,NA,Feature0502,20,31,14,1,0,0,1.55,0.7,0,60.3,6,-8,-1.8,-0.16666666666666666,-9,Amino Sugar,6396263.455118497,6637158.249932767,1.0376617999719036,0.053336309777360966,0.7754137570201007,0.8975915430179037,Upregulated
Feature0501,NA,C16 H28 N2 O5,328.19969,NA,NA,Feature0501,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,137772.804603856,123506.69400239304,0.896451911228178,-0.15770190085497168,0.6016598394985215,0.7919283357501907,Downregulated
Feature0500,NA,C16 H29 N3 O4,327.21588,NA,NA,Feature0500,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,2807669.5853841603,1852340.5929671193,0.6597430846598967,-0.6000237713959327,0.5751237554614844,0.7751995156675667,Downregulated
Feature0499,NA,C9 H22 N2 O2,190.16816,NA,NA,Feature0499,9,22,2,2,0,0,2.4444444444444446,0.2222222222222222,-1.333333333333333,98.29999999999998,0,-2,-0.8,-0.5,-4,Lipid,5842068.869430203,7581701.43085438,1.2977767979640147,0.3760422784372168,0.385881323732832,0.6807033163836934,Upregulated
Feature0498,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0498,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,8966683.58029197,5097947.599471927,0.5685432695179291,-0.8146579439344269,0.15585835686594257,0.5574792106914738,Downregulated
Feature0497,NA,C14 H27 N3 O5,317.19512,NA,NA,Feature0497,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,5630487.518742677,3132805.169276647,0.5564003399080835,-0.8458047936564616,0.026929059839234253,0.5434560019812327,Downregulated
Feature0496,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak1",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,459486.048229631,828314.8323656843,1.8026985488615508,0.8501581663636464,0.28202736378909254,0.6327872241837388,Upregulated
Feature0495,7-Methylguanosine,C11 H15 N5 O5,297.10741,NA,NA,7-Methylguanosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,2059442.78901896,4191911.23789913,2.035458940763291,1.0253541197561684,0.08766992895388356,0.5434560019812327,Upregulated
Feature0494,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,C10 H12 N6 O4,280.09207,NA,NA,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,10,12,4,6,0,0,1.2,0.4,1.4,20.4,8,4,-Inf,0,-2,Lignin,926549.918183992,888164.0453494634,0.9585711767049057,-0.061042534703146634,0.7994599695017457,0.9022552886981726,Downregulated
Feature0493,NA,C7 H10 N2 O2,154.07425,NA,NA,Feature0493,7,10,2,2,0,0,1.4285714285714286,0.2857142857142857,0,60.3,4,2,0,0.25,0,Lignin,6865295.89551438,6399459.0259673735,0.9321461337374587,-0.10137194913687181,0.61693856178802,0.8003048823255108,Downregulated
Feature0492,tyr-his,C15 H18 N4 O4,318.13296,NA,NA,tyr-his,15,18,4,4,0,0,1.2,0.26666666666666666,0.1333333333333333,56.5,9,5,0.14285714285714285,0.3333333333333333,1,Lignin,3407343.70853952,6884733.37488458,2.0205573501816065,1.0147533006173308,0.02845754888490866,0.5434560019812327,Upregulated
Feature0491,NA,C16 H33 N O2,271.25118,NA,NA,Feature0491,16,33,2,1,0,0,2.0625,0.125,-1.625,106.6125,1,-1,-0.15384615384615383,-0.07142857142857142,-2,Lipid,161423.27603036835,219042.24481110164,1.356943373952425,0.44036051749768845,0.20934719926720716,0.5821476316614936,Upregulated
Feature0490,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak2,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,3547285.9784353036,1418553.27115074,0.3998981981645752,-1.3222953141266371,0.18480948677142894,0.5646729954371317,Downregulated
Feature0489,NA,C89 H119 N4 O11 P3,1512.80906,NA,NA,Feature0489,89,119,11,4,0,3,1.3370786516853932,0.12359550561797752,-1.1235955056179776,92.32247191011236,34,23,0.22535211267605632,0.28104575163398693,16,Unsaturated HC,849523.999047175,681794.2801689584,0.8025603525429039,-0.31731820789799614,0.27194765517492286,0.6292487790932914,Downregulated
Feature0488,met-val,C10 H20 N2 O3 S,248.11947,NA,NA,met-val,10,20,3,2,1,0,2,0.3,-0.5999999999999996,77.39999999999999,2,-1,-1,-0.4545454545454546,-4,Lipid,6106986.161231247,4639749.155094313,0.7597445012318287,-0.39641376683019086,0.23461657603497305,0.6058888718354483,Downregulated
Feature0487,"N,N-dimethyl-9H-purin-6-amine",C7 H9 N5,163.08581,NA,NA,"N,N-dimethyl-9H-purin-6-amine",7,9,0,5,0,0,1.2857142857142858,0,0.8571428571428572,35.87142857142857,6,6,0.5,0.5,1,Unsaturated HC,138101.04534292768,279955.56751765066,2.0271792065184937,1.0194736314429265,0.451269628700889,0.7032665602753505,Upregulated
Feature0486,dihomomethionine,C7 H15 N O2 S,177.08241,2-Oxocarboxylic acid metabolism;Other,NA,dihomomethionine,7,15,2,1,1,0,2.142857142857143,0.2857142857142857,-0.8571428571428568,84.72857142857141,1,-1,-1,-0.5,-3,Lipid,245442.30455530967,266548.649716882,1.0859931021256202,0.11901493964249105,0.8108541759555239,0.9088169879054063,Upregulated
Feature0485,Υ-L-Glutamyl-L-glutamic acid,C10 H16 N2 O7,276.09576,Other,NA,Υ-L-Glutamyl-L-glutamic acid,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,267437.33678496,230590.81430076266,0.8622237159285476,-0.21386584971965494,0.5040282034801565,0.7335255813534236,Downregulated
Feature0484,NA,C13 H17 N5 O7,355.11293,NA,NA,Feature0484,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Lignin,7110367.6686969595,6517768.845380424,0.9166570772527808,-0.12554597445355545,0.16035128378064928,0.5577722273602052,Downregulated
Feature0483,NA,C25 H34 O2,366.25594,NA,NA,Feature0483,25,34,2,0,0,0,1.36,0.08,-1.2000000000000002,94.5,9,7,0.30434782608695654,0.3333333333333333,7,Unsaturated HC,708844.7418897504,596433.171695231,0.8414158086369734,-0.24910917097139854,0.46735288426009314,0.7150766004537328,Downregulated
Feature0482,NA,C15 H29 N3 O4,315.21585,NA,NA,Feature0482,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,3359964.5527848303,1863989.88404892,0.554764746700674,-0.8500519823809576,0.14455700592884263,0.5574792106914738,Downregulated
Feature0481,NA,C16 H29 N3 O4,327.2159,NA,NA,Feature0481,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,2640032.349949787,1772611.40905344,0.6714354879352727,-0.5746793038822935,0.10984360713111069,0.5462476753068062,Downregulated
Feature0480,Gly-Tyr,C11 H14 N2 O4,238.09535,Other,NA,Gly-Tyr-peak2,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,2952885.9752211035,7009553.2864949,2.373797479928105,1.2471968569821519,0.04618458930020198,0.5434560019812327,Upregulated
Feature0479,Gly-Tyr,C11 H14 N2 O4,238.09534,Other,NA,Gly-Tyr-peak1,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,168524.63684623767,170912.185077487,1.0141673542570973,0.020295740344028035,0.9541992411237228,0.976095117429702,Upregulated
Feature0478,Phenacetin,C10 H13 N O2,179.09463,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,5927459.17047362,6338714.70392965,1.0693814198678266,0.0967765157397504,0.3784948609313991,0.6777698672492496,Upregulated
Feature0477,metharbital,C9 H14 N2 O3,198.10047,NA,NA,metharbital-peak1,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,10455620.196503224,8257530.557755133,0.7897695595825851,-0.34049633241396426,0.32592867937956466,0.6622174503652659,Downregulated
Feature0476,NA,C17 H31 N3 O4,341.23157,NA,NA,Feature0476,17,31,4,3,0,0,1.8235294117647056,0.2352941176470588,-0.8235294117647056,83.7705882352941,4,0,-0.3,-0.08333333333333333,-3,Lipid,363215.66272231936,436486.8801918007,1.2017292341423549,0.26511187394912944,0.6234520797197509,0.8031390289317553,Upregulated
Feature0475,Lys-phe,C15 H23 N3 O3,293.17398,NA,NA,Lys-phe-peak1,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,2843731.1304792766,5481707.975550006,1.927646364593593,0.946840406940078,0.07351236836953547,0.5434560019812327,Upregulated
Feature0474,NA,C25 H41 N5 O6,507.30589,NA,NA,Feature0474,25,41,6,5,0,0,1.64,0.24,-0.5599999999999996,76.25999999999999,8,2,-0.21428571428571427,0,-3,Lipid,2662490.1457128664,3508002.40639897,1.317564465749308,0.39787355172324,0.0894788559402407,0.5434560019812327,Upregulated
Feature0473,NA,C14 H23 N3 O,249.18412,NA,NA,Feature0473,14,23,1,3,0,0,1.6428571428571428,0.07142857142857142,-0.8571428571428568,84.72857142857141,5,4,0.1,0.14285714285714285,1,Lipid,87708.70073721703,108495.82582980784,1.237001858628266,0.30684766800366653,0.3369805072272865,0.6636048496469049,Upregulated
Feature0472,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0472,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,3589026.2562638302,3286387.7735520867,0.9156767153253458,-0.12708975804983602,0.5866014881206675,0.7818276324755394,Downregulated
Feature0471,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0471,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,4902880.306846676,2699233.6532219434,0.5505403934606707,-0.8610796758615864,0.004294188601099931,0.5434560019812327,Downregulated
Feature0470,NA,C17 H25 N3 O4,335.18463,NA,NA,Feature0470,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,5662357.09108922,1153891.8323730007,0.20378295007018646,-2.2948947444541763,0.3408901914704103,0.6636491383576648,Downregulated
Feature0469,NA,C17 H25 N3 O4,335.18461,NA,NA,Feature0469,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,3658201.600248813,2156377.25071718,0.5894637546958903,-0.7625249882609665,0.10984299170684728,0.5462476753068062,Downregulated
Feature0468,linatine,C10 H17 N3 O5,259.11681,Other,NA,linatine,10,17,5,3,0,0,1.7,0.5,0.20000000000000015,54.599999999999994,4,-1,-2,-0.3333333333333333,-4,Protein,720326.1744542887,460658.677027189,0.6395140054103671,-0.6449521402920543,0.12156134674768623,0.5476726632728204,Downregulated
Feature0467,NA,C6 H9 O P S,160.01125,NA,NA,Feature0467,6,9,1,0,1,1,1.5,0.16666666666666666,-1.666666666666667,107.8,3,2,0,0.14285714285714285,0,Lipid,172387.28280561432,185492.06944098565,1.0760194512152526,0.10570415774411192,0.5057654473521072,0.734624873265814,Upregulated
Feature0466,mycosporine,C11 H19 N O6,261.12129,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak1,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,2482888.66099358,7892369.707558556,3.1787046401026537,1.6684389699029174,0.017895546836265725,0.5434560019812327,Upregulated
Feature0465,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature0465,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,355734.15690606565,277970.80508566636,0.7814003791574805,-0.35586613932932365,0.4732579397309898,0.7183682346812694,Downregulated
Feature0464,NA,C14 H25 N3 O6,331.17446,NA,NA,Feature0464,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,4951723.941386607,2473072.374442763,0.4994366414033657,-1.0016264257402938,0.06982731221285067,0.5434560019812327,Downregulated
Feature0463,NA,C12 H20 N2 O5,272.13725,NA,NA,Feature0463,12,20,5,2,0,0,1.6666666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,4,-1,-0.6,-0.06666666666666667,-3,Protein,139850.13528698866,123252.25832734523,0.881316690001174,-0.18226756836816554,0.3606347318814981,0.6692796802688192,Downregulated
Feature0462,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,C13 H14 N2 O3,246.10046,NA,Superpathway of indole-3-acetate conjugate biosynthesis,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,13,14,3,2,0,0,1.0769230769230769,0.2307692307692308,-0.1538461538461542,64.6846153846154,8,5,0.375,0.47368421052631576,3,Lignin,168975.86857133234,190101.96326266634,1.1250243296273734,0.16995620131184044,0.7456063308729127,0.878954157619147,Upregulated
Feature0461,D-PANTOTHENIC ACID,C9 H17 N O5,219.11065,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak1,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,2263016.3667370398,4689181.15734493,2.0720933468572693,1.0510889972400002,0.1820793020349334,0.5646729954371317,Upregulated
Feature0460,(−)-trans-Methyl dihydrojasmonate,C13 H22 O3,226.15687,NA,NA,(−)-trans-Methyl dihydrojasmonate,13,22,3,0,0,0,1.6923076923076923,0.2307692307692308,-1.2307692307692308,95.37692307692308,3,0,0,0.13043478260869565,0,Lipid,1110417.59998764,491996.1171740063,0.4430730539388809,-1.1743835047614033,0.10231108865409516,0.5434560019812327,Downregulated
Feature0459,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0459,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,1624139.4310517102,724486.1045333246,0.4460738349688267,-1.1646455674164935,0.08659078395537217,0.5434560019812327,Downregulated
Feature0458,7-hydroxyflavanone 7-O-beta-D-glucoside,C21 H22 O8,402.13151,NA,NA,7-hydroxyflavanone 7-O-beta-D-glucoside,21,22,8,0,0,0,1.0476190476190477,0.380952380952381,-0.2857142857142856,68.44285714285714,11,3,0.2307692307692308,0.4117647058823529,3,Lignin,434387.9537836273,3775274.920729192,8.691021212364678,3.119525706550964,0.2641950862389747,0.6292487790932914,Upregulated
Feature0457,Alpha-Methyltryptamine,C11 H14 N2,174.11571,Metabolic pathways;Other,NA,Alpha-Methyltryptamine,11,14,0,2,0,0,1.2727272727272727,0,-0.7272727272727275,81.02727272727273,6,6,0.4444444444444444,0.4444444444444444,4,Unsaturated HC,1964374.2526121233,1864956.39222964,0.9493895522962171,-0.07492792139279132,0.2020991957963787,0.5780722477745703,Downregulated
Feature0456,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",C7 H9 N O3,155.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",7,9,3,1,0,0,1.2857142857142858,0.42857142857142855,0,60.3,4,1,0,0.3333333333333333,0,Lignin,2322020.991032567,2781870.916042247,1.1980386597647388,0.26067446351147766,0.3769038952656133,0.6770680790879628,Upregulated
Feature0455,acetoacetic acid,C4 H6 O3,102.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak2,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,1194581.8997071967,1324261.7585437233,1.1085566915657372,0.14868255148567022,0.47839079562346404,0.7242126968598285,Upregulated
Feature0454,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,7608302.380596464,5769339.856962234,0.7582952895873124,-0.3991683337401574,0.20169371203198247,0.5780722477745703,Downregulated
Feature0453,apronalide,C9 H16 N2 O2,184.12119,NA,NA,apronalide-peak1,9,16,2,2,0,0,1.7777777777777777,0.2222222222222222,-0.666666666666667,79.30000000000001,3,1,-0.2,0,-1,Lipid,8180115.4874789035,7847949.381668457,0.9593934698942961,-0.05980547500939257,0.6918497710986382,0.8459998858209694,Downregulated
Feature0452,NA,C28 H40,376.313,NA,NA,Feature0452,28,40,0,0,0,0,1.4285714285714286,0,-1.4285714285714288,101.01428571428572,9,9,0.32142857142857145,0.32142857142857145,9,Unsaturated HC,1232722.558267036,1023656.6416622763,0.83040310635779635,-0.2681162543724383,0.3974696155895751,0.6848441763516896,Downregulated
Feature0451,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak2,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,1103414.58567391,1176453.2471565034,1.0661933079650066,0.09246903205501147,0.7924636154545399,0.9015670682202759,Upregulated
Feature0450,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak2,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,3545893.79760152,3245447.8059691833,0.9152693202950518,-0.12773177238357716,0.4340903210051512,0.7009176491269988,Downregulated
Feature0449,NA,C16 H29 N3 O6,359.20566,NA,NA,Feature0449,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,5969963.79968547,3912438.5750088366,0.6553538189318611,-0.6096540813679705,0.06230052758999179,0.5434560019812327,Downregulated
Feature0448,2-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,3752194.02331583,3823450.3012795034,1.0189905632600267,0.02714069095318529,0.8970497635067352,0.9533264111545855,Upregulated
Feature0447,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak5,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,4957394.0279062735,2858877.8749620933,0.5766896597020197,-0.794132940413881,0.06858138565995903,0.5434560019812327,Downregulated
Feature0446,(+/-)-Metanephrine,C10 H15 N O3,197.10522,Metabolic pathways;Tyrosine metabolism,NA,(+/-)-Metanephrine-peak2,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,8166199.399331523,6837038.978377134,0.8372363499888096,-0.2562931449634143,0.08984349550571333,0.5434560019812327,Downregulated
Feature0445,NA,C15 H29 N3 O4,315.21587,NA,NA,Feature0445,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,5996202.6269560065,3168723.39894254,0.5284550233004973,-0.920147405535861,0.11840363392463005,0.5462476753068062,Downregulated
Feature0444,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak2,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,74380.15662668853,55733.289034200636,0.7493031953928803,-0.41637849104972435,0.3614190745478922,0.6698511075318702,Downregulated
Feature0443,orciprenaline,C11 H17 N O3,211.12082,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,orciprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,105921.30312547566,111028.628514211,1.0482181132409705,0.06793894411817568,0.6628126977516189,0.8289195086767364,Upregulated
Feature0442,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak4,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,5681577.46830175,3434242.1559396232,0.6044522274139007,-0.7262997736041359,0.03121777240571623,0.5434560019812327,Downregulated
Feature0441,GLY-MET,C7 H14 N2 O3 S,206.07248,NA,NA,GLY-MET,7,14,3,2,1,0,2,0.42857142857142855,0,60.3,2,-1,-4,-1,-4,Protein,3839408.0806685733,5872342.585962327,1.5294916462591155,0.6130522272403722,0.15147865551084722,0.5574792106914738,Upregulated
Feature0440,NA,C11 H21 N O12,359.10644,NA,NA,Feature0440,11,21,12,1,0,0,1.9090909090909092,1.0909090909090908,0.5454545454545454,44.75454545454545,2,-10,5.5,-1.25,-11,Carbohydrate,1076544.9671260165,1138690.9231241487,1.0577272272834448,0.08096762500987564,0.7431778697497189,0.8779242059665437,Upregulated
Feature0439,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine-peak1,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Lignin,5108129.87811514,4724801.56926741,0.9249572117400477,-0.11254146638082885,0.3298378249715096,0.6632819814140921,Downregulated
Feature0438,NA,C17 H33 N O15,491.18523,NA,NA,Feature0438,17,33,15,1,0,0,1.9411764705882353,0.8823529411764706,0,60.3,2,-13,-14,-0.7647058823529411,-14,Carbohydrate,4694414.891992133,3968714.2610936803,0.8454119101964392,-0.24227365763067166,0.05031376487338015,0.5434560019812327,Downregulated
Feature0437,ARG-PHE,C15 H23 N5 O3,321.18018,NA,NA,ARG-PHE-peak1,15,23,3,5,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.0588235294117647,-1,Lipid,3416883.51482469,4870711.868064503,1.4254837330368884,0.5114515759991799,0.33954417525619385,0.6636048496469049,Upregulated
Feature0436,NA,C8 H19 N O4,193.13145,NA,NA,Feature0436,8,19,4,1,0,0,2.375,0.5,-1,88.8,0,-4,-1.6666666666666667,-0.6,-5,Other,1968063.44353052,1973184.4510347834,1.0026020540755927,0.0037490949496666376,0.9896923841487045,0.9949785749245729,Upregulated
Feature0435,NA,C16 H28 N4 O5,356.20606,NA,NA,Feature0435,16,28,5,4,0,0,1.75,0.3125,-0.375,70.9875,5,0,-0.5714285714285714,-0.15789473684210523,-4,Protein,2930475.0229211934,1259238.9467714133,0.42970471917421865,-1.218582473484479,0.21141357675056346,0.5826979461139303,Downregulated
Feature0434,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak3,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,5086022.308119687,5258733.8505910365,1.0339580780437436,0.04817769259242642,0.895163136743313,0.9522105713555311,Upregulated
Feature0433,Chelidonic acid,C7 H4 O6,184.00082,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Chelidonic acid,7,4,6,0,0,0,0.5714285714285714,0.8571428571428571,1.1428571428571428,27.728571428571428,6,0,0,0.75,0,Condensed HC,5388232.4640636565,4644877.70446154,0.862041074775475,-0.21417148199632868,0.09038220848244255,0.5434560019812327,Downregulated
Feature0432,NA,C11 H19 N3 O7,305.12233,NA,NA,Feature0432,11,19,7,3,0,0,1.7272727272727273,0.6363636363636364,0.36363636363636376,49.93636363636363,4,-3,-6,-0.5555555555555556,-6,Amino Sugar,3760570.8925041733,3058496.01770445,0.8133063051146977,-0.2981292965291933,0.30296038855294455,0.6471814605405902,Downregulated
Feature0431,Fenspiride,C15 H20 N2 O2,260.15248,NA,NA,Fenspiride,15,20,2,2,0,0,1.3333333333333333,0.13333333333333333,-0.666666666666667,79.30000000000001,7,5,0.2727272727272727,0.3333333333333333,3,Lignin,8266833.963663316,7787572.3138619065,0.9420259736789206,-0.08616125630071092,0.5914425550595772,0.7845761067117648,Downregulated
Feature0430,NA,C13 H18 N2 O6,298.11654,NA,NA,Feature0430,13,18,6,2,0,0,1.3846153846153846,0.4615384615384616,0,60.3,6,0,-0.4,0.125,-2,Lignin,5699982.394773804,6575525.137287433,1.153604464342977,0.2061486527990459,0.3504534651511405,0.6670930191369346,Upregulated
Feature0429,Gly-Lys,C8 H17 N3 O3,203.12694,NA,NA,Gly-Lys,8,17,3,3,0,0,2.125,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,2533033.8719590767,5120362.866470217,2.0214348189943747,1.015379684772281,0.022343194741933404,0.5434560019812327,Upregulated
Feature0428,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.1212,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak1,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,567889.504778357,947933.8871133156,1.669222408826321,0.7391761936061099,0.10970263068360499,0.5462476753068062,Upregulated
Feature0427,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10552,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak2",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,5899734.391726716,5441488.687445364,0.9223277398853824,-0.11664860595733921,0.2214570852367221,0.5917165652855003,Downregulated
Feature0426,eutypine,C12 H10 O2,186.06813,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,eutypine,12,10,2,0,0,0,0.8333333333333334,0.16666666666666666,-0.5,74.55,8,6,0.6,0.6363636363636364,6,Lignin,197327.57053877,185714.8298063581,0.9411499330747078,-0.08750352020919756,0.8942724869711155,0.9522105713555311,Downregulated
Feature0425,threonylphenylalanine,C13 H18 N2 O4,266.12661,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak1,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,203028.23356841633,213734.81539247197,1.0527344479921692,0.0741415627829019,0.8882274054743216,0.9511107616140966,Upregulated
Feature0424,NA,C19 H34 N4 O7,430.24288,NA,NA,Feature0424,19,34,7,4,0,0,1.7894736842105263,0.3684210526315789,-0.4210526315789478,72.30000000000001,5,-2,-0.75,-0.21739130434782608,-6,Protein,654829.2063439527,182455.11294703,0.2786300781629988,-1.8435770893733971,0.17776082471782673,0.5646729954371317,Downregulated
Feature0423,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak1,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,1049463.3883866786,1237793.3784716642,1.1794536066422496,0.23811867183426297,0.6338259091097393,0.8097293288325026,Upregulated
Feature0422,NA,C13 H25 N3 O5,303.17947,NA,NA,Feature0422,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,5392224.350911637,2436292.9200527836,0.45181594115995777,-1.1461929214855027,7.288293939963751e-4,0.5434560019812327,Downregulated
Feature0421,1-Methylguanine,C6 H7 N5 O,165.06508,NA,NA,1-Methylguanine,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,4456745.592667666,5921670.783715313,1.3286984102161392,0.4100136768775513,0.07410576724583491,0.5434560019812327,Upregulated
Feature0420,NA,C10 H23 N O7,269.14745,NA,NA,Feature0420,10,23,7,1,0,0,2.3,0.7,-0.5999999999999996,77.39999999999999,0,-7,-4,-0.8181818181818182,-8,Carbohydrate,4948622.21978684,6502898.528225333,1.3140826354098705,0.3940560016476639,0.015012931687410195,0.5434560019812327,Upregulated
Feature0419,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08989,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak1,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,799728.8827728927,839728.0367516257,1.0500158926860867,0.07041116420176498,0.7959688139801615,0.9022552886981726,Upregulated
Feature0418,2'-Deoxycytidine-5'-monophosphorate,C9 H14 N3 O7 P,307.05702,Metabolic pathways;Other,Other,2'-Deoxycytidine-5'-monophosphorate,9,14,7,3,0,1,1.5555555555555556,0.7777777777777778,0.44444444444444464,47.633333333333326,5,-2,3,-1.6666666666666667,-6,Carbohydrate,6112527.4140027,3536625.209532296,0.5785863964275275,-0.7893956914906777,0.2996103381645817,0.6452426827392128,Downregulated
Feature0417,NA,C12 H18 N4 O6,314.12269,NA,NA,Feature0417,12,18,6,4,0,0,1.5,0.5,0.5,46.05,6,0,-2,-0.2,-4,Protein,128593.799964595,261888.529817615,2.036556427212815,1.0261317878902139,0.14602922933850834,0.5574792106914738,Upregulated
Feature0416,NA,C8 H18 N O9 P,303.07198,NA,NA,Feature0416,8,18,9,1,0,1,2.25,1.125,-0.25,67.425,1,-8,3.3333333333333335,-3.6666666666666665,-10,Carbohydrate,201858.76227650835,197602.95852306334,0.9789169233703348,-0.030741665423310097,0.6176431952260525,0.8003048823255108,Downregulated
Feature0415,TC2700000,C2 H7 O4 P,126.00817,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,TC2700000,2,7,4,0,0,1,3.5,2,-2,117.3,0,-4,1.6666666666666667,3,-5,Other,715851.4456521337,531101.9271741824,0.7419163995545943,-0.4306714642987208,0.058134021244420325,0.5434560019812327,Downregulated
Feature0414,Levetiracetam,C8 H14 N2 O2,170.10556,NA,NA,Levetiracetam-peak1,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,7148173.61949277,6840836.65727343,0.9570048268859552,-0.06340189357536254,0.5956851233247771,0.7885106188767821,Downregulated
Feature0413,NP-003800,C10 H15 N O3,197.10521,Metabolic pathways;Tyrosine metabolism,NA,NP-003800-peak2,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,79403.9959390439,70707.72868512073,0.8904807352441174,-0.16734369464234775,0.4209279774496751,0.6943057388507786,Downregulated
Feature0412,dictyoquinazol B,C18 H20 N2 O4,328.14238,NA,NA,dictyoquinazol B,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,5027215.5968851205,3363907.139835473,0.6691392232948515,-0.5796216809411757,0.030049461804592104,0.5434560019812327,Downregulated
Feature0411,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",C20 H20 O7,372.12097,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",20,20,7,0,0,0,1,0.35,-0.2999999999999998,68.85,11,4,0.3076923076923077,0.4545454545454546,4,Lignin,1975005.3674805993,3102525.370176467,1.5708946523695682,0.6515864335919527,0.37393805238137456,0.6760416870160604,Upregulated
Feature0410,NA,C7 H16 O6,196.09463,NA,NA,Feature0410,7,16,6,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,1536275.8074558168,1255174.9626072333,0.8170244929430304,-0.29154876643343125,0.2749873022538256,0.6292487790932914,Downregulated
Feature0409,NA,C20 H29 N3 O4,375.21585,NA,NA,Feature0409,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Lignin,675964.9540550606,321744.12896872667,0.47597752966127743,-1.0710346276806861,0.35838318751115855,0.6692796802688192,Downregulated
Feature0408,"4,5,7-Trihydroxycoumarin",C9 H6 O5,194.02152,Biosynthesis of various plant secondary metabolites,NA,"4,5,7-Trihydroxycoumarin",9,6,5,0,0,0,0.6666666666666666,0.5555555555555556,0.44444444444444464,47.633333333333326,7,2,0.5,0.6923076923076923,2,Condensed HC,82251.8961107751,72980.99100851444,0.8872864269320333,-0.17252819553586,0.5017448092730776,0.7334162931788414,Downregulated
Feature0407,NA,C11 H21 N3 O2,227.16337,NA,NA,Feature0407,11,21,2,3,0,0,1.9090909090909092,0.18181818181818185,-0.7272727272727275,81.02727272727273,3,1,-0.3333333333333333,-0.14285714285714285,-2,Lipid,8565695.302128997,6983543.36175681,0.8152920592471992,-0.2946111313120433,0.060115261255085206,0.5434560019812327,Downregulated
Feature0406,Clavamycin D,C13 H21 N3 O6,315.14297,NA,NA,Clavamycin D,13,21,6,3,0,0,1.6153846153846154,0.4615384615384616,0,60.3,5,-1,-1,-0.14285714285714285,-4,Protein,8030351.235704973,5273639.412037836,0.6567134185351571,-0.6066641609563964,0.08782871003557224,0.5434560019812327,Downregulated
Feature0405,NA,C21 H38 N4 O7,458.27426,NA,NA,Feature0405,21,38,7,4,0,0,1.8095238095238095,0.3333333333333333,-0.5714285714285712,76.58571428571427,5,-2,-0.6,-0.18518518518518515,-6,Protein,154024.061507721,93887.1180563763,0.609561370719145,-0.7141566160025873,0.05086530767887626,0.5434560019812327,Downregulated
Feature0404,pro-gln,C10 H17 N3 O4,243.1219,NA,NA,pro-gln,10,17,4,3,0,0,1.7,0.4,0,60.3,4,0,-1,-0.2,-3,Protein,3744016.185578503,820230.002451293,0.21907757920778217,-2.1904862510014063,0.3660323306896132,0.6716464598336302,Downregulated
Feature0403,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0403,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,2632319.94935558,2963043.38355784,1.125639527323882,0.17074489544338053,0.3243284197189016,0.6622100705596555,Upregulated
Feature0402,NA,C11 H15 N5 O,233.12763,NA,NA,Feature0402,11,15,1,5,0,0,1.3636363636363635,0.09090909090909093,0.18181818181818168,55.11818181818182,7,6,0.2,0.2727272727272727,1,Unsaturated HC,6645928.047821507,6072187.0111381635,0.9136702906569366,-0.13025445022719973,0.39753388453597105,0.6848441763516896,Downregulated
Feature0401,NA,C19 H36 N4 O6,416.26354,NA,NA,Feature0401,19,36,6,4,0,0,1.894736842105263,0.3157894736842105,-0.6315789473684212,78.30000000000001,4,-2,-0.6666666666666666,-0.25,-6,Protein,4188732.5187117234,5189254.15479723,1.2388602355524063,0.30901343618789956,0.35081240969645816,0.6670930191369346,Upregulated
Feature0400,Monoethyl malonic acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Monoethyl malonic acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,2093024.6388362467,1761783.19087119,0.8417403016577808,-0.24855290114608825,0.26606714377865265,0.6292487790932914,Downregulated
Feature0399,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10595,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine-peak1,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,3204006.88778779,5527429.71837729,1.7251616216698304,0.7867315270264169,0.15599019797235267,0.5574792106914738,Upregulated
Feature0398,NA,C7 H7 O2 P S,185.99051,NA,NA,Feature0398,7,7,2,0,1,1,1,0.2857142857142857,-0.8571428571428568,84.72857142857141,5,3,0.3333333333333333,0.5,1,Lignin,7438541.686903063,6172403.965225646,0.8297868352466602,-0.26918732617505015,0.23799007989912396,0.6086116585867128,Downregulated
Feature0397,gln-phe,C14 H19 N3 O4,293.13756,NA,NA,gln-phe-peak1,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,4697976.182347253,3585808.3927325634,0.7632666181251229,-0.3897409992195302,0.27982472029289635,0.6311415121079224,Downregulated
Feature0396,Phenacetin,C10 H13 N O2,179.09463,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,1865896.5525034633,1704854.18234447,0.9136916942458981,-0.13022065412997483,0.49531891160639646,0.7334162931788414,Downregulated
Feature0395,asn-tyr,C13 H17 N3 O5,295.11689,NA,NA,asn-tyr-peak2,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,3436599.6639957903,5936308.180416454,1.7273784440501898,0.7885841914608955,0.09761088976223588,0.5434560019812327,Upregulated
Feature0394,6-Hydroxymelatonin,C13 H16 N2 O3,248.11602,Other,Other,6-Hydroxymelatonin-peak2,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,113054.29240092673,110101.89348992106,0.9738851232597563,-0.038176488778640515,0.8990717895212492,0.953701139936653,Downregulated
Feature0393,beta-Aspartylaspartic acid,C8 H12 N2 O7,248.0644,NA,NA,beta-Aspartylaspartic acid,8,12,7,2,0,0,1.5,0.875,1,31.799999999999997,4,-3,5,-0.6,-5,Carbohydrate,1200651.484772116,1008708.9751275043,0.8401347001365327,-0.2513074388537823,0.6653440500430678,0.8294471376272293,Downregulated
Feature0392,N-Acetyltyramine,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,3331825.43054362,2529408.2519399333,0.7591659000955627,-0.3975129034607524,0.12540175748196203,0.5515041946002173,Downregulated
Feature0391,Asp-Trp,C15 H17 N3 O5,319.11688,NA,NA,Asp-Trp,15,17,5,3,0,0,1.1333333333333333,0.3333333333333333,0.1333333333333333,56.5,9,4,0.14285714285714285,0.3684210526315789,1,Lignin,3951624.76200419,5449696.21915837,1.3791026596347133,0.4637298542654388,0.4121024025554332,0.6891426159219188,Upregulated
Feature0390,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak2,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,1432720.9952988166,1732628.7551317667,1.2093273992752507,0.2742048759910574,0.29662015543920545,0.6425392932568532,Upregulated
Feature0389,asn-val,C9 H17 N3 O4,231.12194,NA,NA,asn-val-peak2,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,3619863.8155818433,5539269.454177396,1.530242499823722,0.6137602970818146,0.1592797744832782,0.5574792106914738,Upregulated
Feature0388,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0388,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,3126111.87419595,1461908.88875554,0.46764445662442883,-1.0965160086814103,0.1343136219291936,0.5560403073935072,Downregulated
Feature0387,NA,C26 H43 N5 O5,505.32642,NA,NA,Feature0387,26,43,5,5,0,0,1.6538461538461535,0.19230769230769232,-0.6923076923076925,80.03076923076924,8,3,-0.125,0.02702702702702703,-2,Lipid,3820283.7909793234,4109396.0416030097,1.0756782130443698,0.10524656313944315,0.8424258881396167,0.9263003867197537,Upregulated
Feature0386,cis-acetylacrylic acid,C5 H6 O3,114.03164,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid-peak1,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,1062800.6244784207,1304272.1677806277,1.2272030498859665,0.29537397339179206,0.39112665328485874,0.6823569007873849,Upregulated
Feature0385,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,C14 H19 N O6,297.12132,NA,NA,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,14,19,6,1,0,0,1.3571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,6,0,-0.14285714285714285,0.2,-1,Lignin,326663.06478973565,296248.9392736043,0.9068945075388057,-0.14099335262535415,0.5661363217054707,0.7736764969024864,Downregulated
Feature0384,NA,C8 H19 N O7,241.11608,NA,NA,Feature0384,8,19,7,1,0,0,2.375,0.875,-0.25,67.425,0,-7,-Inf,-1.2857142857142858,-8,Carbohydrate,5306156.370431143,7236711.10518347,1.3638329894517345,0.44766698743991196,0.3244594796720862,0.6622100705596555,Upregulated
Feature0383,Kyotorphin,C15 H23 N5 O4,337.17513,NA,NA,Kyotorphin,15,23,4,5,0,0,1.5333333333333334,0.26666666666666666,0,60.3,7,3,-0.3333333333333333,0,-2,Lipid,2531620.06549395,5247633.116648943,2.0728359630950646,1.05160595118295,0.08223984095241241,0.5434560019812327,Upregulated
Feature0382,NA,C17 H25 N3 O4,335.18464,NA,NA,Feature0382,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,7855958.623668403,4975760.57825149,0.6333740815870055,-0.658870263092706,0.14568996652985294,0.5574792106914738,Downregulated
Feature0381,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000-peak2,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,204398.04224302934,126274.58050710727,0.6177876222364534,-0.6948171289347224,0.42697709810708556,0.6954800040321182,Downregulated
Feature0380,S-Allyl-L-cysteine,C6 H11 N O2 S,161.05105,NA,Other,S-Allyl-L-cysteine,6,11,2,1,1,0,1.8333333333333333,0.3333333333333333,-0.33333333333333304,69.79999999999998,2,0,-1,-0.3333333333333333,-2,Protein,305544.242049528,5874660.15467285,19.226872400758843,4.265052196156516,0.16510152500826927,0.5646729954371317,Upregulated
Feature0379,"4-cyclopropyl-6-methoxy-1,3,5-triazin-2-amine",C7 H10 N4 O,166.08548,Metabolic pathways;ABC transporters;Other,NA,"4-cyclopropyl-6-methoxy-1,3,5-triazin-2-amine",7,10,1,4,0,0,1.4285714285714286,0.14285714285714285,0.5714285714285716,44.014285714285705,5,4,0,0.2,0,Lignin,136126.599708697,135921.01766366966,0.9984897731562584,-0.002180443675108273,0.9872075543401361,0.9930698319787353,Downregulated
Feature0378,?-Ribazole,C14 H18 N2 O4,278.12667,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak2,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,1988838.1275583967,2447421.32387023,1.2305784417331211,0.2993366235761893,0.06893168797095894,0.5434560019812327,Upregulated
Feature0377,Pheneturide,C11 H14 N2 O2,206.10554,Other,NA,Pheneturide,11,14,2,2,0,0,1.2727272727272727,0.18181818181818185,-0.3636363636363633,70.66363636363636,6,4,0.2857142857142857,0.375,2,Lignin,941709.7476648793,553336.485257245,0.5875870846928491,-0.7671254094328459,0.09237117879382001,0.5434560019812327,Downregulated
Feature0376,pyricarbate,C11 H15 N3 O4,253.10625,NA,NA,pyricarbate,11,15,4,3,0,0,1.3636363636363635,0.3636363636363637,0.18181818181818168,55.11818181818182,6,2,-0.25,0.16666666666666666,-1,Lignin,8543219.159334358,6692218.957691947,0.7833369170191543,-0.3522951437343677,0.07231677732706884,0.5434560019812327,Downregulated
Feature0375,NA,C31 H37 N O11,599.23689,NA,NA,Feature0375,31,37,11,1,0,0,1.1935483870967742,0.3548387096774194,-0.387096774193548,71.33225806451611,14,3,0.10526315789473684,0.30612244897959184,2,Lignin,2132726.8255071705,3097895.61948174,1.4525515328223289,0.5385893476768923,0.482147078413739,0.7279475497619197,Upregulated
Feature0374,NA,C7 H14 N2 O2,158.10555,NA,NA,Feature0374,7,14,2,2,0,0,2,0.2857142857142857,-0.5714285714285712,76.58571428571427,2,0,-0.6666666666666666,-0.25,-2,Lipid,2520025.1994681936,2919221.0567726167,1.1584094704246077,0.21214530214595104,0.3299928370131334,0.6632819814140921,Upregulated
Feature0373,NA,C15 H27 N3 O6,345.19011,NA,NA,Feature0373,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,5541482.9200187735,2435592.9125737133,0.4395200612772911,-1.1859990782223548,0.28841478882589455,0.6353376492471592,Downregulated
Feature0372,arg-gln,C11 H22 N6 O4,302.17037,NA,NA,arg-gln,11,22,4,6,0,0,2,0.3636363636363637,0.36363636363636376,49.93636363636363,4,0,-6,-1.3333333333333333,-6,Protein,8209207.504567291,5631797.027001013,0.6860341907385938,-0.5436476153117055,0.2619291852176026,0.6292487790932914,Downregulated
Feature0371,NA,C18 H31 N6 O4 P3,488.16202,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0371,18,31,4,6,0,3,1.7222222222222223,0.2222222222222222,-1.1111111111111107,91.96666666666664,8,4,-1,-0.42857142857142855,-5,Lipid,7181416.33983011,6867634.106258747,0.9563063581440001,-0.06445522712913279,0.790268302582783,0.9015670682202759,Downregulated
Feature0370,L-Hydroxyproline,C5 H9 N O3,131.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,L-Hydroxyproline,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,5669940.19596533,5433933.318577743,0.9583757730715525,-0.061336656409351945,0.5912215789093795,0.7845761067117648,Downregulated
Feature0369,Penicillic acid,C8 H10 O4,170.05799,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak1,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,6818252.49225052,3783847.607177343,0.554958563279665,-0.8495480401501678,0.02466872040433809,0.5434560019812327,Downregulated
Feature0368,NA,C11 H21 N5 O2,255.16954,NA,NA,Feature0368,11,21,2,5,0,0,1.9090909090909092,0.18181818181818185,-0.18181818181818168,65.48181818181817,4,2,-0.75,-0.4,-3,Lipid,8219167.370159296,6940290.88446783,0.8444031581185966,-0.2439961204259818,0.17708023843532092,0.5646729954371317,Downregulated
Feature0367,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak3,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,3219385.684477933,2307864.6840816033,0.7168649271222235,-0.48022678534447943,0.08688864321981944,0.5434560019812327,Downregulated
Feature0366,Desthiobiotin,C10 H18 N2 O3,214.13169,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin-peak2,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,1126515.0061524634,1566687.1499661468,1.3907379319491375,0.47585058674006303,0.2857387207084265,0.6353376492471592,Upregulated
Feature0365,NA,C20 H36 N4 O6,428.2636,NA,NA,Feature0365,20,36,6,4,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,5,-1,-0.5,-0.15384615384615383,-5,Lipid,117025.00376850346,100236.343534085,0.8565378364128964,-0.22341111804733246,0.3921808589729808,0.6827896969169881,Downregulated
Feature0364,NA,C13 H17 N5 O7,355.11296,NA,NA,Feature0364,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Lignin,5738994.08157511,5509090.203525007,0.9599400391806984,-0.058983801426785276,0.5214819160123563,0.7430834801967906,Downregulated
Feature0363,Acetylcarnitine,C9 H17 N O4,203.11573,NA,NA,Acetylcarnitine-peak1,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,620137.5564802503,731103.492389937,1.1789376159371838,0.23748737942094814,0.42053349757164704,0.6943057388507786,Upregulated
Feature0362,NA,C8 H12 N6,192.11229,NA,NA,Feature0362,8,12,0,6,0,0,1.5,0,0.75,38.925,6,6,0,0,0,Lipid,6276569.577904543,4572019.401317759,0.7284264668096209,-0.45714475241707125,0.0599691432564825,0.5434560019812327,Downregulated
Feature0361,Aniflorine,C20 H21 N3 O3,351.15844,NA,NA,Aniflorine,20,21,3,3,0,0,1.05,0.15,-0.2999999999999998,68.85,12,9,0.42857142857142855,0.4838709677419355,6,Lignin,2585398.2211613436,2336377.83318916,0.903681999185284,-0.14611290953639902,0.44126575747482555,0.7009176491269988,Downregulated
Feature0360,N6-Methyladenine,C6 H7 N5,149.07016,NA,NA,N6-Methyladenine,6,7,0,5,0,0,1.1666666666666667,0,1.3333333333333337,22.29999999999999,6,6,1,1,1,Unsaturated HC,115234.42803497847,121364.0636376669,1.0531927454946697,0.07476948909164795,0.8278328306931749,0.9174960842656863,Upregulated
Feature0359,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak1,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,177956.67989938732,224908.56030448966,1.2638388198276562,0.33781248514280227,0.49708719968409065,0.7334162931788414,Upregulated
Feature0358,NA,C43 H57 N6 O4 P3,814.36502,NA,NA,Feature0358,43,57,4,6,0,3,1.3255813953488371,0.09302325581395347,-1.0697674418604652,90.78837209302326,20,16,0.23333333333333336,0.28125,7,Unsaturated HC,2653648.0575954234,2331932.5044077733,0.8787647999263438,-0.18645101300598435,0.6551901329125438,0.8255661958795926,Downregulated
Feature0357,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",C11 H11 N O4,221.06882,NA,NA,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",11,11,4,1,0,0,1,0.3636363636363637,0,60.3,7,3,0.3333333333333333,0.5,2,Lignin,7095796.1825915165,6312251.039333313,0.8895761485961906,-0.1688099879897191,0.10225528269935716,0.5434560019812327,Downregulated
Feature0356,MFCD00037215,C8 H14 N2 O5,218.09028,NA,NA,MFCD00037215,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,286630.307521765,312572.0583704227,1.090505958957909,0.12499765345920949,0.7291096343844596,0.8691848843400948,Upregulated
Feature0355,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak1,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,3518523.86414993,1752827.42816244,0.4981712490348337,-1.005286333187735,0.14713392755629093,0.5574792106914738,Downregulated
Feature0354,NA,C13 H25 N3 O5,303.17954,NA,NA,Feature0354,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,2193625.3547061235,1986573.1443015633,0.9056118630465508,-0.14303523803566445,0.6932198343096666,0.8460478381272156,Downregulated
Feature0353,Phosphonoacetic acid,C2 H5 O5 P,139.98747,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of L-lysine degradation;Other,Phosphonoacetic acid,2,5,5,0,0,1,2.5,2.5,0,60.3,1,-4,1.25,1.6666666666666667,-5,Other,1078873.8615327014,1016411.9011872454,0.9421044826716634,-0.0860410262665549,0.739822299577469,0.8757924356982758,Downregulated
Feature0352,"Hydroxy-1,4-benzoquinone",C6 H4 O3,124.01601,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,"Hydroxy-1,4-benzoquinone",6,4,3,0,0,0,0.6666666666666666,0.5,0.3333333333333335,50.8,5,2,0.6666666666666666,0.7777777777777778,2,Condensed HC,6589935.436042117,6094984.83127322,0.9248929508380491,-0.1126417003203654,0.33851382066023994,0.6636048496469049,Downregulated
Feature0351,Leu-Gly-Pro,C13 H23 N3 O4,285.16889,NA,NA,Leu-Gly-Pro-peak2,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,1206668.33226695,712212.9294612553,0.5902308947838478,-0.7606486563524402,0.040565412293419256,0.5434560019812327,Downregulated
Feature0350,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak3,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,310736.3752328003,118072.80383445807,0.37997741251245276,-1.3960144337648304,0.08434612219575388,0.5434560019812327,Downregulated
Feature0349,NA,C22 H41 N5 O5,455.31091,NA,NA,Feature0349,22,41,5,5,0,0,1.8636363636363635,0.2272727272727273,-0.7272727272727275,81.02727272727273,5,0,-0.4166666666666667,-0.1724137931034483,-5,Lipid,306237.9649078823,276616.9601060883,0.9032745505257517,-0.14676353300665443,0.8206914192584351,0.9152049950809034,Downregulated
Feature0348,Bicine,C6 H13 N O4,163.08447,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,Bicine,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,671511.5753283619,508328.2803402807,0.7569910914666119,-0.4016517727114484,0.25360289782301115,0.6262438905425377,Downregulated
Feature0347,Ethyl L-tyrosinate,C11 H15 N O3,209.1052,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Ethyl L-tyrosinate,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,297600.546802647,182882.04704905467,0.6145218784504869,-0.7024637199767528,0.11674203273759412,0.5462476753068062,Downregulated
Feature0346,Uracil,C4 H4 N2 O2,112.02723,Metabolic pathways;Other,Other,Uracil-peak1,4,4,2,2,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Lignin,1517830.5742499067,2519008.49363083,1.659611116264207,0.730845225690202,0.19601401587191652,0.5705287678471247,Upregulated
Feature0345,Gly-Ser,C5 H10 N2 O4,162.06409,NA,NA,Gly-Ser,5,10,4,2,0,0,2,0.8,0.7999999999999998,37.5,2,-2,4,-2,-4,Carbohydrate,3178640.966226843,5395372.986983167,1.6973835813195541,0.7633126275406125,0.05242219673114007,0.5434560019812327,Upregulated
Feature0344,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23296,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak1,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,3804624.3060542066,2218974.8449445264,0.5832310016559389,-0.7778606866996088,0.05324089993634366,0.5434560019812327,Downregulated
Feature0343,Oglufanide,C16 H19 N3 O5,333.13251,NA,NA,Oglufanide,16,19,5,3,0,0,1.1875,0.3125,0,60.3,9,4,0.125,0.3333333333333333,1,Lignin,2884229.892075383,3555863.7470051497,1.2328641890769962,0.30201388284161207,0.24421587949480333,0.6174652236779057,Upregulated
Feature0342,NA,C13 H21 N3 O5,299.1482,NA,NA,Feature0342,13,21,5,3,0,0,1.6153846153846154,0.38461538461538464,-0.1538461538461542,64.6846153846154,5,0,-0.6,-0.06666666666666667,-3,Protein,190321.932533521,197858.51257075867,1.0395991147048187,0.05602731036223598,0.792453725767327,0.9015670682202759,Upregulated
Feature0341,NA,C19 H41 N O2,315.3138,NA,NA,Feature0341,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,139855.8915724957,1331410.2846501044,9.519872703824955,3.2509422824840275,0.17716982630042138,0.5646729954371317,Upregulated
Feature0340,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",C13 H14 N2 O4,262.09538,NA,NA,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",13,14,4,2,0,0,1.0769230769230769,0.3076923076923077,0,60.3,8,4,0.2857142857142857,0.4444444444444444,2,Lignin,1516900.4291463345,2754777.879543886,1.8160571561669288,0.8608096088077759,0.5470196399229641,0.7624927900031507,Upregulated
Feature0339,ophthalmic acid,C11 H19 N3 O6,289.12729,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,ophthalmic acid,11,19,6,3,0,0,1.7272727272727273,0.5454545454545454,0.18181818181818168,55.11818181818182,4,-2,-2.5,-0.4,-5,Protein,6367465.652231987,5328003.459817884,0.8367541736091281,-0.2571242530028355,0.557515084530019,0.7715935892106635,Downregulated
Feature0338,1581740,C12 H13 N O4,235.08445,NA,NA,1581740-peak1,12,13,4,1,0,0,1.0833333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,7,3,0.2857142857142857,0.4444444444444444,2,Lignin,391438.391846876,316044.1062763073,0.8073916939653133,-0.3086593497046709,0.461399082933455,0.71120113420316,Downregulated
Feature0337,Leu-Glu,C11 H20 N2 O5,260.13726,NA,NA,Leu-Glu-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,3598853.01129511,3795686.93896583,1.0546935168102034,0.07682382735362898,0.8738195885457751,0.9409146589428623,Upregulated
Feature0336,"3-[(1S,4R)-4-Hydroxy-2-cyclohexen-1-yl]-L-alanine",C9 H15 N O3,185.10525,Other,NA,"3-[(1S,4R)-4-Hydroxy-2-cyclohexen-1-yl]-L-alanine",9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,1520225.1675800167,1429114.0795575767,0.9400673729356317,-0.08916393903642938,0.18230262757088175,0.5646729954371317,Downregulated
Feature0335,N-Acetyl-L-leucine,C8 H15 N O3,173.10526,Other,NA,N-Acetyl-L-leucine-peak2,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,5703574.34680809,5493490.559164911,0.9631662927720493,-0.054143190851954355,0.6302002730188716,0.8074733573579681,Downregulated
Feature0334,Alanyltryptophan,C14 H17 N3 O3,275.12704,NA,NA,Alanyltryptophan-peak2,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Lignin,5511616.114961067,4457266.71581621,0.8087041301220405,-0.3063161154448924,0.09340770984394453,0.5434560019812327,Downregulated
Feature0333,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak3,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,3388000.8475838066,2092084.5573510067,0.6174982390700999,-0.6954930723413937,0.025630841547791456,0.5434560019812327,Downregulated
Feature0332,N-Acetylvanilalanine,C12 H15 N O5,253.09505,NA,NA,N-Acetylvanilalanine-peak2,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,4817644.00442189,5879616.560022663,1.220434003555688,0.28739428174975024,0.07343081820064125,0.5434560019812327,Upregulated
Feature0331,tyr-thr,C13 H18 N2 O5,282.12167,NA,NA,tyr-thr-peak2,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Lignin,2865110.57963207,5606106.932696504,1.9566808250090038,0.9684084418457093,0.05910380909936947,0.5434560019812327,Upregulated
Feature0330,Alanyltryptophan,C14 H17 N3 O3,275.12702,NA,NA,Alanyltryptophan-peak1,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Lignin,3417624.30897571,3681648.12250453,1.077253609425534,0.1073579323230644,0.6678070954848903,0.8312014840201353,Upregulated
Feature0329,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0329,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,3822147.1073958133,2783011.15104726,0.7281276918049971,-0.45773661674426896,0.034875326717543065,0.5434560019812327,Downregulated
Feature0328,pre-putrebactin,C16 H30 N4 O7,390.2116,NA,NA,pre-putrebactin,16,30,7,4,0,0,1.875,0.4375,-0.25,67.425,4,-3,-1.4,-0.4117647058823529,-7,Protein,5697857.619987413,2683888.131816543,0.47103460823622195,-1.0860950322966294,0.31673260790534535,0.6589986597210907,Downregulated
Feature0327,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",C13 H10 N2 O,210.07933,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",13,10,1,2,0,0,0.7692307692307693,0.07692307692307693,-0.1538461538461542,64.6846153846154,10,9,0.7,0.7142857142857143,7,Condensed HC,229411.598157075,247641.71468866934,1.0794646682122515,0.11031602350941691,0.7762524265178448,0.8975915430179037,Upregulated
Feature0326,Brivaracetam,C11 H20 N2 O2,212.15246,NA,NA,Brivaracetam,11,20,2,2,0,0,1.818181818181818,0.18181818181818185,-0.9090909090909092,86.2090909090909,3,1,-0.14285714285714285,0,-1,Lipid,6695331.555823283,6428239.92007633,0.9601077805452891,-0.05873172475142703,0.6627434979029835,0.8289195086767364,Downregulated
Feature0325,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak1,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,3606750.15763223,6259242.163633914,1.7354243820822344,0.7952885037596421,0.08201499544630972,0.5434560019812327,Upregulated
Feature0324,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",C18 H20 N2 S,296.13484,NA,NA,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",18,20,0,2,1,0,1.1111111111111112,0,-0.666666666666667,79.30000000000001,10,10,0.4666666666666667,0.4666666666666667,7,Unsaturated HC,76291.05093672826,74733.9693418486,0.9795902458314406,-0.029749686400610178,0.8661300665698097,0.939303571324255,Downregulated
Feature0323,3-Buten-1-amine,C4 H9 N,71.07351,NA,NA,3-Buten-1-amine-peak1,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,517938.57369204966,849575.0188918703,1.6403007268522183,0.7139603376269084,0.10085352164467369,0.5434560019812327,Upregulated
Feature0322,"1-(beta-D-Ribofuranosyl)-1,2-dihydropyrimidine",C9 H14 N2 O4,214.09536,NA,NA,"1-(beta-D-Ribofuranosyl)-1,2-dihydropyrimidine",9,14,4,2,0,0,1.5555555555555556,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Protein,5914343.029238846,6058418.0142076705,1.0243602686311155,0.03472320201476106,0.7484127575068633,0.8799621167815986,Upregulated
Feature0321,NA,C14 H26 N4 O5,330.1904,NA,NA,Feature0321,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,2825717.7503005867,1452670.49065031,0.5140890276446689,-0.9599098743407516,0.055471364896883466,0.5434560019812327,Downregulated
Feature0320,Bis(methylbenzylidene)sorbitol,C22 H26 O6,386.17299,NA,NA,Bis(methylbenzylidene)sorbitol,22,26,6,0,0,0,1.181818181818182,0.2727272727272727,-0.6363636363636367,78.43636363636364,10,4,0.25,0.3684210526315789,4,Lignin,2039145.9412002766,1655275.6853983067,0.8117494937238199,-0.3008935151633253,0.5039095300227653,0.7335255813534236,Downregulated
Feature0319,6-Quinolinecarboxylic acid,C10 H7 N O2,173.04768,Other,NA,6-Quinolinecarboxylic acid,10,7,2,1,0,0,0.7,0.2,0,60.3,8,6,0.7142857142857143,0.75,5,Condensed HC,6337746.07206872,6496551.756029907,1.025057123172079,0.03570430877538031,0.9028337934186474,0.953701139936653,Upregulated
Feature0318,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,924209.9494432494,789653.9360794197,0.8544096896545128,-0.22700008651212275,0.8179627026201486,0.9140031782576067,Downregulated
Feature0317,CMPF,C12 H16 O5,240.09978,NA,NA,CMPF,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Lignin,130595.28703505466,122682.29509371007,0.939408288606766,-0.09017577201859041,0.7792171568388069,0.8982992411548629,Downregulated
Feature0316,Asp-tyr,C13 H16 N2 O6,296.10088,NA,NA,Asp-tyr,13,16,6,2,0,0,1.2307692307692308,0.4615384615384616,0.15384615384615374,55.91538461538462,7,1,-0.2,0.25,-1,Lignin,3659944.9546047403,5699142.954711617,1.5571663031547156,0.6389230304312886,0.11755174080804823,0.5462476753068062,Upregulated
Feature0315,Aspartame,C14 H18 N2 O5,294.12149,Other,NA,Aspartame-peak1,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,580388.3249091897,722303.1182348976,1.2445169677524313,0.3155859001666076,0.14380803693324337,0.5574792106914738,Upregulated
Feature0314,4-Amino-3-hydroxybenzoic acid,C7 H7 N O3,153.04263,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,4-Amino-3-hydroxybenzoic acid,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,193187.76505830267,229074.38063355058,1.1857602916231138,0.245812390120324,0.7078746125277368,0.85469678804133,Upregulated
Feature0313,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13725,NA,NA,L-gamma-Glutamyl-L-leucine-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,254869.5409158313,422120.93502845435,1.6562235468060755,0.7278974120294841,0.2718240800266879,0.6292487790932914,Upregulated
Feature0312,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07399,NA,NA,Phenyl D-glucopyranosiduronic acid-peak1,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,279764.97931893566,187941.94340780063,0.6717850957090108,-0.573928306735646,0.40083781267764435,0.685393667249696,Downregulated
Feature0311,NA,C13 H23 N3 O6,317.15873,NA,NA,Feature0311,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,2293334.8466688036,1890463.4778897834,0.8243294609314409,-0.2787070382372949,0.4988750739951215,0.7334162931788414,Downregulated
Feature0310,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0310,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,3673474.047499603,1924836.5236228933,0.5239826112105128,-0.9324091593395551,0.014811034212069753,0.5434560019812327,Downregulated
Feature0309,Leu-Gly-Pro,C13 H23 N3 O4,285.16893,NA,NA,Leu-Gly-Pro-peak1,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,6522678.777943723,4134032.70622314,0.6337936984114977,-0.6579147793068142,0.10490561549460631,0.5434560019812327,Downregulated
Feature0308,2-Methoxy-5-methylaniline,C8 H11 N O,137.08405,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,2-Methoxy-5-methylaniline,8,11,1,1,0,0,1.375,0.125,-0.75,81.675,4,3,0.3333333333333333,0.38461538461538464,2,Unsaturated HC,7169331.55276031,4232598.54472177,0.5903756178066769,-0.7602949547826839,0.19659755416137314,0.5712457234122917,Downregulated
Feature0307,NA,C11 H14 N2 O5 S,286.06233,NA,NA,Feature0307,11,14,5,2,1,0,1.2727272727272727,0.4545454545454546,0.36363636363636376,49.93636363636363,6,1,-0.6666666666666666,0.09090909090909093,-2,Lignin,4082616.7209526035,3980179.5908940835,0.9749089525027423,-0.03666060413404016,0.6543851042760328,0.8254120377093072,Downregulated
Feature0306,Salsolinol,C10 H13 N O2,179.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Salsolinol,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,673812.8302624377,369294.5741939473,0.5480669966615416,-0.8675758333741188,0.16913490384259874,0.5646729954371317,Downregulated
Feature0305,tyr-thr,C13 H18 N2 O5,282.12161,NA,NA,tyr-thr-peak1,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Lignin,3002719.4768286063,3102200.77740473,1.0331304010726947,0.04702236176119376,0.8127849685222495,0.9088169879054063,Upregulated
Feature0304,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak1,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,3020230.408537403,3248080.28644371,1.0754412237100304,0.10492867903413818,0.6306300187630411,0.8074733573579681,Upregulated
Feature0303,L-Phenylalanine,C9 H11 N O2,165.079,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak1,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,448751.719965352,207603.360658753,0.4626241001923781,-1.1120876704126774,0.3705934840724611,0.6743129559814706,Downregulated
Feature0302,(E)-5-(methylsulfanyl)pentanal oxime,C6 H13 N O S,147.0718,2-Oxocarboxylic acid metabolism;Other,NA,(E)-5-(methylsulfanyl)pentanal oxime,6,13,1,1,1,0,2.1666666666666665,0.16666666666666666,-1,88.8,1,0,-0.6666666666666666,-0.42857142857142855,-2,Lipid,98099.18370332956,87485.29602544283,0.8918045260194506,-0.16520057335928692,0.4555120742509479,0.7072753930165956,Downregulated
Feature0301,NA,C16 H31 N3 O5,345.2265,NA,NA,Feature0301,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1547411.21568326,1052032.8642010633,0.6798663816951448,-0.5566768623592765,0.09782819120433218,0.5434560019812327,Downregulated
Feature0300,NA,C9 H15 N O5,217.09502,NA,NA,Feature0300,9,15,5,1,0,0,1.6666666666666667,0.5555555555555556,-0.22222222222222232,66.63333333333333,3,-2,-1,-0.09090909090909093,-3,Amino Sugar,930845.7240831973,1655334.0337328715,1.7783119059425585,0.8305083869864727,0.33226266819427436,0.6632819814140921,Upregulated
Feature0299,ser-trp,C14 H17 N3 O4,291.12193,NA,NA,ser-trp,14,17,4,3,0,0,1.2142857142857142,0.2857142857142857,0,60.3,8,4,0.14285714285714285,0.3333333333333333,1,Lignin,5600051.296691174,4729192.364019684,0.8444909007912048,-0.24384621650738803,0.5317345188313185,0.7500068900085376,Downregulated
Feature0298,Caffeic acid,C9 H8 O4,180.04231,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak1,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,250522.361340184,183309.21697509466,0.7317080040059949,-0.4506600545962765,0.19526397631438738,0.5701278580652142,Downregulated
Feature0297,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one-peak2,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,5615567.50860687,6103918.74596898,1.0869638262942478,0.12030392887094346,0.19167825971359684,0.5685889950290117,Upregulated
Feature0296,Adenylsuccinic acid,C14 H18 N5 O11 P,463.07418,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of purine nucleotide salvage;Other,Adenylsuccinic acid,14,18,11,5,0,1,1.2857142857142858,0.7857142857142857,1,31.799999999999997,9,-2,2.6666666666666665,-1,-8,Tannin,313211.4611317257,294517.715659637,0.9403158958342627,-0.0887825883177278,0.9041125265751058,0.953701139936653,Downregulated
Feature0295,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak1,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,5078498.294621937,5230771.37329934,1.029983879060993,0.04262175703881528,0.8211992872036441,0.9152049950809034,Upregulated
Feature0294,NA,C16 H21 N5 O9,427.13397,NA,NA,Feature0294,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2763474.6081429166,2732437.405390573,0.988768775851644,-0.016294909528616446,0.8911615468574232,0.9518459397077395,Downregulated
Feature0293,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.07946,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak1",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,5638846.98326244,4888060.37959038,0.8668545881985112,-0.20613808815218776,0.27297096930107495,0.6292487790932914,Downregulated
Feature0292,Succinyladenosine,C14 H17 N5 O8,383.10785,NA,NA,Succinyladenosine,14,17,8,5,0,0,1.2142857142857142,0.5714285714285714,1,31.799999999999997,9,1,-4,0,-4,Lignin,1911867.2556078134,2061224.8380918833,1.0781213141477162,0.10851952453942022,0.2115461846871707,0.5826979461139303,Upregulated
Feature0291,NA,C14 H28 N6 O4,344.21736,NA,NA,Feature0291,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,5564658.988278513,2806707.29198331,0.5043808251135251,-0.9874146646602815,0.13514560990597327,0.5560403073935072,Downregulated
Feature0290,cys-val,C8 H16 N2 O3 S,220.08817,NA,NA,cys-val-peak1,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,5144187.88550186,4050622.9436137,0.7874173793359662,-0.34479953986423045,0.1835921330105703,0.5646729954371317,Downregulated
Feature0289,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak1,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,6115237.832293694,5224692.197749477,0.8543726901607369,-0.2270625625615305,0.33638743128097376,0.6636048496469049,Downregulated
Feature0288,NA,C24 H36 N4 O6,476.26356,NA,NA,Feature0288,24,36,6,4,0,0,1.5,0.25,-0.5,74.55,9,3,-0.07142857142857142,0.1176470588235294,-1,Lipid,108991.50159880897,136028.909476616,1.2480689547459405,0.3196976440734404,0.7006811224002927,0.8508629543699612,Upregulated
Feature0287,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.29814,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak1,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,125690.71165867934,2235449.6390281795,17.78532088432021,4.152615098752476,0.19198501842974497,0.5685889950290117,Upregulated
Feature0286,Deoxyadenosine monophosphate,C10 H14 N5 O6 P,331.06822,Metabolic pathways;Other,NA,Deoxyadenosine monophosphate,10,14,6,5,0,1,1.4,0.6,0.7999999999999998,37.5,7,1,2.5,-2,-5,Lignin,6484397.798463474,2991303.97797214,0.4613079072170667,-1.116198073229339,0.1504318206576545,0.5574792106914738,Downregulated
Feature0285,PYRIDOXAMINE,C8 H12 N2 O2,168.08993,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE-peak1,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,3532097.6746634133,4589896.097368823,1.2994816452255136,0.3779362563348226,0.31254681141537033,0.6547061206079187,Upregulated
Feature0284,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,C9 H15 N O2,169.11033,NA,NA,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,9,15,2,1,0,0,1.6666666666666667,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,1,0,0.14285714285714285,0,Lipid,540061.3464546353,425968.20797182765,0.7887404102667226,-0.34237753538773547,0.27731126099122794,0.6292487790932914,Downregulated
Feature0283,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak2,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,5879930.2114207065,5189747.16014467,0.8826205369010196,-0.18013477841353304,0.1290747442769718,0.5545833428603265,Downregulated
Feature0282,NA,C13 H22 N2 O10,366.12745,NA,NA,Feature0282,13,22,10,2,0,0,1.6923076923076923,0.7692307692307693,0.3076923076923075,51.53076923076924,4,-6,-8,-0.5,-8,Carbohydrate,781967.1646975171,1022825.7673472593,1.3080162614537811,0.3873804767479955,0.22628404704917054,0.5958985050006134,Upregulated
Feature0281,NA,C16 H30 N4 O5,358.22175,NA,NA,Feature0281,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1811192.1996635234,577856.3826234363,0.3190475216991263,-1.6481567674066175,0.12427045573491127,0.5515041946002173,Downregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak1,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,4288527.47366093,3326027.34190287,0.7755639581022865,-0.3666823346031601,0.061737073696820716,0.5434560019812327,Downregulated
Feature0279,Acetophenone,C8 H8 O,120.05746,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Phenylalanine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,Acetophenone-peak1,8,8,1,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,2759498.23331895,4548180.390937373,1.6481910863436608,0.720883513964727,0.26781865451650155,0.6292487790932914,Upregulated
Feature0278,NA,C19 H41 N O,299.31886,NA,NA,Feature0278,19,41,1,1,0,0,2.1578947368421053,0.05263157894736842,-1.8947368421052628,114.29999999999998,0,-1,-0.1176470588235294,-0.08571428571428572,-2,Lipid,159249.70783813435,2878200.621660038,18.073506449289802,4.175804526172655,0.20365347000213135,0.5780722477745703,Upregulated
Feature0277,NA,C16 H35 N O,257.27187,NA,NA,Feature0277,16,35,1,1,0,0,2.1875,0.0625,-1.875,113.7375,0,-1,-0.14285714285714285,-0.10344827586206896,-2,Lipid,7381096.785725816,3607848.593506775,0.488795730261109,-1.0326964119361781,0.15394254127338763,0.5574792106914738,Downregulated
Feature0276,NA,C19 H29 N3 O4,363.21589,NA,NA,Feature0276,19,29,4,3,0,0,1.5263157894736843,0.21052631578947367,-0.6315789473684212,78.30000000000001,7,3,0,0.14285714285714285,0,Lipid,4204964.665573443,1264105.8831870654,0.30062223674230937,-1.7339763668994475,0.3881601640621978,0.6813920392967493,Downregulated
Feature0275,Trigonelline,C7 H7 N O2,137.04766,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak2,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,1134659.7810089644,1454140.7053060234,1.2815653904758741,0.3579070924480345,0.22861445122325194,0.5976433339076987,Upregulated
Feature0274,N-(5-acetamidopentyl)acetamide,C9 H18 N2 O2,186.13687,NA,NA,N-(5-acetamidopentyl)acetamide,9,18,2,2,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,2,0,-0.4,-0.16666666666666666,-2,Lipid,2826564.1487130965,3366582.60338481,1.1910511936966222,0.25223542437328,0.27993300127016685,0.6311415121079224,Upregulated
Feature0273,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea",C14 H20 N4 O2,276.15865,Metabolic pathways;Other,NA,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea-peak1",14,20,2,4,0,0,1.4285714285714286,0.14285714285714285,-0.2857142857142856,68.44285714285714,7,5,0.125,0.2222222222222222,1,Lignin,855613.188686365,337429.3933026397,0.39437142597193925,-1.3423730692921405,0.17532444087300517,0.5646729954371317,Downregulated
Feature0272,N-benzoyl-4-methoxyanthranilic acid,C15 H13 N O4,271.08448,NA,NA,N-benzoyl-4-methoxyanthranilic acid,15,13,4,1,0,0,0.8666666666666667,0.26666666666666666,-0.13333333333333375,64.10000000000001,10,6,0.5,0.5833333333333334,5,Lignin,5285380.457989624,4802537.421752387,0.9086455478323515,-0.13821046945654114,0.07607089222221444,0.5434560019812327,Downregulated
Feature0271,Prolylaspartic acid,C9 H14 N2 O5,230.09029,Biosynthesis of secondary metabolites;Other,NA,Prolylaspartic acid,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,97189.5217244642,103088.59883842936,1.0606966369346817,0.08501209925910275,0.7563741054121289,0.884874126082974,Upregulated
Feature0270,NA,C12 H22 N4 O3,270.16921,NA,NA,Feature0270,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,74442.67220307597,84006.99975911144,1.1284791004001635,0.1743796998516397,0.04737009287858716,0.5434560019812327,Upregulated
Feature0269,NA,C19 H29 N3 O5,379.21071,NA,NA,Feature0269,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,5280878.764038427,2031513.8849063031,0.38469239224737495,-1.3782227959924036,0.26565685616210843,0.6292487790932914,Downregulated
Feature0268,Enicoflavine,C10 H13 N O4,211.0845,NA,NA,Enicoflavine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,420644.2675541013,278317.64521864837,0.6616461145113607,-0.5958683058764075,0.18918806194927587,0.5646729954371317,Downregulated
Feature0267,Methylone,C11 H13 N O3,207.08954,Metabolic pathways;Phenylalanine metabolism;Other,NA,Methylone-peak1,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,5650193.00727261,5527029.49268765,0.9782018924970473,-0.03179583907133683,0.8356720285534222,0.9228214443978652,Downregulated
Feature0266,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate-peak1,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,2985356.9624340767,2807185.558759433,0.9403182246154665,-0.08877901535150581,0.6702535541046195,0.8312524847517372,Downregulated
Feature0265,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak2,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,2358531.5292377565,861536.406679612,0.36528509201572906,-1.45290521913393,0.2167334058061532,0.587247735354029,Downregulated
Feature0264,Phenethylamine,C8 H11 N,121.0891,Metabolic pathways;Phenylalanine metabolism;Other,Other,Phenethylamine,8,11,0,1,0,0,1.375,0,-1,88.8,4,4,0.42857142857142855,0.42857142857142855,3,Unsaturated HC,706072.8773934384,985500.5162556603,1.395749005249665,0.48103952790981186,0.3777266865465296,0.6777698672492496,Upregulated
Feature0263,asn-ile,C10 H19 N3 O4,245.13753,NA,NA,asn-ile,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,3983222.9234229,4474465.107937884,1.1233278161827922,0.16777900500175924,0.5745826492239685,0.7751995156675667,Upregulated
Feature0262,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0262,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1791126.5686751034,547920.3089026234,0.3059082024046576,-1.7088293040753495,0.16778663860064577,0.5646729954371317,Downregulated
Feature0261,beta-Aspartylleucine,C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,beta-Aspartylleucine,10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,2674491.4364411933,4843814.524450904,1.8111161091980597,0.8568790392724301,0.14192918916855332,0.5574792106914738,Upregulated
Feature0260,.alpha.-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,.alpha.-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,945120.3224325913,1271299.0042193462,1.3451186838806113,0.4277334717350114,0.3469212084050713,0.6670930191369346,Upregulated
Feature0259,Norsolorinic acid,C20 H18 O7,370.10536,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Norsolorinic acid,20,18,7,0,0,0,0.9,0.35,-0.20000000000000015,66,12,5,0.38461538461538464,0.5151515151515151,5,Lignin,3006030.3099281867,2909656.930276683,0.9679399840603051,-0.04701049716311856,0.9421613347926634,0.9702257149779767,Downregulated
Feature0258,NA,C7 H16 N2 O3,176.11612,NA,NA,Feature0258,7,16,3,2,0,0,2.2857142857142856,0.42857142857142855,-0.5714285714285712,76.58571428571427,1,-2,-2,-0.7142857142857143,-4,Protein,6268205.32830545,4182336.9531018836,0.6672303688291172,-0.5837431406939917,0.18933545537679503,0.5646729954371317,Downregulated
Feature0257,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin-peak1,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,147878.322420009,135607.65789431566,0.9170218844460395,-0.12497193118149745,0.8065317764927298,0.9072143621372405,Downregulated
Feature0256,NA,C19 H41 N O2,315.31381,NA,NA,Feature0256,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,4367010.342115324,3052701.1063227346,0.6990368392038305,-0.516559607332129,0.6353193161585189,0.81058614175596,Downregulated
Feature0255,NP-003800,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,NP-003800-peak1,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,140952.80525759156,246576.44490345733,1.749354647130565,0.8068227968580757,0.049207463895870746,0.5434560019812327,Upregulated
Feature0254,Desthiobiotin,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin-peak1,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,5706269.58474271,5430249.8662436865,0.9516286928964873,-0.07152932325524634,0.5344413391461225,0.7531976942708248,Downregulated
Feature0253,asn-leu,C10 H19 N3 O4,245.13756,NA,NA,asn-leu-peak1,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,3947412.833891377,4807555.596420857,1.2179003815219265,0.2843961324545021,0.09269984329278354,0.5434560019812327,Upregulated
Feature0252,Isovalerylglutamic acid,C10 H17 N O5,231.11066,NA,NA,Isovalerylglutamic acid-peak2,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,274784.95593496534,311088.30649035,1.132115495303814,0.17902114545114067,0.514267277676117,0.7414202284113551,Upregulated
Feature0251,NA,C13 H24 N4 O6,332.1696,NA,NA,Feature0251,13,24,6,4,0,0,1.8461538461538465,0.4615384615384616,0,60.3,4,-2,-2,-0.5,-6,Protein,4294401.406621924,4246943.250515107,0.9889488309048994,-0.01603221830086102,0.9295508909508715,0.9678298766261686,Downregulated
Feature0250,NA,C8 H10 N2 O2,166.07426,NA,NA,Feature0250,8,10,2,2,0,0,1.25,0.25,0,60.3,5,3,0.25,0.4,1,Lignin,1636315.53491345,1317099.01831644,0.8049175053429445,-0.31308716350014676,0.28031299726847514,0.6311415121079224,Downregulated
Feature0249,Isovalerylglutamic acid,C10 H17 N O5,231.11064,NA,NA,Isovalerylglutamic acid-peak1,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,1332412.97955247,1155872.8339711092,0.8675034330267055,-0.20505862791599896,0.7219239838745699,0.864701245409092,Downregulated
Feature0248,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak1,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,257076.291052736,581385.5834120989,2.2615293733673596,1.1772987342121815,0.03277808279016669,0.5434560019812327,Upregulated
Feature0247,L-dihydroanticapsin,C9 H15 N O4,201.10006,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,L-dihydroanticapsin,9,15,4,1,0,0,1.6666666666666667,0.4444444444444444,-0.44444444444444464,72.96666666666667,3,-1,-0.5,0,-2,Protein,5132254.21675888,4389114.797929507,0.8552021417016478,-0.22566262885131924,0.061201225216388676,0.5434560019812327,Downregulated
Feature0246,NA,C14 H25 N3 O4,299.18456,NA,NA,Feature0246,14,25,4,3,0,0,1.7857142857142858,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,0,-0.42857142857142855,-0.1111111111111111,-3,Lipid,715970.7176812111,447286.1970132633,0.6247269419926463,-0.6787023459331338,0.32196564433032104,0.6622100705596555,Downregulated
Feature0245,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone-peak1,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,1212329.5112844766,927175.3617776653,0.7647882470462282,-0.38686774214716274,0.12304407341657368,0.5515041946002173,Downregulated
Feature0244,SLH,C15 H25 N5 O5,355.18569,NA,NA,SLH,15,25,5,5,0,0,1.6666666666666667,0.3333333333333333,0,60.3,6,1,-0.8,-0.2,-4,Protein,4257921.07233108,3990563.0253211167,0.9372092524806729,-0.093556897790356,0.7224244451531874,0.864701245409092,Downregulated
Feature0243,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16894,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak1,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1788319.95980171,1032540.2767843053,0.5773800550203522,-0.792406822817824,0.027671488072387476,0.5434560019812327,Downregulated
Feature0242,asn-lys,C10 H20 N4 O4,260.14846,NA,NA,asn-lys,10,20,4,4,0,0,2,0.4,0,60.3,3,-1,-2.5,-0.75,-5,Protein,3399525.10670267,5196562.2927307505,1.5286141827530422,0.6122243211087375,0.15351799691929882,0.5574792106914738,Upregulated
Feature0241,Tyrosyltyrosine,C18 H20 N2 O5,344.13731,NA,NA,Tyrosyltyrosine,18,20,5,2,0,0,1.1111111111111112,0.2777777777777778,-0.22222222222222232,66.63333333333333,10,5,0.2727272727272727,0.4074074074074074,3,Lignin,2699693.5370554235,3383805.1987993,1.2534034520414647,0.3258508716202128,0.3604763771997068,0.6692796802688192,Upregulated
Feature0240,ELK,C17 H32 N4 O6,388.23223,NA,NA,ELK,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,3317800.692311473,2952451.7991912165,0.8898822060146951,-0.16831371616283017,0.5002982573490629,0.7334162931788414,Downregulated
Feature0239,7-Methylguanine,C6 H7 N5 O,165.06507,NA,NA,7-Methylguanine-peak1,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,234711.46160423697,209586.27053315067,0.892952858376164,-0.16334408167092765,0.8122569861356745,0.9088169879054063,Downregulated
Feature0238,Leonurine,C14 H21 N3 O5,311.14813,NA,NA,Leonurine-peak1,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,4571743.492324093,4926201.20613508,1.077532283778851,0.10773109432589979,0.08589581484816265,0.5434560019812327,Upregulated
Feature0237,Neostigmine,C12 H18 N2 O2,222.13678,Other,NA,Neostigmine,12,18,2,2,0,0,1.5,0.16666666666666666,-0.666666666666667,79.30000000000001,5,3,0.125,0.2222222222222222,1,Lipid,5485160.70769013,5060590.88494066,0.922596648416476,-0.11622804345681753,0.4229734928099919,0.6949729358100158,Downregulated
Feature0236,N'3-(2-furylmethylidene)pyridine-3-carbohydrazide,C11 H9 N3 O2,215.06947,NA,NA,N'3-(2-furylmethylidene)pyridine-3-carbohydrazide,11,9,2,3,0,0,0.8181818181818182,0.18181818181818185,0.36363636363636376,49.93636363636363,9,7,0.6666666666666666,0.7142857142857143,4,Lignin,728802.5042954626,1108775.2988095502,1.5213659287318302,0.6053672011043892,0.21466179366781496,0.5862718758964077,Upregulated
Feature0235,NA,C14 H21 N O10,363.11672,NA,NA,Feature0235,14,21,10,1,0,0,1.5,0.7142857142857143,0.1428571428571428,56.22857142857143,5,-5,-2,-0.125,-6,Carbohydrate,76035.86822628746,113153.58820277906,1.4881606647276908,0.5735302910246901,0.5369127748652188,0.7558927247528218,Upregulated
Feature0234,NA,C20 H36 N4 O7,444.25844,NA,NA,Feature0234,20,36,7,4,0,0,1.8,0.35,-0.5,74.55,5,-2,-0.6666666666666666,-0.2,-6,Protein,179886.16755141565,108159.67602185553,0.6012673319694856,-0.7339215186682467,0.5020238421388571,0.7334162931788414,Downregulated
Feature0233,Anhalamine,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak2,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,843592.338307471,859366.1356774237,1.0186983649017014,0.026726934839997298,0.8455335598561257,0.9288805774294923,Upregulated
Feature0232,NA,C19 H37 N O2,311.28246,NA,NA,Feature0232,19,37,2,1,0,0,1.9473684210526316,0.10526315789473684,-1.5789473684210522,105.29999999999998,2,0,-0.0625,0,-1,Lipid,139263.21170692035,389939.4049684334,2.800017321078746,1.4854357517977836,0.28949557716714786,0.6360642123490902,Upregulated
Feature0231,NA,C13 H25 N O9,339.15309,NA,NA,Feature0231,13,25,9,1,0,0,1.9230769230769231,0.6923076923076923,-0.3076923076923075,69.06923076923076,2,-7,-2.6666666666666665,-0.4666666666666667,-8,Amino Sugar,87263.25570680336,3136662.867663342,35.944829725380004,5.167712364411849,0.3746605376646297,0.676066007850296,Upregulated
Feature0230,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0230,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,2347175.1271776035,1181857.8630745,0.5035235118973177,-0.9898689488187672,0.18663746057172598,0.5646729954371317,Downregulated
Feature0229,NA,C16 H31 N3 O4,329.23158,NA,NA,Feature0229,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,2024307.7308261634,1583324.2518408932,0.7821559082791748,-0.3544718841807118,0.04200976010526525,0.5434560019812327,Downregulated
Feature0228,NA,C47 H83 N10 O10 P3,1040.55075,NA,NA,Feature0228,47,83,10,10,0,3,1.7659574468085106,0.2127659574468085,-1.0212765957446803,89.4063829787234,13,3,-0.4166666666666667,-0.1724137931034483,-10,Lipid,78143.10631500097,74716.5066329335,0.9561496868545949,-0.06469160264570618,0.8366420802189292,0.9228214443978652,Downregulated
Feature0227,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0227,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,1425038.8478079366,1116749.8411174833,0.7836627351144299,-0.3516951995589879,0.10676733835890734,0.5462476753068062,Downregulated
Feature0226,NA,C16 H32 N2 O10,412.20583,NA,NA,Feature0226,16,32,10,2,0,0,2,0.625,-0.375,70.9875,2,-8,-2.5,-0.5555555555555556,-10,Amino Sugar,3378726.06294731,4459140.265623024,1.3197696950113953,0.4002861956037358,0.2648654001932433,0.6292487790932914,Upregulated
Feature0225,NA,C20 H29 N3 O4,375.2159,NA,NA,Feature0225,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Lignin,421066.082362197,452985.31034680165,1.0758057448026603,0.105417598052147,0.8666531459263647,0.939303571324255,Upregulated
Feature0224,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak1",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,558968.8711811337,360961.4274814113,0.6457630220421379,-0.6309232637896283,0.10230196196290722,0.5434560019812327,Downregulated
Feature0223,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0223,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,2701551.4874207634,1280103.4534741354,0.4738401098164082,-1.0775277692851335,0.1048788648243692,0.5434560019812327,Downregulated
Feature0222,NA,C9 H21 N O7,255.13179,NA,NA,Feature0222,9,21,7,1,0,0,2.3333333333333335,0.7777777777777778,-0.44444444444444464,72.96666666666667,0,-7,-8,-1,-8,Carbohydrate,173798.40497937566,183278.78569328965,1.0545481456808479,0.07662496326757254,0.1987112012890791,0.5754132905704273,Upregulated
Feature0221,NA,C18 H32 N4 O7,416.22724,NA,NA,Feature0221,18,32,7,4,0,0,1.7777777777777777,0.3888888888888889,-0.33333333333333304,69.79999999999998,5,-2,-0.8571428571428571,-0.23809523809523808,-6,Protein,1212245.374229296,868170.688790499,0.7161674585415119,-0.4816311284034207,0.3268457005080544,0.6622174503652659,Downregulated
Feature0220,Succinyl proline,C9 H13 N O5,215.07938,Other,NA,Succinyl proline-peak1,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,484722.22999760567,381469.570970166,0.7869859217557452,-0.34559026702605694,0.1523107359688375,0.5574792106914738,Downregulated
Feature0219,NA,C17 H31 N O9,393.19997,NA,NA,Feature0219,17,31,9,1,0,0,1.8235294117647056,0.5294117647058824,-0.5882352941176467,77.06470588235292,3,-6,-1,-0.21739130434782608,-7,Protein,3070411.37584513,1846545.5486574061,0.6014000479493223,-0.7336031119500943,0.6301496688359596,0.8074733573579681,Downregulated
Feature0218,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.2629,NA,NA,Leucyl-leucyl-norleucine-peak1,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,2591676.6915163733,1160498.9572140267,0.44777921606225746,-1.1591405286883294,0.24970798279523448,0.6202424088784857,Downregulated
Feature0217,NA,C10 H23 N O6,253.15257,NA,NA,Feature0217,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,159375.10738866,944582.9511899011,5.926790994320052,2.567251182395924,0.335709994458866,0.6636048496469049,Upregulated
Feature0216,NP-008521,C14 H18 N2 O2,246.13679,NA,NA,NP-008521,14,18,2,2,0,0,1.2857142857142858,0.14285714285714285,-0.5714285714285712,76.58571428571427,7,5,0.3,0.3636363636363637,3,Lignin,5727667.7433193205,5366217.069261434,0.9368939173401812,-0.09404239128401679,0.49700717324332305,0.7334162931788414,Downregulated
Feature0215,Tryptophyl-tyrosine,C20 H21 N3 O4,367.15331,NA,NA,Tryptophyl-tyrosine,20,21,4,3,0,0,1.05,0.2,-0.20000000000000015,66,12,8,0.38461538461538464,0.4666666666666667,5,Lignin,2460318.929410007,2010642.79184447,0.8172285177379948,-0.2911885461254141,0.44879798120231784,0.7027877448360436,Downregulated
Feature0214,Arachidonoyl Serinol,C23 H39 N O3,377.29295,NA,NA,Arachidonoyl Serinol,23,39,3,1,0,0,1.6956521739130437,0.13043478260869565,-1.304347826086956,97.47391304347823,5,2,0.05263157894736842,0.12195121951219512,1,Lipid,230825.98216783535,218115.085891825,0.9449329916994866,-0.08171606816788664,0.7037880106411987,0.8514861389326834,Downregulated
Feature0213,NA,C8 H9 N5 O3,223.07054,NA,NA,Feature0213,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,3980670.2287193267,3578865.4831258,0.8990610318095109,-0.15350903999274565,0.31313118716779675,0.6547061206079187,Downregulated
Feature0212,Amino-levulinic acid,C5 H9 N O3,131.05828,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,Amino-levulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,2034718.66921135,2595102.936346587,1.2754111787613567,0.35096243134148564,0.11371316803202208,0.5462476753068062,Upregulated
Feature0211,N-Acetyl-L-tyrosine,C11 H13 N O4,223.08448,NA,NA,N-Acetyl-L-tyrosine,11,13,4,1,0,0,1.181818181818182,0.3636363636363637,-0.18181818181818168,65.48181818181817,6,2,0.16666666666666666,0.375,1,Lignin,845487.1082964446,840262.509563182,0.9938206050902544,-0.008942640991532767,0.84263807316124,0.9263003867197537,Downregulated
Feature0210,NA,C16 H21 N5 O9,427.13399,NA,NA,Feature0210,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,1106877.7476036197,1323266.7874086,1.1954949769958432,0.2576080684197532,0.24686271898206244,0.6195339940083167,Upregulated
Feature0209,NA,C20 H33 N O11,463.2054,NA,NA,Feature0209,20,33,11,1,0,0,1.65,0.55,-0.4000000000000003,71.7,5,-6,-0.875,-0.1111111111111111,-7,Protein,82181.82498536333,1318781.2464746407,16.047115608706875,4.004242098092968,0.2755838809634979,0.6292487790932914,Upregulated
Feature0208,2-Keto-glutaramic acid,C5 H7 N O4,145.03751,Metabolic pathways;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Keto-glutaramic acid,5,7,4,1,0,0,1.4,0.8,0.7999999999999998,37.5,3,-1,-Inf,0,-2,Tannin,3679937.3270049365,4577747.978779714,1.2439744408651372,0.3149568436550695,0.521147468641001,0.7430834801967906,Upregulated
Feature0207,NA,C14 H28 N6 O4,344.21733,NA,NA,Feature0207,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,339326.08006208995,358232.883086667,1.0557186851689015,0.07822545441218796,0.8991043052272496,0.953701139936653,Upregulated
Feature0206,Diacetin,C7 H12 O5,176.0685,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,Diacetin,7,12,5,0,0,0,1.7142857142857142,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-3,-1.5,-0.1111111111111111,-3,Carbohydrate,3918577.6200391967,3870877.20478821,0.9878271097637439,-0.017669532543723877,0.7367765558134364,0.8734076175982933,Downregulated
Feature0205,Marimastat,C15 H29 N3 O5,331.21071,NA,NA,Marimastat-peak2,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2937911.750734263,1591311.2279237267,0.5416470482906831,-0.8845750358347844,0.02843685442861233,0.5434560019812327,Downregulated
Feature0204,melanostatin,C13 H24 N4 O3,284.18484,NA,NA,melanostatin,13,24,3,4,0,0,1.8461538461538465,0.2307692307692308,-0.4615384615384617,73.45384615384616,4,1,-0.5,-0.2,-3,Lipid,62927.951730707166,57186.62917834336,0.9087635558688908,-0.13802311526205316,0.5428185806466307,0.7605745869440796,Downregulated
Feature0203,NA,C17 H31 N5 O6,401.22757,NA,NA,Feature0203,17,31,6,5,0,0,1.8235294117647056,0.35294117647058826,-0.23529411764705888,67.00588235294117,5,-1,-1,-0.3333333333333333,-6,Protein,433221.03502278135,260084.54966018067,0.6003506954515814,-0.7361225961904122,0.17496597008981524,0.5646729954371317,Downregulated
Feature0202,NL8513000,C11 H13 N O2,191.09465,NA,Other,NL8513000-peak1,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,3795614.21090601,3161630.8034008234,0.8329694820712942,-0.2636644550839723,0.00909174475815697,0.5434560019812327,Downregulated
Feature0201,NA,C17 H32 N4 O5,372.2374,NA,NA,Feature0201,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,3944242.1675977698,1661169.6758361368,0.4211632058200594,-1.2475486915237517,0.05665744214146724,0.5434560019812327,Downregulated
Feature0200,(+/-)-Metanephrine,C10 H15 N O3,197.10522,Metabolic pathways;Tyrosine metabolism,NA,(+/-)-Metanephrine-peak1,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,4382751.70614744,4384472.163157273,1.000392551785998,5.662213866127121e-4,0.9953527820406288,0.9982993562917853,Upregulated
Feature0199,N-Acetyl-L-leucine,C8 H15 N O3,173.10521,Other,NA,N-Acetyl-L-leucine-peak1,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,758764.5859590584,894782.3790033724,1.179262179022748,0.2378845006131019,0.4673753913079436,0.7150766004537328,Upregulated
Feature0198,NA,C15 H20 N2 O3,276.14743,NA,NA,Feature0198,15,20,3,2,0,0,1.3333333333333333,0.2,-0.5333333333333332,75.5,7,4,0.2,0.30434782608695654,2,Lignin,5444020.687441364,5098483.339924653,0.9365290164466458,-0.09460440075521813,0.48834557093554776,0.7305091897794865,Downregulated
Feature0197,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0197,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1972894.6109824302,1118545.3934827808,0.5669564847793799,-0.8186900856495836,0.22652375441473557,0.5958985050006134,Downregulated
Feature0196,Crotetamide,C12 H22 N2 O2,226.16812,Microbial metabolism in diverse environments;Other,NA,Crotetamide,12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,5679599.63164303,5344134.35300541,0.9409350481733562,-0.08783295632497114,0.6154335455179902,0.7994972592848738,Downregulated
Feature0195,NA,C14 H25 N3 O7,347.1693,NA,NA,Feature0195,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,901690.1189482274,419491.97636912734,0.4652285386674105,-1.1039884956448276,0.17826168735172176,0.5646729954371317,Downregulated
Feature0194,Methionylphenylalanine,C14 H20 N2 O3 S,296.11939,NA,NA,Methionylphenylalanine-peak2,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,3647992.85093898,2382388.1770666665,0.6530682143342054,-0.6146944027453617,0.0838871219849896,0.5434560019812327,Downregulated
Feature0193,NA,C18 H26 N4 O5,378.19035,NA,NA,Feature0193,18,26,5,4,0,0,1.4444444444444444,0.2777777777777778,-0.22222222222222232,66.63333333333333,8,3,-0.1111111111111111,0.13043478260869565,-1,Lignin,4914258.199445473,2610066.7577279266,0.531121209305292,-0.9128869530510321,0.249261352483942,0.6202424088784857,Downregulated
Feature0192,glu-tyr,C14 H18 N2 O6,310.11656,NA,NA,glu-tyr,14,18,6,2,0,0,1.2857142857142858,0.42857142857142855,0,60.3,7,1,-0.16666666666666666,0.2222222222222222,-1,Lignin,3432860.7219561534,2414996.7070922665,0.70349393776632,-0.5073901035394849,0.17678046209544537,0.5646729954371317,Downregulated
Feature0191,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03171,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak2",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,3928961.125404523,4020963.6834928566,1.0234165101541597,0.03339341276721686,0.9078225466173262,0.9558723314246157,Upregulated
Feature0190,DLK,C16 H30 N4 O6,374.21636,NA,NA,DLK,16,30,6,4,0,0,1.875,0.375,-0.375,70.9875,4,-2,-1,-0.3333333333333333,-6,Protein,2793217.9901956734,3961907.0151272435,1.4184023692507077,0.5042668511796058,0.08599391645511324,0.5434560019812327,Upregulated
Feature0189,NP-007065,C8 H10 O3,154.06303,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak1,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,568144.9435737713,522762.36625027866,0.9201214798497984,-0.12010374805788351,0.7336513813946195,0.8727566292714084,Downregulated
Feature0188,NA,C16 H29 N3 O6,359.20576,NA,NA,Feature0188,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,1449786.0728515103,675921.6827878293,0.46622166914487834,-1.1009120349908428,0.23819925008441006,0.6086116585867128,Downregulated
Feature0187,NA,C12 H22 N2 O3,242.16305,NA,NA,Feature0187,12,22,3,2,0,0,1.8333333333333333,0.25,-0.833333333333333,84.04999999999998,3,0,-0.2857142857142857,-0.0588235294117647,-2,Lipid,65880.21201140377,57319.597305594,0.8700578755829149,-0.2008167237658513,0.3491237675255317,0.6670930191369346,Downregulated
Feature0186,NA,C9 H9 O P S,196.01126,NA,NA,Feature0186,9,9,1,0,1,1,1,0.1111111111111111,-1.1111111111111107,91.96666666666664,6,5,0.5,0.5384615384615384,3,Unsaturated HC,130858.55000575967,121343.22030783287,0.9272853803017993,-0.10891468550264863,0.6926811343764372,0.8459998858209694,Downregulated
Feature0185,DH2090000,C9 H10 O5,198.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak1,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,76698.54401728109,78199.93910765994,1.0195752749887999,0.027968293102457204,0.9550101817025214,0.9763350922173032,Upregulated
Feature0184,NA,C8 H11 N O7,233.05354,NA,NA,Feature0184,8,11,7,1,0,0,1.375,0.875,0.75,38.925,4,-3,-Inf,-0.14285714285714285,-4,Tannin,636232.117325752,540262.6951994083,0.8491597335108954,-0.23589213349036037,0.3784768530614748,0.6777698672492496,Downregulated
Feature0183,NA,C23 H32,308.25044,NA,NA,Feature0183,23,32,0,0,0,0,1.391304347826087,0,-1.391304347826087,99.95217391304348,8,8,0.34782608695652173,0.34782608695652173,8,Unsaturated HC,297797.22608992935,332508.841398625,1.1165612445906845,0.1590623867125331,0.6507679070076432,0.8233015940783776,Upregulated
Feature0182,NA,C15 H27 N3 O5,329.19521,NA,NA,Feature0182,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,2262202.6111616464,1703932.3463084467,0.7532182740402167,-0.4088600928808074,0.09789887275719047,0.5434560019812327,Downregulated
Feature0181,NA,C13 H26 N2 O6,306.17912,NA,NA,Feature0181,13,26,6,2,0,0,2,0.4615384615384616,-0.615384615384615,77.83846153846153,2,-4,-1.2,-0.375,-6,Protein,4979095.854791037,3523089.63982818,0.7075761830208905,-0.49904260708501186,0.32792629355182473,0.6628963499723044,Downregulated
Feature0180,(+)-castanospermine,C8 H15 N O4,189.10012,NA,NA,(+)-castanospermine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,202209.3384545904,445624.05040285405,2.203775818706447,1.1399774717809903,0.300694332404982,0.6452426827392128,Upregulated
Feature0179,NA,C20 H29 N3 O6,407.20564,NA,NA,Feature0179,20,29,6,3,0,0,1.45,0.3,-0.4000000000000003,71.7,8,2,-0.09090909090909093,0.14285714285714285,-1,Lignin,235252.31167174628,116171.48997414764,0.4938165714445551,-1.0179528437859058,0.4292807675188905,0.6978902304961617,Downregulated
Feature0178,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",C13 H18 N2 O3,250.13174,NA,NA,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,442271.69600060635,296489.5769181033,0.6703788182676217,-0.5769515294763392,0.33262968160583967,0.6632819814140921,Downregulated
Feature0177,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0177,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,593362.1152333013,386250.3167804617,0.6509521030485638,-0.6193767008612094,0.4537855368734916,0.7058886129143203,Downregulated
Feature0176,NA,C16 H32 N6 O4,372.24864,NA,NA,Feature0176,16,32,4,6,0,0,2,0.25,-0.375,70.9875,4,0,-1,-0.5,-6,Lipid,2600138.9732532767,2444137.6061238735,0.9400026811127655,-0.08926322317945476,0.5828003376538877,0.7788265320293485,Downregulated
Feature0175,Etilevodopa,C11 H15 N O4,225.10013,NA,NA,Etilevodopa-peak1,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Lignin,4706287.318227286,4781606.874259067,1.0160040284281138,0.02290612236769741,0.6028697470535331,0.7929047760160599,Upregulated
Feature0174,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10555,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak1",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,1817473.5058458168,1315817.4890477534,0.7239816618044165,-0.4659749400635367,0.04972060076821881,0.5434560019812327,Downregulated
Feature0173,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",C12 H11 N O3,217.07394,Metabolic pathways;Other,NA,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",12,11,3,1,0,0,0.9166666666666666,0.25,-0.16666666666666696,65.05000000000001,8,5,0.5,0.5789473684210527,4,Lignin,358267.57498608466,388728.24541528535,1.0850221246798117,0.11772446095584833,0.3876126150149458,0.6811366907005375,Upregulated
Feature0172,N-(2-Acetylphenyl)formamide,C9 H9 N O2,163.06336,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N-(2-Acetylphenyl)formamide,9,9,2,1,0,0,1,0.2222222222222222,-0.22222222222222232,66.63333333333333,6,4,0.5,0.5714285714285714,3,Lignin,2782480.335975817,2906811.3741074703,1.0446835280465874,0.06306596463453308,0.5026542599649556,0.7334162931788414,Upregulated
Feature0171,"(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanamide",C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,"(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanamide",6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,2824152.192014763,3529547.41182165,1.249772381885572,0.32166536414580443,0.07034406329235754,0.5434560019812327,Upregulated
Feature0170,NA,C17 H32 N4 O5,372.23738,NA,NA,Feature0170,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,1716469.3738627967,717227.4732152013,0.4178504342324093,-1.2589414597688438,0.05923655498815687,0.5434560019812327,Downregulated
Feature0169,Ser-met,C8 H16 N2 O4 S,236.08315,Microbial metabolism in diverse environments;Other,NA,Ser-met,8,16,4,2,1,0,2,0.5,0,60.3,2,-2,-5,-1,-5,Protein,3923018.8958760034,3650436.74948155,0.9305172486726995,-0.1038952016218225,0.654375000951046,0.8254120377093072,Downregulated
Feature0168,DL-TYROSINE,C9 H11 N O3,181.07393,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,DL-TYROSINE,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,1672265.38022983,2325688.553267827,1.3907413146041405,0.4758540957646972,0.23978132829076668,0.6117312803080704,Upregulated
Feature0167,NA,C9 H19 N O8,269.11107,NA,NA,Feature0167,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,5187273.7340908265,4403925.477365303,0.8489865203030738,-0.23618644717064097,0.2425353403346267,0.6150521953994875,Downregulated
Feature0166,LLK,C18 H36 N4 O4,372.27367,NA,NA,LLK,18,36,4,4,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,-1,-0.5,-0.25,-5,Lipid,5529951.12930378,4014182.4979766863,0.7258983676555694,-0.46216052289664267,0.11452207191248942,0.5462476753068062,Downregulated
Feature0165,NA,C14 H25 N3 O6,331.17443,NA,NA,Feature0165,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,2512361.2838169867,1584787.978937,0.6307962111759895,-0.664754100158474,0.023448473061194457,0.5434560019812327,Downregulated
Feature0164,Paracetamol,C8 H9 N O2,151.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak1,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,3288520.759172627,3507094.80431853,1.0664657641391613,0.0928376527863722,0.6135303448322018,0.7991290476183568,Upregulated
Feature0163,Leucylasparagine,C10 H19 N3 O4,245.13751,NA,NA,Leucylasparagine-peak1,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,1977315.1527995968,2763367.4216813967,1.3975351464681094,0.48288456571436555,0.18703916460773207,0.5646729954371317,Upregulated
Feature0162,2-Pentadecylfuran,C19 H34 O,278.26093,NA,NA,2-Pentadecylfuran,19,34,1,0,0,0,1.7894736842105263,0.05263157894736842,-1.6842105263157894,108.3,3,2,0.1111111111111111,0.13513513513513514,2,Lipid,348399.22009931935,467460.17489445297,1.3417371449947348,0.42410206590774346,0.09861754204422304,0.5434560019812327,Upregulated
Feature0161,Maclurin,C13 H10 O6,262.04778,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Maclurin,13,10,6,0,0,0,0.7692307692307693,0.4615384615384616,0.15384615384615374,55.91538461538462,9,3,0.42857142857142855,0.6,3,Condensed HC,123471.105549567,107521.93965538523,0.8708267345368585,-0.19954239568497886,0.4529423714654816,0.7052246114545274,Downregulated
Feature0160,NA,C17 H32 N4 O6,388.23229,NA,NA,Feature0160,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,3178376.597519599,784213.0261833763,0.24673382845675845,-2.0189725648958374,0.41442936896345595,0.6907296039196943,Downregulated
Feature0159,2-Aminooctanedioic acid,C8 H15 N O4,189.10016,NA,NA,2-Aminooctanedioic acid-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,403795.41852699436,294260.47788399004,0.7287365442565522,-0.45653075494618534,0.4108656030215056,0.6883976477985067,Downregulated
Feature0158,DL-Metanephrine,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,DL-Metanephrine,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,161344.01597013065,221385.70393086364,1.3721345821207798,0.45642199130376676,0.4263736570445888,0.6954800040321182,Upregulated
Feature0157,NP-019811,C6 H7 N O2,125.04763,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak1,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,1219634.1952687635,1024034.5523670684,0.8396243368212614,-0.2521841106030635,0.3128035994065814,0.6547061206079187,Downregulated
Feature0156,nitrilotriacetic acid,C6 H9 N O6,191.04305,NA,NA,nitrilotriacetic acid,6,9,6,1,0,0,1.5,1,1,31.799999999999997,3,-3,4,-0.5,-4,Carbohydrate,5387449.37714934,4438710.973284343,0.8238984095351255,-0.27946163744915525,0.05222000383378171,0.5434560019812327,Downregulated
Feature0155,NA,C9 H20 N2 O3,204.14739,NA,NA,Feature0155,9,20,3,2,0,0,2.2222222222222223,0.3333333333333333,-0.8888888888888893,85.63333333333334,1,-2,-1,-0.4545454545454546,-4,Protein,1408287.9239055493,697747.8971126854,0.49545826905740176,-1.0131645461724907,0.1313444790396499,0.5545833428603265,Downregulated
Feature0154,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,C9 H12 O6 S,248.0355,NA,NA,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,9,12,6,0,1,0,1.3333333333333333,0.6666666666666666,0.22222222222222232,53.96666666666666,4,-2,-1.5,0,-3,Tannin,90310.8469999522,103318.86240622037,1.1440360248894028,0.19413248228324811,0.07078409967023609,0.5434560019812327,Upregulated
Feature0153,2H-Pyran,C5 H6 O,82.04189,NA,NA,2H-Pyran,5,6,1,0,0,0,1.2,0.2,-0.7999999999999998,83.1,3,2,0.5,0.5555555555555556,2,Lignin,312528.028343209,291657.791830626,0.9332212325940127,-0.0997089630800228,0.7771958489814051,0.898069418945771,Downregulated
Feature0152,Pivagabine,C9 H17 N O3,187.12087,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak1,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,3937168.0372481034,4342790.17915922,1.1030238328853823,0.141463963380871,0.06107618910263012,0.5434560019812327,Upregulated
Feature0151,NA,C16 H32 N4 O4,344.24234,NA,NA,Feature0151,16,32,4,4,0,0,2,0.25,-0.75,81.675,3,-1,-0.625,-0.3,-5,Lipid,3970924.43286137,4012585.43724481,1.0104915127668195,0.015057204408750005,0.9038718732579016,0.953701139936653,Upregulated
Feature0150,VLH,C17 H29 N5 O4,367.22207,NA,NA,VLH,17,29,4,5,0,0,1.7058823529411764,0.2352941176470588,-0.35294117647058787,70.35882352941175,6,2,-0.375,-0.1,-3,Lipid,3348748.8920810833,3422477.081320043,1.0220166371426975,0.0314186817235768,0.9379137159249293,0.9692805595037932,Upregulated
Feature0149,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17443,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak2,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,4640720.27989159,2325863.7568273935,0.5011859402311848,-0.9965821515828482,0.2699957346158063,0.6292487790932914,Downregulated
Feature0148,NA,C13 H21 N O8,319.12681,NA,NA,Feature0148,13,21,8,1,0,0,1.6153846153846154,0.6153846153846154,-0.1538461538461542,64.6846153846154,4,-4,-1.25,-0.125,-5,Amino Sugar,152474.36597917392,95094.4566881913,0.6236750425391505,-0.6811335668107332,0.18860736016196902,0.5646729954371317,Downregulated
Feature0147,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0147,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,902148.1249822876,696436.355245826,0.7719756168195766,-0.3733728148150172,0.1847442547519812,0.5646729954371317,Downregulated
Feature0146,NA,C9 H13 N O4 S,231.05654,NA,NA,Feature0146,9,13,4,1,1,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Lignin,3891465.8726280434,3683726.9545214167,0.946616795596788,-0.07914757518882527,0.5995336742504219,0.7909735546574881,Downregulated
Feature0145,NA,C17 H25 N3 O5,351.17943,NA,NA,Feature0145,17,25,5,3,0,0,1.4705882352941178,0.29411764705882354,-0.35294117647058787,70.35882352941175,7,2,-0.1111111111111111,0.13043478260869565,-1,Lignin,4805096.48975017,3241670.2709968933,0.6746316703341448,-0.5678280481566825,0.35004562916704374,0.6670930191369346,Downregulated
Feature0144,Kynurenine,C10 H12 N2 O3,208.08476,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Kynurenine,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Lignin,4451459.19155845,4584253.165060953,1.0298315603463977,0.04240838893759839,0.8250836414873908,0.9172097938816823,Upregulated
Feature0143,6-methoxymellein,C11 H12 O4,208.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak1,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,96194.23198842129,81145.8710111106,0.8435627514639128,-0.24543270229809475,0.19968992183721532,0.5772606272905166,Downregulated
Feature0142,NA,C14 H26 N4 O5,330.19042,NA,NA,Feature0142,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,2860697.4529659,1430277.9692375034,0.4999752657362025,-1.0000713697647345,0.12055449378856545,0.5462476753068062,Downregulated
Feature0141,Isobutyric acid,C4 H8 O2,88.05244,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-lysine degradation;Other,Isobutyric acid,4,8,2,0,0,0,2,0.5,-1,88.8,1,-1,-0.5,0,-1,Protein,313375.1734955067,308584.18809967535,0.9847116625660199,-0.022226749894996813,0.9669943997332345,0.9820674539257189,Downregulated
Feature0140,6-Hydroxymelatonin,C13 H16 N2 O3,248.11607,Other,Other,6-Hydroxymelatonin-peak1,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,4169260.7890980234,3927433.92568122,0.94199766441832,-0.08620461205172904,0.40902193490008043,0.6875574805825382,Downregulated
Feature0139,NA,C15 H27 N3 O5,329.19515,NA,NA,Feature0139,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,2139197.2090868866,1658672.8905332065,0.7753716597457645,-0.3670400901199648,0.09988690658178262,0.5434560019812327,Downregulated
Feature0138,Metalaxyl,C15 H21 N O4,279.14696,NA,NA,Metalaxyl,15,21,4,1,0,0,1.4,0.26666666666666666,-0.666666666666667,79.30000000000001,6,2,0.1,0.25,1,Lignin,183607.46091432066,174813.20719892168,0.9521029610038408,-0.07081049898262996,0.8790349681897132,0.9442518935405035,Downregulated
Feature0137,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0137,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2137654.9139020666,978435.5424915297,0.45771444966554375,-1.127480257544011,0.15789545338446215,0.5574792106914738,Downregulated
Feature0136,NA,C9 H17 N3 O2,199.13218,NA,NA,Feature0136,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,4193490.5312592764,3844628.8822228136,0.916808766721669,-0.12530725536779921,0.4634517079504113,0.7137156302436334,Downregulated
Feature0135,Icacine,C22 H31 N O6,405.21514,NA,NA,Icacine-peak1,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,164192.82929265167,175643.039823501,1.0697363616923907,0.09725528583760702,0.7682885244044675,0.8944884950798405,Upregulated
Feature0134,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",C20 H34 O,290.261,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",20,34,1,0,0,0,1.7,0.05,-1.5999999999999996,105.89999999999998,4,3,0.15789473684210523,0.1794871794871795,3,Lipid,175636.41628214435,163702.85652673666,0.9320553219655913,-0.1015125065778397,0.6535489208800683,0.8254120377093072,Downregulated
Feature0133,lamifiban,C24 H28 N4 O6,468.20092,NA,NA,lamifiban-peak1,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,1363849.3721534,1439685.10276674,1.0556041833957088,0.07806897323824757,0.6007635057286703,0.7913634360065066,Upregulated
Feature0132,N-Acetyl-L-aspartic acid,C6 H9 N O5,175.04806,Metabolic pathways;Other,NA,N-Acetyl-L-aspartic acid,6,9,5,1,0,0,1.5,0.8333333333333334,0.6666666666666665,41.3,3,-2,-Inf,-0.2,-3,Carbohydrate,447063.783190885,522014.6034231427,1.1676512905995242,0.2236094895982051,0.42295797686897446,0.6949729358100158,Upregulated
Feature0131,NA,C20 H26 O7 S,410.14012,NA,NA,Feature0131,20,26,7,0,1,0,1.3,0.35,-0.5,74.55,8,1,0,0.2258064516129032,0,Lignin,3236429.978297067,1646987.21795103,0.5088901131788539,-0.974573932274148,0.14314508892261055,0.5574792106914738,Downregulated
Feature0130,Nipecotic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Nipecotic acid,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,3573629.16195439,3438216.252189053,0.9621077331674559,-0.05572964433893625,0.6634129752886198,0.8289195086767364,Downregulated
Feature0129,Cyclo(leucylleucine),C12 H22 N2 O2,226.16814,Microbial metabolism in diverse environments;Other,NA,Cyclo(leucylleucine),12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,5630131.40496994,4900292.70088418,0.8703691527623134,-0.20030066875115138,0.33004411178450527,0.6632819814140921,Downregulated
Feature0128,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak1,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,356808.70917271497,441199.9941771613,1.2365168865976204,0.306281942149437,0.4043846290245009,0.6875574805825382,Upregulated
Feature0127,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10002,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak2",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,261916.58532751,276213.9539232497,1.0545874885237287,0.07667878600272982,0.8667586715324969,0.939303571324255,Upregulated
Feature0126,Trigonelline,C7 H7 N O2,137.04768,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak1,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,2770399.6780681834,1759505.0818750327,0.6351087519263453,-0.6549244440558806,0.3587595631892165,0.6692796802688192,Downregulated
Feature0125,Methyl picolinate,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Methyl picolinate,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,381338.71652141865,249002.90203857303,0.6529704203915714,-0.6149104558276816,0.3574980529968325,0.6692796802688192,Downregulated
Feature0124,Pyrazinoic acid,C5 H4 N2 O2,124.02723,NA,NA,Pyrazinoic acid,5,4,2,2,0,0,0.8,0.4,1.2000000000000002,26.09999999999999,5,3,1,1,1,Condensed HC,57135.45048496907,56663.768356104265,0.9917444926947956,-0.011959613995473363,0.9266958985624998,0.9660448321014614,Downregulated
Feature0123,NA,C13 H23 N3 O6,317.15875,NA,NA,Feature0123,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,2613288.6938536,3256762.729388287,1.2462315155030994,0.3175721062766057,0.23462992911691502,0.6058888718354483,Upregulated
Feature0122,NA,C13 H24 N4 O5,316.17479,NA,NA,Feature0122,13,24,5,4,0,0,1.8461538461538465,0.38461538461538464,-0.1538461538461542,64.6846153846154,4,-1,-1.25,-0.38461538461538464,-5,Protein,2496132.676174897,1369939.22928249,0.548824684824767,-0.8655827229368084,0.06557610870360407,0.5434560019812327,Downregulated
Feature0121,delta-guanidinovaleric acid,C6 H13 N3 O2,159.10079,NA,NA,delta-guanidinovaleric acid-peak1,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,4715108.965204056,3793531.0741342935,0.8045479122814122,-0.3137497562847488,0.09523843445949906,0.5434560019812327,Downregulated
Feature0120,NA,C14 H28 N6 O4,344.2173,NA,NA,Feature0120,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,4325091.93031362,2343749.5952523295,0.5418959025646376,-0.8839123563665322,0.2083749566951414,0.5821476316614936,Downregulated
Feature0119,NA,C27 H39 N5 O6,529.28996,NA,NA,Feature0119,27,39,6,5,0,0,1.4444444444444444,0.2222222222222222,-0.44444444444444464,72.96666666666667,11,5,0,0.15789473684210523,0,Lignin,94616.49110980106,84637.4005382536,0.8945311704704112,-0.1607963401679417,0.5888282023607818,0.7841136051951803,Downregulated
Feature0118,L-Glutaminyl-L-Leucine,C11 H21 N3 O4,259.15319,NA,NA,L-Glutaminyl-L-Leucine,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,2363852.1547026564,1580654.11466357,0.668677231576861,-0.5806181004194151,0.027121150414541634,0.5434560019812327,Downregulated
Feature0117,NA,C9 H19 N O8,269.11113,NA,NA,Feature0117,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,692366.736587189,2556082.5086205066,3.691804319225295,1.8843260862543088,0.05072314359345164,0.5434560019812327,Upregulated
Feature0116,Val-pro,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Val-pro,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,775688.0862259603,386831.6169657697,0.4986948025047847,-1.0037709278571583,0.046479286544757296,0.5434560019812327,Downregulated
Feature0115,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0115,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,719400.028483517,529331.0093508497,0.7357950908991071,-0.4426240439626388,0.018650721688734127,0.5434560019812327,Downregulated
Feature0114,Pyridoxal,C8 H9 N O3,167.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak1,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,332897.5509768223,240197.74844622234,0.7215365440250592,-0.47085562941747444,0.18430228698422157,0.5646729954371317,Downregulated
Feature0113,Fasoracetam,C10 H16 N2 O2,196.12116,NA,NA,Fasoracetam,10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,2336548.2206038367,2452422.1843265635,1.0495919419513549,0.06982854908593132,0.6055217335005119,0.7953846552938431,Upregulated
Feature0112,NA,C22 H42 N4 O5,442.31572,NA,NA,Feature0112,22,42,5,4,0,0,1.9090909090909092,0.2272727272727273,-0.9090909090909092,86.2090909090909,4,-1,-0.38461538461538464,-0.16129032258064516,-5,Lipid,2267751.69871611,1188278.7063991,0.5239897767784035,-0.9323894303287916,0.31958282593214654,0.6620868237165941,Downregulated
Feature0111,DL-Ornithine,C5 H12 N2 O2,132.08986,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Other,DL-Ornithine,5,12,2,2,0,0,2.4,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Other,112664.29165886364,152426.88434684934,1.3529298600516915,0.4360870476081982,0.38681032176606617,0.6807033163836934,Upregulated
Feature0110,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,C14 H25 N3 O6 S,363.1465,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,14,25,6,3,1,0,1.7857142857142858,0.42857142857142855,-0.14285714285714324,64.37142857142858,4,-2,-1.5,-0.42857142857142855,-6,Protein,3911478.2239245865,3066254.3149887766,0.7839118971017168,-0.3512365741652407,0.09776761408308507,0.5434560019812327,Downregulated
Feature0109,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10628,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak1,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,1439078.64889404,1382065.6373016466,0.9603822823469663,-0.05831930669382429,0.5852638814802198,0.7806590671082616,Downregulated
Feature0108,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione-peak1",9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,3500882.32913924,3354063.5171732935,0.9580623402437966,-0.06180856101941511,0.5454856024388237,0.7611636001082103,Downregulated
Feature0107,NA,C14 H27 N3 O5,317.19514,NA,NA,Feature0107,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,1933204.14684277,1324779.4553495666,0.6852765433558283,-0.5452417897112811,0.09200149869360467,0.5434560019812327,Downregulated
Feature0106,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14221,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak1",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,217508.653840649,185778.59222572765,0.8541204634636405,-0.22748853583154632,0.670987502800402,0.8312524847517372,Downregulated
Feature0105,NA,C14 H27 N3 O4,301.20018,NA,NA,Feature0105,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2966119.015842857,1866150.0954884565,0.6291555010169302,-0.6685114596271894,0.18219664821289924,0.5646729954371317,Downregulated
Feature0104,NA,C14 H27 N O10,369.16362,NA,NA,Feature0104,14,27,10,1,0,0,1.9285714285714288,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-8,-3,-0.5,-9,Carbohydrate,2017767.20773517,3584301.69089841,1.7763702755986341,0.8289323356806506,0.43644090553357967,0.7009176491269988,Upregulated
Feature0103,NA,C15 H28 N4 O5,344.20609,NA,NA,Feature0103,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,4861199.6454031635,2539095.9555505365,0.5223187979846807,-0.9369974683909416,0.005267618258357281,0.5434560019812327,Downregulated
Feature0102,NP-006105,C15 H16 O5,276.09975,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,NP-006105,15,16,5,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,8,3,0.3,0.44,3,Lignin,214121.41019920734,165638.56143182464,0.7735730923765316,-0.3703904812645319,0.7173378088999176,0.8612120824071299,Downregulated
Feature0101,"N,N-diacetyllegionaminic acid",C13 H22 N2 O8,334.13758,Metabolic pathways;Other,NA,"N,N-diacetyllegionaminic acid",13,22,8,2,0,0,1.6923076923076923,0.6153846153846154,0,60.3,4,-4,-2,-0.2857142857142857,-6,Amino Sugar,724828.5513283627,913262.913262072,1.2599709429055652,0.33339046308279524,0.3326076419728468,0.6632819814140921,Upregulated
Feature0100,NA,C16 H31 N3 O9,409.20616,NA,NA,Feature0100,16,31,9,3,0,0,1.9375,0.5625,-0.25,67.425,3,-6,-2.25,-0.5294117647058824,-9,Amino Sugar,243268.02530384334,347158.0860355293,1.427060073357058,0.5130460676168427,0.4062189818438759,0.6875574805825382,Upregulated
Feature0099,NA,C14 H27 N3 O4,301.20024,NA,NA,Feature0099,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,3454858.1136467867,2701195.7192428834,0.7818543136614162,-0.3550282859978974,0.08035022520148702,0.5434560019812327,Downregulated
Feature0098,NA,C20 H30 N6 O8,482.21265,NA,NA,Feature0098,20,30,8,6,0,0,1.5,0.4,0.20000000000000015,54.599999999999994,9,1,-0.8333333333333334,-0.1,-5,Protein,80395.1872175175,101727.31106809927,1.2653408069424046,0.3395260127971676,0.6996141407433721,0.8502112898335427,Upregulated
Feature0097,imazamox,C15 H19 N3 O4,305.13767,NA,NA,imazamox,15,19,4,3,0,0,1.2666666666666666,0.26666666666666666,-0.13333333333333375,64.10000000000001,8,4,0.125,0.3,1,Lignin,1125641.156718014,1559621.5666407966,1.3855406381800408,0.47044902596982757,0.15727722005524652,0.5574792106914738,Upregulated
Feature0096,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one-peak1,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,199884.38270026434,141221.19477051537,0.7065144002885054,-0.5012091287894488,0.46010280396981,0.7109067016940792,Downregulated
Feature0095,Proglumide,C18 H26 N2 O4,334.18921,NA,NA,Proglumide,18,26,4,2,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,7,3,0.08333333333333333,0.21428571428571427,1,Lignin,180906.28595580466,129891.82477798963,0.7180061438535207,-0.4779319058960224,0.4681999276982966,0.7150766004537328,Downregulated
Feature0094,3477,C12 H20 N2 O3,240.14735,NA,NA,3477,12,20,3,2,0,0,1.6666666666666667,0.25,-0.666666666666667,79.30000000000001,4,1,-0.14285714285714285,0.0588235294117647,-1,Lipid,3405140.627535,1729519.8707730367,0.5079143741634675,-0.9773427915550007,0.03294708557690269,0.5434560019812327,Downregulated
Feature0093,NA,C14 H27 N3 O5,317.19523,NA,NA,Feature0093,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,2643820.450582057,1563218.69960555,0.5912726407957831,-0.7581045722265927,0.14592174126173238,0.5574792106914738,Downregulated
Feature0092,NA,C14 H25 N3 O5,315.17946,NA,NA,Feature0092,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,2453660.2733540265,1586813.1393475067,0.6467126507201485,-0.6288032628335498,0.040805894094053864,0.5434560019812327,Downregulated
Feature0091,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,C25 H30 N4 O7,498.21169,NA,NA,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,25,30,7,4,0,0,1.2,0.28,-0.16000000000000014,64.86,13,6,0.14285714285714285,0.3142857142857143,2,Lignin,103158.63051051783,100697.08197483984,0.976138220103387,-0.03484264859616722,0.891078327565086,0.9518459397077395,Downregulated
Feature0090,NA,C19 H34 N4 O8,446.2376,NA,NA,Feature0090,19,34,8,4,0,0,1.7894736842105263,0.42105263157894735,-0.3157894736842106,69.3,5,-3,-1,-0.2727272727272727,-7,Protein,240221.92914735607,144342.99593542202,0.600873519115233,-0.7348667521185199,0.5154981960216891,0.7419319830592535,Downregulated
Feature0089,HC blue 2,C12 H19 N3 O5,285.13253,NA,NA,HC blue 2-peak1,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,84176.59013995511,228713.2597448473,2.717064915133533,1.4420490343204544,0.09959232080795008,0.5434560019812327,Upregulated
Feature0088,NA,C10 H15 N O5,229.09499,NA,NA,Feature0088,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,465029.5178915927,297440.2722636013,0.6396158970986877,-0.6447222986888355,0.13928170694331388,0.5574792106914738,Downregulated
Feature0087,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0087,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1994998.4297828334,923465.9231861687,0.4628905513909066,-1.1112569805198296,0.19831859350874434,0.5752597558284468,Downregulated
Feature0086,NA,C15 H27 N3 O7,361.18494,NA,NA,Feature0086,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,366952.05720196967,469433.0630567457,1.2792762810384537,0.3553278719130369,0.4752197751484317,0.7200557237043321,Upregulated
Feature0085,NA,C19 H29 N3 O6,395.20574,NA,NA,Feature0085,19,29,6,3,0,0,1.5263157894736843,0.3157894736842105,-0.4210526315789478,72.30000000000001,7,1,-0.2,0.07692307692307693,-2,Protein,172340.41142800936,98532.70906214124,0.5717330499892689,-0.8065864047950707,0.25682313367161685,0.628842322173499,Downregulated
Feature0084,(+)-sesamin monocatechol,C19 H18 O6,342.11027,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak1,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,3246532.494112977,3599212.9128044867,1.1086329551085765,0.14878179877853334,0.3549986835656423,0.6692796802688192,Upregulated
Feature0083,S-methyl D-thioglycerate,C4 H8 O3 S,136.0194,NA,NA,S-methyl D-thioglycerate,4,8,3,0,1,0,2,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,2857497.8556775767,2733364.6925097033,0.9565587904392535,-0.06407445504710066,0.642539609681565,0.8159386047980293,Downregulated
Feature0082,NA,C15 H25 N3 O6,343.17444,NA,NA,Feature0082,15,25,6,3,0,0,1.6666666666666667,0.4,-0.2666666666666666,67.89999999999999,5,-1,-0.6666666666666666,-0.1111111111111111,-4,Protein,2132609.0273096864,2920589.7869403968,1.3694914302340537,0.45364023822473293,0.26564862130087735,0.6292487790932914,Upregulated
Feature0081,Deferiprone,C7 H9 N O2,139.06334,NA,NA,Deferiprone,7,9,2,1,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,4,2,0.25,0.4,1,Lignin,3346216.744354957,3327464.20542967,0.9943958983060729,-0.00810774932730648,0.9741266852197397,0.9875347724489761,Downregulated
Feature0080,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak1,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,3466386.569668567,3522914.99915038,1.0163075953433602,0.023337113837055282,0.8256073173725824,0.9172097938816823,Upregulated
Feature0079,NA,C15 H21 N3 O7,355.13805,NA,NA,Feature0079,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,297056.107180166,1365805.764220511,4.5978040215552385,2.2009449734166764,0.05375079368192664,0.5434560019812327,Upregulated
Feature0078,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0078,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,705742.525654474,322114.72320942,0.45641960275910143,-1.1315673396410948,0.00702005996662191,0.5434560019812327,Downregulated
Feature0077,Tiglic acid,C5 H8 O2,100.0524,NA,NA,Tiglic acid-peak1,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,499209.7953716317,738011.0767631833,1.4783585650874067,0.5639962270853394,0.04098108973523673,0.5434560019812327,Upregulated
Feature0076,Anhydroecgonine,C9 H13 N O2,167.09465,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak1,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,79039.81035053893,257853.4088074602,3.262323222486098,1.7058997275974892,0.2221429930085902,0.5926145356796091,Upregulated
Feature0075,NA,C17 H30 N4 O8,418.20647,NA,NA,Feature0075,17,30,8,4,0,0,1.7647058823529411,0.4705882352941176,-0.117647058823529,63.65294117647058,5,-3,-1.4,-0.3333333333333333,-7,Protein,1072378.3569378387,1053307.3643803033,0.9822161717138788,-0.025887518883004633,0.8566863031752854,0.9356715651701699,Downregulated
Feature0074,NA,C16 H30 N4 O5,358.22175,NA,NA,Feature0074,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1703031.5141949968,924940.773528593,0.543114302829447,-0.8806722379787624,0.1162514227018135,0.5462476753068062,Downregulated
Feature0073,NA,C18 H27 N3 O5,365.19518,NA,NA,Feature0073,18,27,5,3,0,0,1.5,0.2777777777777778,-0.44444444444444464,72.96666666666667,7,2,-0.1,0.12,-1,Lipid,2190143.3014186765,785327.57242502,0.35857360197221805,-1.4796588133336417,0.14319784721728465,0.5574792106914738,Downregulated
Feature0072,NP-016455,C11 H18 N2 O4,242.12667,NA,NA,NP-016455-peak1,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,4106963.6631157734,4025987.30321642,0.9802831564772306,-0.028729560516015582,0.7227963184765491,0.864701245409092,Downregulated
Feature0071,Methionylphenylalanine,C14 H20 N2 O3 S,296.11937,NA,NA,Methionylphenylalanine-peak1,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,1317952.5819933047,563345.318719291,0.42743974739005663,-1.2262070252231052,0.09704351616063861,0.5434560019812327,Downregulated
Feature0070,NA,C14 H25 N3 O5,315.17952,NA,NA,Feature0070,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,503218.9179195513,368725.3910935993,0.7327335637897198,-0.4486393932212818,0.3360405198100343,0.6636048496469049,Downregulated
Feature0069,NA,C19 H29 N3 O5,379.21082,NA,NA,Feature0069,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,206105.32499609733,152692.05255179966,0.740844772228427,-0.4327568057923387,0.4394157571426859,0.7009176491269988,Downregulated
Feature0068,NA,C11 H13 N3 O3,235.09569,NA,NA,Feature0068,11,13,3,3,0,0,1.181818181818182,0.2727272727272727,0.18181818181818168,55.11818181818182,7,4,0.2,0.38461538461538464,1,Lignin,61967.88999928777,58101.25740065434,0.9376026422930025,-0.09295145940872895,0.6624344323595514,0.8289195086767364,Downregulated
Feature0067,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0067,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,2853319.5358958403,2093358.8920158567,0.7336573649325318,-0.4468216467012883,0.07059240551138243,0.5434560019812327,Downregulated
Feature0066,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",C16 H23 N O3,277.16771,NA,NA,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",16,23,3,1,0,0,1.4375,0.1875,-0.875,85.2375,6,3,0.16666666666666666,0.25925925925925924,2,Lignin,240588.29932005034,241060.411484498,1.0019623238776862,0.0028282608517346116,0.9871827967135571,0.9930698319787353,Upregulated
Feature0065,allobarbital,C10 H12 N2 O3,208.08478,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,allobarbital,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Lignin,3624506.2985055363,2335701.1182621,0.6444191086728587,-0.6339288206150151,0.22633132982219673,0.5958985050006134,Downregulated
Feature0064,Ala-Tyr,C12 H16 N2 O4,252.11102,NA,NA,Ala-Tyr,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,93631.65065722067,82745.96212275863,0.8837392221748409,-0.17830737954492917,0.6104144165173344,0.7991290476183568,Downregulated
Feature0063,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak1,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,175058.1145700531,125209.66693245119,0.7152462897248101,-0.48348798616903393,0.5443029780036922,0.760766703579418,Downregulated
Feature0062,Glu-Lys,C11 H21 N3 O5,275.14821,Metabolic pathways;Other,NA,Glu-Lys,11,21,5,3,0,0,1.9090909090909092,0.4545454545454546,-0.18181818181818168,65.48181818181817,3,-2,-1.6666666666666667,-0.4545454545454546,-5,Protein,1557692.02579259,1431419.40028697,0.9189360775976434,-0.1219635856475879,0.32570457259533,0.6622174503652659,Downregulated
Feature0061,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak1,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,4871352.235891053,2785531.1135891466,0.5718188664465619,-0.806369874219036,0.06198394831366686,0.5434560019812327,Downregulated
Feature0060,NA,C16 H31 N3 O5,345.22649,NA,NA,Feature0060,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,3709602.820167413,2287164.437415703,0.6165523772468138,-0.6977046354831307,0.19481962780919684,0.5699904136593773,Downregulated
Feature0059,Acetyl-L-methionine,C7 H13 N O3 S,191.0617,NA,NA,Acetyl-L-methionine-peak1,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,192810.891734948,431449.8901984003,2.2376842216543604,1.162006459908346,0.20962813182615767,0.5821476316614936,Upregulated
Feature0058,Ajmaline,C20 H26 N2 O2,326.19951,Biosynthesis of secondary metabolites;Other,NA,Ajmaline,20,26,2,2,0,0,1.3,0.1,-0.7999999999999998,83.1,9,7,0.3125,0.35294117647058826,5,Unsaturated HC,98042.31458566284,90753.25754822163,0.9256539682049988,-0.1114551148499589,0.6585075844530062,0.828145395741197,Downregulated
Feature0057,NA,C12 H22 N4 O3,270.16923,NA,NA,Feature0057,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,70373.50422949954,74235.71078727843,1.0548815438433135,0.07708100300383336,0.7757023868867524,0.8975915430179037,Upregulated
Feature0056,Uric acid,C5 H4 N4 O3,168.02837,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Uric acid,5,4,3,4,0,0,0.8,0.6,2.8,-19.5,6,3,0.5,-1,-1,Condensed HC,96534.2855111671,85915.15979475013,0.8899963296958515,-0.16812870840440783,0.4856332424757253,0.7299573555543155,Downregulated
Feature0055,NA,C21 H33 N3 O4,391.24697,NA,NA,Feature0055,21,33,4,3,0,0,1.5714285714285714,0.1904761904761905,-0.7619047619047619,82.0142857142857,7,3,0,0.125,0,Lipid,601092.4377405196,247875.90081939765,0.41237567677802167,-1.2779688543893795,0.4205597905211775,0.6943057388507786,Downregulated
Feature0054,NA,C16 H30 N4 O5,358.22173,NA,NA,Feature0054,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1070040.460957244,1573853.0079268194,1.470835043488796,0.556635455100421,0.4366739472069677,0.7009176491269988,Upregulated
Feature0053,NA,C25 H54 N2 O5 P2 S,556.32268,NA,NA,Feature0053,25,54,5,2,1,2,2.16,0.2,-1.84,112.74,1,-4,-0.6,-0.37142857142857144,-9,Lipid,128746.17349318501,138540.51489190443,1.0760748155302484,0.10577838666980406,0.7442858476078142,0.8780085138214744,Upregulated
Feature0052,NA,C19 H30 N4 O6,410.21666,NA,NA,Feature0052,19,30,6,4,0,0,1.5789473684210529,0.3157894736842105,-0.3157894736842106,69.3,7,1,-0.3333333333333333,0,-3,Protein,106512.4594996438,105887.42743227056,0.9941318408164697,-0.008490901571556722,0.9758245087843452,0.9886643049525602,Downregulated
Feature0051,NA,C15 H33 N O,243.2562,NA,NA,Feature0051,15,33,1,1,0,0,2.2,0.06666666666666667,-1.8666666666666665,113.5,0,-1,-0.15384615384615383,-0.1111111111111111,-2,Lipid,3545700.8290606723,1328180.840825843,0.37458908826712967,-1.4166192202187984,0.32719953126076007,0.6622174503652659,Downregulated
Feature0050,N-feruloylglycine,C12 H13 N O5,251.07936,NA,NA,N-feruloylglycine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Lignin,614577.6263327317,595636.6256661146,0.9691804584887989,-0.045162778754232205,0.8672816685345094,0.939303571324255,Downregulated
Feature0049,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10007,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak1",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,376847.6358919473,1006874.2841218987,2.671833887822498,1.4178303159466037,0.05131205429427744,0.5434560019812327,Upregulated
Feature0048,NA,C27 H42 N2 O2,426.32469,NA,NA,Feature0048,27,42,2,2,0,0,1.5555555555555556,0.07407407407407407,-1.1851851851851851,94.07777777777778,8,6,0.17391304347826086,0.20833333333333337,4,Lipid,146995.30867730099,127600.35844910127,0.8680573522874974,-0.2041377306423416,0.5025549907147904,0.7334162931788414,Downregulated
Feature0047,NA,C14 H27 N3 O5,317.19516,NA,NA,Feature0047,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,937439.9709973333,916962.1171091943,0.9781555571325247,-0.03186417811708706,0.8820318521294406,0.9465322559237448,Downregulated
Feature0046,asn-tyr,C13 H17 N3 O5,295.11678,NA,NA,asn-tyr-peak1,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,2993305.6551122367,3271364.21729255,1.092893474378542,0.12815278666815066,0.7138290743318184,0.8584487988453087,Upregulated
Feature0045,NA,C7 H9 N O3 S,187.03034,NA,NA,Feature0045,7,9,3,1,1,0,1.2857142857142858,0.42857142857142855,0.2857142857142856,52.15714285714286,4,1,-0.5,0.14285714285714285,-1,Lignin,2970497.5475562466,4011166.912202223,1.3503350357929462,0.4333174032085199,0.02959123133380964,0.5434560019812327,Upregulated
Feature0044,Vinylbital,C11 H16 N2 O3,224.11608,NA,NA,Vinylbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,1312868.54547949,1272503.8706298666,0.9692545952231026,-0.04505242509675463,0.7349770519853778,0.8731073815310167,Downregulated
Feature0043,NA,C12 H17 N O4,239.11576,NA,NA,Feature0043,12,17,4,1,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Lignin,720842.69377165,707488.561308744,0.9814742764568599,-0.02697763841796765,0.9238183950696597,0.9658892545574694,Downregulated
Feature0042,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17436,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak1,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,946775.291520838,976167.2663998622,1.0310442986231831,0.04410631915707579,0.7779848874935033,0.8982992411548629,Upregulated
Feature0041,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0041,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1619136.44144895,1313551.0754198832,0.8112664515440087,-0.30175226529447685,0.4089627036261336,0.6875574805825382,Downregulated
Feature0040,NA,C19 H27 N3 O6,393.19014,NA,NA,Feature0040,19,27,6,3,0,0,1.4210526315789471,0.3157894736842105,-0.3157894736842106,69.3,8,2,-0.1,0.15384615384615383,-1,Lignin,731166.045582988,382016.8533851963,0.5224761949669025,-0.9365627881925258,0.3855519949079865,0.6807033163836934,Downregulated
Feature0039,NA,C26 H48 N2 O6,484.35117,NA,NA,Feature0039,26,48,6,2,0,0,1.8461538461538465,0.2307692307692308,-1.1538461538461542,93.1846153846154,4,-2,-0.2222222222222222,-0.04761904761904761,-4,Lipid,361515.433687069,280170.450631608,0.7749889064878102,-0.3677524356870287,0.29041371546776074,0.6362566437415571,Downregulated
Feature0038,NA,C14 H25 N3 O6,331.17447,NA,NA,Feature0038,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,2029010.67035216,1056273.4713908029,0.520585468980049,-0.9417930523020789,0.18072194856383234,0.5646729954371317,Downregulated
Feature0037,Anhalamine,C11 H15 N O3,209.10523,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak1,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,199163.80413907534,127533.23638109594,0.6403434445951833,-0.6430822008450091,0.10119612157888953,0.5434560019812327,Downregulated
Feature0036,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak1,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,85873.25416798833,151053.19110718468,1.7590248858123978,0.8147758934887638,0.09880600798505508,0.5434560019812327,Upregulated
Feature0035,NA,C8 H9 N5 O3,223.07052,NA,NA,Feature0035,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,3131115.3717609434,2912385.06210395,0.930143005387253,-0.10447555361042687,0.3382876895974863,0.6636048496469049,Downregulated
Feature0034,NA,C12 H23 N3 O5,289.16377,NA,NA,Feature0034,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,3257085.8260644865,1355931.9507508758,0.41630218642080996,-1.2642969593489946,0.14634970116382873,0.5574792106914738,Downregulated
Feature0033,Isoquinoline,C9 H7 N,129.05782,NA,NA,Isoquinoline,9,7,0,1,0,0,0.7777777777777778,0,-0.44444444444444464,72.96666666666667,7,7,0.75,0.75,6,Condensed HC,3538611.5245083035,3365390.82057848,0.9510483977316802,-0.07240933488370473,0.44790415853726434,0.7027877448360436,Downregulated
Feature0032,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03174,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak1",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,4082841.3953979933,3283518.1797886235,0.8042237897092125,-0.3143310818181368,0.022255282974488932,0.5434560019812327,Downregulated
Feature0031,NA,C14 H27 N3 O5,317.19507,NA,NA,Feature0031,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,3818533.380342143,2071037.0417787766,0.5423645246733997,-0.8826652780494133,0.0669551908076897,0.5434560019812327,Downregulated
Feature0030,NA,C15 H19 N3 O3 S,321.11473,NA,NA,Feature0030,15,19,3,3,1,0,1.2666666666666666,0.2,-0.13333333333333375,64.10000000000001,8,5,0.125,0.2631578947368421,1,Lignin,100943.67443519634,184450.96687581032,1.8272662245341966,0.8696868435080721,0.18643098901975041,0.5646729954371317,Upregulated
Feature0029,MFCD08277025,C12 H19 N O4,241.13144,Other,NA,MFCD08277025,12,19,4,1,0,0,1.5833333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,4,0,-0.14285714285714285,0.1111111111111111,-1,Protein,254723.471189018,188014.59576302566,0.7381125692320246,-0.43808723701882185,0.45785464324959096,0.7089632227283429,Downregulated
Feature0028,NA,C12 H23 N3 O5,289.16387,NA,NA,Feature0028,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,1666098.44235096,730965.4250672583,0.4387288328748596,-1.1885985727593416,0.027572085516572212,0.5434560019812327,Downregulated
Feature0027,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak1,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,4038920.131518553,1154842.6372939113,0.2859285649849465,-1.8062733388444188,0.1042188322790467,0.5434560019812327,Downregulated
Feature0026,NA,C16 H21 N5 O9,427.13396,NA,NA,Feature0026,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2927686.2059017066,3244835.6430763765,1.1083276740981844,0.14838447336214866,0.4749837271223939,0.7200557237043321,Upregulated
Feature0025,NA,C17 H32 N6 O6,416.23845,NA,NA,Feature0025,17,32,6,6,0,0,1.8823529411764703,0.35294117647058826,-0.117647058823529,63.65294117647058,5,-1,-1.4,-0.5,-7,Protein,2484126.4675959935,1932137.7305989934,0.7777936251646698,-0.36254068446726806,0.12566742568812508,0.5515041946002173,Downregulated
Feature0024,NA,C11 H19 N3 O5,273.13255,Biosynthesis of secondary metabolites;Other,NA,Feature0024,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,3258773.3757356033,3040852.269073677,0.9331278731179841,-0.09985329754862422,0.4791957769678217,0.7247836126638303,Downregulated
Feature0023,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1209311.3497813046,1383014.6495823467,1.1436381952691133,0.19363070906655608,0.34817275780506557,0.6670930191369346,Upregulated
Feature0022,NA,C20 H38 N4 O6,430.27919,NA,NA,Feature0022,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,302110.942394926,193595.841460039,0.6408104252210974,-0.6420304760227118,0.363545840582641,0.6716464598336302,Downregulated
Feature0021,NA,C16 H30 N4 O5,358.22177,NA,NA,Feature0021,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1762995.1703297934,1189834.4157675,0.6748937466147026,-0.5672677087213525,0.11796435336058828,0.5462476753068062,Downregulated
Feature0020,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C19 H20 O7,360.12104,NA,NA,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",19,20,7,0,0,0,1.0526315789473684,0.3684210526315789,-0.3157894736842106,69.3,10,3,0.25,0.41935483870967744,3,Lignin,4610988.73552233,2376039.6130330465,0.515299374888603,-0.9565172525335435,0.10022373258586806,0.5434560019812327,Downregulated
Feature0019,Crotanecine,C8 H13 N O3,171.08956,Other,NA,Crotanecine-peak1,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,189972.15499311447,213039.10534145095,1.1214227966681356,0.16533030281572336,0.8300554617086118,0.9184284468545972,Upregulated
Feature0018,NA,C14 H27 N3 O4,301.20015,NA,NA,Feature0018,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1052625.324159847,450301.39541200333,0.42778886758345036,-1.2250291553744057,0.18704942400939872,0.5646729954371317,Downregulated
Feature0017,?-Ribazole,C14 H18 N2 O4,278.12676,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak1,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,405220.07314353634,502174.9721977636,1.2392647982665066,0.30948448637187415,0.3170507129118589,0.6589986597210907,Upregulated
Feature0016,NA,C15 H21 N3 O7,355.1381,NA,NA,Feature0016,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,210308.51393715266,204897.97697218967,0.9742733336674148,-0.03760151579800633,0.7989819824996771,0.9022552886981726,Downregulated
Feature0015,NA,C17 H31 N3 O6,373.22133,NA,NA,Feature0015,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,1630417.403396987,504435.38331415434,0.30939033296820767,-1.6924999750128507,0.26702270398320194,0.6292487790932914,Downregulated
Feature0014,Marimastat,C15 H29 N3 O5,331.21086,NA,NA,Marimastat-peak1,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2906497.3653925667,1718458.4603140599,0.591247210740876,-0.7581666224561291,0.06322294486788024,0.5434560019812327,Downregulated
Feature0013,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,C10 H14 N2 O3,210.10041,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,10,14,3,2,0,0,1.4,0.3,-0.20000000000000015,66,5,2,0,0.2307692307692308,0,Lignin,550333.1881227783,497261.6374910517,0.9035646917592648,-0.1463001986794508,0.5147648373165435,0.7415064918488306,Downregulated
Feature0012,Pentoxifylline,C13 H18 N4 O3,278.13793,NA,NA,Pentoxifylline,13,18,3,4,0,0,1.3846153846153846,0.2307692307692308,0,60.3,7,4,0,0.2,0,Lignin,71255.27864756563,69789.40543618427,0.97942786500588,-0.02998885316585072,0.8822753436266783,0.9465322559237448,Downregulated
Feature0011,NA,C16 H30 N4 O5,358.22167,NA,NA,Feature0011,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,4131557.131462503,1517068.9157967032,0.367190593649055,-1.4453989932970739,0.041874981484770264,0.5434560019812327,Downregulated
Feature0010,NA,C16 H30 N6 O6,402.22286,NA,NA,Feature0010,16,30,6,6,0,0,1.875,0.375,0,60.3,5,-1,-1.75,-0.5714285714285714,-7,Protein,891441.3179684334,1177264.7784040954,1.3206307074559263,0.40122709716301225,0.32521891963328675,0.6622174503652659,Upregulated
Feature0009,APM,C7 H13 N O4,175.08446,NA,NA,APM-peak1,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,180526.00073432634,188562.44446269766,1.0445168213757654,0.06283572641170787,0.847299412402988,0.9302172421326388,Upregulated
Feature0008,NA,C15 H27 N3 O7,361.18502,NA,NA,Feature0008,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,550173.7644770497,1125273.5728156767,2.0453057660524214,1.032316537148625,0.001674647228601693,0.5434560019812327,Upregulated
Feature0007,(Z)-dehydrobutyrine,C4 H7 N O2,101.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak1,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,2453098.2932700533,2832862.5254106433,1.154810034796589,0.20765554913299522,0.1762466684393035,0.5646729954371317,Upregulated
Feature0006,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak1,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,90522.70818000633,95014.10064725416,1.049616196394794,0.06986188714768105,0.9006060287120247,0.953701139936653,Upregulated
Feature0005,NA,C14 H27 N3 O6,333.19005,NA,NA,Feature0005,14,27,6,3,0,0,1.9285714285714288,0.42857142857142855,-0.4285714285714288,72.51428571428572,3,-3,-1.2,-0.375,-6,Protein,746802.235716649,784207.5491244791,1.0500873077487978,0.07050928333880199,0.7940957143390939,0.9022120322538062,Upregulated
Feature0004,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",C16 H19 N O5,305.12642,NA,NA,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",16,19,5,1,0,0,1.1875,0.3125,-0.375,70.9875,8,3,0.2,0.36,2,Lignin,93094.58822885767,68304.19045735807,0.7337074233514358,-0.44672321305573237,0.4194669518754448,0.6943057388507786,Downregulated
Feature0003,NA,C15 H28 N4 O5,344.20604,NA,NA,Feature0003,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,732391.1882994233,461906.3416645316,0.6306825492221659,-0.6650140800213312,0.31326404515062767,0.6547061206079187,Downregulated
Feature0002,NA,C21 H21 O6 P S,432.07976,NA,NA,Feature0002,21,21,6,0,1,1,1,0.2857142857142857,-0.5714285714285712,76.58571428571427,12,6,0.3076923076923077,0.4375,4,Lignin,65068.5080796928,55501.26240150757,0.8529665738383347,-0.22943888875124988,0.5540357021459703,0.768050712518752,Downregulated
Feature0001,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,C12 H24 N4 O4,288.17983,NA,NA,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,12,24,4,4,0,0,2,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,-1,-1.25,-0.5,-5,Protein,2558979.084674527,1774550.48792599,0.6934603328935346,-0.5281147345800257,0.24914330004125299,0.6202424088784857,Downregulated
